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Abstract 
 
The link between early life and development of metabolic disorders and 
obesity in later life has been the focus of many studies over the past 
decades.  Fetal life and early infancy are two of the most critical periods of 
physiological and metabolic development and plasticity, and thus, are 
periods whereby a stimulus can cause long term consequences on the 
health of an individual (developmental programming).  
 
Accelerated weight gain during early life per se or in combination with 
extreme birth weights (low/high birth weight) have been postulated as factors 
that can affect the development of individuals with later consequences in 
health. However, there is not a clear understanding of the specific 
contribution at different ages to impaired health neither of the mechanisms 
involved in these alterations. 
 
In this thesis, I used an isogenic murine model with natural birth weight 
variation within a normal range to investigate the effects of extreme birth 
weights on body composition and appetite regulation at different stages of 
life.  I compared low and high birth weights phenotypes during lactation, at 
the time of weaning, and a young adulthood as well as early matured age. 
Mice were challenged to a moderate high fat diet for 12 weeks after weaning 
in order to assess the effects of both birth weight and a hypercaloric feed on 
body composition and hypothalamic neural activity. 
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At weaning, adiposity was positively related to birth weight and weight gain 
but negatively related to growth rate. Low birth weight male mice (LBWm) 
had a lower plasma glucose concentration but similar levels of insulin to High 
birth weight male mice (HBWm), indicating a degree of hyperinsulinemia. 
Low birth weight females (LBWf) were hyperinsulinemic and hyperglycemic 
compared to High birth weight females (HBWf). There was an upregulation 
in the expression of genes related to insulin signaling, adipogenesis/lipid 
metabolism and thermoregulation in Subcutaneous Adipose Tissue (SAT) of 
LBWm mice compared to HBWm mice but the contrary was seen in LBWf 
mice in respect to their counterpart.  
 
 LBWm mice caught up in weight with HBWm mice at younger age than the 
equivalent catch up in female mice. Birth weight and diet impacted body fat 
patterning and appetite regulation differently in both young males and 
females. However, at week 51 of age (early matured age), diet seemed to 
override the effects of birth weight on total body fat. LBWm mice tended to 
have smaller adipocytes than young and matured HBWm mice, especially 
when fed a HF diet, and this pattern was independent of fat mass.  
 
In conclusion, the current study suggests that extreme birth weights in an 
isogenic mouse model (within natural birth weight variation), as well as 
postnatal nutrition influenced growth, glucose / lipid metabolism, body fat 
patterning and appetite regulation in an age-gender dependent manner.  
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1. Introduction 
1.1 Early Life Programming 
Clinical and experimental studies have demonstrated that there are 
associations between the early nutritional environment, patterns of postnatal 
growth and the development of obesity and altered fat distribution, 
cardiovascular diseases (CVDs), insulin resistance and type 2 diabetes in 
adult life (Fall, Osmond et al. 1995, Loos, Beunen et al. 2002, Cripps, Martin-
Gronert et al. 2005).  
 
Clinical and animal studies are widely supporting the concept of 
Developmental Programming whereby a stimulus, occurring during a critical 
period of developmental plasticity, has long-term consequences on the 
health of an individual (Gluckman and Hanson 2004, Desai, Beall et al. 
2013). Fetal and early infancy are two of the most critical periods of 
physiological and metabolic development and thus, are periods that could be 
linked to the onset of the metabolic syndrome and related disorders, such as 
obesity, cardiovascular risk, hypertension and renal dysfunction (Hales and 
Barker 1992).  
 
Low birth weight and infant and /or early childhood catch-up growth have 
been associated with a significant risk of adult obesity (Dietz 1994, Ong 
2006). High birth weight associated with maternal obesity, with or without 
gestational diabetes, has also been related to an increased risk of obesity in 
children and adults. However, some studies have demonstrated a positive 
	   39	  
relationship between high birth weight, insulin sensitivity and lean body mass 
(Seidman, Laor et al. 1991, Hales and Ozanne 2003, Singhal, Wells et al. 
2003, Bouhours-Nouet, Dufresne et al. 2008). Overall, it has been shown 
that early life environment can permanently affect the metabolism of an 
individual.  
 
Studies in young rodents (3 months of age) have demonstrated that low birth 
weight offspring had an improved glucose tolerance with reduced plasma 
insulin levels, which suggested improved insulin sensitivity at this age (Hales, 
Desai et al. 1996, Ozanne, Wang et al. 1998). This phenotype seems to be 
altered with age, such that by 15 months, the male offspring had impaired 
glucose tolerance and females developed glucose intolerance by 21 months 
(Fernandez-Twinn, Wayman et al. 2005).  
 
Developmental programming seems to be the result of different complex 
interconnected mechanisms, but the underlying mechanisms are not well 
understood. Therefore, it is important to increase our understanding of the 
relationship between early life and altered metabolic processes. 
 
Different hypotheses have been postulated throughout the years involving 
early life factors that could be associated with the susceptibility to become 
obese or metabolically unhealthy. Some of these hypotheses are described 
in the following sections.  
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1.1.1 Thrifty genotype hypothesis  
James V. Neel proposed the “thrifty genotype” hypothesis for the first time in 
1962 (Neel 1962) to explain the high incidence of obesity and type 2 
diabetes mellitus among the Pima Indians in the United States. He proposed 
that genes that predispose to diabetes (thrifty genes) were historically 
advantageous for hunter gatherer populations especially childbearing women 
allowing them to store fat during times of plenty for later use in times of 
famine. However, these thrifty genes became detrimental in the modern 
world of constant abundance of food. (Scott, Mohlke et al. 2007, Sladek, 
Rocheleau et al. 2007). Neel tried to find more evidence of this hypothesis 
under the presumption that if a propensity to develop diabetes were an 
evolutionary adaptation, diabetes would have been an established condition 
in those populations currently experiencing a high frequency of diabetes.  
However, Neel did no find any evidence of diabetes among these 
populations earlier in the century (Spielman, Fajans et al. 1982).  
 
Because it is no longer thought that hunter-gatherer faced the challenges of 
feast/famine, a modified “thrifty genotype” hypothesis argues that periods of 
famine and seasonal shortage of food that occurred only during the 
agricultural period, may have exerted enough pressure to select for thrifty 
genes (Prentice, Hennig et al. 2008). 
 
Genetic predisposition to obesity has been observed in animal studies such 
as the ob/ob model and in clinical studies of its human homologue leptin 
deficiency (Zhang, Proenca et al. 1994). However, failure to find similar 
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mutations in the general obese population opened the door for a polygenic 
etiology of obesity (more than one gene) rather than a monogenic obesity 
(only one gene). Indeed 22 other gene associations with obesity have been 
suggested in some studies (see table 1.1.1.1), including members of the 
leptin-melanocortin pathway, proinflammatory cytokines and uncoupling 
proteins (Walley, Blakemore et al. 2006). 
 
 
Table 1.1.1.1 Genes with five or more positive associations of variants with obesity 
related phenotypes (Walley, Blakemore et al. 2006).  
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1.1.2 Thrifty phenotype hypothesis  
Hales and Barker introduced the thrifty phenotype hypothesis, which 
proposes that poor early life nutrition produces permanent changes in 
glucose-insulin metabolism leading to the development of diseases in 
adulthood such as type 2 diabetes and cardiovascular alterations (Hales and 
Barker 2001). It is proposed that poor nutrition in utero causes an adaptive 
response in development of organs. To optimise the growth of certain 
essential organs, such as the brain, nutrients are diverted away from other 
tissues, such as the viscera, thereby improving perinatal survival. This 
altered growth permanently changes the structure and function of the body.  
 
One of the most recognised causes of poor nutrition in early life is maternal 
undernutrition (Hales and Barker 2001, Cripps, Martin-Gronert et al. 2005, 
Martin-Gronert and Ozanne 2005). However, other influences, such as 
placental function, may also be involved. The combination of undernutrition 
during fetal life and infancy followed by overnutrition in childhood and 
adulthood implies the transition from chronic under nutrition to adequate 
nutrition triggers glucose intolerance (possibly due to decrease beta cell 
numbers) and other metabolic abnormalities including obesity (Fall, Stein et 
al. 1998).  
 
 
 
 
 
	   43	  
1.1.3 Predictive adaptive response  
The Predictive Adaptive Response (PAR) hypothesis, proposed by 
Gluckman and Hanson (Gluckman, Hanson et al. 2005), extends Barker 
hypothesis to nutritional imbalance both undernutrition and overnutrition 
during early life. This hypothesis suggests that prenatally programmed 
predisposition will confer survival benefits if a postnatal nutrition is 
maintained as predicted in utero. However, it will predispose the individual to 
an imbalanced metabolism if the postnatal diet mismatches the prenatal 
nutritional resource. The failure to develop metabolic alterations in adult life 
may indicate that the adult diet is within the predictive adaptive range. 
 
1.2 Birth Weight and Accelerated Growth  
1.2.1 Birth weight  
A number of epidemiological studies have shown that birth weight as well as 
early accelerated growth and excess childhood weight gain are associated 
with an increased risk of adult cardiovascular diseases, hypertension, 
glucose intolerance, insulin resistance, type 2 diabetes and obesity (Hales 
and Barker 2001, Martin-Gronert and Ozanne 2005, Bieswal, Ahn et al. 
2006, Mook-Kanamori, Durmus et al. 2011).  
 
Low birth weight, as a measure of adverse intrauterine environment, has 
been used as an indicator of obesity and other complications later in life. A 
vast number of studies have shown an inverse association between birth 
weight and truncal fat in adulthood, which at the same time suggests a role 
for fetal development in determining adult fat distribution (Parsons, Power et 
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al. 1999, Te Velde, Twisk et al. 2003). The prevalence of impaired glucose 
tolerance or type 2 diabetes inversely associated with birth weight has been 
confirmed in different populations worldwide (China, UK, India, Pima Indians, 
black South African children, and others) (Hales, Barker et al. 1991, 
McCance, Pettitt et al. 1994, Barker 1998, Stanner and Yudkin 2001, Yajnik, 
Fall et al. 2003). Overall, fetal adaptation to intrauterine suboptimal 
conditions may alter fetal physiology, endocrine response, metabolism, and 
neural circuits resulting in the survival of the fetus but being detrimental later 
in life. Both environmental and genetic factors and their interactions may 
contribute to both fetal and postnatal growth and their link with long-term 
disease risks.  
 
Recent investigations have focused on the impact of a high birth weight on 
later life, but contradictory effects have been reported. Some studies have 
reported that a high birth weight is associated with an increased risk of later 
life obesity, as measured by a positive relation with adult body mass index 
(BMI: ≥30 kg/m2) (Seidman, Laor et al. 1991, Dietz 1994, Curhan, Willett et 
al. 1996, Parsons, Power et al. 1999). Other studies have suggesed that the 
association of high birth weight and disease is influenced by maternal 
diabetes, family history of diabetes, and specific ethnicities such as the Pima 
Indians in Arizona, USA (McCance, Pettitt et al. 1994, Wei, Sung et al. 
2003).  
 
Conversely, a retrospective study of an Icelandic population, who have one 
of the highest incidences of high birth weight in the world, found that they 
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had low incidence of both coronary diseases and high blood pressure in 
adults (Gunnarsdottir, Birgisdottir et al. 2004). This study also showed high 
birth weight was positively related to BMI in adulthood but these infants were 
not at increased risk of adult obesity (defined as BMI ≥30Kg/m2). A protective 
effect of high birth weight against very high truncal fat was seen in both 
genders.  
 
Similarly, studies from France have shown that high birth weight and early 
weight gain are positively related to insulin sensitivity and low central fat 
deposition. This has been referred to as a metabolic healthy obese 
phenotype (Bouhours-Nouet, Dufresne et al. 2008).  
 
As BMI is associated with both total lean mass and fat mass, the positive 
association between birth weight and BMI later in life might be associated 
with lean mass rather than fat mass (Singhal, Wells et al. 2003). Shinghal 
proposes that this possible relationship could explain the paradoxical results 
obtained in different investigations. Indeed, it may be the case that birth 
weight may program body composition rather than simply predisposing to a 
big body size in adulthood.  
 
1.2.2 Accelerated growth  
Poor fetal growth alone (low birth weight) or in synergy with poor infant 
growth, and restricted fetal growth followed by accelerated infant growth or 
rapid growth in infancy by itself have been implicated in metabolic alterations 
in adulthood (Dulloo, Jacquet et al. 2006, Ong 2006).  
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Accelerated growth has been described as a phenomenon seen in young 
children as well as in other mammals after a period of growth restriction, 
when the restraints upon growth are removed (Gafni and Baron 2000). 
Growth acceleration shows a rate above the expected limits for chronological 
age and/or maturity for a period of time, followed by a progressive 
deceleration until normal growth is reached (Williams 1981). This catch up, at 
least after fetal growth retardation, seems to be related to a faster proportion 
of fat accretion rather than lean muscle (Dulloo 2006). The fat distribution in 
these infants tends to be located centrally rather than peripherally. Moreover, 
central adiposity seems to be positively related to metabolic disturbances at 
young and adult ages (Mook-Kanamori, Durmus et al. 2011).  
 
Different studies have concluded that early catch up growth during infancy 
exacerbates central fat deposition, hypertension and insulin resistance (Ong 
2006). Other studies have shown that neonatal catch up growth in weight 
normalised both neurobehavioral and cardiovascular phenotypes, but led to 
insulin resistance and high-fat diet-induced diabetes (Hermann, Miller et al. 
2009). However, others have shown that restricted perinatal growth is an 
independent risk factor for the development of type 2 diabetes, hypertension 
and coronary heart disease from childhood and onwards (Eriksson, Forsen 
et al. 2007, Bouhours-Nouet, Dufresne et al. 2008). Overall, the evidence 
indicates that in general, early life is a highly sensitive period that can affect 
mammalian metabolism permanently but the specific alterations involving 
birth weight and or accelerated growth are still under investigation.   
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1.3 Obesity, Definition and Other Aspects 
The World Health Organisation (WHO) defines obesity, as an abnormal or 
excessive fat accumulation that presents a risk to health whose main cause 
is an energy imbalance between calories consumed and calories expended 
(World Health Organisation 2013).  
 
The Body Mass Index (BMI) is the most widely and easy obtainable index to 
classify overweight and obesity worldwide. It is defined as an individual’s 
weight in kilograms divided by the square of their height in metres (kg/m2). 
An adult with a BMI of 30 or more is generally considered obese and an 
individual with a BMI equal to or greater than 25 is considered overweight 
(World Health Organisation 2013). Pediatric overweight is defined as a BMI 
equal to or greater than 95th percentile for age, sex, and ethnicity (Must, 
Dallal et al. 1991). 
 
BMI like other anthropometric measurements may not correspond to the 
same degree of fatness in different populations due, in part, to different body 
fat distribution (Consultation 2004, Flegal, Shepherd et al. 2009). Waist 
circumference (WC) is widely used as a surrogate of central fat content, but 
is unable to distinguish between different fat compartments (intra abdominal 
adipose tissue and abdominal subcutaneous tissue). Moreover, total 
body/trunk fat, waist to hip ratio, and skin fold thickness measurements 
cannot predict differences in internal stores of adipose tissue (Thomas, 
Parkinson et al. 2012). Therefore, health risks associated with increasing 
BMI and/or other anthropometric measurements may differ for different 
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populations (He, Horlick et al. 2002, Yajnik, Fall et al. 2003).  
 
Overweight and obesity are a major risk factor for non-communicable 
diseases such as cardiovascular diseases, diabetes, musculoskeletal 
disorders (i.e., osteoarthritis) and cancers (colon, endometrial and breast 
cancer), which were the leading cause of deaths in 2008 (World Health 
Organisation 2013). WHO estimates indicate that approximately 1.4 billion 
adults were classified as overweight and 500 million people classified as 
obese (World Health Organisation 2013). Statistical modeling has projected 
that there will be 65 million more obese adults in the USA and 11 million 
more obese adults in the UK by 2030 and thus, an increase in non-
communicable diseases. The treatment of these chronic diseases are 
estimated to cost to the health service an exorbitant increment of £2 billion 
per year in the UK and average of $58 billion per year in the USA by 2030 
(Wang, McPherson et al. 2011). 
 
Epidemiological studies indicate that not only is adult obesity increasing 
alarmingly, but children are also critically affected. The international obesity 
task force has reported that 1 in 10 children (approximately 155 million) 
worldwide aged between 5 and 17 years were overweight in 2008. In 2011, 
the estimated number of overweight children under five was more than 40 
million. Approximately 30 million of these children are living in developing 
countries, especially in urban settings, with the remaining 10 million in 
developed countries (World Health Organisation 2013). 
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Overweight and obese children are at a high risk of a continuous obesogenic 
phenotype through their lives and therefore will be more prone to subsequent 
metabolic alteration such as insulin resistance, diabetes and cardiovascular 
complications (Yu, Han et al. 2011, World Health Organisation 2013). 
Therefore, it is imperative to understand the mechanisms underlying the 
onset of obesity at an early age to be able to tackle the vicious cycle of 
obesity from a better approach such that the epidemic can be controlled.  
 
1.3.1 Origins of obesity  
Egger and Swinburg proposed the term “obesogenic environment” as the 
driving force for the increasing prevalence of obesity in our society (Egger 
and Swinburn 1997, Swinburn, Egger et al. 1999, Swinburn and Egger 
2001). This obesogenic environment where inexpensive, easily available, 
and high calorie food, combined with societal pressure and a high physical 
inactivity and genetic susceptibility drive the increment of obesity and non 
communicable diseases such as diabetes, Cardio Vascular Diseases (CVD) 
and metabolic syndrome in our population (Egger and Swinburn 1997). They 
proposed three main causes affecting the balance of body fat: biological, 
behavioural and environmental. This equilibrium is mediated by energy 
intake and energy expenditure, but moderated by physiological adjustments 
during periods of energy imbalance (Figure 1.3.1.1).  
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Figure 1.3.1.1 Ecological paradigm that include the factors that are related to 
obesity (Egger and Swinburn 1997). 
 
It is now well known that there is a complex net of behavioural, societal, 
genetic and environmental factors that in combination or individually can 
contribute to the onset of obesity.  
 
Important maternal and placental effects have been added to the list of 
factors that increase the risk of developing metabolic diseases in the progeny 
(Armitage, Khan et al. 2004, Poston 2010). Epidemiological studies and 
animal models have demonstrated that both maternal malnutrition 
(under/over nutrition) and body composition before and during pregnancy 
can adversely influence the progeny response to a later obesogenic 
environment or mismatched postnatal environment (Samuelsson, Matthews 
et al. 2008, Poston 2010). Moreover, the response to this new environment 
might be maladaptive when plasticity declines throughout life and therefore it 
generates detrimental conditions in the individual. Therefore, interventions in 
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older or middle-aged adults may not be as successful as interventions in 
early life.   
 
1.4 Adipose Tissue 
Adipose tissue is an endocrine organ capable of controlling the metabolism 
of several organs in humans and animals. It is formed mainly of adipocytes, 
but also contains blood vessels, connective tissue matrix (connective tissue 
and reticular fibres), nerve fibres, and the Stromal Vascular Fraction (SVF) of 
cells including preadipocytes (undifferentiated adipocytes), mesenchymal 
stem cells, endothelial progenitor cells, fibroblasts, and immune cells 
(Kershaw and Flier 2004, Vazquez-Vela, Torres et al. 2008) (Figure 1.4.1).  
 
The composition of the stromal vascular fraction can differ between depots 
and physiological state. As an endocrine organ, adipose tissue also 
produces hormones such as leptin, estrogen and cytokines (adipokines) 
such as resistin, adiponectin, Monocyte Chemoattractant Protein-1 (MCP-1), 
Plasminogen Activator Inhibitor-1 (PAI-1), proteins of the renin-angiotensin 
system and Tumor Necrosis Factor alpha (TNF-alpha) (Vazquez-Vela, 
Torres et al. 2008). It has also been indentified as a major site of metabolism 
of sex steroids (Siiteri 1987). 
 
Previously, adipose tissue was seen as an inactive tissue whose primary 
functions were storage of energy, structural support and protection of the 
internal organs (Zhang, Proenca et al. 1994). However, it is now known that 
it is a complex tissue that has an important secretory function of endocrine 
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and paracrine factors (adipokines). Within its endocrine functions are 
included regulation of metabolism, immune responses and neuroendocrine 
effects. 
 
Adipose tissue also has the ability to receive efferent signals from the 
autonomic and central nervous system through the receptors they express. 
Therefore, adipose tissue composition and structure can impact its metabolic 
and endocrine function as well as the organs where it exerts its effects. An 
example of this is the adverse effect of an excessive accumulation adipose 
tissue causing obesity and relative metabolic disorders such as the metabolic 
syndrome. However, the development of the metabolic syndrome seems to 
be related to an abnormal distribution of fat with an increased internal 
deposition of fat (visceral adipose tissue) rather than a total subcutaneous fat 
or total body fat accretion (Ouchi, Parker et al. 2011). 
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Figure 1.4.1 Illustration of adipose tissue structure, containing adipocytes, 
preadipocytes, T-cells, macrophages, fibroblasts, blood vessels, endothelial cells 
and Extracellular Matrix (ECM) (Ouchi, Parker et al. 2011). 
 
 
1.4.1 Types of adipose tissue  
There are two main types of adipose tissue: White Adipose Tissue (WAT) 
and Brown Adipose Tissue (BAT) containing mainly white adipocytes and 
brown adipocytes respectively. Recent studies have demonstrated the 
presence of a third type of adipocyte within the WAT. This adipocyte is 
known as “beige” or “brite” adipocyte (Wu, Bostrom et al. 2012, Lee, 
Swarbrick et al. 2013).  
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1.4.1.1 White Adipose Tissue (WAT) 
 Functions of WAT include energy storage in the form of triglycerides, 
insulation, cushioning of vital organs, and secretion of hormones (Torres-
Leal, Fonseca-Alaniz et al. 2010).   
 
White adipocyte cells are spherical, but they may appear polyhedral or oval 
when crowded within the adipose tissue. They store energy in unilocular lipid 
droplets in the form of triglycerides. This droplet flattens and displaces the 
nucleus to the periphery, occupying approximately 95% of the entire cell 
body. They also contain a small amount of mitochondria as well as fewer 
sympathetic nerve fibres and blood vessels than BAT (Cinti 2005, Gesta, 
Tseng et al. 2007). 
 
White adipocytes are the main storage tissue of excess energy derived from 
food that is used when the energy demand exceeds intake. It is found 
throughout the body, but the distribution varies depending on genetics, 
gender, age, sensitivity to hormones and glucocorticoids. It has been 
reported that adipose tissue from different depots are distinct and that these 
differences may contribute to the type of obesity and metabolic status of an 
individual (Trujillo and Scherer 2006). 
 
The distribution of WAT is typically classified as being subcutaneous WAT 
(beneath the skin throughout the body), and internal WAT that refers to the 
deeper inner body adipose tissue surrounding organs (Abate and Garg 
1995). 
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Subcutaneous WAT in rodents can be divided into anterior subcutaneous 
WATs including the bilateral superficial subcutaneous adipose tissue 
between the skin and muscle fascia posterior to the lower segment of the 
upper limbs, and the inguinal subcutaneous WAT (attached dorsally along 
the pelvis to the thigh of the hindlimb). It can also be described as the flank 
or posterior subcutaneous WAT (divided into dorsolumbar, inguinal, and 
gluteal portion) (Frontini and Cinti 2010). 
 
Internal WAT depots can be further categorised depending on the location. 
Intrathoratic adipose tissue that includes mediastinal, pericardial and 
retrosternal adipose tissue (very small compartments in rodents when 
compared to humans); intrabdominal or visceral WAT (inside the abdominal 
cavity) includes the gonadal WAT (surrounding the uterus and ovaries in 
females and the epididymis and testes in males), retroperitoneal WAT 
(located within the abdominal cavity along the dorsal wall of the abdomen, 
surrounding the kidneys and when massive extend into the pelvis), 
mesenteric WAT (lining the outer surface of the intestines), and omental 
WAT (surrounding the stomach; very small in rodents when compared to 
humans). In female mice, perirenal, periovarian, parametrial and perivesical 
fat form a single anatomical structure called the abdomino-pelvic depots 
(Frontini and Cinti 2010) (figure 1.4.1.1.1).  
 
Adipose tissue is also found in the bone marrow fat (yellow bone marrow), 
mammary fat, around the lungs, in the adventitia of major blood vessels, and 
intramuscular adipose tissue (Ouchi, Parker et al. 2011, Sanchez-
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Gurmaches and Guertin 2014) (figure 1.4.1.1.1). 
 
 
Figure 1.4.1.1.1 White adipose tissue distribution in humans and a female mouse. 
Distribution of WAT in humans a). Distribution of WAT in a female mouse 
acclimatised at 28˚C b): a) Anterior subcutaneous WAT (cervical, interscapular, 
subscapular, and axillothoracic), and f) posterior subcutaneous WAT (dorsolumbar, 
inguinal, and gluteal); b) mediastinal WAT, c) mesenteric; d) retroperitoneal; e) 
periovarian (gonadal) and perirenal WAT. Figure a) adapted from Ouchi et al, 
2011(Ouchi, Parker et al. 2011) and figure b) adapted from the original (Frontini and 
Cinti 2010). 
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1.4.1.2 Brown Adipose Tissue (BAT) 
 Brown adipocytes store energy for thermogenesis as perilipin coated lipid 
droplets and glycogen granules. Brown adipocytes have a polygonal shape, 
central nucleus, and multilocular lipid droplets with more space in the cell for 
the high number of mitochondria needed for fatty acid oxidation (non-
shivering thermogenesis) in the form of heat by uncoupling the respiratory 
chain of oxidative phosphorylation within mitochondria. BAT also has a rich 
supply of blood vessels and nerves (sympathetic nerve fibres mainly), and 
perivascular mesenchymal cells (niche of preadipocytes). This rich supply in 
addition to the high mitochondrial density give rise to the dark red-brown 
colour, compared to the pale white colour of the WAT (Klaus 1997, Lee, 
Swarbrick et al. 2013, Bartelt and Heeren 2014).  
 
PPAR Gamma coactivator 1 alpha (PGC1alpha) is known as the master 
regulator of mithocondrial biogenesis and brown adipogenesis. PGC1a 
stimulates the synthesis of Uncoupling Protein 1 (UCP-1) by activating its 
promoter. It was first identified as a protein highly expressed in BAT and not 
in WAT.  However, it has been shown that it also expressed in WAT and that 
cold exposure or beta-adrenergic agents can stimulate its expression. The 
expression of PGC1a and UCP-1 are closely associated to energy 
production (thermogenesis) (Enerback, Jacobsson et al. 1997, Puigserver, 
Wu et al. 1998, Lin, Wu et al. 2004, Leone, Lehman et al. 2005, Lee, 
Swarbrick et al. 2013). 
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Although WAT is found in both small mammals and humans, it was 
previously believed that BAT was only present in small rodents and infants 
but not in adults. Recently studies using Positron Emission Tomography 
(PET) have demonstrated the presence of fat with high metabolic activity in 
adults in the cervical, supraclavicular, axillary and paravertebral regions. 
Furthermore, brown adipocytes have been discovered in the visceral depots, 
mainly near the aorta. These fat depots were found to increase their activity 
following cold exposure or adrenergic stimulation. These findings have 
helped to confirm the active presence of BAT in adults. BAT generates heat 
via the mitochondrial Uncoupling Protein, protecting against hypothermia and 
excessive accumulation of white adipose fat (obesity) (figure 1.4.1.2.1) 
(Cypess, Lehman et al. 2009, Saito, Okamatsu-Ogura et al. 2009, Lee, 
Swarbrick et al. 2013).  
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Figure 1.4.1.2.1 Brown adipose tissue distribution in humans a) and in a female 
mouse acclimatized at 28˚C b). In figure a): 1.Cervical BAT, 2.Supraclavicular BAT, 
3.Paravertebral BAT, 4.Axillary BAT, 5.Mediastinal BAT, 6.Pericardial BAT, 
7.Perirenal BAT, 8.Trachea-oesophageal BAT, 9.Intercostal BAT, 10.Mesenteric 
BAT. Red colour in figure a) reveals the distribution of BAT by PET scanning and 
histology and blue colour the BAT distribution by histology alone.  In figure b): a) 
Interscapular BAT; b) Cervical BAT; c) Axillar BAT; d) Mediastinic BAT, and e) 
Perirenal BAT. Figures adapted from the originals (Frontini and Cinti 2010, Lee, 
Swarbrick et al. 2013). 
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1.4.1.3 Brown Like Adipocytes 
Recent studies have demonstrated the existence of a different type of 
paucilocular (intermediate) brown adipocytes known as brown like-
adipocytes or “beige”/“brite” adipocytes within the WAT (Petrovic, Walden et 
al. 2010, Seale, Conroe et al. 2011, Walden, Hansen et al. 2012, Wu, 
Bostrom et al. 2012). These beige cells have a dual function: when energy 
intake exceeds energy expenditure, the surplus energy can be stored in 
beige fat cells (basal condition) and these beige cells take on a more white 
morphology (figure 1.4.1.3.1). Moreover, certain stimuli including cold, 
sympathetic stimulation via catecholamines and beta-adrenergic receptors, 
hormones (irisin), and pharmaceutical stimulation such as Thiazolidinediones 
(TZDs) can activate beige fat cells resulting in increased energy dissipation 
in the form of heat activating the expression of genes /proteins such as 
PGC1a and its downstream target UCP-1 as in classical BAT.  
 
Although both BAT and beige adipocytes are thermogenic, they seem to be 
regulated differently (Kozak 2000, Coulter, Bearden et al. 2003). Moreover, 
beige fat cell express different genes compared to white adipocytes. It has 
also been observed that the subcutaneous adipose tissue depots have a 
higher susceptibility toward expression of UCP-1 and other brown fat cell 
genes as compared to the visceral white adipose tissue (Cousin, Cinti et al. 
1992, Cinti 2012).  
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Figure 1.4.1.3.1 Morphology of mouse adipose tissue by electron microscopy.   
White adipocytes in inguinal WAT containing a single lipid droplet a). Brown 
adipocytes in interscapular brown adipose tissue containing multilocular lipid 
droplets b). Browning of WAT (induced by pharmacological activation of β3-
adrenergic receptors) leads to formation of islets of multilocular beige adipocytes 
within inguinal WAT c). Beige adipocytes within WAT showing their high 
mitochondrial content d).  Scale bars: a–c, 50 µm; d, 5 µm. Abbreviations: C, 
capillary; E, endothelial cell; LD, lipid droplet; M, mitochondria; WAT, white adipose 
tissue (Bartelt and Heeren 2014). 
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1.4.2 Transcriptional control of adipogenesis and lipid metabolism 
BAT and WAT originate from Mesenchymal Stem Cells (MSCs), which can 
differentiate into adipocytes, osteoblasts, chondrocytes and myoblasts. 
These stem cells reside in the vascular stroma of adipose tissue as well as in 
the bone marrow (Covas, Panepucci et al. 2008).  
 
1.4.2.1 Adipogenesis  
Adipogenesis, or the formation of adipocytes, involves two stages of 
commitment and differentiation. With an appropriate stimulation, MSCs 
undergo a process of commitment in which they are recruited to an adipocyte 
lineage (preadipocytes). In the second phase, which is the terminal 
differentiation, the adipocyte takes on the characteristics of the mature 
adipocyte.  
 
This process is controlled by the interaction of different transcription factors 
such as CCAAT Enhancer Binding protein alpha, beta and delta (CEBP-
alpha, beta, delta); Peroxisome Proliferator Activated Receptor Gamma1-2 
(PPARG1-2). Augmented expression of CEBP alpha and PPARGs are critical 
elements for the retention of the adipocyte phenotype (Rosen, Hsu et al. 
2002, Wang, Shi et al. 2006, Huang and Tindall 2007). The action of 
PPARGs is mediated through two protein isoforms: PPARG1 and PPARG2. 
The expression of the latter is limited to adipose tissue whereas the former is 
constitutively expressed (Spiegelman, Puigserver et al. 2000).  
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Recruitment of new small adipocytes seems to decrease insulin resistance 
by increasing the capacity of lipid storage. This is due in part to PPARGs, 
which increase Glucose Transport 4 (GLUT4), uncoupling proteins and 
adiponectin (Vazquez-Vela, Torres et al. 2008). 
 
1.4.2.2 Lipid metabolism: lipogenesis and lipolysis in adipocytes 
Steroid Regulatory Element Binding Protein 1c (SREBP1c) has been 
identified as a proadipogenic factor that stimulates PPARGs expression and 
also as a mediator of glucose metabolism and lipogenesis via insulin 
regulation. Some of its downstream lipogenic gene targets are Fatty Acid 
Synthase (FAS), and Acetyl-Coenzyme A Carboxylase (ACC) (Gosmain, Dif 
et al. 2005). However other studies have suggested that SREBP1c is not 
associated with lipogenesis in adipocytes as it is in liver (Sekiya, Yahagi et 
al. 2007). mRNA expression has also been found to be upregulated in 
models of lipodystrophy (Shimomura, Hammer et al. 1998), but others 
studies have seen a downregulation in adipose tissue of diabetic obese 
humans suggesting in general than an alteration on its regulation may 
impaired insulin sensitivity of adipose tissue (Sewter, Berger et al. 2002) 
(figure 1.4.2.2.1). 
 
Lipoprotein lipase (LPL) and fatty acid synthase (FAS) are two enzymes 
involved in adipose tissue lipid (triglyceride) accumulation. Whilst FAS is 
implicated in the de novo lipogenesis (Vazquez-Vela, Torres et al. 2008), 
LPL regulates the hydrolysis of circulating triglycerides. The local tissues 
reuptake the resulting fatty acids and monoacylglycerols helping in the 
	   64	  
accumulation of lipids in adipose tissues, cardiac, skeletal muscle, islets and 
macrophages (Wang and Eckel 2009) (figure 1.4.2.2.1). 
 
Triglycerides stored in lipid droplets are first hydrolysed by the enzyme 
Adipose Triglyceride Lipase (ATGL) to diacylglycerols. Subsequently, 
diacylglycerols are hydrolysed by the Hormone Sensitive Lipase (HSL) and 
finally by Monoglyceride Lipase (MGL), producing free fatty acids and 
glycerol. Perilipin A is a protein that surrounds the lipid droplet inhibiting 
hydrolysis. Beta-adrenergic stimulation and the Protein Kinase A-dependent 
phosphorylation of HSL and perilipin activate the translocation of HSL from 
the cytoplasm to the lipid droplet inducing intracellular lipolysis.  
 
Insulin has antilipolytic effects and in fed states decreases the mobilization of 
lipids from adipose tissue inhibiting lipolytic enzymes such as HSL 
(Fredrikson, Tornqvist et al. 1986, Egan, Greenberg et al. 1992, Brasaemle, 
Rubin et al. 2000, Holm 2003, Villena, Roy et al. 2004, Vazquez-Vela, Torres 
et al. 2008) (figure 1.4.2.2.1). 
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Figure 1.4.2.2.1 Lipid metabolism in adipocyte cells. Glucose excess is oxidized via 
glycolysis to acetyl-CoA in the adipocyte and then converted into acyl-CoA, which 
are then esterified in the Endoplasmic Reticulum (ER) to Triglycerides (TG). 
Subsequently they are then translocated into the lipid droplet. Fatty Acids (FA) 
obtained from lipoproteins are also esterified into TG and stored. Under fasting 
conditions, lipolysis is activated by G-protein-coupled receptors resulting in an 
increase in Cycling Adenosine Monophosphate (cAMP) that phosphorylates the 
protein perilipin located in the membrane of the lipid droplet. cAMP also 
phosphorylates the hormone-sensitive lipase (HSL) triggering its translocation from 
the cytoplasm to the lipid droplet and induces the hydrolysis of diglycerides 
produced by the ATGL to form monoglycerides (MGs). MGs are then released to 
non-adipose tissues, mainly for energy purposes. (Adapted from Vasquez -Vela et 
al) (Vazquez-Vela, Torres et al. 2008). 
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1.4.3 Adipose tissue and adipokines 
Adipose tissue has the ability to produce and secrete hormones and 
cytokines and therefore is considered an endocrine organ. The adipose 
derived factors are known as adipokines and these participate in the 
regulation of energy balance. The expression of these factors is generally 
high in adipose tissue but their expression is not limited to adipocytes. As 
such, their action is not specifically related to adipocyte function. Some of 
these adipokines are described below.  
 
1.4.3.1 Adiponectin 
Adiponectin has both autocrine and paracrine effects. Its concentration in 
serum has been positively related to benefitial effects on insulin sensitivity, 
inflammation, lipid profiles and cardioprotection and angiogenesis. A strong 
correlation between adiponectin and LPL activity has been linked to 
improved lipid clearance and insulin sensitivity. Adiponectin receptors have 
been found in skeletal, cardiac and smooth muscle, adipose tissue, 
endothelial cells and liver and thus it is implicated in their functioning (von 
Eynatten, Schneider et al. 2004, Berg and Scherer 2005, Trujillo and Scherer 
2005). 
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1.4.3.2 Leptin 
Leptin in both human and rodents is produced mainly by adipocytes and 
smaller amounts can be synthetised in placenta, gastric parietal cells, ovary 
and liver (Campfield, Smith et al. 1995, Cripps, Martin-Gronert et al. 2005). It 
is thought to regulate energy homeostasis by reducing food intake, weight 
gain and increasing energy expenditure in adults. It is produced by adipose 
tissue in proportion to the body fat content rather than body mass.  
 
Leptin also plays a role in signaling food deprivation with an extensive 
reduction on fasting, which is disproportionate to changes in fat mass 
(Trayhurn, Thomas et al. 1995). It has also been demonstrated that leptin 
regulates adipose tissue growth through its action on the central nervous 
system in the hypothalamic nuclei.  Other studies have shown that leptin 
receptors are also present in others organs such as liver, skeletal muscle, 
heart, kidneys and pancreas, among others (Hoggard, Mercer et al. 1997, 
Lollmann, Gruninger et al. 1997). The leptin receptor is expressed in 
adipocytes suggesting an autocrine and paracrine role of the leptin hormone. 
It appears that leptin stimulates lipolysis of intracellular triglycerides and 
reduces the gene expression of SREBP1c and ACC; therefore inhibits 
lipogenesis and stimulate fatty acid oxidation reducing the possibility of 
ectopic fat deposition and thus lipotoxicity (Fruhbeck, Aguado et al. 1997, 
Unger and Orci 2002).  
 
Others functions of leptin are stimulation of hematopoiesis, angiogenesis and 
accelerated wound healing. It also influences immune response and 
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sympathetic nervous system, and regulates bone mass (Kershaw and Flier 
2004). Hyperleptinemia during obesity is associated with leptin resistance. 
This leptin resistance or reduction of sensitivity to leptin action could be due 
to malfunction at different levels such as altered leptin transport across the 
Blood Brain Barrier (BBB) or impairment in the leptin-signaling cascade 
(Kershaw and Flier 2004). 
 
Experimental studies in neonatal rodents have demonstrated that leptin does 
not exert its biological effects on body weight regulation and feed intake 
during the neonatal period (Mistry, Swick et al. 1997, Proulx, Richard et al. 
2002). Plasma leptin concentrations are high in neonates. Leptin actions 
seem to be developmentally regulated to optimise growth and survival of 
neonates enhancing their ability to increase thermoregulatory metabolic rates 
in order to maintain body temperature without suppressing food intake 
(Mistry, Swick et al. 1997). Furthermore, Bouret et al have found that leptin 
also modulates development of the neural circuitries in the hypothalamus 
(Bouret and Simerly 2004). 
 
1.4.3.3 Resistin 
The hormone resistin is expressed mainly in white adipocytes in rodents but 
in humans tends to be expressed in stromal vascular cells in adipose tissue. 
It is also found in BAT and the mammary gland (Steppan, Bailey et al. 2001). 
Its role and mechanism of action are not completely understood. It has been 
suggested that resistin antagonises insulin effects in glucose metabolism. In 
the liver for example, it has been shown that administration of resistin results 
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in severe hepatic but not peripheral insulin resistance and increased 
expression of gluconeogenic enzymes in liver. Transgenic overexpression of 
resistin results in increased fasting glucose and glucose intolerance 
suggesting an insulin resistant state (Rajala, Obici et al. 2003, Banerjee, 
Rangwala et al. 2004, Rangwala, Rich et al. 2004). It has also been shown 
that resistin alters lipid metabolism increasing the secretion of triglycerides 
from the liver. (Sato, Kobayashi et al. 2005). 
 
1.4.3.4 Proinflammatory adipocytokines 
Proinflammatory factors are predominantly produced by the cells within the 
stromal vascular fraction of the adipose tissue. Dyslipidemia, insulin 
resistance and obesity have been linked to chronic low-grade inflammation. 
Cytokines involved in the inflammatory response are not only produced by 
immune cells but also by adipose tissue. This suggests that obesity is an 
inflammatory state or that these cytokines are involved in the maintenance of 
fuel homeostasis (Yu and Ginsberg 2005). Inflammation is characterised by 
abnormal cytokine production and other regulators of inflammatory signaling.  
 
1.4.3.4.1 Tumor Necrosis Factor alpha (TNF-a)  	  
TNF-a expression seems to be increased in the adipose tissue of obese 
mammals and has been associated with whole body insulin resistance.  
TNF-a induces lipolysis in adipose tissue leading to elevation of fatty acid 
levels. Additionally, it reduces the expression of genes involved in 
adipogenesis and lipogenesis in adipocytes (Ruan, Hacohen et al. 2002). 
Conversely in liver TNF-a increases the expression of genes involved in de 
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novo lipogenesis and decreases the expression of those involved in fatty 
acid oxidation (Grunfeld and Feingold 1992). Although TNF-a levels are low 
in circulation and there is no clear correlation with obesity and insulin 
resistance, its tissue expression levels seem to be linked positively with both 
conditions (Yu and Ginsberg 2005). This means that TNF-a association with 
insulin resistance may be more related to local conditions rather than its 
general increased in periphery. 
 
1.4.3.4.2 Interleukin 6 (IL-6)  	  
IL-6 unlike TNF-a is secreted by the adipose tissue and enters the circulation 
where its concentration is relatively high. Plasma levels have been found to 
correlate positively with fat mass, insulin resistance and free fatty acids 
levels. In vitro studies have indicated that IL-6 increases leptin and lipolysis 
whereas suppressing LPL activity contributes to the metabolic changes 
related to obesity. However, it seems to have an opposite role in the central 
nervous system. Centrally, IL-6 is negatively related to fat mass in obesity. 
Its administration in rodents increases energy expenditure suggesting a 
protective role against obesity (Wallenius, Wallenius et al. 2002, Stenlof, 
Wernstedt et al. 2003, Kershaw and Flier 2004, Trujillo, Sullivan et al. 2004). 
 
1.4.3.4.3 Monocyte Chemotactic Protein 1 (MCP-1/CCL2) 	  
 MCP-1 is one of the key chemokines (attracts and activate immune cells) 
that regulate migration and infiltration of monocytes/macrophages into 
inflammation by inducing leukocyte-endothelial adhesion and promoting 
transendothelial migration. Recently, other functions have been attributed to 
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MCP-1 including angiogenesis. It is produced by a vast number of cells such 
as epithelial and endothelial cells, fibroblasts, keratinocytes, smooth muscle 
cells, mesothelial, mesangial cells, chondrocytes, osteoblasts, liver, 
astrocytes, microglia, mononuclear cells, eosinophils, mast cells and 
adipocytes (Van Coillie, Van Damme et al. 1999). Some reports have 
positively associated circulating MCP-1 levels with insulin resistance, 
hyperglycemia, type 2 diabetes and obesity (Panee 2012). Mice with MCP-1 
receptors deletion gain as much weight as wild-type mice on a high-fat diet, 
but do not have adipose tissue inflammation and maintain their insulin 
sensitivity (Ouchi, Parker et al. 2011). 
 
1.5 Insulin  
Insulin is an anabolic hormone composed of two polypeptide chains (A-B) 
containing 51 amino acids secreted from the pancreatic beta cells in 
response to increased blood glucose following ingestion of a meal. Insulin 
exerts its actions through binding to specific receptors in cells, primarily on 
adipocytes, liver and muscle cells. The primary action of insulin is to regulate 
glucose concentration in blood by stimulating glucose uptake into muscle 
and adipose tissue and by suppressing glucose production in the liver 
promoting glycogenesis and concomitantly reducing glucagon secretion from 
pancreatic alpha cells to reduce production of glucose via glycogenolysis and 
gluconeogenesis. Other functions of insulin include stimulation of protein 
synthesis in the liver and muscle, free fatty acid uptake and synthesis in 
adipose tissue, inhibition of lipolysis and proliferation of cell growth such as 
adipose tissue growth and adipocyte differentiation via different adipokines 
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and transcription factors such as PPARG (Gerich, Schneider et al. 1974, 
Saltiel and Kahn 2001). 
 
The secretion of insulin after a meal occurs into two phases. The first phase 
releases preformed insulin, rapidly followed by a second phase of insulin 
synthesis and slow sustained release. Long-term release of insulin occurs 
when high levels of glucose are maintained in blood (Gerich, Schneider et al. 
1974). Other factors are known to stimulate the release of insulin apart from 
the potent glucose. These include increased concentration of some amino 
acids in circulation such as arginine, leucine and lysine; the incretins 
Glucagon Like Peptide 1 (GLP-1), and Glucose-dependent Insulinotropic 
Peptide (GIP) derived from the intestinal L and K cells respectively, 
Cholecystokinin (CCK), parasympathetic release of acetylcholine and via 
beta-2 adrenergic receptors. Insulin release is inhibited by noradrenaline, 
release of catecholamines (alpha-2 adrenergic receptors), and by the 
sympathetic nervous system (Nakaki, Nakadate et al. 1980, Holst 1994, 
Drucker 2001, Cawston and Miller 2010).  
 
In energy balance regulation, insulin acts as both a short-term and long term 
signal. It is released in response to changes in energy levels such as meal 
ingestion, but it seems that its circulating levels are positively related to fat 
mass. In the hypothalamus region of the brain it acts on receptors in the 
Arcuate Nucleus (ARC) and Ventromedial Hypothalamus (VMH) and 
increases energy expenditure. Exogenous administration of insulin in the 
hypothalamus leads to a reduction in food intake. However in type 2 
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diabetes, patients placed on exogenous insulin treatment tend to gain weight 
as the anorexigenic effect is overcome by the antilipolytic effect of insulin 
(Henry, Gumbiner et al. 1993, Benoit, Clegg et al. 2004, Cripps, Martin-
Gronert et al. 2005). 
 
 1.5.1 Insulin signaling 
Insulin signaling is mediated by a series of molecular pathways. In the 
presence of insulin, the Insulin Receptor (IR) localised in caveola 
invaginations in the plasma membrane binds to insulin through its alpha 
subunits inducing trans-autophosporylation of the beta subunits, which 
become active (Gustavsson, Parpal et al. 1999, Karlsson, Thorn et al. 2004).  
 
Following the phosphorylation of IR at tyrosine residues intracellular 
signaling proteins are recruited and can be phosphorylated by docking on 
the phosphorylated IR. Among these are members of the Insulin Receptor 
Substrate (IRS). Consequently after interaction with the IR tyrosines residues 
the IRS are phosphorylated. This creates docking sites for other intracellular 
proteins with SH2 domains. The insulin signal is transduced via a cascade of 
phosphorylations and dephosphorylations that constitute the insulin signaling 
inside the adipocyte. Downstream signaling occurs through two main kinase 
domains: the mitogenic and metabolic pathways. These pathways are a 
complex network of feedbacks and cross talks with other pathways in the cell 
(White 1998). 
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The IR-mediated tyrosine phosphorylation of IRS-1 activates a metabolic 
signaling pathway by binding to the regulatory subunit p85 of the 
Phosphatidylinositol 3 Kinase (PIK3). Then the catalytic subunit p110 is 
activated and this phosphorylates Phosphatidylinositol (4,5) bisphosphate 
(PIP2) conforming phosphatidylinositol (3,4,5) triphosphate (PIP3). Protein 
kinase B (PKB/Akt) is then recruited to the plasma membrane and Akt is 
phosphorylated at threonine 308 and serine 403 for maximal activation. 
Another target of PIK3 in adipocytes is the atypical Protein Kinase C-Zeta 
and Lambda (PKC-Z/ λ). Both PKB/Akt and PKC appear to be important for 
insulin stimulation of insulin-dependent Glucose Transporter 4 (GLUT4) 
translocation to the plasma membrane to induce and enhanced glucose 
uptake (Tanti, Grillo et al. 1997, Farese 2001, Saltiel and Kahn 2001, 
Hietakangas and Cohen 2009) (figure 1.5.1.1). 
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Figure 1.5.1.1 Insulin signaling pathways in an adipocyte. Both the metabolic and 
mitogenic pathways are illustrated (Adapted from Danielsson, 2007) (Danielsson 
2007). 
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1.5.2 Insulin resistance 
 
Insulin resistance is defined as the loss of the normal effect that insulin would 
have at its normal circulating concentration. In the presence of insulin 
resistance, insulin would not exert its function as in normal subjects. Defects 
in insulin function impair the suppression of glucose production in the liver 
and this will continue to produce glucose and release it into circulation. The 
most common cause of insulin resistance is the impaired signaling that can 
occur beyond the receptor (protein and gene expression). The lack of signal 
to reduce glucose in circulation will incur in the hyperresponsiveness of the 
pancreas to produce more insulin causing an increase in insulin 
concentration in periphery (hyperinsulemia), which initially will compensate 
for the effects of insulin resistance. Eventually, the system will fail in 
maintaining glucose levels at a normal level and hyperglycemia will develop, 
later progressing to type 2 diabetes (Dinneen, Gerich et al. 1992, Weyer, 
Bogardus et al. 1999, Kahn, Hull et al. 2006). 
 
1.5.2.1 Insulin resistance and adipose tissue distribution 
A vast number of studies have demonstrated that there is a link between 
adipose tissue mass and metabolic alterations such as insulin resistance and 
type 2 diabetes(Abate and Garg 1995, Ozanne, Lewis et al. 2004, Giorgino, 
Laviola et al. 2005). However, it is not only the total amount of fat mass that 
accounts for this relationship but in particular the sites where the fat is 
deposited in the body. Furthermore, it has been postulated that excess 
accumulation of visceral fat is associated with these metabolic changes 
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independently of overall body fat mass (Abate and Garg 1995, Giorgino, 
Laviola et al. 2005). One of the reasons postulated is that visceral fat 
secretes its hormones and lipids into the portal system, which has direct 
access to the liver. This increases the delivery of lipids to the liver, 
overloading its capacity in comparison to that it receives from to systemic 
subcutaneous fat (Unger, Clark et al. 2010). This overload will then increase 
the risk of lipotoxicity. Other possible reasons are metabolic and endocrine 
differences between different fat depots (Van Harmelen, Reynisdottir et al. 
1998). Visceral fat for example seemed to recruit more proinflammatory 
macrophages than subcutaneous adipose tissue and activation of PPARG is 
lower in the former. This seems to be in accordance with the high lipolytic 
activity of visceral fat. As insulin inhibits lipolysis, the reduction of this effect 
can also be linked to the lower insulin sensitivity of these adipocytes (Sauma, 
Franck et al. 2007).  
 
Adipose tissue expansion involves both increments in cell number 
(hyperplasia) and by increasing the size of existing mature adipocytes 
(hypertrophy) through the deposition of lipid. Overfeeding has been 
associated with a hypertrophic growth of adipocytes. These enlarged 
adipocytes become resistant to the antilipolytic effect of insulin, which leads 
to a greater release of free fatty acids into circulation (Iozzo 2009). These in 
turn are stored in ectopic sites such as muscle and liver increasing the risk of 
insulin resistance and further development of type 2 diabetes. In humans, 
visceral adipocytes have been found to be more enlarged than 
subcutaneous adipocytes (Boden 1997, Lundgren, Buren et al. 2004). 
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1.6 Hypothalamus and Appetite Regulation 	  
The integration of different signals in the central nervous system is pivotal for 
the regulation of energy homeostasis in response to food intake and energy 
expenditure. Peripheral signals related to acute and long-term energy status 
(i.e, incretins, leptin and insulin) are integrated in the brain by neural 
networks primarily in the hypothalamus and brainstem generating an 
appropriate response balancing the expression of satiety (anorexigenic) and 
hunger (orexigenic) neurotransmitters (Elmquist, Coppari et al. 2005, 
Chaudhri, Parkinson et al. 2006). 
 
The hypothalamus regulates food intake and energy balance, and other 
responses such as immune response and reproduction (Butte, Wong et al. 
2004, Welt, Chan et al. 2004). It is subdivided in different nuclei carefully 
interconnected.  
 
The Arcuate Nucleus (ARC) is located in the mediobasal hypothalamus 
adjacent to the third ventricle and it is directly above the median eminence, 
which is one of the circumventricular organs characterised by a partially 
permeable blood brain barrier (Ciofi 2011). This positioning of the ARC 
allows it to be an ideal integrator of peripheral signals such as circulating 
nutrients and hormonal signals of energy status including leptin, insulin, 
glucose, sex hormones and glucocorticoids (Tong, Zhao et al. 1990, Glaum, 
Hara et al. 1996, Sato, Kobayashi et al. 2005). The ARC nucleus has a 
number of inputs from other areas in the brain including other hypothalamic 
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nuclei, the hindbrain, limbic areas (amygdala) and cortical areas 
(somatosensory cortex) (DeFalco, Tomishima et al. 2001). 
 
ARC neurons are known as first order neurons because of their partial 
contact with the circulation. It contains two main populations of neurons 
involved in the control of energy balance. The first population of neurons 
coexpresses Neuropeptide Y (NPY) and Agouti Related Peptide (AgRP). The 
second population expresses Proopiomelanocortin (POMC), which is 
cleaved to produce Cocaine and Amphetamine Regulated Transcript (CART) 
and alpha Melanocyte Stimulating Hormone (alpha-MSH). The first 
population of neurons increase food intake and decrease energy expenditure 
(orexigenic). They are inhibited by leptin and activated by ghrelin, a gut 
hormone that signals meal initiation (Cone, Cowley et al. 2001, Cowley, 
Smith et al. 2003, van den Top, Lee et al. 2004). The second population of 
hormones are activated by leptin (anorexigenic) (Cheung, Clifton et al. 1997). 
Both populations of hormones project to a second order of neurons in other 
hypothalamic nuclei including the Ventromedial Hypothalamus (VMH) and 
the Paraventricular Hypothalamus (PVN).  
 
Along with the hypothalamus, centres in the brain stem also play an 
important role in appetite regulation interacting with hypothalamic centres 
such as PVN and lateral hypothalamus as well as receiving inputs from the 
vagus nerve, which links the gastrointestinal tract and brain (Ritter 2004). In 
addition to food intake and energy expenditure, other factors such as 
pleasure and preference of certain tastes and textures (hedonic responses) 
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involving brain reward centres intervene in the energy homeostasis (Saper, 
Chou et al. 2002) (figure 1.6.1). 
 
 
 
Figure 1.6.1 The appetite regulation circuits in hypothalamus and brain stem. 
Peripheral signals enter in the hypothalamus and brainstem through a partial 
permeable blood brain barrier. These signals alter the activity of anorexigenic and 
orexigenic neurotransmitters regulating appetite and energy homeostasis. Adapted 
from Parkinson et al 2009 (Parkinson, Chaudhri et al. 2009).  
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1.7 Hypothesis and Aims of Thesis 
 
1.7.1 Hypothesis 
Birth weight and accelerated weight gain modulate body fat patterning and 
hypothalamic function. Exposure to a high fat diet postnatally amplifies the 
impact of birth weight and that response is sex-age dependent.  
 
1.7.2 Aims 
Ø To elucidate the effects of birth weight and post weaning diet on fat 
content and its distribution as well as appetite regulation.  
Ø To assess the association between weight gain and fat content and its 
distribution with appetite.  
Ø To provide evidence of early metabolic alterations linked to 
deterioration of health later in life.  
Ø To explore the potential underlying mechanism associated with early 
life programming of appetite and body composition.  
 
1.7.2.1 Primary outcomes 
Ø Measurements in vivo of body fat content and distribution using MRS 
and MRI techniques at weaning (3 weeks of age) and 15 weeks of 
age. In addition, MRS will be used to quantify hepatic lipid content.  
Ø Manganase-Enhanced MRI (MEMRI) will be used to determine in vivo 
neural activity in the hypothalamic centres ARC, PVN, VMH and Pe, 
which are associated with appetite control.  
Ø Biochemical analysis of plasma metabolites associated with metabolic 
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alterations such as insulin, leptin, resistin, GIP, ghrelin and some 
proinflammatory cytokines.  
Ø Assessment of gene expression in adipose tissue. This will add 
information to underpin the early adaptations of the organisms that 
can program an adverse metabolic profile later in life.  
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2. Material and Methods 
2.1. Study 1. Effects of Birth Weight and Accelerated Growth 
on Body Composition and Appetite Regulation at Lactation 
(From Birth Until 3 Weeks of Life) 
 
2.1.1 Animals  
All protocols were conducted in accordance with the UK Animals (Scientific 
Procedures) Act, 1986. C57BL/6J female mice (6-8 weeks old; Harlan U.K) 
and male mice (8-10 weeks old; Harlan U.K) were used as parental animals 
and were maintained on a standard rodent chow (RM3, Special Diet Services 
Ltd, UK) prior to the experiment. All mice were acclimatised during 7 days 
from arrival at the animal husbandry unit and housed in individually 
ventilated cages under controlled conditions (12h:12h dark-light cycle and 
21-23°C) with ad libitum access to food and water.  
 
2.1.2 Diet composition 
The diet used for this study was a standard purified 20% protein diet (TD 
91352, 20% kcal protein intake, Harlan Teklad). The macronutrient 
composition of this diet is shown in table 2.1.2.1.  
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Table 2.1.2.1 Nutritional composition of the diet used in study 1. The diet used in 
this study was a standard 20 % protein diet. Values in grey correspond to the 
percentage of each macronutrient in terms of weight. Values in bold correspond to 
the percentage kilocalories from each component of the diets. Last row correspond 
to the number of kilocalories per gram of food. 
 
 2.1.3 Study design  
The diagram of the study design is shown in figure 2.1.4.1. After 7 days of 
acclimatisation, mice were mated, and copulation was confirmed by the 
presence of a vaginal plug. At conception (day0), pregnant female mice were 
separated from the male mice and housed individually, and were fed a 
normal 20% protein purified diet as mentioned above.  
 
Litters were adjusted to 5-7 pups/litter/dam to obtain similar conditions as 
possible during lactation. Pups were kept within the same litter until weaning.  
 
Macronutrients 
 
Protein diet 
Protein (% by weight) 
(% kcal) 
20.3 
21.5 
Carbohydrate (% by weight)                               
(% kcal) 
65.3 
71.4 
Fat (% by weight) 
(% kcal) 
5.5 
13.1 
Kcal/g 3.8 
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Mice were classified into two groups according to their birth weights but were 
kept within the same litter during the lactation period until the time of weaning 
at 3 weeks of life. These two groups were: 1) Low birth weight mice (LBW) 
and 2) High birth weight mice (HBW). LBW mice were defined as mice with a 
birth weight below the 10
th 
percentile within the colony (≤1.18g) and HBW as 
mice with a birth weight higher than the 90
th 
percentile within the colony 
(≥1.38g). Cut off values were calculated from a preliminary study taken into 
account birth weights from a colony of approximately 10-15 litters for both 
males (m) and females (f). 
 
2.1.4 Methods 
 Birth weight was recorded 24 hours after delivery. Body weight was 
monitored weekly throughout lactation until week 3 of age (time of weaning). 
Whole body MRS and MRI, and localised liver MRS was performed at the 
end of lactation (3 weeks of life). Pups were dissected at the end of the study 
and biochemical analysis was performed on plasma samples. Tissues were 
harvested and adipose signaling was assessed (see figure 2.1.4.1).  Details 
of these methods are described in section 2.4. 
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                                                    Pregnant females  
(Gestation approx.19 days; fed standard purified diet (20%protein)  
 
 
 
 
                                                               Birth 
(recorded and classification: LBW or HBW m/f; 
pups remained within the same litter)  
 
 
 
 
                                                          Lactation  
(Duration: 22-23 days; mums fed same diet as in pregnancy)  
 
 
 
                                                           Weaning  
                                                   (At 22-23 days old)  
 
 
  
   MRS-MRI                                   Biochemistry                                  Cell signaling:   
            Adipose tissue  
                          (RT-qPCR) 
 
Figure 2.1.4.1 Protocol designed for study 1. Pregnant females were caged 
individually and kept on a standard purified diet from pregnancy until weaning (3 
weeks old). Pups were classified into two groups according to their birth weights in 
either Low birth weight male/ female mice (LBWm/f) or High birth weight 
male/female mice (HBWm/f). Whole body MRS and MRI, and localised liver MRS 
was performed in pups at weaning (22-23 days of life). Tissue samples were 
collected at weaning (n=8-10). Adipose tissue signaling was assessed using RT-
qPCR (n=6-8).   
 
LBWm/f 
HBWm/f 
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2.2 Study 2. Effects of Birth Weight and Diet on Body 
Composition and Appetite Regulation in Young Mice (From 
Week 3 of Life Until Week 15)  
 
2.2.1 Animals  
All protocols were conducted in accordance with the UK Animals (Scientific 
Procedures) Act, 1986. C57BL/6J offspring mice were housed in individually 
ventilated cages under controlled conditions (12h:12h dark-light cycle and 
21-23°C) with ad libitum access to food and water.  
 
2.2.2 Diet composition 
The two diets used in this study were a purified normal fat control diet (TD 
05072, 9% kcal fat intake) and purified moderated high fat diet (TD 05073, 
27% kcal fat intake). Anhydrous milk fat was used as the source of saturated 
fat in both diets. The macronutrient composition of the diets is shown in table 
2.2.2.1. 
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Table 2.2.2.1 Nutritional composition of the two diet used in study 2. The two diet 
used in this study were a purified control fat diet (9%kcal fat intake) and a 
moderated high fat diet (27% kcal fat intake). Values in grey correspond to the 
percentage of each macronutrient in terms of weight. Values in bold correspond to 
the percentage kilocalories from each component of the diets. Last row correspond 
to the number of kilocalories per gram of food. 
 
2.2.3 Study design  
The diagram of the study design is shown in figure 2.2.3.1. Offspring were 
obtained and maintained until weaning as aforementioned in study 1 (section 
2.1). At weaning (week 3 of life), mice were separated from their litters and 
divided by birth weight into two categories taking into account the parameters 
mentioned in study 1 (section 2.1.3). These two groups were: Low birth 
weight mice (LBW) and High birth weight mice (HBW). Offspring was further 
subdivided by diet using the diets described in section 2.2.2 and by gender: 
male (m) or female (f) mice.  In total, four groups were formed per gender as 
 
Macronutrients 
 
Control diet Moderate high fat 
Protein (% by weight) 
(% kcal) 
17.7 
19.6 
17.7 
17.3 
Carbohydrate (% by weight)                               
(% kcal) 
64.5 
71.4 
56.6 
55.4 
Fat (% by weight) 
(% kcal) 
3.6 
9.0 
12.4 
27.3 
Kcal/g 3.6 4.1 
	   89	  
follow: 1). Low birth weight mice fed a Normal Fat diet (LBW-NF), 2). High 
birth weight mice fed a Normal Fat diet (HBW-NF), 3). Low birth weight mice 
fed a High Fat diet (LBW-HF) and 4). High birth weight mice fed a High Fat 
diet (HBW-HF).   
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Figure 2.2.3.1 Diagram of the protocol designed for study 2. Offspring was obtained 
as mentioned in study 1 (section 2.1). At weaning, offspring was divided into eight 
groups depending on their birth weight and the diet given, and by gender: Low birth 
weight males fed a normal fat diet (LBWm-NF); Low birth weight males fed a high 
fat diet (LBWm-HF); High birth weight males fed a normal fat diet (HBWm-NF); 
High birth weight males fed a high fat diet (HBWm-HF); Low birth weight females 
fed a normal fat diet (LBWf-NF); Low birth weight females fed a high fat diet (LBWf-
HF); High birth weight females fed a normal fat diet (HBWf-NF) and High birth 
weight females fed a high fat diet (HBWf-HF).  
 
 
       Pregnant females 
(Gestation 18-20 days; fed standard purified diet) 
 
 
 
        Birth 
(Labelled pups; weighed and recorded; pups remained within the same litters) 
 
 
                 
         Lactation 
       (Duration: 22-23 days; mum onto same diet as in pregnancy) 
 
 
 
         Weaning 
         (3 weeks old) 
 
 
 
Low birth weight (LBW)                                        High birth weight  (HBW) 
 ≤ 10th percentile                                                            ≥ 90th percentile 
 
 
LBWm-NF           LBWm-HF                              HBWm-NF          HBWm-HF 
LBWf-NF             LBWf-HF                                HBWf-NF            HBWf-HF 
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2.2.4 Methods 
The diagram of this study is shown in figure 2.2.4.1. Body weight and 
kilocaloric intake were monitored weekly. Whole body MRS and MRI, and 
localised liver MRS were performed at age 14 weeks, and MEMRI was 
performed at age 15 weeks.  
 
An Intraperitoneal Glucose Tolerance Test (IPGTT) was performed at week 
14 of age to assess glucose tolerance. Tissues were harvested at 15 weeks 
old. Samples of gonadal and subcutaneous adipose tissue were taken for 
adipocyte extraction and analysis of adipocyte number and distribution. 
Different subsets of mice were used for each procedure when possible to 
minimise stress related metabolic changes in mice. Details of these methods 
are described in section 2.4.  
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Figure 2.2.4.1 Diagram of the methods for study 2. Mice were weaned and groups 
were formed as mentioned above in study 2 (study design 2.2.3) Body weight and 
kilocaloric intake were recorded weekly. Whole body MRS and MRI, and localised 
liver MRS was performed in mice at 14 weeks old, to assess body composition and 
liver fat content. MEMRI was performed in mice at week 15 to assess neural activity 
in the hypothalamus. IPGTT was performed at week 14 in a different subset of 
animals. Tissue samples were collected at the end of the study (15 weeks old). 
Adipocyte size distribution was assessed in both gonadal and subcutaneous 
adipose tissue in males only.  
 
 
 
 
 
MRS-MRI = 14 weeks old 
MEMRI = 15 weeks old 
 
IPGTT =14 weeks old 
 
Plasma - tissue 
collection= 15 weeks old 
Biochemistry 
Adipocyte size distribution 
 
Body weight, kcal intake= 
weekly (from 3 weeks old 
until 15 weeks old) 
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2.3 Study 3. Effects of Birth Weight and Diet on Body 
Composition in Matured Mice (from 16 weeks old to 51 weeks 
old) 
 
2.3.1 Animals  
All protocols were conducted in accordance with the UK Animals (Scientific 
Procedures) Act, 1986. C57BL/6J offspring mice were housed in individually 
ventilated cages under controlled conditions (12h:12h dark-light cycle and 
21-23°C) with ad libitum access to food and water.  
 
2.3.2 Diet composition 
The two diets used in this study were a purified normal fat control diet (TD 
05072, 9% kcal fat intake) and purified moderated high fat diet (TD 05073, 
27% kcal fat intake). Anhydrous milk fat was used as the source of saturated 
fat in both diets as in study 2. The macronutrient composition of the diets is 
shown in table 2 (section 2.2.2). 
 
2.3.3 Study design  
The study design for this study was followed as described in the study 2 
(section 2.2.3).  Mice were kept until the age of 51 weeks and maintained on 
the same diets as described in the study 2 throughout post weaning life.  
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2.3.4 Methods 
The diagram of this study is shown in figure 2.3.4.1 Body weight and 
kilocaloric intake were monitored weekly. Adipose tissue index was 
calculated from the weight of gonadal, mesenteric, retroperitoneal and 
subcutaneous adipose tissues of mice at the end of the study (51 weeks old). 
Tissues were harvested and weighed at the end of the study and metabolic 
markers were assessed in plasma samples. Samples of gonadal and 
subcutaneous adipose tissue were taken for adipose cell extraction and 
analysis of adipose cell number and distribution. Details of these methods 
are described in section 2.4.  
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Figure 2.3.4.1 Diagram of the methods for study 3. Mice were weaned and groups 
were formed as described in study 2 (study design 2.2.3) Body weight and 
kilocaloric intake were recorded weekly. Adipose tissue index was calculated from 
the pad weight of gonadal, mesenteric, retroperitoneal and subcutaneous adipose 
tissues. Tissue samples were collected at the end of the study (51 weeks old). 
 
 
 
 
 
 
 
Adipose tissue index= end 
of the study (51 weeks). 
 
 
 
Plasma - tissue collection= 
Biochemical 
analysis=plasma 
 
Adipocyte distribution= 
gonadal and subcutaneous 
adipose tissue.  
 
Body weight, kcal intake= 
weekly (from 16 weeks old 
until 51 weeks old) 
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2.4 Methods Used to Study the Effects of Birth Weight and 
Accelerated Weight on Body Composition and Appetite 
Regulation 
 
2.4.1 Whole body 1H MRS and MRI as a tool to study body composition 
and liver fat content; brief overview 
 
In this project, body adiposity was assessed using whole body Magnetic 
Resonance Imaging (MRI) and Proton Magnetic Resonance Spectroscopy 
(1H MRS) and hepatic fat content was quantified using localised 1H MRS.  
 
Magnetic Resonance Imaging (MRI) is a powerful non-invasive imaging 
technique used for functional, anatomical and molecular studies in humans 
and animal models. It has also the advantages of a high spatial resolution 
and better contrast resolution between soft tissues (such as brain, muscle, 
adipose tissue, etc.) compared to other invasive techniques such as 
Computerised Axial Tomography (CAT) or Dual Energy X-ray Absorptiometry 
(DEXA) (Makowski, Wiethoff et al. 2009). Moreover, it is ideal for longitudinal 
studies, as unlike CAT or DEXA it does not use radiation.  
 
MRI is a technique that allows an accurate and reproducible measurement of 
compartmental adipose tissue stores that could not be predicted from indirect 
measurements such as Body Mass Index (BMI) and waist to hip ratio.  
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While MRI gives information about structural conditions of tissues 
(distribution, localisation and volume), MRS provides biochemical analysis of 
those tissues and fluids (chemical composition) (Ross, Leger et al. 1991).  
 
Proton Magnetic Resonance Spectroscopy (1H MRS) has been used to 
detect and quantify whole body fat and ectopic fat in organs such as liver, 
muscle, heart and pancreas (Thomas, Parkinson et al. 2012). Whole body 1H 
MRS takes advantage of the differential behaviour of protons associated with 
lipids versus water when placed in a magnetic field and thus, yielding 
discrete peaks of proton resonance frequency that correspond to body lipid 
and body water (Ross, Leger et al. 1991, Mystkowski, Shankland et al. 
2000). When ectopic fat is quantified, MRI is used to localise the organ of 
interest and it is combined with MRS to obtain total lipid content versus water 
content.  
 
2.4.1.1 Preparation of animals for whole body MRS and MRI 
Mice were fasted overnight for 16-18 hours. Before scanning, anesthesia 
was induced with a 4-3% oxygen-isofluorane mix via a facemask. This mix 
was maintained at 2% oxygen-2% isofluorane according to respiration and 
body temperature during the scan. Respiration and temperature were 
monitored using a standard monitoring equipment (SA Instruments, Inc). The 
temperature was kept at 37°C and the respiration rate maintained at 60-80 
breaths per minute (bpm) approximately. Mice were positioned dorsally in a 
whole body birdcage coil and scanned in a 4.7T Unity Inova MR scanner 
(Agilent Technologies) as shown in figure 2.4.1.1.2. 
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Figure 2.4.1.1.2 Positioning a mouse on a bed before placing it inside the 
radiofrequency coil (RF coil). The mouse was prepared for scanning in a dorsal 
position. A rectal temperature probe was placed to control the temperature at 37°C 
and a breathing pad was placed on the chest centrally to monitor the respiration.  
 
2.4.1.3 Parameters used for whole body MRI 
Following a preliminary image to determine the correct positioning of the 
mouse in the bore of the scanner (scout image figure 2.4.1.3.1.a), 
consecutive transverse MR images were collected using a T1-weighted Spin 
Echo Multislice (SEMS) sequence with the following parameters:  
 
Orientation: transverse 
Repetition time (TR): 2.2s 
Echo time (TE): 20ms 
Field of view (FOV): 45mm x 45mm, 
Matrix size: 256 x 192 
Averages: 2 
RF	  coil 
Rectal	  temperature	  probe 
Face	  mask 
Respiration	  pad 
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Slice thickness:  2mm  
Slices: interleaved 
Number of slices: 45-50 
 
The images collected were converted into stack images and saved into the 
appropriate format using ImageJ (Rasband). Image segmentation analysis 
was performed using a SliceOmaticTM software (Tomovision®, Montreal, 
Canada) to provide volumes and mass of total, internal and subcutaneous 
adipose tissue depots.  A trained analyst blinded to the study performed the 
analysis. The images obtained are T1-weighted images and thus, adipose 
tissue appears brighter compared to other tissues. Pixels of this contrast 
were manually assigned as adipose tissue and tagged in a particular color 
for better quantification (figure 2.4.1.3.1b and c). 
 
To calculate the volume of adipose tissue, the following equation was used: 
Volume of adipose tissue (mm3)= (FOV / matrix size) 2 x number of 
pixels x slice thickness (mm) 
 
Imaging parameters described above for FOV, matrix size and slice 
thickness were used along for the calculation of volumes with the number of 
pixels highlighted for a specific adipose tissue depot.  
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The calculated volumes were then converted into adipose tissue mass in 
grams by using the density of adipose tissue (0.92 g/mm3). The equation 
used for this conversion was:  
Adipose tissue mass (g)= adipose tissue volume (mm3) x 0.92 g/ mm3 
 
This adipose tissue mass was then expressed as percentage adipose tissue 
in respect to individual body weights: 
% Adiposity= 100x adipose tissue (g) /body weight (g) 
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Figure 2.4.1.3.1 Images across the body using MRI. A) A sagittal scout image 
through the whole mouse body (head to tail, left to right) including 50 slices (in 
yellow) placed where they will be acquired. B) A representative image of a 
transverse slice acquired in the abdominal region and C) the same slice after fat 
segmentation (subcutaneous adipose tissue in green and internal adipose tissue in 
red). (Picture kindly provided by Dr. Jelena Anastasovska). 
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2.4.1.4 Parameters used for whole body 1H MRS  
Whole body 1H MRS was performed using a single pulse sequence 
(SPULS) with the following parameters: 
Repetition time (TR): 10 s 
Pulse angle: 45° 
Averages: 4 
Spectral width (SW): 20.000 Hz 
 
The spectra obtained (peaks) were analysed using MNOVA version 8.0 
(Santiago de Compostela, Spain). After automated Fourier transformation, 
an exponential line broadening (apodisation) of 1.5 Hz was applied. After 
this, spectra were phasing and baseline corrected. Areas under the curve for 
individual spectra were obtained using line integrals. The water peak 
obtained was referenced at 4.7 ppm and the lipid peak referenced at 1.2-1.3 
ppm. The lipid integral represents the lipid content as a percentage of the 
water integral (figure 2.4.1.4.1). 
 
To calculate whole body adiposity, the individual lipid and water integrals 
from above were employed. Lean mass was predicted using the equation 
lean mass= 0.38*(integral water) as described by Mystkowski (Mystkowski, 
Shankland et al. 2000). The percentage of total body adiposity was therefore 
calculated using the following equation:  
Total adiposity (%)= Lipid integral  /  (lipid integral + water integral + 
0.38 x (water integral).  Value of the water integral was assumed to be 1 for 
correspondent percentage assignation of lipid peaks.  
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Figure 2.4.1.4.1 A representative whole body spectrum of a mouse obtained using 
MNOVA software. Integrals of water and lipid peaks are highlighted above. Lipid 
content in this spectrum is 63% relative to the water content of the mouse. The 
percentage of whole body adiposity was 31.34% obtained by substituting the fat 
integral (0.63) and water integral (1) into the equation mentioned above. Water 
integral was always 1 for all individuals. 
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2.4.1.5 Parameters used for localised 1H hepatic MRS 
To be able to visualise the liver for fat quantification, MRI was performed as 
described in section 2.4.1.3.  When liver images were obtained, a Point 
Resolved Spectroscopy (PRESS) sequence was used, placing a single voxel 
on the top left of the liver (figure 2.4.1.5.1). The following parameters were 
applied:  
 
Voxel size: 2x2x2 mm3   
TR: 10 s 
TE: 9 ms 
Averages: 64 
Spectral width: 20.000 Hz 
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Figure 2.4.1.5.1 A transverse MR image slice through the liver, with a 2x2x2mm3 
voxel placed on the top left of the liver (in respect to the location of the mouse). 
Attention was paid to the placement of the voxel to ensure 1H MR spectra are 
acquired from the same location in all individuals.  A dead space was left between 
the voxel and possible interferences such as fat areas, presence of vessels or 
borders of the liver in order to keep a homogeneous area of quantification. 
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2.4.2 Manganese Enhanced Magnetic Resonance Imaging (MEMRI) as a 
tool to study hypothalamic activity 
 
Manganese Enhanced MRI (MEMRI) is an emerging contrast agent based 
technique used for high resolution imaging of animal brain in vivo for 
anatomical, functional and neural connectivity studies (Pautler 2004).  
 
MEMRI relies on the shortening effect of divalent manganese ions (Mn2+) on 
the T1 relaxation times of tissue water. As a consequence of this effect, T1- 
weighted images become brighter in areas with sufficient manganese 
accumulation (Lin and Koretsky 1997).  Mn2+ ions are also a calcium (Ca2+) 
analog and therefore can be taken up by excitable cells, such as neurons 
and cardiac cells via voltage-gated Ca2+ channels. Influx of Ca2+ into neurons 
is necessary for release of neurotransmitters, which is the result of neural 
activation. This supports the notion that the uptake of Mn2+   by a neuron is 
directly coupled to its physiologic activity and function.  
 
Others advantages of Mn2+ in MRI is that these ions accumulate in the 
activated neural tissue and have a slow clearance from the stimulated region 
of the brain. This allows the measurement of peak, or steady state activity 
during the two-hour period of the scan used in this project.  Our laboratory 
has previously shown that Mn2+ can enter key appetite centres within the 
hypothalamus. Kuo et al and Anastasovksa et al have shown that this 
technique is able to detect significant changes in neural activity by Mn+2 
uptake in experiments involving gut hormone administration and nutritional 
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interventions (Parkinson, Chaudhri et al. 2009, Anastasovska, Arora et al. 
2012). 
2.4.2.1 Preparation of animals for MEMRI  
MEMRI was performed to visualise and quantify neural activity in specific 
regions of the hypothalamus in the brain associated with appetite. Before 
scanning, anesthesia was induced with a 4-3% oxygen-isofluorane mix via a 
facemask. This mix was maintained at 2% oxygen-(1.0-1.5)% isofluorane 
according to respiration and body temperature during the scan, using a 
standard monitoring equipment (SA Instruments, Inc). The temperature was 
kept at 37°C and the respiration maintained at around 90-100 bpm before 
manganese infusion and at 30-50 bpm after infusion. Mice were positioned 
ventrally in a bed and mice were cannulated in the tail vein using a 27G 
butterfly cannula connected via an infusion line to a syringe containing 
100mM MnCl2 solution that was placed in a syringe pump (Harvard 
Apparatus). The head of the mice were placed and fixed in a transmit-receive 
birdcage head coil and scanned in a 9.4T Unity Inova MR scanner (Agilent 
Technologies) as shown in figure 2.4.2.1.2. 
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Figure 2.4.2.1.2 Set up of a mouse for MEMRI. a) Mouse set up in the bed with its 
head restrained in a head holder and with the i.v. cannula (butterfly) placed in the 
tail vein for infusion of MnCl2 solution. b) Mouse head placed inside the RF coil, 
which was placed inside a cradle in a specific position, so that once placed inside 
the bore of the scanner it will remain isocentred.  Anaesthesia is maintained through 
a face mask. Breathing rate and temperature are monitored via a breathing pad and 
the rectal temperature probe respectively connected to a standard monitoring 
system.  
 
 
 
 
 
 a) 
b) 
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2.4.2.2 Parameters used for MEMRI 
Following a preliminary image to determine the correct positioning of the 
mouse head in the bore of the scanner, transverse MR images were 
acquired repeatedly in an array, 66 times, using a two dimensional (2D) Fast 
Spin Echo Multislice (F-SEMS) sequence with the following parameters: 
 
Orientation: transverse 
TR: 1.8s 
ETL: 6ms 
Effective TE: 5.20 ms 
FOV: 25mmx25mm 
Matrix size: 192x192 
Averages: 2 
Slice thickness: 0.4mm 
Slices: interleaved 
Number of slices per array: 46 
Array: 66 acquisitions of the 46 slices, each 1 min 55 seconds long, with  
1-second time gap between acquisitions. 
 
Slices were piloted so that the whole brain was covered (scout image figure 
2.4.2.2.1). Correction for inhomogeneities in the magnetic field (shimming) 
was performed using a fast-map automated shimming on a 4x4x4 mm3 voxel 
placed in the brain.  
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Figure 2.4.2.2.1 Piloting of the transverse MRI images across the brain. a) A sagittal 
pilot image (scout image) through the mouse head, with the brain delineated in 
yellow. b) A sagittal scout image of the brain with the 46 slices placed in the location 
where they will be acquired. c) A transverse slice acquired in the hypothalamus 
before and d) after MnCl2 infusion. (Picture kindly provided by Dr. Jelena 
Anastasovska). 
 
At the end of the third acquisition, MnCl2 infusion was started using a syringe 
pump at a rate of 0.2ml/g of Fat Free Mass (FFM)/hour at a dose of 
0.5mmol/g of FFM. Each mouse received a volume of 5ul of 100mM MnCl2   
per gram of fat free body mass. Fat free mass (FFM) was calculated using 
the integral of the lipid peak from the whole body MRS by using the equation 
described by Mystkowski et al., 2000) and converting percentages to grams 
as followed: 
Fat Free Mass (FFM)= (100-% adiposity) x 0.01 x total body mass (body 
weight). 
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Motion correction was applied to acquire images and then registered to a 
brain atlas (Dorr et al, 2008) by using the tools from AFNI (Medical College 
of Wisconsin) and FSL (FMRIB, UK).  Specific Regions of Interest (ROI) 
were identified and manually delineated using the brain atlas aforementioned 
as a model for further regional specific measurement of Signal Intensities 
(SI) throughout the 66 arrays per each slice (ARC, VMH, PVN, Pe nuclei; 
figure 2.4.2.2.1). Each SI measurement collected was normalised to that of 
the 4th ventricle, which is outside the Blood Brain Barrier (BBB). As the 4th 
ventricle lies outside the BBB, it was chosen as a suitable control for the 
correction for the differences in rates at which MnCl2 is entering to the brain. 
This normalisation was assumed to correct any differences in the dose of 
MnCl2 received to the brain of each mouse. The 4th ventricle was also used 
as a reference for successful arrival of MnCl2 to the brain and to evaluate 
differences in the circulation among animals. The Normalised Percentage 
Enhancement (NPE) in SIs was calculated for each mouse by calculating the 
percentage change of SI measurement from baseline SI (before MnCl2 
infusion).  
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Figure 2.4.2.2.1 Regions of Interest (ROI) highlighting appetite centres analysed in 
hypothalamus by MEMRI. The diagram on the top shows the mouse brain with the 
location of the slices shown below it (a-c). These pictures are transverse images 
through the hypothalamus (shown within a highlighted yellow square, which has 
been enlarged in the images below (i-iv), after IV MnCl2 infusion. The ROIs used for 
SIs measurements in the hypothalamus were drawn, highlighting the approximate 
location of the following regions: PVN: Paraventricular Nucleus (a,i), ARC: Arcuate 
Nucleus and VMH: Ventromedial Hypothalamic nucleus (b,ii), AP: Anterior Pituitary 
(c,iii) and 4th ventricle (d,iv). (Picture kindly provided by Dr. Meliz Sahuri). 
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2.4.3 Intraperitoneal Glucose Tolerance Test (IPGTT) 
Intraperitoneal glucose tolerance test measures the changes in blood 
glucose levels over a 2-hour interval following the administration of an 
intraperitoneally injected glucose load from the body. Altered changes in 
blood glucose levels (clearance of glucose) help to identify disturbances in 
glucose metabolism in conjunction with other parameters such as fasting 
glucose and insulin levels.  
 
Mice were fasted overnight for 16-18 hours before glucose measurements. 
Baseline (fasting) glucose concentrations were determined before injecting 
the mice intraperitoneally with 2g/Kg body weight of 20% D-glucose. Blood 
glucose concentrations were detected after 15,30,60 and 120 minutes of the 
glucose load. Glucose levels were measured using a commercially available 
glucometer and glucose strips (Boots Stores, UK and Abbott Diabetes care 
UK respectively). Glucose tolerance was analysed at each time point and by 
calculating the area under the curve (AUC).  
 
2.4.5 Tissue harvesting 
Tissues were collected between 10:00 and 12:00 pm from fed mice. 
Anaesthesia was induced with a 4-3% oxygen-isoflurane mix and maintained 
at 3-2% with the same mix. Blood samples were taken by cardio puncture 
and collected in EDTA-coated vacutainers. Protein inhibitors were added to 
blood samples to avoid further protein degradation (100µl/ml plasma of 
AEBSF (Pefabloc Sc. Roche), 10µl protease inhibitor cocktail (Sigma, UK) 
and DPPIV inhibitor (Millipore, USA)). Blood was gently inverted to mix and 
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then centrifuged for 15 minutes at 4500 rpm at 4°C. Plasma was separated 
and aliquoted in 1.5 ml eppendorf tubes and stored at -80°C for further 
analysis.  
 
Different organs were collected and frozen on dry ice and then stored at -
80°C. White adipose tissue (subcutaneous, gonadal, retroperitoneal and 
mesenteric), brown adipose tissue, liver, pancreas, kidneys, heart and hind 
limb muscle were dissected and weighed in an analytical balance. Brains 
were weighed and immediately fast frozen with isopentane (2-methyl 
butane), which was cooled with dry ice first (placing the isopentane in a 
beaker throughout the process). Brains were immersed in isopentane for 25 
seconds and then stored at -80°C as with the others harvested tissues for 
further analysis. 
 
2.4.6 Adipocytes extraction for cell counting and distribution  
Samples of adipose tissue (subcutaneous and gonadal adipose tissue) were 
used to extract adipocytes for cell quantification and to assess the relative 
distribution of these cells using a Beckman Coulter Multisizer 4 (MIAMI, FL, 
USA).  The principle of this instrument is based on an electrical conductivity 
difference between particles and common diluent (Isoton II, Beckman 
Instruments). Particles act as insulators and diluents as good conductors. 
 
 The particles suspended in an electrolyte are made to pass through a small 
aperture in which an electrical current path has been established. As each 
particle displaces electrolyte in the aperture, a pulse essentially proportional 
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to the particle volume is produced. Particles in the range of 1 to 500µm can 
be counted and measured volumetrically.  
 
Subcutaneous and gonadal adipose tissues were dissected and immediately 
weighed. A collagenase solution was prepared with a 4% albumin in a 
concentration of 1mg of collagenase (Type I; Sigma Aldrich (C0130) per 
milliliter of Dulbecco’s Modified Eagle Medium (DMEM, Gibco®). Samples of 
40-50 mg of tissue were minced and digested in a bijou tube containing 1ml 
of the collagenase solution described before per each 0.5mg of adipose 
tissue. Subsequently, minced tissues were incubated at 37°C in a shaking 
water bath (145 cycles/min) for 90 minutes. The cell suspension produced 
was then gently filtered in a 250µm diameter nylon mesh, washed three 
times with DMEM media enriched with 4% albumin and 1mg of trypsin 
inhibitor per 40ml of media.  
 
Adipocytes layer (top layer) was transferred to a clean sterilin tube and 
resuspended in DMEM + 4 % albumin and kept in the shaking water bath 
(135 cycles/min) for 15-20 minutes at 37 °C.  After this, cell suspensions 
were counted using the Coulter Counter Multisizer 4. Cell suspensions were 
swirled before counting to ensure even suspension. Blank readings using 
100 ml of isoton buffer were performed before proceeding with the cell 
counting. 500µl of the cell suspensions was added to 100ml isoton buffer 
and counted using a 200µm diameter aperture under continuing stirring. The 
effective cell size range used was 20µm to 120µm. Cells size distribution 
was calculated as relative frequencies (%).  
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2.4.7 Biochemical analysis in plasma  
A Milliplex MAG Mouse Metabolic Hormone (MMHMAG) panel was used to 
assess metabolic biomarkers in plasma samples (Millipore, USA). Milliplex 
MAG is an immunofluorescence technique that uses fluorescent coded 
magnetic beads (microspheres) as the substrate on which assays are 
performed. These microspheres are internally color-coded with two different 
fluorescent dyes. In the assay, the beads capture a specific analyte from the 
sample, and then a biotinylated detection antibody is introduced. The 
reaction is then incubated with Streptavidin-PhycoErythrin (Streptavidin-PE) 
conjugate to capture the biotinylated protein of interest. The Streptavidin 
binding protein is conjugated to the reporter molecule (chromophore) PE for 
the final detection. The microspheres in each well of the plate are then 
quantified by the Mag Pix system, which is a fluorescent-based detection 
system that uses imaging technology for precise quantification.  
 
The microspheres pass through a laser, which excites the internal dyes 
marking the microsphere set. A second laser excites the chromophore PE 
whose fluorescence signal is quantified. Subsequently, high-speed digital 
signal processors identify each individual microsphere and quantify the 
concentration of each biomarker based on the fluorescent reporter signals. 
The software used to quantify the results was xPonent software for curve 
fitting analysis (Luminex Corp, US) incorporated in the Mag Pix system. This 
system uses a magnetic field to force the beads onto solid surface where 
they can be imaged and quantify. 
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The assay was performed according to the manufacturer’s protocol using 
undiluted plasma (see figures 2.4.7.1 and 2.4.7.2 for a brief description). The 
volume of sample used in this assay was 10µl and 10 metabolic biomarkers 
were quantified per sample: insulin, leptin, glucagon, resistin, MCP-1, GIP, 
C-peptide, ghrelin, TNF-alpha and IL-6.   
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Figure 2.4.7.1 Schematic of the protocol used for the Milliplex MAG Mouse 
Metabolic Hormone (MMHMAG) panel on day 1. Protocol followed according to the 
manufacturer’s guidance.  
 
 
 
Standard preparation (7): dilution 1:5 
Assay buffer added per well (200µl) 
Plate shaking per 10 min (RT) 
Removal of buffer by decantation 
10µl matrix solution to background,  
standards, and control wells  
10µl assay buffer to background and sample wells 
10µl standard or control to appropriate wells 
10µl sample to appropriate wells 
25µl beads mix to each well 
Incubation overnight (18-20hours) at 4°C, on a plate shaker  
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Figure 2.4.7.2 Schematic of the protocol used for the Milliplex MAG Mouse 
Metabolic Hormone (MMHMAG) panel in day 2. Sheath fluid or flow cell-liquid 
stream carries and aligns the cells so that they pass single file through the light 
beam for sensing. Protocol followed according to the manufacturer’s guidance. 
 
Next day after incubation overnight 
Reagents and assay plate left at 
RT for 20min 
Plate on plate shaker for 1 min and placed on the magnet of the plate washer 
for 60s prior to aspiration 
Decantation of excess in the plate and washing 3 times with 200µl wash buffer 
50µl detection antibody added per well 
Incubation for 30 min at RT 
Not decantation 
50µl Streptavidin-Phycoerythrin per well 
Incubation for 30 min at RT 
Decantation and washing 3 times 
with 200µl wash buffer  
100µl sheath fluid per well 
Plate read on Mag Pix system  
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2.4.8 Gene expression analysis 
2.4.8.1 RNA extraction 
Adipose tissue (subcutaneous adipose tissue) RNA was extracted using a 
RNeasy Lipid Tissue Mini Kit, which integrates a phenol/guanidine-based 
sample lysis and silica-membrane purification of total RNA. QIAzol lysis 
reagent was used as homogeniser to facilitate lysis of adipose tissue and 
inhibition of RNases.  General protocol can be seen in figure 2.4.8.1.2. 
 
40-50mg of frozen adipose tissue was placed in 2ml microcentrifuge tubes, 
and kept on dry ice during this step. Care was taken when weighing and 
placing tissues in tubes in order to avoid thawing during handling. 
Subsequently, tubes were placed at room temperature and tissues were 
disrupted and homogenised by placing one steel bead (5mm mean diameter) 
to each microcentrifuge tube, adding 1ml QIAzol lysis reagent immediately 
after, and placing tubes in a TissueLyser Adapter set 2x24 for 2 minutes at 
20Hz twice (rotating the rack of tubes before repeating the process for even 
homogenisation).  
 
Lysates (homogenates) were pipetted into new 1.5 ml tubes and kept at 
room temperature for 5 minutes. 200µl chloroform were added and tubes 
were securely cap and vigorously shaken for 15 seconds by hand, before 
being left a further 2-3 minutes at room temperature. Samples were then 
centrifuged at 12000 x g for 15 minutes at 4°C. The aqueous phase 
(containing the RNA) was transferred to a new 1.5ml eppendorf tube and 1 
volume (usually 600µl) of 70% ethanol was added to the aqueous phase and 
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mixed by vortexing to precipitate the RNA. Samples were transferred to the 
RNeasy spin column (which was placed in a 2ml eppendorf tube) and 
centrifuged for 15 seconds at ≥8000 x g  at 23°C and flow through discarded. 
Membranes (columns) were washed with two different buffers (included in 
the kit) as specified in the manufacturer’s protocol. Subsequently, columns 
were left to dry for 10 minutes at room temperature in a new 1.5ml eppendorf 
tube. Finally, RNA was eluted using 30µl RNase-free water and centrifuging 
for 1 minute at ≥8000 x g. RNA was stored at -80°C until further use.  
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Figure 2.4.8.1.2 RNA Extraction procedure. Steps required for the extraction of RNA 
form adipose tissue, using RNeasy Lipid Tissue Mini Kit, Qiagen. Procedure was 
followed as described in the manufacturer’s protocol. Figure reproduced from 
manufacture’s handbook. 
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2.4.8.2 RNA quantification and cDNA synthesis 
The amount of RNA extracted (as described above) was quantified using a 
NanoDrop 2000 spectrophotometer (Thermo Scientific, USA). The Nanodrop 
measures RNA quantity using only 1-2 µl of the sample. The sample is 
pipetted directly onto an optical measurement surface.  A drop of the RNA 
(diluted in RNAase free water) is held in place by inherent surface tension 
during the analysis. The 260nm/280nm was automatically calculated. The 
ratio of absorbance at 260nm and 280nm was used to assess the purity of 
RNA. A ratio of approximately 2.0 was accepted as pure RNA as indicated in 
the manufacturer manual. Approximately 500-800ng/µl was obtained per 
adipose tissue sample.  
 
2.4.8.3 cDNA synthesis 
Complementary DNA (cDNA) synthesis is the first step of the two-step 
quantitative reverse transcriptase Polymerase Chain Reaction (RT-qPCR). 
cDNA is generated by the enzyme reverse transcriptase (RT), which has the 
ability to use the information in the RNA to generate the DNA that is 
complementary to the messenger RNAs (mRNAs) that encodes proteins of 
interest. mRNA is transcribed into complementary DNA (cDNA) by using the 
RT with access to the four Deoxynucleotide Triphosphates (dNTPs) and a 
short sequence of deoxy –Thymine nucleotides (oligo(dT)20) primers to be 
able to initiate synthesis de novo. Subsequently, mRNA is removed by using 
an RNAase enzyme (RNAaseOUTTM) leaving a single stranded cDNA ready 
for the secondreal time Polymerase chain Reaction (RT-PCR). 
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2µg of subcutaneous adipose tissue RNA was used to synthesise cDNA as 
described in the Thermoscript Reverse Transcriptase Polymerase Chain 
Reaction RT-PCR System protocol (Invitrogen, UK). This system is used for 
the detection and analysis of RNA molecules in a two-step RT-qPCR 
process. RNA was added to a mix of oligo (dT)20 primer, 10mM 
deoxyribonucleotide triphosphate mix (dNTP), and Diethylpyrocarbonate 
(DEPC)-treated water or RNAase-free water. RNA was denatured by 
incubation in a thermal cycler preheated at 65°C for 5 minutes and 
immediately placed on ice. The samples were then incubated with 5x cDNA 
synthesis buffer, 0.1M Dithriothreitol (DTT; it stabilises and facilitates the 
enzymatic activity of the RT and RNAase inhibitor), DEPC-treated water, 
RNAaseOUTTM enzyme, and avian Thermoscript Reverse Transcriptase. 
cDNA synthesis was completed by incubating the samples at 50°C for 60 
minutes and ending the reaction at 85°C for 5 minutes, after which the 
samples were stored at -20°C until real-time PCR was performed.  
 
2.4.8.4 Real time quantitative PCR Polymerase Chain Reaction (RT-
qPCR) 
Gene expression in subcutaneous tissue was determined by Real Time 
Quantitative Polymerase Chain Reaction (RT-qPCR). Sequence specific 
primers bind to the cDNA previously obtained in the first step of the RT-
qPCR (section 2.4.8.3). The amount of amplified product is measured at 
each PCR cycle by using fluorescent probes and reading the signal emitted 
from the dyes while performing the thermal cycling.   
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The real time PCR reaction consists of three important steps that make up 
each cycle. These steps are: 1) Denaturation at 95°C, where high 
temperature incubation “melts” the double-stranded DNA (dsDNA) into 
single-stranded DNA (ssDNA) and loosen secondary structures in single 
stranded DNA. 2) Annealing at 60°C, during which primers of the gene of 
interest hybridise to complementary ssDNA. 3) Extension at 60°C; once 
primers are hybridised they are elongated, making a copy of the gene of 
interest.  
 
4µl of cDNA was mixed with 5µl of RNAase water, (10-20ng of cDNA) 10 µl 
of TaqMan Universal Master Mix II no UNG, 1 µl of TaqMan gene of interest, 
for a total volume of 20µl per reaction. Samples and mix were added in 
triplicate to a MicroAmp Fast 96-well reaction plate (Applied Biosystems, 
USA), including a 1:5 serial dilution of the cDNA templates used for each 
primer.  
 
Actin beta (Actb) and Hypoxanthine-guanine phosphoribosyltransferase 
(Hprt) (TaqMan, Life Technologies, UK) were tested to find the best control 
for normalisation. No significant differences were found between groups. 
Therefore, Actb was chosen as control for normalisation of all genes of 
interest. Plates were sealed with a PCR-specific seal (Invitrogen, UK) then 
placed in a preheated Applied Biosystems 7500 Fast Real-Time PCR 
System at a cycling program of polymerase activation at 95°C for 10 
minutes, 40 cycles of denaturation at 95°C for 15 seconds and annealing 
and extension at 60°C for 1 minute.  
	   126	  
Baseline was set at the range of 3 to 15 cycles of amplification. The 
threshold was set at 0.1 for all readings. The threshold is the level of signal 
that reflects a statistically significant increase over the calculated baseline 
signal. It is set above the background and within the exponential growth 
phase of the amplification curve. The threshold cycle (Ct) is the cycle number 
at which the fluorescent signal of the reaction crosses the threshold. This 
value is proportionate to the initial amount of cDNA copy number. List of 
TaqMan genes of interest used for the gene expression assays are shown in 
table 2.4.8.4.1. 
 
Gene expression level was analysed using a comparative quantification 
method delta delta Ct values. This method assesses the fold change 
compared to a calibrator sample (control or group of reference). Cts for 
genes of interest in both the calibrator and test samples are adjusted in 
relation to a reference (housekeeper) gene (B-actin) Ct from the same two 
samples (calibrator and test sample). The delta delta value is then used to 
determine the fold change or difference in expression of the gene of interest 
in respect to the control or reference group (Bookout & Mangelsdorf, 2003; 
Bookout et al., 2006). Equations used for the analysis are described below. 
 
Delta Ct sample= Av Cts gene of interest - Av Cts B-actin 
Delta Ct calibrator= Av Ctc gene of interest - Av Ctc B-actin 
 
St.dev. delta Ct=     (st. dev. B-actin)2 + (st. dev. GOI)2 
Delta delta Ct= delta Ct sample - delta Ct calibrator 
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St.dev. delta delta Ct= St. dev. delta Ct 
Fold induction for each sample relative to calibrator = 2 (-delta delta Ct) 
St.dev. fold change= (ln2) (st.dev. delta delta Ct)(2- delta delta Ct ) 
 
Gene Symbol Gene Name TaqMan Assay ID 
C/EBP alpha CCAAT/ enhancer binding 
protein (C/EBP) alpha 
Mm00514283_s1 
Glut4/Sic2a4 Solute carrier family 2 
(facilitated glucose 
transporter), member 4 
Mm01245502_m1 
HSL Hormone sensitive lipase Mm00495359_m1 
IRS Insulin receptor substrate 1 Mm01278327_m1 
PGC-1a Peroxisome proliferative 
activated receptor, gamma, 
coactivator 1 alpha 
Mm01208835_m1 
PIK3cb/p110beta Phosphatidylinositol 3-
kinase, catalytic, beta 
polypeptide or p110beta 
Mm00659576_m1 
PrKCZ Protein kinase C, zeta Mm00776345_g1 
PPARG2 Peroxisome proliferator 
activated receptor gamma 
Mm01184322_m1 
UCP-1 Uncoupling protein 1 
(mitochondrial, proton 
carrier) 
Mm01244861_m1 
Serbf1/SREBP1c Sterol regulatory element 
binding transcription factor-
1 
Mm00550338_m1 
 
Table 2.4.8.4.1 Genes used for gene expression analysis using subcutaneous 
adipose tissue as tissue of interest.  
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2.4.5 Statistics 
Normal distribution was assessed using a Kolmogorov-Smirnov test and 
homogeneity of variances was assessed using the Levene’s test. Data that 
did not have a normal distribution was analysed using a Mann-Whitney test 
or other non-parametric analysis. Whether homogeneity of variances was 
significant, a test for unequal variances, or natural log transformation of the 
data followed by a parametric test was used for the analysis. Data was 
reported as means ±SEM if a parametric analysis was used or as medians 
with interquartile range (25%-75%) if a non-parametric test was used for the 
analysis. Natural log transformed data was presented as means with a 95% 
confidential interval.  P values ≤ 0.05 were considered statistically significant. 
Analysis was performed and reported separately by sex.  
 
A two factorial analysis General Linear Model (GLM, 2x2) was used to 
assess the effects of birth (LBW-HBW) and postnatal diets (NF-HF), and 
their interactions on body fat content, food intake and feed efficiency in study 
2. When interactions were significant, simple main effects were analysed. A 
mixed general linear model followed by an appropriate post hoc analysis was 
used for body weight analysis or as specified. One-way ANOVA was used for 
between groups analysis for biochemical analysis, gene expression, and 
adipose cell distribution followed by a protected Fisher’s least significant 
difference (LSD) post hoc analysis or Tukey’s high significance difference 
(HSD) post hoc analysis if necessary.  Area Under the Curve (AUC) was 
used for IPGTT analysis as well as a time point Mann-Whitney analysis.  
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The software used for the statistical analysis was SPSS (IBM Statistics) and 
GraphPad (San Diego, CA, USA; version 4) when required. 
 
MEMRI analysis was conducted using Generalised Estimating Equation 
(GEE) for continuous data (STATA 9.1 software; Stata Corp, College Station, 
TX, USA) as described in previous publications (Kuo, Herlihy et al. 2006, 
Anastasovska, Arora et al. 2012).  
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3. Study 1. The Effects of Birth Weight and 
Accelerated Growth on Body Composition and 
Appetite Regulation During Lactation (Birth to 3 
Weeks) 
 
3.1 The Effects of Birth weight and Accelerated Growth on 
Body Weight During Lactation (Birth to 3 Weeks) 
 
The protocol of this study is described in section 2.1. Pregnant females were 
caged individually and fed a standardised purified diet (20% protein kcal 
intake). After 24 hours of delivery, pups were weighed and labelled and kept 
within the same litter until the time of weaning, which was at the end of 
lactation (3 weeks old). As described in study 1 (section 2.1.3), mice were 
classified as either Low birth weight male/female mice (LBWm/f) or High 
birth weight male/female mice (HBWm/f). The average body weight at birth 
of all litters was 1.28 ±0.1g with no significant differences between genders: 
males (m)= 1.28 ±0.1g and females (f)=1.29±0.1g; p=0.81, unpaired student 
t-test.  Figures 3.1.1 and 3.1.2 show the growth curve during lactation of both 
males and females respectively.  
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3.1.1 Body weight in Males 
Males with a High birth weight (HBWm) were significantly heavier than those 
males with a Low birth weight (LBWm) throughout lactation (figure 3.1.1.1 
and table 3.1.1.1).  
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Figure 3.1.1.1 Body weight of High birth weight male and female mice (HBWm/f) 
and Low birth weight male and female mice (LBWm/f) throughout lactation (birth to 
3 weeks). Data for male a) and female offspring b). Statistical analysis was 
performed using repeated measures ANOVA followed by a Tukey’s high 
significance difference (HSD) post hoc test. Data presented as mean ±SEM. LBWm 
n=83, HBWm n=83; LBWf n=70; HBWf n=58. ***p≤0.001. 
 
a) 
b) 
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Males Age 
(Weeks) 
LBWm 
Body weight (g) 
n=83 
HBWm 
Body weight (g) 
n=83 
 
P value 
Birth (week0) 1.15 ± 0.01 1.43± 0.01*** <0.001 
Week 1 3.44 ±0.06 4.06±0.06*** <0.001 
Week 2 6.28±0.09 7.01±0.09*** <0.001 
Week 3 8.57±0.12 9.91±0.12*** <0.001 
 
Table 3.1.1.1 Body weight of male mice (HBWm and LBWm) from birth to week 3. 
Statistical analysis was performed using repeated measures ANOVA followed by a 
Tukey’s high significance difference (HSD) post hoc test. Data presented as mean 
±SEM. LBWm n=83, HBWm n=83. 
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3.1.2 Body weight in Females 
Female offspring had a similar phenotype to that seen in males. High birth 
weight females (HBWf) were heavier at all time points during lactation than 
Low birth weight females (LBWf) as shown in figure 3.1.2.1 and table 
3.1.2.1.   
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Figure 3.1.2.1 Body weight of High birth weight female and male mice (HBWf/m) 
and Low birth weight female and male mice (LBWf/m) throughout lactation (birth to 
3 weeks). Data for female a) and male offspring b). Statistical analysis was 
performed using repeated measures ANOVA followed by a Tukey’s high 
significance difference (HSD) post hoc test. Data presented as mean ±SEM. LBWf 
n=70; HBWf n=58; LBWm n=83, HBWm n=83. ***p≤0.001. 
 
a) 
b) 
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Females Age 
(Weeks) 
LBWf 
Body weight (g) 
 n=70 
HBWf 
Body weight (g) 
n=58 
 
P value  
Birth (week0) 1.15 ± 0.01 1.42± 0.01*** <0.001 
Week 1 3.56 ±0.06 4.1±0.06*** <0.001 
Week 2 6.31±0.1 6.89±0.11*** <0.001 
Week 3 8.41±0.12 9.31±0.13*** <0.001 
 
Table 3.1.2.1 Body weight of female mice (HBWf and LBWf) from birth to week 3. 
Statistical analysis was performed using repeated measures ANOVA followed by a 
Tukey’s high significance difference (HSD) post hoc test. Data presented as mean 
±SEM. LBWf n=70, HBWf n=58. 
 
 
At birth, similar body weights between LBWf and LBWm groups were 
observed as well as between HBWf and HBWm groups. Females were 
heavier than their respective male groups at week 1. However, by week 2, 
LBWm were heavier 0.03g compared to LBWf, and HBWm 0.11g heavier 
than HBWf mice. This phenotype was maintained at week 3 with a major 
difference of 0.61g between HBWm and HBWf followed by 0.16g between 
LBWm and LBWf. 
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3.1.3 Body weight gain in Males 
HBWm gained more absolute weight than LBWm (HBWm= 8.434±0.139g, 
LBWm= 7.365±0.096g; p<0.001, two-tailed unpaired student t-test; figure 
3.1.3.1a). However, the change in growth over lactation (growth rate) 
showed that LBWm mice significantly accelerated their growth rate in 
respect to their counterparts (HBWm= 583.1 ±8.37%, LBWm= 648.3 
±9.11%; p<0.001, two-tailed unpaired student t-test; figure 3.1.3.1b; growth 
rate per day at lactation: HBWm= 0.28 ±0.004g/d, LBWm= 0.309 ±0.004g/d; 
p<0.001, two-tailed unpaired student t-test). Although LBWm mice 
accelerated their growth rate, it was not enough for them to catch up in 
weight at the time of weaning in respect to the HBWm mice (LBWm = 
8.57±0.12, HBWm= 9.92±0.12; p<0.001). 
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Figure 3.1.3.1 Total body weight gain and growth rate of male and female offspring 
at lactation (birth to 3 weeks). Total body weight gain (absolute weight gain in 
grams) a) and c) and total growth rate (as percentage body weight at week 3) b) 
and d). Figures on the top correspond to male mice and data below to female mice. 
Statistical analysis was performed using a two-tailed unpaired student t-test. Data 
presented as mean ±SEM. LBWm n=81, HBWm n=75; LBWf n=72; HBWf n=52.  
*** p≤0.001.            
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3.1.4 Body weight gain in Females 
HBWf offspring, similarly to the respective male group, gained more absolute 
weight in grams than LBWf (HBWf= 7.88±0.102, LBWf= 7.03±0.127; 
p<0.001, two-tailed unpaired student t-test; figure 3.1.4.1a) but their growth 
velocity was slower than the LBWf as seen in the male group ((HBWf= 
549.4±7.47, LBWf= 630.1±11.72; p<0.001, two-tailed unpaired student t-
test; figure 3.1.4.1b; growth rate per day at lactation: HBWf= 0.262 
±0.003g/d, LBWf= 0.30±0.006g/d; p<0.001, two-tailed unpaired student t-
test with Welch’s correction). Despite having acceleration in growth, LBWf 
mice did not catch up on weight with the HBWf by the time of weaning at 
week 3 as LBWm mice (LBWf= 8.407±0.116, HBWf= 9.31±0.128; p<0.001). 
 
Females did grow slower than their respective male groups. LBWf grew 
2.81% less than LBWm, and HBWf 5.78% in relation to HBWm mice. 
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Figure 3.1.4.1 Total body weight gain and relative body weight gain of female and 
male offspring at lactation (birth to 3 weeks). Total body weight gain a) and c) and 
total growth rates (as percentage body weight at week 3) b) and d). Figures on the 
top correspond to female mice and data below to male mice. Statistical analysis 
was performed using a two-tailed unpaired student t-test. Data presented as mean 
±SEM. LBWf n=72; HBWf n=52; LBWm n=81, HBWm n=75. *** p≤0.001.  
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3.2 The Effects of Birth Weight and Accelerated Growth on 
Total Body Adiposity and Intrahepatocellular Lipid Content at 
Weaning (3 Weeks) 
 
3 weeks old pups were fasted for 3 hours before assessing non-invasively 
the whole body adiposity and intrahepatocellular lipid content using 1H MRS 
and MRI techniques. Detailed information of the parameters of these 
methods is provided in section 2.4.1.  
 
As mentioned before in section 3.1.1, HBWm had a higher body weight than 
LBWm by the time of weaning at week 3 (HBWm= 9.92±0.12, LBWm = 
8.57±0.12; p<0.001). 
 
3.2.1 Whole body adiposity and intrahepatocellular lipid content (IHCL) 
in Males 
Whole body adiposity showed that HBWm had a higher adiposity compared 
to LBWm (HBWm= 6.255±0.563%, LBWm= 3.899±0.586%; p=0.015, figure 
3.2.1.1).  
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Figure 3.2.1.1 Percentage whole body adiposity of male and female offspring at 
weaning (3 weeks). Figure a) corresponds to male offspring and figure b) to female 
offspring. Whole body adiposity was assessed using 1H MRS. Statistical analysis 
was performed using a two-tailed unpaired student t-test. Data presented as mean 
±SEM. LBWm n=7; HBWm n=6; LBWf n=6; HBWf n=6. * p≤0.05. 
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Intrahepatocellular lipid content (IHCL) in LBWm mice was reduced 
significantly than HBWm mice (LBWm= 1.325±0.229, HBWm= 2.808±0.334; 
p=0.007; figure 3.2.1.2).  
 
 
Figure 3.2.1.2 Intrahepotcellular lipid content (IHCL%) measured in male and 
female offspring at weaning. Figure a) corresponds to male offspring and figure b) 
to female offspring. IHCL as percentage was assessed using localised 1H MRS. 
Statistical analysis was performed using a two-tailed unpaired student t-test. Data 
presented as mean ±SEM. LBWm n=5; HBWm n=5; ** p≤0.01. 
 
 
 
 
 
 
 
 
	   144	  
3.2.2 Whole body adiposity and intrahepatocellular lipid content (IHCL) 
in Females 
 
As in males, LBWf had less adiposity than HBWf (LBWf= 3.651±0.213%, 
HBWf= 5.661±0.686%; p=0.038; figure 3.2.2.1).  
 
Male mice did have more fat than female mice but the difference between 
both HBWf and HBWm is more pronounced than in LBWm/f (difference 
between HBWf vs. HBWm= 0.604%, LBWf vs. LBWm= 0.248%). 
 
IHCL content was not significantly reduced in females, but similar pattern 
was seen as in LBWm with a lower lipid percentage in LBWf compared to 
HBWf (LBWf=1.358±0.209, HBWf=2.496 ±0.929; p=0.156 figure 3.2.2.2). 
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Figure 3.2.2.1 Percentage whole body adiposity of female and male offspring at 
weaning (3 weeks). Figure a) corresponds to female offspring and figure b) to male 
offspring. Whole body adiposity was assessed using 1H MRS. Statistical analysis 
was performed using a two-tailed unpaired student t-test with Welch’s correction 
test. Data presented as mean ±SEM. LBWf n=6; HBWf n=6; LBWm n=7; HBWm 
n=6. * p≤0.05. 
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Figure 3.2.2.2 Intrahepatocellular lipid content (IHCL%) measured in female and 
male offspring at weaning. Figure a) corresponds to female offspring and figure b) 
to male offspring. IHCL as percentage was assessed using localised 1H MRS. 
Statistical analysis was performed using a two-tailed unpaired student t-test with 
Welch’s correction. Data presented as mean ±SEM. LBWf n=5; HBWf 
n=5;p=0.156; LBWm n=5; HBWm n=5;  ** p≤0.01. 
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3.3 The Effects of Birth Weight and Accelerated Growth on 
Adipose Tissue Distribution at Weaning (3 Weeks) 
 
3 weeks old pups were fasted for 3 hours before assessing non-invasively 
adipose tissue content and distribution by using MRI for localisation and 
subsequent quantification and distribution of adipose tissue by segmentation 
analysis, as described in section 2.4.1.  
 
3.3.1 Adipose tissue distribution in Males 
Total body fat in LBWm was significantly lower than in HBWm 
(LBWm=1.714±0.191g; HBWm=2.728±0.353g; p=0.021; figure 3.3.1.1a). 
This significant difference was not maintained when normalising to body 
weight but it followed the same pattern (LBWm=18.86±2.152%; 
HBWm=26.08±2.879%; p=0.071; figure 3.3.1.1b). This matches the pattern 
obtained using whole body 1H MRS aforementioned (figure 3.2.1.1).  
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Figure 3.3.1.1 Total body fat content from male and female offspring at weaning. 
Total adipose tissue content in grams a) and c) and as a percentage of body weight 
b) and d). Figures on the top correspond to males and figures below to females. 
Total fat content was measured by using images generating by MRI and 
subsequent segmentation analysis. Statistical analysis was performed using a two-
tailed unpaired student t-test. Data presented as mean ±SEM. LBWm n=7; HBWm 
n=6; LBWf n=5; HBWf n=6. * p≤0.05.  
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A comparison of subcutaneous adipose tissue showed LBWm had 
significantly less subcutaneous adipose tissue than HBWm mice, both in 
absolute values and relative to body weight (LBWm=1.103±0.06g; 
HBWm=1.632±0.117; p=0.001; figure 3.3.1.2a; LBWm=12.75±0.894%; 
HBWm=15.67±0.687; p=0.034; figure 3.3.1.2b). 
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Figure 3.3.1.2 Subcutaneous adipose tissue content from male and female offspring 
at weaning. Subcutaneous adipose tissue content in grams a) and c) and as a 
percentage of body weight b) and d). Figures on the top correspond to males and 
figures below to females. Subcutaneous adipose tissue was quantified from MR 
images using segmentation analysis. Statistical analysis was performed using a 
two-tailed unpaired student t-test. Data presented as mean ±SEM. LBWm n=7; 
HBWm n=6; LBWf n=5; HBWf n=6. * p≤0.05, **p≤0.01. 
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Analysis of absolute internal adipose content (grams) showed LBWm had a 
significantly lower internal adipose tissue (LBWm=0.508±0.107g; 
HBWm=1.096±0.254; p=0.048; figure 3.3.1.3a. However, when analysing 
internal adipose tissue as a percentage of body weight, a similar pattern was 
observed, but the differences did not reach statistical significance 
(LBWm=6.111±1.394%; HBWm=10.41±2.305; p=0.131; figure 3.3.1.3b).  
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Figure 3.3.1.3 Internal adipose tissue content from male and female mice offspring 
at weaning. Internal adipose tissue content in grams a) and c) and as a percentage 
of body weight b) and d). Figures on the top correspond to males and figures below 
to females. Internal adipose tissue was quantified from MR images using 
segmentation analysis. Statistical analysis was performed using a two-tailed 
unpaired student t-test. Data presented as mean ±SEM. LBWm n=7; HBWm n=6.  
LBWf n=5; HBWf n=6. *p≤0.05. 
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Assessment of internal:subcutaneous adipose tissue ratio did not show 
significant differences between groups (LBWm=0.463±0.089; 
HBWm=0.648±0.13; p=0.257; figure 3.3.1.4).  
 
 
 
Figure 3.3.1.4 Internal to subcutaneous adipose tissue ratio from male and female 
offspring at weaning. Figure a) corresponds to males and figure b) to females. 
Statistical analysis was performed using a two-tailed unpaired student t-test. Data 
presented as mean ±SEM. LBWm n=7; HBWm n=6; LBWf n=5; HBWf n=6. 
*p≤0.05. 
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3.3.2 Adipose tissue distribution in Females 
Assessment of total body fat content between female groups showed no 
apparent significant differences in absolute total adipose tissue content 
(LBWf=1.999±0.178g; HBWf=1.956±0.114g; p=0.838; figure 3.3.2.1a). 
However, when normalising to current body weight, a significant difference 
was seen between groups (LBWf=26.66±2.345%; HBWf=20.91±1.02%; 
p=0.04; figure 3.3.2.1b). This contrast with the results obtained using whole 
body adiposity by 1H MRS, which shows significant reduced adiposity in 
LBWf (figure 3.2.2.1).  
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Figure 3.3.2.1 Total body fat content from female and male offspring at weaning. 
Total adipose tissue content in grams a) and c) and as a percentage of body weight 
b) and d). Figures on the top correspond to females and figures below to males. 
Total fat content was quantified from MR images using segmentation analysis. 
Statistical analysis was performed using a two-tailed unpaired student t-test. Data 
presented as mean ±SEM. LBWf n=5; HBWf n=6; LBWm n=7; HBWm n=6. 
*p≤0.05.  
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A comparison of subcutaneous adipose tissue between females showed 
LBWf had significantly less subcutaneous adipose tissue than HBWf but 
(LBWf=1.214±0.047g; HBWf=1.4±0.05g; p=0.05; figure 3.3.2.2a). When 
normalising subcutaneous adipose tissue to body weight differences were 
not statistically significant between groups (LBWf=16.23±0.633%; 
HBWf=14.93±0.407%; p=0.107; figure 3.3.2.2b). 
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Figure 3.3.2.2 Subcutaneous adipose tissue content from female and male offspring 
at weaning. Subcutaneous adipose tissue content in grams a) and c) and as a 
percentage of body weight b) and d). Figures on the top correspond to females and 
figures below to males. Subcutaneous adipose tissue was quantified from MR 
images using segmentation analysis. Statistical analysis was performed using a 
two-tailed unpaired student t-test. Data presented as mean ±SEM. LBWf n=5; 
HBWf n=6; LBWm n=7; HBWm n=6. * p≤0.05, **p≤0.01. 
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Analysis of absolute internal adipose tissue showed no differences between 
groups (LBWf=0.785±0.132g; HBWf=0.556±0.07g; p=0.143; figure 
3.3.2.3a). However, when normalising internal adipose tissue to body weight, 
differences were significant with LBWf having a higher internal adipose 
content (LBWf=10.43±1.789%; HBWf=5.985±0.742%; p=0.036; figure 
3.3.2.3b). 
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Figure 3.3.2.3 Internal adipose tissue content from female and male offspring at 
weaning. Internal adipose tissue content in grams a) and c) and as a percentage of 
body weight b) and d). Figures on the top correspond to females and figures below 
to males. Internal adipose tissue was quantified from MR images using 
segmentation analysis Statistical analysis was performed using a two-tailed 
unpaired student t-test. Data presented as mean ±SEM. LBWf n=5; HBWf n=6; 
LBWm n=7; HBWm n=6. * p≤0.05. 
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Assessment of internal:subcutaneous adipose tissue ratio showed an 
opposite pattern compared to males. LBWf had a significantly higher ratio 
compared to HBWf mice (LBWf=0.632±0.09; HBWf=0.399±0.044; p=0.037; 
figure 3.3.2.4).  
 
 
 
Figure 3.3.2.4 Internal to subcutaneous adipose tissue ratio from female and male 
offspring at weaning. Statistical analysis was performed using a two-tailed unpaired 
student t-test. Data presented as mean ±SEM. LBWf n=5; HBWf n=6; LBWm n=7; 
HBWm n=6.  * p≤0.05. 
	  	  	  	  
The table below summarises the distribution of adipose tissue for both male 
and female mice (table 3.3.1). 
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 LBWm HBWm p LBWf HBWf p m vs. f   
difference 
Total fat 
(g) 
-  ✓  - x ✓ 
Total fat 
(%) 
-  x  - ✓ ✓ 
SAT (g) -  ✓ -  ✓ x 
SAT (%) -  ✓  - x ✓ 
IAT (g) -  ✓  - x ✓ 
IAT (%) -  x  - ✓ ✓ 
IAT:SAT 
ratio 
-  x  - ✓ ✓ 
 
Table 3.3.1 Summary table of the adipose tissue distribution in both male and 
female mice at weaning. Arrows indicate that the measurement was higher in the 
respective group compared to its counterpart. ✓indicates that the difference 
between groups was significantly different in p column (p value); in the last column 
indicates a different finding between genders. x indicates that the difference 
between groups was not significantly different in p column; in the last column 
indicates a similar finding between genders. IAT= internal adipose tissue; SAT= 
subcutaneous adipose tissue.  
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3.4 The Effects of Birth Weight and Accelerated Growth on 
Metabolic Markers at Weaning (3 Weeks) 
 
Plasma samples were used to assess the impact of birth weight and 
accelerated growth in some metabolic markers.  
 
3.4.1 Metabolic markers in Males 
Whole blood glucose levels were significantly higher in HBWm compared to 
LBWm mice (HBWm =7.614±0.414 mmol/L, LBWm=6.375±0.372 mmol/L, 
p=0.044; figure 3.4.1.1).  
 
 
Figure 3.4.1.1 Whole blood glucose levels in male and female offspring at weaning. 
Glucose concentration units: mmol/L. Figure a) corresponds to males and figure b) 
to females. Statistical analysis was performed using a two-tailed unpaired student t-
test. Data presented as mean ±SEM. LBWm n=7; HBWm n=7; LBWf n=8; HBWf 
n=7. * p≤0.05.  
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C-peptide plasma levels were not significantly different between groups (C-
peptide: LBWm= 2153.073± 307.977pg/ml, HBWm=1959.828± 344.359 
pg/ml, p=0.682; figure 3.4.1.2a), as insulin (LBWm=1146.124± 
232.716pg/ml, HBWm=847.333± 199.027 pg/ml, p=0.344; figure 3.4.1.2b). 
and glucagon levels (LBWm =154.31± 19.772 pg/ml, HBWm=124.37± 8.315 
pg/ml, p=0.195; figure 3.4.1.2c). 
 
Interestingly, the incretin glucose-dependent insulinotropic peptide (GIP) was 
significantly higher in LBWm compared to HBWm mice (LBWm =338.485± 
91.403 pg/ml, HBWm=116.036± 11.625 pg/ml, p=0.045; figure 3.4.1.2d). 
This may suggest that GIP greatly stimulated beta cells in the pancreas in 
order to produce the high amount of insulin that effectively reduced the level 
of glucose in peripheral circulation in LBWm mice.  
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Figure 3.4.1.2 Metabolic markers related to pancreatic stimulation and function 
measured in male offspring at weaning. Metabolic markers were measured in 
plasma samples in 3 hour fasted male offspring at weaning. Plasma concentration 
of c-peptide a), insulin b), glucagon c), give information about the pancreatic 
secretion/stimulation of b cells (a,b) and delta cells (c) and GIP=glucose-dependent 
insulinotropic peptide gives information about intestinal stimulation of the pancreas 
to release insulin d) in LBWm and HBWm at weaning. Statistical analysis was 
performed using a two-tailed unpaired student t-test. Data are presented as mean 
±SEM. LBWm n=7; HBWm n=7; * p≤0.05.  
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The appetite related gut hormone ghrelin did not show differences between 
groups (LBWm= 475.4± 96.687 pg/ml, HBWm= 553.151± 115.4 pg/ml, 
p=0.611; figure 3.4.1.3). 
 
 
 
Figure 3.4.1.3 Appetite related gut hormone ghrelin levels in plasma measured in 
male offspring at weaning. Statistical analysis was performed using a two-tailed 
unpaired student t-test. Data presented as mean ±SEM. LBWm n=7; HBWm n=7.  
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Adipokines, including leptin and resistin were not significantly different 
between groups (leptin: LBWm=930.399± 269.01pg/ml, HBWm=503.232± 
126.946 pg/ml, p=0.194; figure 3.4.1.4a; resistin: LBWm=10597.304± 
1653.523 pg/ml, HBWm=10945.594± 1662.376 pg/ml, p=0.884; figure 
3.4.1.4b). However, the proinflammatory adipokine monocyte chemotactic 
protein-1 (MCP-1) was significantly higher in LBWm mice (LBWm= 
209.047± 13.786 pg/ml, HBWm=162.859± 10.873 pg/ml, p=0.018; figure 
3.4.1.5a). Tumor Necrosis Factor alpha (TNF-alpha) and interleukin 6 (IL-6) 
plasma levels were not significantly different between groups (TNF-alpha: 
LBWm= 44.154± 3.399 pg/ml, HBWm=47.1019± 2.208 pg/ml, p=0.478; 
figure 3.4.1.5b; IL-6: LBWm= 66.083± 5.131 pg/ml, HBWm=75.642± 8.284 
pg/ml, p=0.331; figure 3.4.1.5c). 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   167	  
 
Figure 3.4.1.4 Adipokines leptin and resistin measured in male offspring at weaning. 
Plasma levels of leptin a) and resistin b) in LBWm and HBWm at week 3 of age. 
Statistical analysis was performed using a two-tailed unpaired student t-test. Data 
presented as mean ±SEM. LBWm n=7; HBWm n=7.  
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Figure 3.4.1.5 Proinflammatory adipokines measured in male offspring at weaning. 
Plasmatic levels of MCP-1= monocyte chemotactic protein-1 a), TNF-alpha= tumor 
necrosis factor alpha b) and IL-6= interleukin 6 c). Statistical analysis was 
performed using a two-tailed unpaired student t-test. Data presented as mean 
±SEM. LBWm n=7; HBWm n=7; * p≤0.05.  
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3.4.2 Metabolic markers in Females 
The metabolic effect of birth weight and accelerated growth in females was 
different from males in some of the metabolites analysed. Glucose levels in 
blood were significantly different between female groups, but in the opposite 
direction to that found in males, the LBWf mice had a higher level than 
HBWf mice (LBWf=8.629 ±0.532mmol/L, HBWf =6.867 ± 0.503mmol/L; 
p=0.036; figure 3.4.2.1).  
 
 
 
Figure 3.4.2.1 Whole blood glucose levels in female and male offspring at weaning. 
Glucose concentration units: mmol/L. Statistical analysis was performed using a 
two-tailed unpaired student t-test. Data presented as mean ±SEM. LBWf n=8; 
HBWf n=7; LBWm n=7; HBWm n=7. * p≤0.05.  
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Although levels of C-peptide were higher in LBWm compared to HBWm 
differences did not reach significance difference. On the contrary, in females, 
levels were substantially higher in LBWf compared to HBWf 
(LBWf=2949.769 ±431.534 pg/ml, HBWf =1467.631 ± 224.253 pg/ml; 
p=0.019; figure 3.4.2.2a). Also insulin reached statistical significance 
between females with higher values in LBWf mice (LBWf=1485 (1071,1934) 
pg/ml, HBWf =733.9 (446.8,888.8) pg/ml; p=0.005; figure 3.4.2.2b).  
 
There was also a difference between male and female mice in the levels of 
glucagon. LBWf did have a substantial higher level of glucagon than HBWf 
(LBWf= 154.163±16.841, HBWf =111.167 ±5.699; p=0.04; figure 3.4.2.2c). 
Male mice did not show any significance.   
 
 
A similar significant pattern in the levels of GIP was seen in males and 
females respective groups (LBWf= 414.553 ±108.553, HBWf =138.295 ± 
29.731; p=0.04; figure 3.4.2.2d). 
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Figure 3.4.2.2 Metabolic markers related to pancreatic function and stimulation 
measured in female offspring at weaning. Plasma concentration of c-peptide a), 
insulin b), glucagon c), give information about the pancreatic secretion/stimulation of 
b cells (a,b) and delta cells (c) and GIP=glucose-dependent insulinotropic peptide 
gives information about intestinal stimulation of the pancreas to release insulin d) in 
LBWf and HBWf at weaning.  Statistical analysis for c-peptide, glucagon and GIP 
was performed using a two-tailed unpaired student t-test. Statistical analysis for 
insulin was performed using a Mann Whitney test. Data presented as mean ±SEM 
for a), c) and d) and as median with interquartile range (25%,75%) for b. LBWf n=8; 
HBWf n=7; * p≤0.05, ** p p≤0.001. 
 
	   172	  
The appetite related gut hormone ghrelin was not significantly different 
between female groups as in males (LBWf= 473.1 ±151.921 pg/ml, HBWf= 
633.787± 165.692 pg/ml, p=0.611; figure 3.4.2.3). 
 
 
 
 
Figure 3.4.2.3 Appetite related gut hormone ghrelin (active) levels in plasma 
measured in female offspring at weaning. Statistical analysis was performed using a 
two-tailed unpaired student t-test. Data presented as mean ±SEM. LBWf n=8; 
HBWf n=7.  
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Adipokines such as leptin and resistin did not show significant differences 
between females groups as in male mice (leptin: LBWf=939.544 ±238.651 
pg/ml, HBWf=772.575 ±276.334 pg/ml, p=0.654; figure 3.4.2.4a; resistin: 
LBWf=12232.751 ±2321.519 pg/ml, HBWf=13088.417 ±1380.059 pg/ml, 
p=0.765; figure 3.4.2.4b).  
 
Whilst the levels of the proinflammatory adipokine MCP-1 were significant 
different between male groups, the level of lL-6 (also proinflammatory 
adipokine) was significantly different between females as well as MCP-1   
(IL-6: LBWf= 76.925± 16.448 pg/ml, HBWf=33.215 ±9.131 pg/ml, p=0.039; 
figure 3.4.2.5a; MCP-1: LBWf= 162.7 ±4.459 pg/ml, HBWf=124.2 ±11.94 
pg/ml, p=0.023; figure 3.4.2.5b). TNF-alpha was not significant different 
between female groups as between male groups (LBWf=42.199 ±3.923 
pg/ml, HBWf=33.384 ±6.32 pg/ml, p=0.247; figure 3.4.2.5c). 
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Figure 3.4.2.4 Adipokines leptin and resistin measured in female offspring at 
weaning. Plasma levels of leptin a) and resistin b) in LBWf and HBWf at week 3 of 
age. Statistical analysis was performed using a two-tailed unpaired student t-test. 
Data presented as mean ±SEM. LBWf n=8; HBWf n=7.  
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Figure 3.4.2.5 Proinflammatory adipokines measured in female offspring at 
weaning. Plasma levels of IL-6= interleukin 6 a), MCP-1= monocyte chemotactic 
protein-1 b) and TNF-alpha= tumor necrosis factor alpha c). Statistical analysis was 
performed using a two-tailed unpaired student t-test. Data presented as mean 
±SEM. LBWf n=8; HBWf n=7; * p≤0.05.  
	  
 
The table below summarises the metabolic profiles for both male and female 
mice (table 3.4.1).	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Metabolite LBWm HBWm p LBWf HBWf p m vs. f   
difference 
Glucose -  ✓  - ✓ ✓ 
C-peptide  - x  - ✓ ✓ 
Insulin  - x  - ✓ x 
Glucagon  - x  - ✓ x 
GIP  - ✓  - ✓ x 
Ghrelin -  x -  x x 
Leptin  - x -  x ✓ 
Resistin -  x -  x x 
MCP-1  - ✓  - ✓ x 
TNF-a -  x  - x ✓ 
IL-6 -  x  - ✓ ✓ 
 
Table 3.4.1 Summary of the metabolic profiles of both male and female mice. 
Arrows indicate that the measurement was higher in the respective group compared 
to its counterpart. ✓indicates that the difference between groups was significantly 
different in p column (p value); in the last column indicates a different finding 
between genders. x indicates that the difference between groups was not 
significantly different in p column; in the last column indicates a similar finding 
between genders.  
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3.5 The Effects of Birth weight and Accelerated Growth on 
Organs Mass at Weaning (3 Weeks) 
 
At week 3, which was the end of the lactation, offspring was separated from 
their litters and mothers (weaning). As aforementioned, mice were classified 
as either Low birth weight male/female mice (LBWm/f) or High birth weight 
male/female (HBWm/f) mice. Pups were dissected at this time point as 
described previously in methods 2.1.4. Organ mass and proportional organ 
weights to current body weight were recorded and analysed. 
 
3.5.1 Organ mass in Males 
At weaning, LBWm mice had a lower body weight compared to the HBWm 
mice (LBWm= 8.566±0.12, HBWm= 9.916±0.12; p<0.001). Absolute weight 
in grams of heart, pancreas, kidneys, liver and muscle were significantly 
lighter in LBWm mice than HBWm mice (heart: p=0.005; pancreas: p=0.038; 
kidneys: p=0.028, liver: p<0.001; muscle: p<0.001; figure 3.5.1.1 and table 
3.5.1.1). Brain, brown adipose tissue and spleen were not significantly 
different between groups (brain: p=0.275; brown adipose tissue: p=0.163; 
spleen: p=0.081; figure 3.5.1.1 and table 3.5.1.1). 
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Figure 3.5.1.1 Organ mass of male and female offspring at week 3 (weaning). 
BAT=brown adipose tissue. Figure a) corresponds to males and figure b) to 
females. Statistical analysis was performed using a two-tailed unpaired student t-
test per each organ. Data presented as mean ±SEM. LBWm n=10; HBWm n=10; 
LBWf n=9; HBWf n=9. * p≤0.05, ** p≤0.01, *** p≤0.001. 
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Upon normalising organ mass to current body weight, relative weight of brain 
was increased in LBWm in respect to HBWm mice (p=0.001; figure 3.5.1.2 
and table 3.5.1.1), contrary to rest of organs weighed. Liver and muscle were 
still lighter in LBWm mice (liver: p=0.015; muscle: p<0.001; figure 3.5.1.2 
and table 3.5.1.1). Furthermore, the relative weight of pancreas, kidneys and 
heart was not significantly different between groups (pancreas: p=0.732; 
kidneys: p=0.496; heart: p=0.161; figure 3.5.1.2 and table 3.5.1.1). Brown 
adipose tissue remained not significantly different between both groups 
(brown adipose tissue: p=0.995; figure 3.5.1.2 and table 3.5.1.1).  
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Figure 3.5.1.2 Organ mass as a percentage of current body weight of male and 
female offspring at week 3 (weaning). BAT=brown adipose tissue. Figure a) 
corresponds to males and figure b) to females. Statistical analysis was performed 
using a two-tailed unpaired student t-test with Welch’s correction for unequal 
variances when necessary. Data presented as mean ±SEM. LBWm n=10; HBWm 
n=10; LBWf n=9; HBWf n=9. * p≤0.05, ** p≤0.01, *** p≤0.001. 
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Table 3.5.1.1 Absolute organ mass and as a percentage of current body weight of 
male offspring at week 3 (weaning). BAT=brown adipose tissue. Statistical analysis 
was performed using a two-tailed unpaired student t-test. Data presented as mean 
±SEM. LBWm n=10; HBWm n=10. 
 
 
 
 LBWm  HBWm P value  
Brain 0.387±0.006 0.397±0.007 0.275 
Brain (%) 4.618±0.139 3.897±0.125 0.001 
BAT 0.097±0.011 0.119±0.01 0.163 
BAT (%) 1.16±0.142 1.161±1.371 0.995 
Heart 0.069±0.002 0.080±0.003 0.005 
Heart (%) 0.837±0.024 0.787±0.024 0.161 
Pancreas 0.044±0.003 0.055±0.003 0.038 
Pancreas (%) 0.522±0.038 0.542±0.041 0.732 
Kidneys 0.123±0.007 0.144±0.005 0.028 
Kidneys (%) 1.467±0.049 1.413±0.192 0.496 
Liver 0.311±0.013 0.455±0.003 <0.001 
Liver (%) 3.728±0.13 4.425±0.217 0.013 
Muscle  0.105±0.006 0.163±0.008 <0.001 
Muscle (%) 1.267±0.085 1.597±0.068 0.008 
Spleen  0.06±0.007 0.085±0.01 0.081 
Spleen (%) 0.705±0.072 0.826±0.099 0.343 
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3.5.2 Organ mass in Females 
Female absolute weight in grams of kidneys, liver and muscle had a similar 
phenotype as in the male groups, being lighter in LBWf than HBWf 
((kidneys: p<0.001; liver: p=0.03; muscle: p=0.005; figure and 3.5.2.1 and 
table 3.5.2.1).  However, LBWf did have a significantly lighter brain than 
HBWf, whilst differences between males were not significantly different 
(LBWf vs. HBWf brain: p=0.002; figure and 3.5.2.1 and table 3.5.2.1. LBWm 
vs. HBWm brain: p=0.275; figure and 3.5.1.1 and table 3.5.1.1). Moreover, 
heart and pancreas were not significantly different between females groups, 
but were between the male groups being both lighter in LBWm mice (LBWf 
vs. HBWf heart: p=0.092; pancreas: p=0.484; figure and 3.5.2.1 and table 
3.5.2.1 LBWm vs. HBWm heart: p=0.005; pancreas: p=0.038; figure and 
3.5.1.1 and table 3.5.1.1). Spleen mass was nearly significant between 
males, with a lighter spleen in LBWm mice vs. HBWm (p=0.081; figure and 
3.5.1.1 and table 3.5.1.1). On the contrary, it was significantly different 
between females, although it had the same pattern as seen in the male 
groups (LBWf spleen was lighter than HBWf mice; p=0.021). Brown adipose 
tissue was similarly not significant between both females and males (LBWf 
vs. HBWf brown adipose tissue: p=0.195; LBWm vs. HBWm brown adipose 
tissue: p=0.163). 
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Figure 3.5.2.1 Organ mass of female and male offspring at week 3 (weaning). 
BAT=brown adipose tissue. Figure a) corresponds to females and figure b) to 
males. Statistical analysis was performed using a two-tailed unpaired student t-test 
or Mann Whitney test when necessary. Data presented as mean ±SEM. LBWf n=9; 
HBWf n=9; LBWm n=10; HBWm n=10. *p≤0.05, ** p≤0.01, *** p≤0.001. 
 
 
After normalising organ mass to current body weight, LBWf had a heavier 
brain that HBWf, although it did not reach significance (LBWf vs. HBWf 
p=0.09 figure 3.5.2.2 and table 3.5.2.1). The rest of the organs did not show 
any differences between female groups (figure 3.5.2.2 and table 3.5.2.1).  
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Figure 3.5.2.2 Organ mass as a percentage of current body weight of female and 
male offspring at week 3 (weaning). BAT=brown adipose tissue. Figure a) 
corresponds to females and figure b) to males. Statistical analysis was performed 
using a two-tailed unpaired student t-test with Welch’s correction for unequal 
variances when necessary. Data presented as mean ±SEM. LBWf n=9; HBWf n=9; 
LBWm n=10; HBWm n=10. *p≤0.05, ** p≤0.01, *** p≤0.001. 
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Table 3.5.2.1 Absolute organ mass and as a percentage of current body weight of 
female offspring at week 3 (weaning). BAT=brown adipose tissue. Statistical 
analysis was performed using a two-tailed unpaired student t-test. Data presented 
as mean ±SEM. LBWf n=9, HBWf n=9. 
	  	  
The table below summarises the organ masses for both male and female 
mice (table 3.5.2.2). 
 LBWf HBWf P value 
Brain 0.369±0.01 0.413±0.009 <0.001 
Brain (%) 4.759±0.166 4.363±0.147 0.094 
BAT 0.091±0.011 0.108±0.006 0.195 
BAT (%) 1.176±0.13 1.141±0.07 0.931 
Heart 0.068±0.003 0.075±0.002 0.092 
Heart (%) 0.837±0.024 0.787±0.024 0.077 
Pancreas 0.051±0.005 0.055±0.003 0.484 
Pancreas (%) 0.522±0.038 0.542±0.041 0.364 
Kidneys 0.118±0.004 0.148±0.003 <0.001 
Kidneys (%) 1.524±0.033 1.559±0.043 0.528 
Liver 0.344±0.028 0.431±00.022 0.028 
Liver (%) 4.384±0.207 4.509±0.159 0.638 
Muscle  0.097±0.007 0.137±0.008 <0.001 
Muscle (%) 1.275±0.109 1.437±0.076 0.242 
Spleen  0.054±0.009 0.082±0.008 0.021 
Spleen (%) 0.676±0.103 0.865±0.089 0.191 
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 LBWm HBWm p LBWf HBWf p m-f diff. 
Brain (g) -  x -  ✓ x 
Brain (%)  - ✓  - x x 
BAT (g) -  x -  x x 
BAT(%) - - x  - x ✓ 
Heart (g) -  ✓ -  x ✓ 
Heart (%)  - x  - x x 
Pancreas 
(g) 
-  ✓ -  x x 
Pancreas 
(%) 
-  x  - x ✓ 
Kidneys 
(g) 
 - x -  ✓ ✓ 
Kidneys 
(%) 
 - x -  x ✓ 
Liver (g) 	   -  ✓ -  ✓ x 
Liver (%) -  ✓ -  x x 
Muscle 
(g) 
-  ✓ -  ✓ x 
Muscle 
(%) 
-  ✓ -  x x 
Spleen 
(g) 
-  x -  ✓ x 
Spleen 
(%) 
-  x -  x x 
 
Table 3.5.2.2 Summary of organ masses results by gender. Arrows indicate that the 
measurement was higher in the respective group compared to its counterpart. 
✓indicates that the difference between groups was significantly different in p column 
(p value); in the last column indicates a different finding between genders. x 
indicates that the difference between groups was not significantly different in p 
column; in the last column indicates a similar finding between genders.  
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3.6 The Effects of Birth weight and Accelerated Growth on 
White Adipose Tissue Mass at Weaning (3 Weeks) 
 
White adipose tissue was (WAT) was extracted and subdivided into 
subcutaneous (SAT) and internal adipose tissue (IAT). IAT was further 
subdivided into gonadal, retroperitoneal and mesenteric fat depots.  
 
3.6.1 White adipose tissue mass in Males 
Total WAT was heavier in HBWm mice than in LBWm (p=0.003, figure, 
3.6.1.1 and table 3.6.1.1) as well as all the regional white fat depots (SAT: 
p=0.014, gonadal fat: p<0.001, retroperitoneal fat: p=0.043, mesenteric fat: 
p=0.035; IAT: p<0.001; figure 3.6.1.1 and table 3.6.1.1).  
 
After normalisation to current body weight (relative body weight), total WAT, 
gonadal and IAT remained heavier in HBWm mice compared to LBWm mice 
(total WAT: p=0.023, gonadal: p<0.001, IAT: p<0.001; figure 3.6.1.2, and 
table 3.6.1.1). On the contrary, SAT, retroperitoneal and mesenteric fat were 
not significantly different between groups (SAT: p=0.119, retroperitoneal fat: 
p=0.121, mesenteric: p=0.131; figure 3.6.1.2 table 3.6.1.1).  
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Figure 3.6.1.1 Absolute white adipose tissue mass of male and female offspring at 
week 3 (weaning). Figure a) corresponds to males and figure b) to females. 
Statistical analysis was performed using a two-tailed unpaired student t-test. Data 
presented as mean ±SEM. LBWm n=10; HBWm n=10; LBWf n=9; HBWf n=9. 
*p≤0.05, *** p≤0.001. WAT= white adipose tissue, SAT=subcutaneous adipose 
tissue, IAT=internal adipose tissue (as the sum of gonadal, retroperitoneal and 
mesenteric fat).  
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Figure 3.6.1.2 Relative white adipose tissue mass of male and female offspring at 
week 3 (weaning). Figure a) corresponds to males and figure b) to females. 
Statistical analysis was performed using a two-tailed unpaired student t-test. Data 
presented as mean ±SEM. LBWm n=10; HBWm n=10; LBWf n=9; HBWf n=9. 
*p≤0.05, *** p≤0.001. WAT= white adipose tissue, SAT=subcutaneous adipose 
tissue, IAT=internal adipose tissue (as the sum of gonadal, retroperitoneal and 
mesenteric fat).  
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Table 3.6.1.1 White adipose tissue mass and as a percentage of current body 
weight of male offspring at week 3 (weaning). SAT= subcutaneous adipose tissue, 
IAT= internal adipose tissue (as the sum of gonadal, retroperitoneal and mesenteric 
fat depots). Statistical analysis was performed using a two-tailed unpaired student t-
test. Data presented as mean ±SEM. LBWm n=10, HBWm n=10. 
 
 
 
 
 
 
 LBWm HBWm P value 
Total WAT 0.205±0.019 0.329±0.028 0.003 
Total WAT % 2.45±0.162 3.199±0.245 0.023 
SAT 0.153±0.014 0.231±0.025 0.014 
SAT% 1.812±0.145 2.252±0.225 0.119 
Gonadal 0.031±0.003 0.059±0.004 <0.001 
Gonadal% 0.362±0.029 0.577±0.038 <0.001 
Retroperitoneal 0.006±0.001 0.013±0.003 0.043 
Retroperitoneal% 0.078±0.011 0.121±0.024 0.121 
Mesenteric 0.013±0.002 0.025±0.004 0.035 
Mesenteric% 0.162±0.031 0.249±0.043 0.131 
IAT 0.053±0.006 0.097±0.006 <0.001 
IAT% 0.591±0.044 0.947±0.045 <0.001 
IAT/SAT 0.335±0.035 0.453±0.042 0.047 
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A comparison of the ratio of IAT to SAT tissue mass between the groups 
showed that LBWm had a lower ratio compared to HBWm (p=0.047, table 
3.6.1.1). This suggests that an enhanced adipose tissue mass was mostly 
related to a higher internal fat deposition in HBWm vs. LBWm.  
 
The distribution of different WAT depots as a percentage of the total WAT 
showed that HBWm had a significantly higher gonadal fat content in 
comparison to LBWm (HBWm=18.51±1.213%; LBWm=14.33±0.874%, 
p=0.014; figure 3.6.1.3). On the contrary, the percentage of subcutaneous fat 
mass was significantly reduced in HBWm mice than LBWm mice (HBWm= 
69.31±1.963%; LBWm= 75.3±1.985%; p=0.047). The distribution of the 
retroperitoneal and mesenteric fat depots was not different between groups 
(figure 3.6.1.3). This showed that although differences in relative SAT were 
not evident in both groups, the distribution of WAT showed that LBWm did 
have a preference for SAT deposition compared to other compartments and 
HBWm for IAT, especially gonadal fat deposition. 
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Figure 3.6.1.3 Relative distribution of white adipose tissue mass as a percentage of 
total WAT of male and female offspring at week 3 (weaning). Figure a) corresponds 
to males and figure b) to females. Statistical analysis was performed using a two-
tailed unpaired student t-test. Data presented as mean ±SEM. LBWm n=10; HBWm 
n=10; LBWf n=9; HBWf n=9. *p≤0.05.  
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3.6.2 White adipose tissue mass in Females 
In the female groups, only total WAT and absolute SAT mass were 
significantly higher in HBWf than in LBWf (WAT: p=0.008; SAT: p=0.007; 
figure 3.6.2.1 and table 3.6.2.1). Moreover, this difference was still significant 
when normalising to body weight (WAT: p=0.013; SAT: p=0.017; figure 
3.6.2.2 and table 3.6.2.1). In general, females had more total WAT% than 
their respective male group and subcutaneous adipose tissue than males.  
 
Although absolute mass of gonadal, retroperitoneal and mesenteric tended 
to be less in LBWf as in LBWm (figure 3.6.2.1 and table 3.6.2.1), differences 
were not significantly different between females. This pattern was maintained 
for gonadal and retroperitoneal fat when normalising to body weight but 
differences did not reach significance. However, mesenteric fat was similar 
between groups contrary to the males groups. In general, female mice had 
less gonadal than males (LBWf= 53.315% less gonadal fat than LBWm 
mice and HBWf= 59.272 % less than HBWm mice) but more retroperitoneal 
fat than males (LBWf= 89.743% more than LBWm and HBWf= 71.074% 
more than HBWm) as well as mesenteric fat (LBWf= 87.037% more than 
LBWm and HBWf= 19.277% more than HBWm). 
 
IAT in both, absolute values (g) and relative values (%), was not significantly 
different between groups (table 3.6.2.1), contrary to the respective male 
groups. Interestingly, IAT% in LBWf mice was approximately 12.69% more 
than in LBWm mice but HBWf had 23.44% less IAT% than HBWm. 
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Figure 3.6.2.1 Absolute white adipose tissue mass of female and male mice 
offspring at week 3 (weaning). Figure a) corresponds to females and figure b) to 
males. Statistical analysis was performed using a two-tailed unpaired student t-test. 
Data presented as mean ±SEM. LBWf n=9; HBWf n=9; LBWm n=10; HBWm n=10. 
*p≤0.05, **p≤0.01, ***p≤0.001. WAT= white adipose tissue, SAT=subcutaneous 
adipose tissue, IAT=internal adipose tissue (as the sum of gonadal, retroperitoneal 
and mesenteric fat).  
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Figure 3.6.2.2 Relative white adipose tissue mass of female and male offspring at 
week 3 (weaning). Figure a) corresponds to females and figure b) to males. 
Statistical analysis was performed using a two-tailed unpaired student t-test. Data 
presented as mean ±SEM. LBWf n=9; HBWf n=9; LBWm n=10; HBWm n=10. 
*p≤0.05, ***p≤0.001. WAT= white adipose tissue, SAT=subcutaneous adipose 
tissue, IAT=internal adipose tissue (as the sum of gonadal, retroperitoneal and 
mesenteric fat).  
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Table 3.6.2.1 White adipose tissue mass and as a percentage of current body 
weight of female offspring at week 3 (weaning). SAT= subcutaneous adipose tissue, 
IAT= internal adipose tissue (as the sum of gonadal, retroperitoneal and mesenteric 
fat depots). Statistical analysis was performed using a two-tailed unpaired student t-
test. Data presented as mean ±SEM. LBWf n=9, HBWf n=9. 
 
 
 
 
 
 LBWf HBWf P value 
Total WAT 0.212±0.03 0.336±0.027 0.008 
Total WAT% 2.654±0.222 3.501±0.201 0.013 
SAT 0.161±0.022 0.267±0.025 0.007 
SAT% 2.01±0.198 2.781±0.21 0.017 
Gonadal 0.014±0.002 0.023±0.004 0.092 
Gonadal% 0.169±0.023 0.235±0.044 0.198 
Retroperitoneal 0.015±0.003 0.018±0.003 0.491 
Retroperitoneal% 0.194±0.048 0.187±0.03 0.902 
Mesenteric 0.024±0.004 0.028±0.005 0.528 
Mesenteric% 0.303±0.06 0.297±0.059 0.948 
IAT 0.052±0.008 0.069±0.009 0.164 
IAT% 0.666±0.106 0.725±0.086 0.669 
IAT/SAT 0.358±0.079 0.274±0.041 0.344 
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Contrary to what was seen in male groups, a comparison of the ratio 
IAT/SAT showed no difference between groups (p=0.344; table 3.6.2.1). 
LBWf had a 6.866% higher ratio than LBWm, but HBWf had a 39.514% 
lower ratio than HBWm mice.  
 
The distribution of different WAT depots as a percentage of the total WAT did 
not show significant differences between the groups, opposite to what was 
seen in the male groups (figure 3.6.2.3).  SAT was the adipose tissue with 
the highest percentage from the total WAT in both genders. The difference 
between LBWf and LBWm was 0.47%, where females had the highest 
percentage (LBWf= 75.77±3.389%, LBWm=75.30±1.985%). A 9.64% 
difference was seen between HBWf and HBWm (HBWf=78.95±2.441%; 
HBWm=69.31±1.963%), as well as similar trend in deposition as in LBW 
mice. However, gonadal adipose tissue was preferentially accumulated in 
males than in females with a 133% increment compared to females 
(LBWf=6.142±0.522% vs. LBWm=14.33±0.874%), and a 161.8% more 
deposition in HBWm in respect to HBWf mice (HBWf=7.071±1.381% vs. 
HBWm=18.51±1.213%).  
 
Retroperitoneal (LBWm= 3.076±0.343%, HBWm= 3.828±0.682%; LBWf= 
6.856±1.939%, HBWf=5.746±0.87%) as well as mesenteric distribution 
(LBWm=7.295±1.827%, HBWm=8.349±1.54%; LBWf=11.30±2.193%, 
HBWf=8.607±1.789%) was augmented in females in respect to the 
respective male groups. 
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Figure 3.6.2.3 Relative distribution of white adipose tissue mass as a percentage of 
total WAT of female and male offspring at week 3 (weaning). Figure a) corresponds 
to females and figure b) to males. Statistical analysis was performed using a two-
tailed unpaired student t-test. Data presented as mean ±SEM. LBWf n=9; HBWf 
n=9; LBWm n=10; HBWm n=10. *p≤0.05. WAT= white adipose tissue.  
 
The table below summarises the white adipose tissue masses for both male 
and female mice (table 3.6.3). 
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 LBWm HBWm p LBWf HBWf p m-f diff. 
WAT (g) -  ✓ -  ✓ x 
WAT (%) -  ✓ -  x x 
SAT (g) -  ✓ -  ✓ x 
SAT(%) -  x -  x x 
Gonadal 
(g) 
-  ✓ -  x x 
Gonadal 
(%) 
-  ✓ -  x x 
Retrop. (g) -  ✓ -  x x 
Retrop.(%) -  x  - x ✓ 
Mesent. (g) -  ✓ -  x x 
Mesent.(%) -  x  - x ✓ 
IAT (g) -  ✓ -  x x 
IAT (%) -  ✓ -  x x 
IAT/SAT -  ✓  - x ✓ 
 
Table 3.6.3 Summary of white adipose tissue depots findings by gender. Arrows 
indicate that the measurement was higher in the respective group compared to its 
counterpart. ✓indicates that the difference between groups was significantly 
different in p column (p value); in the last column indicates a different finding 
between genders. x indicates that the difference between groups was not 
significantly different in p column; in the last column indicates a similar finding 
between genders. 
 
 
	   200	  
3.7 The Effects of Birth Weight and Accelerated Growth on 
Adipose Tissue Gene Expression at Weaning (3 Weeks) 
 
Subcutaneous adipose tissue was harvested and processed as mentioned in 
section 2.4.8. qPCR was used to assess changes in adipose tissue gene 
expression. mRNA expression of genes involved in insulin signaling, 
adipocyte differentiation, lipid metabolism, and non-shivering thermogenesis 
in white adipose tissue were determined.  
 
In the insulin pathway, insulin receptor substrate 1 (IRS-1), 
Phosphatidylinositol-3 Kinase catalytic subunit p110b (PIK3/p110b), protein 
kinase C isoform zeta (PKC-Z), and Glucose Transporter 4 (GLUT4) genes 
were assessed.  
 
Key transcriptional regulators of adipogenesis and lipogenesis such as 
Peroxisome Proliferator Activated Receptor Gamma 2(PPARg-2), 
CCAAT/enhancer-binding protein alpha (CEBPa), and Sterol Regulatory 
Element Binding Protein 1c (SREBP1c) were analysed. SREBP1c 
downstream target gene Fatty Acid Synthase (FASN) and Lipoprotein Lipase 
(LPL) expression were also analysed. To assess mobilization of lipids from 
adipose tissue to circulation (lipolytic function) mRNA expression of Hormone 
Sensitive Lipase (HSL) was determined.  
 
 
 
	   201	  
To investigate changes in mitochondrial biogenesis and adaptive 
thermogenesis, Peroxisome Proliferator-activated Receptor Gamma 
Coactivator 1 alpha (PGC1a) and its downstream target gene Uncoupling 
Protein 1 (UCP1) expression were evaluated. PGC1a expression and activity 
are regulated directly by the beta-adrenergic signaling. Adrenergic 
expression was also assessed measuring mRNA levels of beta-3 adrenergic 
receptor (adrb3).  	  
3.7.1 Adipose tissue expression of insulin signaling related genes at 
weaning (3 weeks) 
3.7.1.1 Expression of insulin signaling related genes in Males 
mRNA expression of IRS-1, (p<0.001), PIK3/p110b (p<0.001), Akt2 
(p<0.001), PKC-Z (p=0.027) and GLUT4 (p<0.001) were significantly higher 
in LBWm mice than in HBWm mice (figure 3.6.1). This data suggests that 
transcriptional insulin signaling was highly activated in SAT in LBWm, which 
could contribute to the increment in SAT mass in this group of mice (figure 
3.7.1.1.1). 
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Figure 3.7.1.1.1 mRNA expression of insulin-signaling components in subcutaneous 
adipose tissue from male and female offspring at weaning. Figure a) corresponds to 
males and figure b) to females. Data presented as fold change of LBWm/f mice in 
relation to HBWm/f mice respectively. mRNA expression was determined by RT-
qPCR and normalised to mRNA expression of housekeeping gene actin beta (Actb). 
Statistical analysis was performed using an unpaired student t-test.  Data presented 
as mean± SD. LBWm n=8; HBWm n=8; LBWf n=6; HBWf n=5. *p≤0.05, 
***p≤0.001.  
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3.7.1.2 Expression of insulin signaling related genes in Females 
Different mRNA expression was seen between female groups. Contrary to 
LBWm, LBWf had a reduction of the expression of IRS-1 (p<0.001; figure 
3.7.1.2.1), PIK-3/p110b (p<0.001; figure 3.4.2), PCK-Z (p<0.001) and 
GLUT4 (p<0.001; figure 3.7.1.2.1).  
 
 
Figure 3.7.1.2.1 mRNA expression of insulin-signaling components in subcutaneous 
adipose tissue from female and male offspring at weaning. Figure a) corresponds to 
females and figure b) to males. Data presented as fold change of LBWf/m mice in 
relation to HBWf/m mice respectively. mRNA expression was determined by RT-
qPCR and normalised to mRNA expression of housekeeping gene actin beta (Actb). 
Statistical analysis was performed using an unpaired student t-test.  Data presented 
as mean± SD. LBWf n=6; HBWf n=5; LBWm n=8; HBWm n=8. *p≤0.05, *** 
p≤0.001. 
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3.7.2 Adipose tissue expression of adipogenic and lipid related genes 
at weaning (3 weeks) 
3.7.2.1 Expression of adipogenic related genes in Males 
Adipogenic key regulators PPARG2 and CEBPa were significantly higher in 
LBWm mice than HBWm mice (p<0.001 both; figure 3.7.2.1.1). This 
suggests that adipogenesis was more active in SAT of these mice which 
correlates with the overexpression of genes regulated by insulin as 
aforementioned. Insulin action is very important in triggering differentiation of 
adipocytes as the key regulators PPARG2 and CEBPa.  
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Figure 3.7.2.1.1 mRNA expression of key adipogenic transcriptional regulators in 
subcutaneous adipose tissue from male and female offspring at weaning. Figure a) 
corresponds to males and figure b) to females. Peroxisome proliferator activated 
receptor gamma 2= PPARG2, CCAAT/enhancer-binding protein alpha=CEBPa. 
Data presented as fold change of LBWm/f mice in relation to HBWm/f mice 
respectively. mRNA expression was determined by RT-qPCR and normalised to 
mRNA expression of housekeeping gene actin beta (Actb). Statistical analysis was 
performed using an unpaired student t-test.  Data presented as mean± SD. LBWm 
n=8; HBWm n=8; LBWf n=6; HBWf n=5. *p≤0.05, *** p≤0.001. 
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3.7.2.2 Expression of adipogenic related genes in Females 
Contrary to LBWm, LBWf had a reduction in fold change in PPARG-2 and 
CEBP1a compared to HBWf (p<0.001; p=0.016 respectively; figure 
3.7.2.2.1). 
 
 
Figure 3.7.2.2.1 mRNA expression of key adipogenic transcriptional regulators in 
subcutaneous adipose tissue from female and male offspring at weaning. Figure a) 
corresponds to females and figure b) to males. Peroxisome proliferator activated 
receptor gamma 2= PPARG2, CCAAT/enhancer-binding protein alpha=CEBPa. 
Data presented as fold change of LBWf/m mice in relation to HBWf/m mice 
respectively. mRNA expression was determined by RT-qPCR and normalised to 
mRNA expression of housekeeping gene actin beta (Actb). Statistical analysis was 
performed using an unpaired student t-test.  Data presented as mean± SD. LBWf 
n=6; HBWf n=5; LBWm n=8; HBWm n=8. *p≤0.05, ***p≤0.001.  
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3.7.2.3 Expression of lipogenic related genes in Males 
Fold change of the lipogenic regulator SREBP1c was substantially increased 
in LBWm in relation to HBWm (p<0.001; figure 3.7.2.3.1). FASN and LPL 
fold change was also increased in LBWm (p<0.001 both genes; figure 
3.7.2.3.1).  
 
 
Figure 3.7.2.3.1 mRNA expression of lipogenic genes in subcutaneous adipose 
tissue from male and female offspring at weaning.  Figure a) corresponds to males 
and figure b) to females. Sterol regulatory element binding protein 1c =SREBP1c, 
fatty acid synthase =FASN, and lipoprotein lipase =LPL. mRNA expression was 
determined by RT-qPCR and normalised to mRNA expression of housekeeping 
gene actin beta (Actb). Statistical analysis was performed using an unpaired student 
t-test.  Data presented as mean± SD. LBWm n=8; HBWm n=8; LBWf n=6; HBWf 
n=4. ** p≤0.01, *** p≤0.001 
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3.7.2.4 Expression of lipogenic related genes in Females 
In females, SREBP1c expression was undetectable in the samples used. 
However, FASN and LPL expression was significantly reduced in LBWf 
compared to HBWf (p<0.001; p= 0.003 respectively; figure 3.7.2.4.1). It 
would be expected to have a lower expression of SREBP1c, as its 
downstream target gene FASN is down regulated.  
 
These results suggest that LBWf accumulated less lipid in the SAT than 
HBWf, contrary to what was observed between male groups were LBWm 
presented a higher accumulation of lipid in SAT according to mRNA levels of 
lipogenic regulators. 
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Figure 3.7.2.4.1 mRNA expression of lipogenic genes in subcutaneous adipose 
tissue from female and male offspring at weaning. Figure a) corresponds to females 
and figure b) to males. Sterol regulatory element binding protein 1c =SREBP1c, 
fatty acid synthase =FASN, and lipoprotein lipase =LPL. mRNA expression was 
determined by RT-qPCR and normalised to mRNA expression of housekeeping 
gene actin beta (Actb). Statistical analysis was performed using an unpaired student 
t-test.  Data presented as mean± SD. LBWf n=6; HBWf n=4; LBWm n=8; HBWm 
n=8. **p≤0.01, *** p≤0.001.  
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3.7.2.5 Expression of a lipolytic related gene in Males 
To assess lipolytic function in SAT, HSL mRNA levels were determined. 
LBWm did have an enhanced fold change in expression of HSL in respect to 
HBWm (p<0.001, figure 3.7.2.5.1). De novo lipogenesis (as measured by 
FAS expression) and lipid uptake from circulating lipids (estimating LPL 
expression) in LBWm was increased, as did HSL. This may suggests an 
increased in lipid turnover (synthesis-uptake-lipolysis) in SAT of LBWm 
mice.    
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Figure 3.7.2.5.1 mRNA expression of the lipolytic hormone sensitive lipase (HSL) in 
subcutaneous adipose tissue from male and female offspring at weaning. Figure a) 
corresponds to males and figure b) to females. Hormone sensitive lipase was 
assessed as lipolytic regulator. mRNA expression was determined by RT-qPCR and 
normalised to mRNA expression of housekeeping gene actin beta (Actb). Statistical 
analysis was performed using an unpaired student t-test.  Data presented as mean± 
SD. LBWm n=8; HBWm n=8; LBWf n=6; HBWf   n=5. ** p≤0.01, *** p≤0.001. 
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3.7.2.6 Expression of a lipolytic related gene in Females 
mRNA levels of HSL in females were contrary to what was seen in males. 
LBWf had a lower fold change in respect to HBWf (p=0.009, figure 
3.7.2.6.1).          
 
 
Figure 3.7.2.6.1 mRNA expression of the lipolytic hormone sensitive lipase (HSL) in 
subcutaneous adipose tissue from female and male offspring at weaning. Figure a) 
corresponds to females and figure b) to males. Hormone sensitive lipase was 
assessed as lipolytic regulator. mRNA expression was determined by RT-qPCR and 
normalised to mRNA expression of housekeeping gene actin beta (Actb). Statistical 
analysis was performed using an unpaired student t-test.  Data presented as mean± 
SD. LBWf n=6; HBWf n=5; LBWm n=8; HBWm n=8. ** p≤0.01, *** p≤0.001 .  
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3.7.3 Adipose tissue expression of thermogenic genes at weaning (3 
weeks) 
3.7.3.1 Adipose tissue expression of thermogenic genes in Males 
 PGC1a and UCP-1 mRNA expression in LBWm were increased compared 
to HBWm (p<0.001 in both; figure 3.7.3.1.1). This is accordance to the 
results obtained for the adrenergic receptor adrb3, whose mRNA expression 
was also increased in LBWm (p<0.001; figure 3.7.3.1.2).  
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Figure 3.7.3.1.1 mRNA expression of genes related to thermogenic activity in 
subcutaneous adipose tissue from male and female offspring at weaning. Figure a) 
corresponds to males and figure b) to females. Peroxisome proliferator-activated 
receptor gamma coactivator 1 alpha (PGC1a) and its downstream target gene 
uncoupling protein 1 (UCP1) expression were evaluated. mRNA expression was 
determined by RT-qPCR and normalised to mRNA expression of housekeeping 
gene actin beta (Actb). Statistical analysis was performed using an unpaired student 
t-test.  Data presented as mean± SD. LBWm n=7; HBWm n=7; LBWf n=6; HBWf 
n=5. *** p≤0.001.  
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Figure 3.7.3.1.2 mRNA expression of beta 3 adrenergic receptor in subcutaneous 
adipose tissue from male and female offspring at weaning. Figure a) corresponds to 
males and figure b) to females. Beta-adrenergic transcriptional regulation of PGC1a 
was analysed measuring beta 3 adrenergic receptor expression. mRNA expression 
was determined by RT-qPCR and normalised to mRNA expression of housekeeping 
gene actin beta (Actb). Statistical analysis was performed using an unpaired student 
t-test.  Data presented as mean± SD. LBWm n=6; HBWm n=6; LBWf n=6; HBWf 
n=5. *** p≤0.001.  
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3.7.3.2 Adipose tissue expression of thermogenic genes in Females 
In females, LBWf mice had a reduced fold change in the expression of 
PGC1a and UCP1 (p<0.001 in both; figure 3.7.3.2.1) as well as beta 3 
adrenergic receptor expression (Adrb3) (p< 0.001; figure 3.7.3.2.2). 
 
	  
Figure 3.7.3.2.1 mRNA expression of genes related to thermogenic activity in 
subcutaneous adipose tissue from female and male offspring at weaning. Figure a) 
corresponds to females and figure b) to males. Peroxisome proliferator-activated 
receptor gamma coactivator 1 alpha (PGC1a) and its downstream target gene 
uncoupling protein 1 (UCP1) expression were evaluated. mRNA expression was 
determined by RT-qPCR and normalised to mRNA expression of housekeeping 
gene actin beta (Actb). Statistical analysis was performed using an unpaired student 
t-test.  Data presented as mean± SD. LBWf n=6; HBWf n=5; LBWm n=7; HBWm 
n=7. *** p≤0.001.  
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Figure 3.7.3.2.2 mRNA expression of beta 3 adrenergic receptor in subcutaneous 
adipose tissue from female and male offspring at weaning. Figure a) corresponds to 
females and figure b) to males. Beta-adrenergic transcriptional regulation of PGC1a 
was analysed measuring beta 3 adrenergic receptor expression. mRNA expression 
was determined by quantitative reverse transcriptase PCR RT-qPCR and 
normalised to mRNA expression of housekeeping gene actin beta (Actb). Statistical 
analysis was performed using an unpaired student t-test.  Data presented as mean± 
SD. LBWf n=6; HBWf n=5; LBWm n=6; HBWm n=6. *** p≤0.001.  
 
 
 
 
 
 
 
The table below summarises the adipose tissue gene expression for both 
male and female mice (table 3.7.1). 
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 LBWm HBWm p LBWf HBWf p m-f diff. 
IRS-1  - ✓ -  ✓ ✓ 
p110b  - ✓ -  ✓ ✓ 
Akt2  - ✓ -  ✓ ✓ 
PKC-Z  - ✓ -  ✓ ✓ 
GLUT4  - ✓ -  ✓ ✓ 
PPARG2  - ✓ -  ✓ ✓ 
CEBP1a  - ✓ -  ✓ ✓ 
SREBP1c  - ✓ -  ✓ ✓ 
FASN  - ✓ -  ✓ ✓ 
LPL  - ✓ -  ✓ ✓ 
HSL  - ✓ -  ✓ ✓ 
PGC1a  - ✓ -  ✓ ✓ 
UCP1  - ✓ -  ✓ ✓ 
Adrb3  - ✓ -  ✓ ✓ 
 
 
 
Table 3.7.1 Summary of adipose tissue gene expression by gender. Arrows indicate 
that the measurement was higher in the respective group compared to its 
counterpart. ✓indicates that the difference between groups was significantly 
different in p column (p value); in the last column indicates a different finding 
between genders. x indicates that the difference between groups was not 
significantly different in p column; in the last column indicates a similar finding 
between genders. Adrb3= beta 3 adrenergic receptor. 
	  	  	  
	   219	  
3.8 Summary 
 
LBWm/f mice grew faster than HBWm/f mice but did not catch up in weight 
with HBWm/f mice.  
 
There were sexually dimorphic differences at weaning: LBWm mice had an 
asymmetrical growth with an enhanced brain growth (measured as weight). 
In contrast, liver, muscle, and white adipose tissue growth was rectricted. No 
differences in growth were found between female groups, although brain and 
heart weights tended to be higher in LBWf mice. 
 
Adipose tissue distribution was sexually dimorphic with LBWm mice having a 
lower SAT% than HBWm mice, whereas LBWf mice had a higher IAT% 
compared to HBWf mice. Intrahepatocellular lipid content (IHCL) was lower 
in LBWm/f compared to HBWm/f mice. 
 
Fasting glucose levels were significantly higher in LBWm mice than HBWm 
mice. Levels of insulin were higher in LBWm mice than HBWm mice but it 
did not reach statistical significance.  GIP levels were higher in LBWm than 
HBWm mice. LBWf had an impaired fasting glucose compared to HBWf 
mice accompanied by high c-peptide, insulin, GIP and glucagon levels in 
plasma.  
 
Proinflammatory markers MCP-1 and IL-6 were significantly higher in LBWf 
compared to HBWf mice, but only MCP-1 in LBWm compared to HBWm 
mice.  
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SAT translational insulin signaling, adipogenesis and lipid metabolism were 
upregulated in LBWm mice and downregulated in LBWf mice compared to 
their respective counterparts (HBWm/f). 
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4. Study 2. Effects of Birth Weight and Diet on Body 
Composition and Appetite Regulation in Young Mice 
(From Week 3 Until Week 15)  
 
At weaning (week 3 of life), pups were separated from their litters and 
divided by birth weight into two categories taking into account the parameters 
mentioned in study 1 (section 2.1.3). These two groups were: Low birth 
weight mice (LBW) and High birth weight mice (HBW). Offspring was further 
subdivided by diet (section 2.2.2: control fat diet =9%kcal fat intake) and a 
moderated high fat diet =27% kcal)	  and by gender: male (m) or female (f) 
mice.  In total, four groups were formed per gender as follow: 1). Low birth 
weight mice fed a Normal Fat diet (LBWm/f-NF), 2). High birth weight mice 
fed a Normal Fat diet (HBWm/f-NF), 3). Low birth weight mice fed a High Fat 
diet (LBWm/f-HF) and 4). High birth weight mice fed a High Fat diet 
(HBWm/f-HF).   
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4.1 The Effects of Birth Weight and Diet on Body Weight in 
Young Mice (From Week 3 Until Week 15)  
 
Body weight was monitored weekly, starting when the pups were 3 weeks 
old and ending at age 15 weeks. Detailed information of the protocol used for 
this study can be found in section 2.2.4. 
 
4.1.1 Body weight in Male mice 
Figures 4.1.1.1 and 4.1.1.2 show the growth pattern of the 4 groups following 
maintenance on both normal fat control diet (9% kcal fat intake) and purified 
moderated high fat diet (27% kcal fat intake).  
 
Mice fed a HF diet increased rapidly their body weight; by week 5 of age 
HBWm-HF had significantly higher body weights compared to HBWm-NF 
mice (HBWm-HF =20.613±0.286g vs. HBWm-NF =19.49±0.236g, p=0.025; 
figures 4.1.1.1 and 4.1.1.2b) and one week later between LBWm mice 
(LBWm-HF=21.061±0.248g vs. LBWm-NF=19.769±0.22g, p=0.002; figures 
4.1.1.1 and 4.1.1.2a). Comparison between LBWm mice and HBWm mice 
showed significant differences in weight until the age of 9 weeks on a NF diet 
(figures 4.1.1 and 4.1.2c), and until the age of 11 weeks on a HF diet (figures 
4.1.1.1 and 4.1.1.2d). 
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Figure 4.1.1.1 Body weight of male and female mice from weaning (week 3) until 
early adulthood (week 15). LBWm/f and HBWm/f were subdivided into 4 further 
groups according to the diet given from weaning until week 51, either a normal fat 
diet =NF (9% kcal fat) or moderated high fat diet =HF (27% fat intake). The groups 
were: Low birth weight males/females fed a normal fat diet =LBWm/f-NF; Low birth 
weight males/females fed a high fat diet= LBWm/f-HF; High birth weight 
males/females fed a normal fat diet =HBWm/f-NF; High birth weight males/females 
fed a high fat diet=HBWm/f-HF. Statistical analysis was performed using a mixed 
general linear model (GLM) followed by a Games-Howell post hoc analysis for 
unequal variances.  Data presented as mean± SEM. LBWm-NF n=40; LBWm-HF 
n=42; HBWm-NF n=33; HBWm-HF n=38; LBWf-NF n=39; LBWf-HF n=36; HBWf-
NF n=24, HBWf-HF n=30. Figure a) corresponds to males and figure b) to females.  
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Figure 4.1.1.2 Body weight of male mice from weaning (week 3) until early 
adulthood (week 15). Figures a) and b) show the body weights throughout the study 
by diets (NF-HF respectively) in mice within the same birth weight category. Figure 
c) and d) show the body weights throughout the study by  (LBWm-HBWm 
respectively) in mice within the same diet category. Statistical analysis was 
performed using a mixed general linear model (GLM) followed by a Games-Howell 
post hoc analysis for unequal variances.  Data presented as mean± SEM. LBWm-
NF n=40; LBWm-HF n=42; HBWm-NF n=33, HBWm-HF n=38. * p≤0.05, **p≤0.01, 
*** p≤0.001. 
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4.1.2 Body weight in Female mice 
As with males, diet affected the body weight of mice, with higher body 
weights in females fed a HF diet.  Differences between HBWf mice reached 
significance by week 6, compared to 5 weeks in males (HBWf-HF 
=17.884±0.162g vs. HBWm-NF =16.886±0.242g, p=0.004; figures 4.1.2.1 
and 4.1.2.2b); by week 7 differences between LBWf mice reached 
significance, whilst in small males was one week before (LBWm-
HF=17.466±0.1742g vs. LBWm-NF=16.709±0.16.292g, p=0.023; figures 
4.1.2.1 and 4.1.2.2a). 
 
Contrary to males, compared to HBWf mice LBWf mice had a significant 
lower body weight throughout the study (females: figures 4.1.2.1 and figures 
4.1.2.2c-d; males: figures 4.1.1.1 and 4.1.1.2c-d). 
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Figure 4.1.2.1 Body weight of female and male mice from weaning (week 3) until 
early adulthood (week 15). LBWf/m and HBWf/m were subdivided into 4 further 
groups according to the diet given from weaning until week 51, either a normal fat 
diet =NF (9% kcal fat) or moderated high fat diet =HF (27% fat intake). Statistical 
analysis was performed using a mixed general linear model (GLM) followed by a 
Tukey’s high significance difference (HSD) post hoc analysis.  Data presented as 
mean± SEM. LBWf-NF n=39; LBWf-HF n=36; HBWf-NF n=24, HBWf-HF n=30; 
LBWm-NF n=40; LBWm-HF n=42; HBWm-NF n=33, HBWm-HF n=38. Figure a) 
corresponds to females and figure b) to males. 
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Figure 4.1.2.2 Body weight of female mice from weaning (week 3) until early 
adulthood (week 15). Figures a) and b) show the body weights throughout the study 
by diets (NF-HF respectively) in mice within the same birth weight category. Figure 
c) and d) show the body weights throughout the study by  (LBWf-HBWf 
respectively) in mice within the same diet category. Statistical analysis was 
performed using a mixed general linear model (GLM) followed by a Tukey’s high 
significance difference (HSD) post hoc analysis.  Data presented as mean± SEM. 
LBWf-NF n=39; LBWf-HF n=36; HBWf-NF n=24, HBWf-HF n=30. * p≤0.05, 
**p≤0.01, *** p≤0.001. 
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4.1.3 Body weight gain in Male mice 
A 2x2 factorial ANOVA was performed to examine the independent effects of 
birth weight and diet on body weight gain as well as a possible interaction 
between these two factors.  
 
Assessment of body weight gain (g) from week 3 to week 15 showed that 
both factors, birth weight and diet, had an effect on body weight gained 
during this period (: F(1,134)=4.338 p=0.039; diet: F(1,134)=41.53 p<0.001; 
figure 4.1.3.1a and table 4.1.3.1(left)) and these effects were independent as 
the interaction between  and diet was not significant (interaction birth weight 
x diet: F(1,134)=0.026 p=0.873; figure 4.1.3.1a and table 4.1.3.1(left). This 
suggests that LBWm mice gained more weight than HBWm irrespective of 
the diet given, and at the same time, mice fed a HF diet gained more weight 
than mice fed a NF diet, independently of the size at birth.   
 
 Assessment of body weight gain normalised to initial body weight (relative 
body weight gain or total growth %) showed a similar pattern as seen in 
absolute body weight gain (g) where birth weight and diet effects were 
maintained without an interaction (birth weight: F(1,134)=30.826 p<0.001; 
diet: F(1,134)=10.986 p=0.001; interaction birth weight x diet: 
F(1,134)=0.156 p=0.693; figure 4.1.3.1b and table 4.1.3.1 (right). 
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Figure 4.1.3.1 Body weight gain of male and female offspring from week 3 to week 
15. Total body weight gains in grams a) and c) and body weight gains normalised to 
initial body weight (growth%) b) and d). Figures on the top correspond to males and 
figures below to females. Statistical analysis was performed using a 2x2 factorial 
ANOVA analysis. Data presented as mean± SEM. Main effect of diet= + p≤0.001 in 
a), b) and c); significant main effect of birth weight represented with different letters 
p≤0.05 in a) and p≤0.001 in b) and d). LBWm-NF n=30; LBWm-HF n=40; HBWm-
NF n=30, HBWm-HF n=40; LBWf-NF n=30; LBWf-HF n=27; HBWf-NF n=22, 
HBWf-HF n=25.  
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Birth weight   Diet Total body weight gain 
(g) 
Total body weight gain   
(growth%) 
LBWm             NF 
                        HF      
 
18.799± 0.387 
21.057± 0.329 
224.158±7.066 
248.088±5.912 
HBWm            NF 
                        HF 
 
17.993± 0.387 
20.366± 0.329 
190.893±6.827 
209.725±5.912 
 Birth weight effect p=0.039 
 
p<0.001 
Diet p<0.001 
 
p=0.001 
Interaction 
( x diet) 
p=0.873 p=0.693 
 
Table 4.1.3.1 Body weight gain of male offspring from week 3 to week 15. Total 
body weight gains in grams (left) and body weight gains normalised to initial body 
weight (growth%; left). Statistical analysis was performed using a 2x2 factorial 
ANOVA analysis. Data presented as mean± SEM. LBWm-NF n=30; LBWm-HF 
n=40; HBWm-NF n=30, HBWm-HF n=40.  
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4.1.4 Body weight gain in Female mice 
Contrary to males, only diet had a significant main effect per se on body 
weight gained in females (diet: F(1,100)=13.858 p<0.001; birth weight: 
F(1,100)=0.248 p=0.619; interaction diet x birth weight: F(1,100)=0.007 
p=0.932; figures 4.1.4.1a and table 4.1.4.1(left)). This suggests that females 
that were fed a HF diet had a greater body weight gain compared to females 
fed a NF diet, and this effect was not dependent on birth weight.  
 
However, evaluation of normalised body weight to initial body weight (%) 
showed a different pattern with a significant main effect of birth weight on 
body weight and a marginal effect of diet with no interaction between both 
factors (birth weight: F(1,100)=16.275 p<0.001; diet: F(1,100)=3.492 
p=0.065; interaction diet x birth weight: F(1,100)=0.348 p=0.557; figures 
4.1.4.1b and table 4.1.4.1(right)). This indicated that females accelerated 
more their weight gain if they had a lower birth weight (LBWf) compared to 
their heavier counterparts (HBWf). 
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Figure 4.1.4.1 Body weight gain of female and male offspring from week 3 to week 
15. Total body weight gains in grams a) and c) and body weight gains normalised to 
initial body weight (growth%) b) and d). Figures on the top correspond to females 
and figures below to males. Statistical analysis was performed using a 2x2 factorial 
ANOVA analysis. Data presented as mean± SEM. Significant main effect of diet= + 
p≤0.001 in a), c) and d) and N/S=no significant (p=0.065) in b). No significant effect 
of birth weight (p=0.619) represented with equal letters in a) and significant main 
effect of birth weight represented with different letters, p≤0.05 in c), and p≤0.001 in 
b) and d). LBWf-NF n=30; LBWf-HF n=27; HBWf-NF n=22, HBWf-HF n=25; 
LBWm-NF n=30; LBWm-HF n=40; HBWm-NF n=30, HBWm-HF n=40. 
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Birth Weight   Diet Total body weight gain 
(g) 
Total body weight gain   
(growth%) 
LBWf              NF 
                       HF      
 
12.098± 0.303 
13.322± 0.314 
159.937±6.958 
178.168±7.211 
HBWf             NF 
                       HF 
 
12.286± 0.341 
13.455± 0.327 
134.397±7.813 
143.878±7.648 
Birth weight effect p=0.619 
 
p<0.001 
Diet p<0.001 
 
p=0.065 
Interaction 
(birth weight x diet) 
p=0.932 p=0.557 
 
Table 4.1.4.1 Body weight gain of female offspring from week 3 to week 15. Total 
body weight gains in grams (left) and body weight gains normalised to initial body 
weight (growth%; right). Statistical analysis was performed using a 2x2 factorial 
ANOVA analysis. Data presented as mean± SEM. LBWf-NF n=30; LBWf-HF n=27; 
HBWf-NF n=22, HBWf-HF n=25.  
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4.2 The Effects of Birth Weight and Diet on Caloric Intake in 
Young Mice (From Week 3 Until Week 15)  
 
Total kilocalorie intake was calculated using weekly food intake 
measurements and the values of the caloric content of the diets described in 
section 2.2, table 2.2.1, and section 2.3. A 2x2 factorial ANOVA was 
performed to examine the independent effects of birth weight and diet on 
total kilocalorie intake and a possible interaction between these two factors.  
 
4.2.1 Total kilocalorie intake in Male mice 
Figure 4.2.1.1a and table 4.2.1.1(left) shows the total kilocalorie intake of 
LBWm and HBWm mice fed both a control fat diet (9% kcal fat intake) and a 
purified moderated high fat diet (27% kcal fat intake). 
 
There was a main effect of both, diet and birth weight on the total kilocalorie 
intake in mice (diet: F(1,22)=25.363 p<0.001; birth weight: F(1,22)=5.826 
p=0.025; figure 4.2.1a and table 4.2.1(left)) but the interaction was not 
significant (interaction diet x birth weight: F(1,22)=0.497 p=0.488; figure 
4.2.1a and table 4.2.1(left). This indicated that mice fed HF diet had a higher 
intake of kilocalories independently of the birth weight of mice. However, 
birth weight per se had an effect on kilocaloric intake as well. This means 
that both factors presented in the study can affect food intake independently 
of each other.  
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Normalisation of kilocalorie intake to body weight0.75 showed that differences 
between groups had a different pattern. The two independent factors (diet 
and birth weight) did not have a main effect per se (diet: F(1,72)=1.895 
p=0.173; birth weight: F(1,72)=0.261 p=0.611; figure 4.2.1.1b and table 
4.2.1.1(right) but the effect of each factor depended on the other factor 
(interaction diet x birth weight: F(1,72)=5.643 p=0.02; figure 4.2.1.1b and 
table 4.2.1.1(right). This indicated that the effect of diet depended on the 
birth weight of mice and vise versa. LBWm-NF had a higher kilocaloric 
intake that LBWm-HF but the difference did not reach significance (p=0.472; 
figure 4.2.1.1b and table 4.2.1.1(right). On the contrary, HBWm-NF had a 
lower intake that HBWm-HF (p=0.011; figure 4.2.1.1b). Moreover, LBWm-
NF had a higher intake than HBWm-NF but differences did not reach 
significance (p=0.243; figure 4.2.1.1b). However, LBWm-HF did consume 
less kilocalories than HBWm-HF mice (p=0.021; figure 4.2.1.1b).  
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Figure 4.2.1.1 Total kilocalorie intake of male and female mice from week 3 to week 
15 of age. Total kilocalories consumed in absolute values a) and c) and normalised 
to body weight0.75 b) and d). Statistical analysis was performed using a 2x2 factorial 
ANOVA analysis. Significant main effect of diet= + *p≤0.05 in c) and *** p≤0.001 in 
a) and d). Significant main effect of birth weight= different letters in a), p=0.025. 
Simple main effects were assessed in b) as interaction was significant. Data 
presented as mean± SEM. LBWm-NF n=5/14; LBWm-HF n=9/27; HBWm-NF 
n=5/14, HBWm-HF n=7/21; LBWf-NF n=10/27; LBWf-HF n=5/15; HBWf-NF 
n=6/18, HBWf-HF n=6/16.  
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Birth weight     Diet Total kilocalories   
(kcal) 
Total kilocalories / bw0.75 
(kcal/g0.75) 
LBWm              NF 
                         HF 
 
3386.898± 110.109 
3818.115± 82.07 
84.219±2.495 
81.996±1.797 
HBWm             NF 
                         HF 
 
3557.038± 110.109 
4128.565± 93.059 
80.068±2.495 
88.422±2.037 
Birth weight effect p=0.025 
 
p=0.173 
Diet p≤0.001 
 
p=0.611 
Interaction 
(Birth weight x diet) 
p=0.488 p=0.02 
 
 
Table 4.2.1.1 Total kilocalories consumed from week 3 until week 15 in male 
offspring. Total kilocalories consumed in absolute values (left) and normalised to 
body weight0.75 (right). Statistical analysis was performed using a 2x2 factorial 
ANOVA analysis. Data presented as mean± SEM. Data for kilocalories in absolute 
values was analysed by cage and by mouse/cage for normalised data. LBWm-NF 
n=5/14; LBWm-HF n=9/257; HBWm-NF n=5/14, HBWm-HF n=7/21.  
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4.2.2 Total kilocalorie intake in Female mice 
As in males, females were affected by the diet given during the study but 
there was not a main effect of birth weight or interaction between both 
variables (diet: F(1,23)=4.123 p=0.05; birth weight: F(1,23)=0.385 p=0.541; 
interaction diet x birth weight: F(1,23)=0.352 p=0.559; figure 4.2.2.1a and 
table 4.2.2.1(left). 
 
This pattern was maintained after normalisation to body weight0.75 (diet: 
F(1,72)=11.567 p=0.001; birth weight: F(1,72)=0.416 p=0.521; interaction 
diet x birth weight: F(1,72)=0.507 p=0.479; figure 4.2.2.1b and table 4.2.2.1 
(right). 
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Figure 4.2.2.1 Total kilocalorie intake of female and male mice from week 3 to week 
15 of age. Total kilocalories consumed in absolute values a) and c) and normalised 
to body weight0.75 b) and d). Figures on the top correspond to females and figures 
below to males. Statistical analysis was performed using a 2x2 factorial ANOVA 
analysis. Data presented as mean± SEM. Main effect of diet= + and main effect of 
birth weight= lowercase letters (different letters= significant effect; p=0.025 in c)). 
LBWf-NF n=10/27; LBWf-HF n=5/15; HBWf-NF n=6/18, HBWf-HF n=6/16; LBWm-
NF n=5/14; LBWm-HF n=9/27; HBWm-NF n=5/14, HBWm-HF n=7/21. *p≤0.05, 
**p≤0.01, ***p≤0.001. 
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Birth weight     Diet Total kilocalories   
(kcal) 
Total kilocalories / bw0.75 
(kcal/g0.75) 
LBWf               NF 
                        HF 
 
3026.01± 72.099 
3156.416± 101.963 
86.649±1.035 
91.728±1.319 
HBWf              NF 
                        HF 
 
3028.505± 93.079 
3266.511± 93.079 
86.732±1.244 
90.052±1.319 
Birth weight effect p=0.541 
 
p=0.521 
Diet p=0.05 
 
p=0.001 
Interaction 
(Birth weight x diet) 
p=0.559 p=0.479 
 
Table 4.2.2.1 Total kilocalories consumed from week 3 until week 15 in female 
offspring. Total kilocalories consumed in absolute values (left) and normalised to 
body weight0.75 (right). Statistical analysis was performed using a 2x2 factorial 
ANOVA analysis. Data presented as mean± SEM. Data for kilocalories in absolute 
values was analysed by cage and by mouse/cage for normalised data. LBWf-NF 
n=10/27; LBWf-HF n=5/15; HBWf-NF n=6/18, HBWf-HF n=6/16.  
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4.3 The Effects of Birth Weight and Diet on Feed Efficiency in 
Young Mice (From Week 3 Until Week 15)  
 
Feed efficiency was calculated as the body weight gain divided by total 
kilocalories consumed. Total kilocalorie intake was calculated using weekly 
food intake measurements and the values of the caloric content of the diets 
mentioned in section 2.2, table 2.2.1. A 2x2 factorial ANOVA was performed 
to examine the independent effects of birth weight and diet on feed intake 
and a possible interaction between these two factors. 
 
4.3.1 Feed efficiency in Males 
Figure 4.3.1.1 and table 4.3.1.1 show that LBWm mice were more efficient in 
gaining weight per kilocalorie consumed than HBWm mice  (birth weight: 
F(1,72)=26.267 p<0.001), and there was not a significant effect of diet (diet: 
F(1,72)=3.184 p=0.079), or interaction between birth weight and diet 
(interaction diet x birth weight: F(1,72)=0.159, p=0.691). 
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Figure 4.3.1.1 Feed efficiency of male and female mice from week 3 until week 15. 
Figure a) corresponds to males and figure b) to females. Total kilocalories were 
obtained from weekly-recorded food intake and the calculated kilocaloric content 
per gram of each diet (NF= 3.6 kcal/g and HF=4.1 kcal/g). Statistical analysis was 
performed using a 2x2 factorial ANOVA analysis. Data presented as mean± SEM. + 
Main effect of diet: p=0.079 in males a); significant main effect of birth weight 
represented with different letters: p≤0.001 in males a). As interaction was significant 
between groups in b), simple main effects were assessed after the factorial ANOVA. 
N/S= No significant difference.  LBWm-NF n=14; LBWm-HF n=27; HBWm-NF 
n=14, HBWm-HF n=20; LBWf-NF n=26; LBWf-HF n=14; HBWf-NF n=19, HBWf-
HF n=15.    
  
 
 
 
 
 
	   243	  
Birth weight     Diet Feed efficiency (mg/kcal) 
LBWm              NF 
                         HF 
 
276.286± 8.274 
286.515± 5.958 
HBWm             NF 
                         HF 
 
235.5± 8.274 
251.619± 6.756 
Birth weight effect p<0.001 
 
Diet p=0.079 
 
Interaction 
(Birth weight x diet) 
p=0.691 
 
Table 4.3.1.1 Feed efficiency of male mice from week 3 until week 15. Statistical 
analysis was performed using a 2x2 factorial ANOVA analysis. Data presented as 
mean± SEM. LBWm-NF n=14; LBWm-HF n=27; HBWm-NF n=14, HBWm-HF 
n=20.  
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4.3.2 Feed efficiency in Females 
Contrary to what was seen in males, there was an interaction between both 
birth weight and diet in female mice (interaction diet x birth weight: 
F(1,70)=5.673 p=0.02; figure 4.3.2.1 and table 4.3.2.1). This indicated that 
the effect of both variables depended on each other. LBWf-NF mice had a 
lower efficiency in gaining weight per kilocalorie consumed than LBWf-HF 
mice (p=0.001; figure 4.3.2.1 and table 4.3.2.1). However, there was not a 
significant difference between HBWf mice (p=0.904; figure 4.3.2.1 and table 
4.3.2.1). Furthermore, there was a significance difference between mice fed 
a HF diet, with a higher feed efficiency in LBWf-HF mice compared to HBWf-
HF mice (p<0.001; figure 4.3.2.1 and table 4.3.2.1) but not difference was 
seen between females fed a NF diet (p=0.455; figure 4.3.2.1 and table 
4.3.2.1).  
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Figure 4.3.2.1 Feed efficiency of female and male mice from week 3 until week 15. 
Total kilocalories were obtained from weekly-recorded food intake and the 
calculated kilocaloric content per gram of each diet (NF= 3.6 kcal/g and HF=4.1 
kcal/g). Statistical analysis was performed using a 2x2 factorial ANOVA analysis. 
Data presented as mean± SEM. As interaction was significant between groups in 
females a), simple main effects with Bonferroni correction were assessed after the 
factorial ANOVA. + Main effect of diet: p=0.079 in b); significant main effect of birth 
weight represented with different letters: p≤0.001 in b). N/S= No significant 
difference (LBWf-NF vs. HBWf-NF p=0.455; HBWm-NF vs. HBWf-HF p=0.904); 
***p≤0.001 (LBWf-NF vs. LBWf-HF; LBWf-HF vs. HBWf-HF). LBWf-NF n=26; 
LBWf-HF n=14; HBWf-NF n=19, HBWf-HF n=15; LBWm-NF n=14; LBWm-HF 
n=27; HBWm-NF n=14, HBWm-HF n=20. 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   246	  
 
Birth weight     Diet Feed efficiency (mg/kcal) 
LBWf                NF 
                         HF 
 
190.41± 4.355 
214.804± 5.934 
HBWf               NF 
                         HF 
 
185.377± 5.094 
184.452± 5.733 
Interaction 
(birth weight x diet) 
p=0.02 
 
 
Table 4.3.2.1 Feed efficiency of female mice from week 3 until week 15. Statistical 
analysis was performed using a 2x2 factorial ANOVA analysis. Data presented as 
mean± SEM. LBWf-NF n=26; LBWf-HF n=14; HBWf-NF n=19, HBWf-HF n=15. 
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4.4 The Effects of Birth Weight and Diet on Total Body 
Adiposity and Intrahepatocellular Lipid Content in Young 
Mice (From Week 3 Until Week 15) 
 
15 weeks old mice were fasted overnight before assessing non-invasively 
the whole body adiposity and intrahepatocellular lipid content (IHCL) using 
1H MRS and MRI techniques. Detailed information of the parameters of 
these methods is described in section 2.4.1. A 2x2 factorial ANOVA was 
performed to examine the independent effects of birth weight and diet on 
body adiposity and hepatic lipid content and a possible interaction between 
these two factors. 
 
4.4.1 Whole body adiposity in Males and intrahepatocelullar lipid 
content (IHCL) 
Whole body adiposity showed an interaction between both diet and birth 
weight (interaction diet x birth weight: F(1,68)=3.874 p=0.05; figure 4.4.1.1). 
Simple main effects assessment revealed that in general mice fed a HF diet 
had a higher adiposity than mice fed a NF diet, but the difference only 
reached significance between HBWm mice (HBWm-HF=21.327±1.156% vs. 
HBWm-NF=15.697±1.156%, p=0.001; LBWm-HF=20.635±1.016% vs. 
LBWm-NF= 19.461±1.191%, p=0.456; figure 4.4.1.1). Furthermore, LBWm-
NF had a significantly higher adiposity than HBWm-NF mice (p=0.027; figure 
4.4.1.1), but it was comparable between LBWm-HF and HBWm-HF 
(p=0.654; figure 4.4.1.1).  
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Figure 4.4.1.1 Whole body adiposity (%) of male and female mice at the end of the 
study (week 15). Whole body adiposity was assessed using 1H MRS. Statistical 
analysis was performed using a 2x2 factorial ANOVA analysis. Data presented as 
mean± SEM. As interaction was significant between groups in males a), simple 
main effects with Bonferroni correction were assessed after the factorial ANOVA. 
N/S= No significant difference (LBWm-NF vs. LBWm-HF p=0.456; LBWm-HF vs. 
HBWm-HF p=0.654); * p≤0.05 (LBWm-NF vs. HBWm-NF); *p≤0.001 (HBWm-NF 
vs. HBWm-HF). LBWm-NF n=16; LBWm-HF n=22; HBWm-NF n=17, HBWm-HF 
n=17. Main effect of diet + =***p≤0.001 in females b). Significant main effect of birth 
wieght represented with different letters (p=0.037) in female mice b). LBWf-NF 
n=12; LBWf-HF n=12; HBWf-NF n=12, HBWf-HF n=15. 
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Birth weight       Diet Adiposity (%) 
LBWm              NF 
                         HF 
 
19.461± 1.191 
20.635± 1.016 
HBWm             NF 
                         HF 
 
15.697± 1.156 
21.327± 1.156 
Interaction 
(birth weight x diet) 
p=0.05 
 
 
Table 4.4.1.1 Whole body adiposity (%) of male mice at the end of the study (week 
15). Whole body adiposity was assessed using 1H MRS. Statistical analysis was 
performed using a 2x2 factorial ANOVA analysis. Data presented as mean± SEM. 
LBWm-NF n=16; LBWm-HF n=22; HBWm-NF n=17, HBWm-HF n=17.  
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Assessment of the intrahepatocellular lipid content (IHCL) showed a 
significant main effect of birth weight on the percentage of hepatic lipid 
content in male mice (F(1,61)=5.063 p=0.028; figure 4.4.2.1 and table 
4.4.2.1). This indicated that LBWm mice had a higher lipid content compared 
to HBWm mice independently of the diet given throughout the study. There 
was not a main effect of diet or significant interaction between both variables 
(diet: F(1,61)=0.832 p=0.365; interaction birth weight x diet:  F(1,61)=0.124 
p=0.725; figure 4.4.1.2 and table 4.4.1.2). 
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Figure 4.4.1.2 Intrahepatocellular lipid content (IHCL%) of male and female mice at 
the end of the study (week 15). IHCL was assessed using localised 1H MRS. 
Statistical analysis was performed using a 2x2 factorial ANOVA analysis. Data 
presented as mean± SEM. Main effect of diet: N/S= No significant difference 
(p=0.365) in male mice a) and significantly different in female mice b) += * p≤0.05. 
Main effect of birth weight represented with different letters in a), p=0.028 and b), 
p=0.034. LBWm-NF n=15; LBWm-HF n=17; HBWm-NF n=16, HBWm-HF n=17; 
LBWf-NF n=8; LBWf-HF n=8; HBWf-NF n=10, HBWf-HF n=13.  
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Birth weight       Diet IHCL (%) 
LBWm              NF 
                         HF 
 
20.947± 1.798 
18.759± 1.689 
HBWm             NF 
                         HF 
 
16.444± 1.741 
15.476± 1.689 
Birth -weight effect p=0.028 
 
Diet p=0.365 
 
Interaction 
(birth weight x diet) 
p=0.725 
 
 
Table 4.4.1.2 Intrahepatocellular lipid content (IHCL%) of male mice at the end of 
the study (week 15) using localised 1H MRS. Statistical analysis was performed 
using a 2x2 factorial ANOVA analysis. Data presented as mean± SEM. LBWm-NF 
n=15; LBWm-HF n=17; HBWm-NF n=16, HBWm-HF n=17.  
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4.4.2 Whole body adiposity in Females and intrahepatocellular lipid 
content (IHCL) 
Contrary to male mice, females did not have an interaction between both 
birth weight and diet (F(1,47)=1.282 p=0.263; figure 4.4.2.1 and table 
4.4.2.1). However, there was a independent main effect of both birth weight 
(F(1,47)=4.595 p=0.037; figure 4.4.2.1 and table 4.4.2.1) and diet 
(F(1,47)=17.405 p<0.001; figure 4.4.2.1 and table 4.4.2.1). This indicated 
that LBWf mice had a lower adiposity compared to HBWf mice and 
furthermore, females fed a HF had a higher lipid content than females fed NF 
diet. Female mice had in general a lower adiposity compared to their 
respective male group (figures 4.4.1.1 and 4.4.1.2 and tables 4.4.1.1 and 
4.4.1.2). 
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Figure 4.4.2.1 Whole body adiposity (%) of female and male mice at the end of the 
study (week 15). Whole body adiposity was assessed using 1H MRS. Statistical 
analysis was performed using a 2x2 factorial ANOVA analysis. Data presented as 
mean± SEM. Main effect of diet + =***p≤0.001 in female mice a). Significant main 
effect of birth weight represented with different letters (p=0.037) in a). LBWf-NF 
n=12; LBWf-HF n=12; HBWf-NF n=12, HBWf-HF n=15. As interaction was 
significant between groups in male mice b), simple main effects with Bonferroni 
correction were assessed after the factorial ANOVA. N/S= No significant difference 
(LBWm-NF vs. LBWm-HF p=0.456; LBWm-HF vs. HBWm-HF p=0.654); * p≤0.05 
(LBWm-NF vs. HBWm-NF); *p≤0.001 (HBWm-NF vs. HBWm-HF). LBWm-NF 
n=16; LBWm-HF n=22; HBWm-NF n=17, HBWm-HF n=17. 
 
 
 
 
 
 
 
 
 
 
 
 
	   255	  
 
Birth weight       Diet Adiposity (%) 
LBWf                NF 
                         HF 
 
10.955± 1.249 
14.654± 1.249 
HBWf               NF 
                         HF 
 
12.186± 1.249 
18.641± 1.117 
Birth weight effect p=0.037 
 
Diet p<0.001 
 
Interaction 
( x diet) 
p=0.263 
 
 
Table 4.4.2.1 Whole body adiposity (%) of female mice at the end of the study 
(week 15). Whole body adiposity was assessed using 1H MRS. Statistical analysis 
was performed using a 2x2 factorial ANOVA analysis. Data presented as mean± 
SEM. LBWf-NF n=12; LBWf-HF n=12; HBWf-NF n=12, HBWf-HF n=15.  
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Evaluation of the hepatic lipid content in female mice showed, as in males, 
showed a main effect of birth weight (F(1,35)=4.871 p=0.034; figure 4.4.2.2 
and table 4.4.2.2). However, female mice were also affected by the diet 
given throughout the study with a higher IHCL% in females fed a HF diet 
than NF fed females (F(1,35)=4.131 p=0.05; figure 4.4.2.2 and table 4.4.2.2). 
There was not an interaction between variables (F(1,35)=0.044 p=0.835; 
figure 4.4.4 and table 4.4.4). Interestingly, females had higher lipid content in 
the liver compared to their respective male group (figures 4.4.1.2 and 4.4.2.2 
and tables 4.4.1.2 and 4.4.2.2).  
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Figure 4.4.2.2 Intrahepatocellular lipid content (IHCL%) of female and male mice at 
the end of the study (week 15). Statistical analysis was performed using a 2x2 
factorial ANOVA analysis. Data presented as mean± SEM. Main effect of diet + 
=*p≤0.05 in female mice a). No significant different=N/S in male mice b), p=0.365. 
Significant main effect of birth weight represented with different letters in a), 
p=0.034 and b) p=0.028. LBWf-NF n=8; LBWf-HF n=8; HBWf-NF n=10, HBWf-HF 
n=13; LBWm-NF n=15; LBWm-HF n=17; HBWm-NF n=16, HBWm-HF n=17. 
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Birth weight       Diet IHCL (%) 
LBWf                NF 
                         HF 
 
34.838± 2.999 
39.888± 2.999 
HBWf               NF 
                         HF 
 
28.14± 2.682 
34.354± 2.352 
Birth weight effect p=0.034 
 
Diet P=0.05 
 
Interaction 
( x diet) 
p=0.835 
 
 
Table 4.4.4 Intrahepatocellular lipid content (IHCL%) of female mice at the end of 
the study (week 15). IHCL was assessed using 1H MRS. Statistical analysis was 
performed using a 2x2 factorial ANOVA analysis. Data presented as mean± SEM. 
LBWf-NF n=8; LBWf-HF n=8; HBWf-NF n=10, HBWf-HF n=13.  
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4.5.1 The Effects of birth weight and diet on adipose tissue distribution 
in young mice (From week 3 until week 15) 
 
15 weeks old offspring was fasted overnight before assessing non-invasively 
adipose tissue content and distribution by using MRI for localisation followed 
by subsequent quantification and distribution of adipose tissue by 
segmentation analysis, as described in section 2.4.1. A 2x2 factorial ANOVA 
was performed to examine the independent effects of birth weight and diet 
on adipose tissue distribution and a possible interaction between these two 
factors. 
 
4.5.1 Adipose tissue distribution in Male offspring 
For male offspring, data for total and regional distribution of fat content in 
grams as well as data normalised to current body weight was naturally log 
transformed (Ln) in order to correct for unequal variances within groups. 
 
Figure 4.5.1.1a and table 4.5.1.1 show the results of total fat in grams after 
Ln transformation (Log total fatg). There was an interaction between both 
birth weight and diet given to mice throughout the study (F(1,66)=5.198 
p=0.026). This indicated that differences between groups depended on the 
relationship between variables. Mice fed a HF diet had a higher total fat 
content compared to those mice fed a NF diet (LBWm-HF vs. LBWm-NF 
p=0.042; HBWm-HF vs. HBWm-NF p<0.001). Furthermore, there was a 
significant difference between mice fed a NF diet, with a higher total fat 
content in LBWm-NF mice than HBWm-NF mice (p=0.036) but the 
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difference did not reach significance between mice fed a HF diet (LBWm-HF 
vs. HBWm-HF p=0.29).  
 
After normalisation to current body weight, Log total fat% (Ln) maintained a 
comparable pattern between groups. Interaction was significant between 
variables (F(1,66)=5.136 p=0.027). Difference between LBWm-HF vs. 
LBWm-NF was comparable (p=0.122; figure 4.5.1.1b and table 4.5.1.1). 
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Figure 4.5.1.1 Total fat content of male offspring at 15 weeks of age. Total fat in 
grams a) and normalised to current body weight (%) b) were natural log transformed 
(Ln) to correct for unequal variances. *p≤0.05,***p≤0.001. N/S= no significant 
difference. As interaction was significant between variables, simple main effects 
with Bonferroni correction were assessed after the factorial ANOVA. N/S= No 
significant difference (LBWm- HF vs. HBWm-HF p=0.29 in a); LBWm-HF vs. 
LBWm-NF p=0.122 and LBWm-HF vs. HBWm-HF p=0.371 in b)). *p≤0.05 (LBWm-
NF vs. HBWm-NF a) and b) and LBWm-HF vs. LBWm-NF in a); *p≤0.001 (HBWm-
NF vs. HBWm-HF a) and b). Data presented as mean with 95% confidence interval 
(CI).  LBWm-NF n=16; LBWm-HF n=20; HBWm-NF n=18, HBWm-HF n=16.  
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Absolute values (grams) of subcutaneous adipose tissue (SAT) and internal 
adipose tissue (IAT) had similar trends as seen in total fat content. 
Interactions were significant for both fat depots (log transformed SAT in 
grams (Ln SATg): (F(1,66)=6.124 p=0.016; table 4.5.1. Log transformed IAT 
in grams (Ln IATg): (F(1,66)=4.204 p=0.044; table 4.5.1). Mice fed a HF diet 
had a higher SAT (Ln) and IAT (Ln) compared to mice fed a NF diet (SAT 
(Ln): LBWm-HF vs. LBWm-NF p=0.03; HBWm-HF vs. HBWm-NF p<0.001; 
figure 4.5.1.2a and table 4.5.1. IAT (Ln):  LBWm-HF vs. LBWm-NF p=0.049; 
HBWm-HF vs. HBWm-NF p<0.001; figure 4.5.1.2c and table 4.5.1.1). 
 
Interactions were maintained after normalisation to current body weight (log 
transformed SAT normalised to body weight (Ln SAT%): (F(1,66)=6.124 
p=0.016; table 4.5.1. Log transformed IAT normalised to body weight (Ln 
IAT%): (F(1,66)=4.204 p=0.044; table 4.5.1). However, the significant 
difference between LBWm mice disappeared in both fat depots (SAT (Ln):  
LBWm-HF vs. LBWm-NF p=0.19; figure 4.5.1.2b and table 4.5.1.1. IAT (Ln): 
LBWm-HF vs. LBWm-NF p=0.258; figure 4.5.1.2d and table 4.5.1.1).  
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Figure 4.5.1.2 Adipose tissue distribution of male offspring at 15 weeks of age. 
SATg (Ln)= natural log transformed subcutaneous adipose tissue in grams a); SAT% 
(Ln)= natural log transformed subcutaneous adipose tissue normalised to body 
weight b); IATg (Ln)= natural log transformed internal adipose tissue in grams c); 
IAT%(Ln)= natural log transformed internal adipose tissue normalised to body weight 
d). As interaction was significant between variables, simple main effects with 
Bonferroni correction were assessed after the factorial ANOVA. N/S= No significant 
difference (LBWm- HF vs. HBWm-H a); LBWm-HF vs. LBWm-NF and LBWm-HF 
vs. HBWm-HF p=0.371 b)). *p≤0.05 (LBWm-NF vs. HBWm-NF a)-d) and LBWm-
HF vs. LBWm-NF in a) and c); ***p≤0.001 (HBWm-NF vs. HBWm-HF a)-d). Data 
presented as mean with 95% confidence interval (CI).  LBWm-NF n=16; LBWm-HF 
n=20; HBWm-NF n=18, HBWm-HF n=16.  
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Assessment of internal to adipose tissue ratio showed a main effect of birth- 
weight (F(1,65)=4.176 p=0.045; figure 4.5.1.3 and table 4.5.1.1) and diet per 
se (diet: F(1,66)=9.997 p=0.002; table 4.5.1.1). No interaction between 
variables was found (F(1,65)=1.079 p=0.303; table 4.5.1.1).This indicated 
that LBWm mice had a higher ratio compared to HBWm mice. Moreover, 
mice fed a HF had a higher ratio compared to mice fed a NF diet 
independently of the birth weight.  
 
 
Figure 4.5.1.3 Internal to subcutaneous adipose tissue ratio of male offspring at 15 
weeks of age. Statistical analysis was performed using a 2x2 factorial ANOVA 
analysis. Main effect of diet + =***p≤0.001. Significant main effect of birth weight 
represented with different letters (p=0.045). Data presented as mean± SEM. 
LBWm-NF n=15; LBWm-HF n=20; HBWm-NF n=18, HBWm-HF n=16.  
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Table 4.5.1 Adipose tissue distribution in male offspring at 15 weeks. Total WATg 
(Ln)= natural log transformed total fat in grams, Total WAT% (Ln)= natural log 
transformed total fat normalised to body weight as percentage, SATg (Ln)= natural 
log transformed subcutaneous adipose fat in grams, SAT% (Ln)= natural log 
transformed subcutaneous adipose fat normalised to body weight as percentage, 
IATg (Ln)= natural log transformed internal adipose fat in grams, IAT% (Ln)= natural 
log transformed internal adipose fat normalised to body weight as percentage. 
Statistical analysis was performed using a 2x2 factorial ANOVA. When interaction 
was significant between variables, simple main effects with Bonferroni correction 
were assessed after the factorial ANOVA. Data presented as mean with 95% 
confidence intervals (CI) except from IAT:SAT ratio (presented as  mean± SEM). 
 LBWm-NF1 LBWm-HF2 
 
HBWm-NF3 
 
HBWm-HF4 
 
p-value 
Total WATg 
(Ln) 
1.78 
(1.646-1.815) 
1.969 
(1.848-2.09) 
1.581 
(1.454-1.708) 
2.066 
(1.931-2.2) 
1 vs.2=0.042 
3vs.4<0.001 
1vs.3=0.036 
2vs.4=0.29 
Total WAT% 
(Ln) 
3.125 
(3.008-3.242) 
 
3.248 
(3.144-3.353) 
2.941 
(2.83-3.051) 
3.319 
(3.202-3.436) 
1 vs.2=0.122 
3vs.4<0.001 
1vs.3=0.025 
2vs.4=0.371 
SATg  
(Ln) 
1.264 
(1.154-1.373) 
1.427 
(1.329-1.525) 
1.096 
(0.992-1.199) 
1.521 
(1.329-1.631) 
1 vs.2=0.03 
3vs.4<0.001 
1vs.3=0.03 
2vs.4=0.209 
SAT%  
(Ln) 
2.608 
(2.514-2.703) 
2.691 
(2.607-2.776) 
2.455 
(2.366-2.544) 
2.775 
(2.68-2.869) 
1 vs.2=0.198 
3vs.4<0.001 
1vs.3=0.022 
2vs.4=0.193 
IATg  
(Ln) 
0.862 
(0.691-1.033) 
1.092 
(0.939-1.245) 
0.62 
(0.459-0.782) 
1.188 
(1.017-1.358) 
1 vs.2=0.049 
3vs.4<0.001 
1vs.3=0.044 
2vs.4=0.41 
IAT%  
(Ln) 
2.207 
(2.039-2.376) 
2.336 
(2.186-2.487) 
1.98 
(1.821-2.139) 
2.441 
(2.273-2.61) 
1 vs.2=0.258 
3vs.4<0.001 
1vs.3=0.05 
2vs.4=0.357 
 
IAT:SAT 
ratio 
 
 
0.699±0.029 
 
 
0.756±0.024 
 
 
0.616±0.027 
 
 
0.729±0.028 
Main effect 
birth weight: 
p=0.045 
Main effect 
diet: 
p=0.002 
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4.5.2 Adipose tissue distribution in Female offspring 
After normalisation, assessment of total fat showed that diet had a 
significantly main effect on total fat (total fatg (Ln): F(1,37)=14.708 p<0.001). 
Birth weight did not have an independent effect on total fat (Ln) 
(F(1,37)=1.516 p=0.226) and there was not an interaction between birth 
weight and diet (F(1,37)=0.18 p=0.674). This indicated that females that 
were fed a HF diet had a higher total adiposity compared to females fed a NF 
diet irrespectively of their birth weight (figure 4.5.2.1a and table 4.5.2.1). 
These differences were maintained after normalisation of total body fat to 
current body weight (%) (diet: (F(1,37)=7.866 p=0.008; birth weight: 
F(1,37)=0.068 p=0.796; interaction diet x birth weight: F(1,37)=0.141 p=0.71; 
figure 4.5.2.1b and table 4.5.2.1). As aforementioned in section 4.1 (figure 
4.1.2.1 and 4.1.2.2), LBWf mice had a lower body weight throughout the 
study. Therefore, although these females were lighter in weight they had a 
comparable total fatg (Ln) and total fat (%) to the heavier females.  
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Figure 4.5.2.1 Total fat content of female offspring at 15 weeks of age. Total fat in 
grams a) was natural log transformed (Ln) to correct for unequal variances. Total fat 
%= total fat normalised to current body weight expressed as percentage (%). Main 
effect of diet + =***p≤0.001 a) and b). No significant main effect of birth weight 
represented with equal letters (p=0.226 in a) p=0.796 in b)). Data presented as 
mean with 95% confidence interval (CI) for total fatg (Ln) and as mean± SEM for 
Total fat (%).  LBWf-NF n=12; LBWf-HF n=9; HBWf-NF n=5, HBWf-HF n=15.  
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Subcutaneous adipose tissue (SAT) and internal adipose in grams (IAT) had 
similar patterns as seen in total fatg (Ln), with a main effect of diet only 
(SAT(g): F(1,37)=14.266 p=0.001; IAT(g): F(1,37)=14.266 p=0.002; figures 
4.5.2.2a and 4.5.2.2c respectively; table 4.5.2.1). The main effect of diet was 
maintained when normalising to body weight for both regional fat depots 
(SAT%: (F(1,37)=9.316 p=0.004; IAT%: (F(1,37)=6.286 p=0.017; figures 
4.5.2.2b and 4.5.2.2d; table 4.5.2.1). 
 
 
 
 
 
	   269	  
 
Figure 4.5.2.2 Adipose tissue distribution of female offspring at 15 weeks of age. 
SAT (g)= subcutaneous adipose tissue in grams a); SAT(%)= subcutaneous 
adipose tissue expressed as percentage of body weight b); IAT(g)= internal adipose 
tissue in grams c); IAT(%)=internal adipose tissue expressed as percentage of body 
weight d). Main effect of diet + =***p≤0.001 in a) and **p≤0.01 in c)-d). No significant 
main effect of birth weight represented with equal letters (p=0.277 in a), p=0.441 in 
b), p=0.803 in c) and p=0.721 in d)). Data presented as mean± SEM.  LBWf-NF 
n=12; LBWf-HF n=9; HBWf-NF n=5, HBWf-HF n=15.  
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Table 4.5.2.1 Adipose tissue distribution in female offspring at 15 weeks. Total 
WATg (Ln)=natural log transformed total fat in grams, Total WAT(%)=total fat 
normalised to body weight (%), SAT(g)=subcutaneous adipose fat in grams, SAT 
(%)=subcutaneous adipose fat normalised to body weight (%), IAT (g)=internal 
adipose fat in grams, IAT(%)=internal adipose fat normalised to body weight as 
percentage. Statistical analysis was performed using a 2x2 factorial ANOVA 
analysis.Data presented as mean± SEM except from Total WATg (Ln) which is 
presented as mean with 95% confidence intervals (CI). LBWf-NF n=12; LBWf-HF 
n=9; HBWf-NF n=5, HBWf-HF n=15.  
 LBWf-NF1 
 
LBWf-HF2 
 
 
HBWf-NF3 
 
 
HBWf-HF4 
 
 
Effects and 
Interaction 
Total WATg 
(Ln)  
1.31 
(1.156-1.465) 
1.692 
(1.514-1.87) 
1.458 
(1.219-1.698) 
1.764 
(1.626-1.902) 
Birth weight: 
p=0.226 
Diet: 
p<0.001 
Interaction: 
p=0.674 
Total WAT  
(%) 
20.482 
±1.848 
 
 
27.14 
±2.134 
 
21.811 
±2.614 
26.899 
±1.653 
Birth weight: 
p=0.796 
Diet: 
p=0.008 
Interaction: 
p=0.71 
SAT 
(g) 
2.442 
±0.267 
 
3.701 
±0.309 
 
 
2.892 
±0.378 
 
 
3.92 
±0.239 
 
Birth weight: 
p=0.277 
Diet: 
p=0.001 
Interaction: 
p=0.706 
SAT 
(%) 
 
12.609 
±1.169 
 
17.872 
±1.292 
 
14.966 
±1.582 
 
17.51 
±1.01 
 
Birth weight: 
p=0.441 
Diet: 
p=0.004 
Interaction: 
p=0.295 
IAT 
(g) 
1.314 
±0.166 
 
 
1.925 
±0.192 
 
1.333 
±0.235 
 
2.01 
±0154 
 
Birth weight: 
p=0.803 
Diet: 
p=0.002 
Interaction: 
p=0.882 
IAT 
(%) 
 
7.184 
±0.742 
 
 
 
9.267 
±0.856 
 
6.845 
±1.049 
 
8.998 
±0.687 
 
Birth weight: 
p=0.721 
Diet: 
p=0.017 
Interaction: 
p=0.968 
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Assessment of the internal to subcutaneous adipose tissue ratio showed a 
marginal effect of diet (F(1,37)=3.153 p=0.084; figure 4.5.2.3 ant table 
4.5.2.2). There was not a main effect of birth weight or interaction between 
variables (: (F(1,37)=1.686 p=0.202; interaction diet x birth- weight: 
(F(1,37)=1.126 p=0.296).  
 
 
Figure 4.5.2.3 Internal to subcutaneous adipose tissue ratio of female offspring at 
15 weeks of age. Statistical analysis was performed using a 2x2 factorial ANOVA 
analysis. Effect of diet +: N/S= no significant (p=0.084). No significant effect of birth 
weight represented with equal letters. Data presented as mean± SEM.  LBWf-NF 
n=12; LBWf-HF n=9; HBWf-NF n=5, HBWf-HF n=15. 
 
 
 
 
 
	   272	  
 
Table 4.5.2.2 Internal to subcutaneous adipose tissue ratio in female offspring at 15 
weeks. Statistical analysis was performed using a 2x2 factorial ANOVA. Data 
presented as mean± SEM. LBWf-NF n=12; LBWf-HF n=9; HBWf-NF n=5, HBWf-
HF n=15. 
 
 
 
 
 
 
 
 
 
 
 
 LBWf-NF1 
 
LBWf-HF2 
 
 
HBWf-NF3 
 
 
HBWf-HF4 
 
 
Effects and 
Interaction 
 
IAT:SAT 
ratio 
 
 
0.519±0.029 
 
 
0.542±0.033 
 
 
0.444±0.039 
 
 
0.534±0.024 
Birth weight: 
p=0.296 
Diet: 
p=0.084 
Interaction: 
p=0.296 
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4.6 The Effects of Birth Weight and Diet on Metabolic Markers 
and Glucose Tolerance in Young Mice (From Week 3 Until 
Week 15) 
 
Plasma samples were used to assess metabolic markers in both male and 
female mice at week 15 of age. Samples were collected in a postprandial 
state.  
 
To assess changes in glucose tolerance due to the effect of birth weight and 
diet an intraperitoneal glucose tolerance test (IPGTT) was performed. Mice 
were fasted overnight for 16-18 hours prior to the test. The protocol for this 
test is described in detailed in section 2.4.3. 
 
4.6.1 Metabolic markers in Male mice 
Whole blood glucose assessment showed a main effect of birth weight on 
the level of glucose (F(1,43)=4.698 p=0.036; figure 4.6.1.1). This indicated 
that LBWm mice had a higher glucose level than HBWm mice, 
independently of the diet given throughout the study; no main effect of diet 
was found (F(1,43)=1.87 p=0.179; figure 4.6.1.1 and table 4.6.1.1). 
Furthermore, there was not a significant interaction between variables 
(F(1,43)=0.668 p=0.418; figure 4.6.1.1 ant table 4.6.1.1). 
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Figure 4.6.1.1 Glucose level in male and female offspring at 15 weeks of age. 
Glucose was measured in whole blood at the time of tissue collection. Statistical 
analysis was performed using a 2x2 factorial ANOVA test. Main effect of diet +: 
N/S= no significant (p=0.179). Main effect of birth weight represented with different 
letters. Data presented as mean± SEM. LBWm-NF n=12; LBWm-HF n=11; HBWm-
NF n=10, HBWm-HF n=15. 2x2 factorial ANOVA test was followed by simple main 
effects analysis in female mice b), as the interaction was significant. N/S= no 
significant difference (p=0.309); *p≤0.05, **p≤0.01, ***p≤0.001. LBWf-NF n=10; 
LBWf-HF n=13; HBWf-NF n=8, HBWf-HF n=6.  
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Following the evaluation of insulin (Ln), there was a comparable level 
between groups by birth weight (birth weight: (F(1,42)=1.058 p=0.31) but 
there was main effect of diet: (F(1,42)=4.867 p=0.033) without interaction 
(F(1,42)=1.439 p=0.237; figure 4.6.1.2a and table 4.6.1.1). Mice fed a HF 
diet had higher insulin than mice fed a NF diet.  
 
Insulin related markers such as c-peptide, GIP and glucagon were also 
assessed. There was not a significant main effect of either birth weight or 
diet between groups in the level of c-peptide ((birth weight: (F(1,45)=0.042 
p=0.838; diet: (F(1,45)=0.205 p=0.653; interaction (F(1,45)=0.096 p=0.758; 
figure 4.6.1.2b and table 4.6.1.1). Natural log transformed GIP (Ln) showed a 
significant interaction between both birth weight and diet (F(1,39)=5.02 
p=0.031; figure 4.6.1.2c and table 4.6.1.1). After simple main effects 
analysis, no significant difference was found between mice fed a NF diet or a 
HF diet (LBWm-NF vs. HBWm-NF p=0.133; LBWm-HF vs. HBWm-HF 
p=0.108). Whilst levels of LBWm-NF mice tended to be higher than HBWm-
NF mice, GIP levels of LBWm-HF mice tended to be lower than HBWm-HF 
mice. Furthermore, GIP levels were significantly higher in HBWm-HF 
compared to HBWm-NF (p=0.037). Differences between LBWm mice did 
not reach significance (p=0.326). Glucagon was only affected by the diet 
given to mice and not for the birth weight (diet: F(1,40)=6.469 p=0.015; 
F(1,40)=0.168 p=0.684; interaction: F(1,40)=1.295 p=0.262; figure 4.6.1.2d 
and table 4.6.1.1). Mice fed a NF diet had higher levels of glucagon than 
mice fed a HF diet.  
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Figure 4.6.1.2 Metabolic markers in plasma of male mice fed both a NF diet and HF 
diet at 15 weeks of age. This figure shows insulin levels a) and some metabolic 
markers related to insulin secretion and stimulation/regulation such as c-peptide b), 
GIP c) and glucagon d). GIP= glucose dependant- insulinotropic peptide GIP values 
were natural log transformed before the analysis. Statistical analysis was performed 
using a 2x2 factorial ANOVA test followed by simple main effects when interaction 
was significant (only c).  Main effect of diet +: N/S= no significant for b); *p≤0.05 in a) 
and ** p≤0.01 in d). Data presented as mean± SEM, except from insulin and GIP, 
which are presented as mean with 95% confidence interval (CI). LBWm-NF n=10-
12; LBWm-HF n=11-12; HBWm-NF n=9-11, HBWm-HF n=13-15.  
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The gut peptide ghrelin was affected by the interaction between both birth 
weight and diet (F(1,43)=5.251 p=0.027; figure 4.6.1.3 and table 4.6.1.1). 
Ghrelin levels were lower in LBWm-NF mice compared to HBWm-NF mice 
(p=0.003); difference between mice fed a HF diet was not significant 
(p=0.955). Furthermore, HBWm-NF mice had a significant higher level 
compared to HBWm-HF mice (p=0.028). Different pattern was seen between 
LBWm mice with a higher level of ghrelin in LBWm-HF compared to LBWm-
NF but the difference did not reach statistical significance (p=0.321). 
 
 
Figure 4.6.1.3 Ghrelin levels in plasma of male offspring at 15 weeks of age. 
Statistical analysis was performed using a 2x2 factorial ANOVA test followed by 
simple main effects, as interaction was significant. N/S= no significant difference:  
(LBWm-NF vs. LBWm-HF p=0.321; LBWm-HF vs. HBWm-HF p=0.955). *p≤0.05, 
**p≤0.01. Data presented as mean± SEM. LBWm-NF n=10; LBWm-HF n=12; 
HBWm-NF n=11, HBWm-HF n=14.  
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Adipokines such as leptin and resistin were also evaluated. Both birth weight 
and diet interacted affecting the levels of leptin in males (F(1,41)=7.004 
p=0.011; figure 4.6.1.4a and table 4.6.1.1). There was significant difference 
between males fed a NF diet with a higher level in LBWm mice (p=0.045; 
figure 4.6.1.4a and table 4.6.1.1) but there was not a significant difference 
between males fed a HF diet (p=0.105). Furthermore, there was a significant 
difference between HBWm mice (p<0.001; but not between LBWm mice 
(p=0.356. Resistin was also affected by the interaction of diet and birth- 
weight (F(1,40)=5.803 p=0.021; figure 4.6.1.4b and table 4.6.1.1). Mice fed a 
HF had a significant difference with LBWm-HF having a lower level than 
HBWm-HF (p=0.041) but not significant difference was found between mice 
fed NF diet (p=0.194). Comparable differences were found between LBWm 
mice (p=0.516) but there was a significant difference between HBWm mice 
(p<0.001). 
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Figure 4.6.1.4 Leptin and resistin levels in plasma of male offspring at 15 weeks of 
age. Leptin a) and resistin b) levels. Statistical analysis was performed using a 2x2 
factorial ANOVA test followed by simple main effects, as interaction was significant. 
N/S= no significant difference. *p≤0.05, ***p≤0.001. Data presented as mean± SEM. 
LBWm-NF n=11; LBWm-HF n=11-12; HBWm-NF n=9-10, HBWm-HF n=12-13.  
 
 
Proinflammatory cytokines such as IL-6 and MCP-1 were also assessed.  
IL-6 levels were significantly affected by birth weight per se but not for diet; 
there was not a significant interaction between both (birth weight: 
F(1,21)=6.687 p=0.017; diet: F(1,21)=0.205 p=0.656; interaction: 
F(1,21)=0.869 p=0.362; figure 4.6.1.5a and table 4.6.1.1). HBWm mice had 
a higher level of IL-6 in plasma than LBWm mice irrespectively of the diet 
given to them.  However, the MCP-1 levels in plasma were affected by both 
birth weight and diet, in a independent manner with no interaction between 
both (birth weight: F(1,40)=4.24 p=0.046; diet: F(1,40)=5.826 p=0.02; 
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interaction: F(1,40)=0.002 p=0.967; figure 4.6.1.5b and table 4.6.1.1). LBWm 
mice had a higher MCP-1 level concentration than HBWm mice, but at the 
same time, mice fed a HF diet had a higher level of MCP-1 compared to 
mice fed a NF diet, independently of birth weight and vise versa.  
 
 
Figure 4.6.1.5 Proinflammatory cytokines of male offspring plasma at 15 weeks of 
age. IL-6= interleukine 6 a) and MCP-1= monocyte chemotactic peptide 1 b). Main 
effect of diet + = N/S= no signficant in a) and *p≤0.05 in b). Significant main effect of 
birth weight represented with different letters. Statistical analysis was performed 
using a 2x2 factorial ANOVA analysis. Data presented as mean± SEM. LBWm-NF 
n=4/10; LBWm-HF n=5/10; HBWm-NF n=5/10, HBWm-HF n=11/14.  
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Table 4.6.1.1 Metabolic markers measured in plasma from male mice at week 15 of 
age. Data presented as mean± SEM except from GIP (Ln) and insulin (Ln), which 
are presented as mean with 95% confidence interval (CI).  
 
 LBWm-NF1 LBWm-HF2 HBWm-NF3 HBWm-HF4 P value 
 
C-peptide 
pg/ml 
 
2328.178 
±381.033 
 
2039.78 
±381.033 
 
2288.813 
±397.976 
 
2234.733 
±352.768 
Birth weight: 
p=0.838 
Diet: 
p=0.653 
Interaction: 
p=0.758 
 
GIP 
(Ln) 
 
4.722 
±0.274 
 
4.354 
±0.25 
 
4.111 
±0.289 
 
4.935 
±0.25 
1 vs.2=0.326 
3vs.4=0.037 
1vs.3=0.133 
2vs.4=0.108 
 
Glucagon 
pg/ml 
 
123.694 
±16.8 
 
63.931 
±24.273 
 
98.575 
±17.709 
 
75.76 
±14.199 
Birth weight: 
p=0.684 
Diet: 
p=0.015 
Interaction: 
p=0.262 
 
Insulin  
(Ln) 
 
 
6.524 
(5.8-7.22) 
 
 
6.863 
(6.2-7.527) 
 
5.773 
(4.995-6.552) 
 
6.921 
(6.352-7.489) 
Birth weight: 
p=0.416 
Diet: 
p=0.703 
Interaction: 
p=0.797 
 
Ghrelin 
pg/ml 
 
417.373 
±73.197 
 
516.951 
±66.82 
 
734.42 
±69.791 
 
522.149 
±61.863 
1 vs.2=0.321 
3vs.4=0.028 
1vs.3=0.003 
2vs.4=0.955 
 
Leptin 
pg/ml 
 
3133.036 
±482.55 
 
3756.486 
±462.007 
 
1647.123 
±533.48 
 
4819.86 
±443.882 
1 vs.2=0.356 
3vs.4<0.001 
1vs.3=0.045 
2vs.4=0.105 
 
Resistin 
pg/ml 
 
9659.14 
±769.751 
 
10372.459 
±769.751 
 
 
 
8186.564 
±807.321 
 
12617.217 
±736.98 
1 vs.2=0.516 
3vs.4<0.001 
1vs.3=0.194 
2vs.4=0.041 
 
Il-6 
pg/ml 
 
6.326 
±4.985 
 
8.385 
±4.459 
 
21.422 
±4.459 
 
15.481 
±3.01 
Birth weight: 
p=0.017 
Diet: 
p=0.656 
Interaction: 
p=0.362 
 
MCP-1 
pg/ml 
 
61.597 
±8.318 
 
 
80.609 
±8.318 
 
44.749 
±8.318 
 
64.431 
±7.03 
Birth weight: 
p=0.046 
Diet: 
p=0.02 
Interaction: 
p=0.967 
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4.6.2 Metabolic markers in Female mice  
Contrary to males, there was an interaction between variables in the female 
group (F(1,33)=13.457 p=0.001; figure 4.6.2.1) when assessing blood 
glucose concentration. LBWf-NF mice had a higher blood glucose compared 
to LBWf-NF mice (p=0.012). However, LBWf-HF had a higher blood glucose 
level than HBWf-HF mice (p=0.016). Difference between LBWf mice was 
significantly different (p<0.001), whilst the difference between HBWf did not 
reach significance (p=0.309).  
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Figure 4.6.2.1 Glucose level in female and male offspring at 15 weeks of age. 
Glucose was measured in whole blood at the time of tissue collection. Statistical 
analysis was performed using a 2x2 factorial ANOVA test followed by simple main 
effects analysis, as the interaction was significant in female mice a). N/S= no 
significant difference (p=0.309); *p≤0.05, **p≤0.01, ***p≤0.001. Data presented as 
mean± SEM. LBWf-NF n=10; LBWf-HF n=13; HBWf-NF n=8, HBWf-HF n=6. Main 
effect of diet in male mice b) +: N/S= no significant (p=0.179). Main effect of birth 
weight represented with different letters in male mice b). LBWm-NF n=12; LBWm-
HF n=11; HBWm-NF n=10, HBWm-HF n=15. 
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Log transformed insulin (Ln) analysis showed diet had an effect on the level 
of insulin independently of  (F(1,19)=7.192 p=0.015; figure 4.6.2.2a and table 
4.6.2.1), with HF fed females having a higher insulin level compared to NF 
fed females.  
 
Insulin related markers such as c-peptide, GIP and glucagon were also 
assessed as in males. C-peptide levels between groups were marginally 
significant for main effect of birth weight (birth weight: (F(1,29)=3.405 
p=0.075; figure 4.6.2.2b and table 4.6.2.1), with LBWf  mice having a lower 
value than HBWf mice. Diet effect was no significant (F(1,29)=0.102 
p=0.752) and there was no interaction between variables (F(1,29)=0.057 
p=0.812; figure 4.6.2.2b and table 4.6.2.1). GIP levels was not affected by 
the interaction between variables as in males, but there was an effect of diet 
(F(1,30)=4.371 p=0.045; figure 4.6.2.2c and table 4.6.2.1). HF fed mice had 
a higher level of GIP compared to mice fed a NF diet.  Glucagon was not 
affected by either diet or birth weight per se (diet: F(1,31)=0.143 p=0.707; 
birth weight: (F(1,31)=0.49 p=0.489; figure 4.6.2.2d and table 4.6.2.1) and 
there was not interaction between both variables (F(1.31)=0.481 p=0.493).  
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Figure 4.6.2.2 Metabolic markers in plasma from female mice fed both a NF diet 
and HF diet at 15 weeks of age. This figure shows insulin levels a) and some 
metabolic markers related to insulin secretion and stimulation/regulation such as c-
peptide b), GIP c) and glucagon d). Insulin values were natural log transformed 
before the analysis. Statistical analysis was performed using a 2x2 factorial ANOVA 
test.  Main effect of diet +: N/S= no significant for b) and d); *p≤0.05 in c) and ** 
p≤0.01 in a). No significant effect of birth weight represented with equal letters. Data 
presented as mean± SEM, except from insulin, which is presented as mean with 
95% confidence interval (CI). LBWfNF n=6-8; LBWf-HF n=7-12; HBWf-NF n=6-7, 
HBWf-HF n=5-8.  
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The gut peptide ghrelin was affected by the interaction between both birth 
weight and diet (F(1,28)=5.706 p=0.024; figure 4.6.2.3 and table 4.6.2.1). 
Ghrelin levels were lower in HBWf-NF mice compared to HBWf-HF mice 
(p=0.014) but there was a comparable level between mice fed a NF diet 
(p=0.498). Moreover, there was a significant difference between HBWf mice 
(p=0.009) but not between LBWf mice (p=0.784). 
 
 
Figure 4.6.2.3 Ghrelin levels in plasma of female offspring at 15 weeks of age. 
Statistical analysis was performed using a 2x2 factorial ANOVA test followed by 
simple main effects, as interaction was significant. N/S= no significant difference: 
(LBWf-NF vs. LBWf-HF p=0.784; LBWf-NF vs. HBWf-NF p=0.498). *p≤0.05, 
**p≤0.01. Data presented as mean± SEM. LBWf-NF n=9; LBWf-HF n=11; HBWf-
NF n=7, HBWf-HF n=7.  
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Adipokines such as leptin and resistin were also evaluated. Leptin was 
affected by both birth weight (F(1,33)=4.008 p=0.05; figure 4.6.2.4a and 
table 4.6.2.1) and diet (F(1,33)=8.135 p=0.007; figure 4.6.2.4a and table 
4.6.2.1) independently as their interaction was not significant (F(1,33)=0.478 
p=0.494). Resistin on the contrary, was not affected by any of the variables 
(diet: F(1,35)=0.283 p=0.598; birth weight: (F(1,35)=0.757 p=0.39); 
interaction: F(1,35)=1.426 p=0.24; figure 4.6.2.4b and table 4.6.2.1).  
 
 
Figure 4.6.2.4 Leptin and resistin levels in plasma of female offspring at 15 weeks of 
age. Statistical analysis was performed using a 2x2 factorial ANOVA. Main effect of 
diet +: **p≤0.01 in a) and N/S= no significant difference in b). Main effect of birth 
weight represented with different letters in a) and no significant effect represented 
with equal letters in b). Data presented as mean± SEM. LBWf-NF n=9-10; LBWf-
HF n=13; HBWf-NF n=8, HBWf-HF n=7-8.  
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Proinflammatory cytokines such as IL-6 and MCP-1 were again assessed.  
IL-6 levels of HBWf-NF were below the detection limit and could not be 
assessed. However, when comparing the rest of the groups with a one-way 
ANOVA test, significant differences were found between LBWf mice 
(p=0.05) and between mice fed a HF diet (p=0.024). As the values of HBWf-
NF were lower than the minimum detectable level, it suggested that LBWf-
NF had a higher level than this groups as well as HBWf-HF (figure 4.6.2.5a 
and table 4.6.2.1). MCP-1 levels was affected by birth weight (F(1,26)=4.218 
p=0.05; figure 4.6.2.5b) but it was not affected by diet (F(1,26)=0.001 
p=0.981). 
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Figure 4.6.2.5 Proinflammatory cytokines of female offspring plasma at 15 weeks of 
age. IL-6 a) and MCP-1 b). Main effect of diet += N/S= no signficant in b). Significant 
main effect of birth weight represented with different letters in b). Statistical analysis 
was performed using a one-way ANOVA for IL-6 and 2x2 factorial ANOVA analysis 
for MCP-1. Data presented as mean± SEM. LBWf-NF n=8; LBWf-HF n=11; HBWf-
NF n=6, HBWf-HF n=5. *p≤0.05. 
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Table 4.6.2.1 Metabolic markers measured in plasma of female mice at week 15 of 
age. Data presented as mean± SEM except from insulin (Ln), which is presented as 
mean with 95% confidence interval (CI).  
 
 LBWf-NF1 LBWf-HF2 HBWf-NF3 HBWf-HF4 P value 
 
C-peptide 
pg/ml 
 
911.926 
±161.694 
 
924.96 
±132.022 
 
1176.196 
±172.858 
 
1268.026 
±186.708 
Birth weight: 
p=0.075 
Diet: 
p=0.752 
Interaction: 
p=0.812 
 
GIP 
pg/ml 
 
39.249 
±19.773 
 
76.121 
±16.144 
 
65.564 
±21.138 
 
110.873 
±21.138 
Birth weight: 
p=0.131 
Diet: 
p=0.045 
Interaction: 
p=0.832 
 
Glucagon 
pg/ml 
 
168.945 
±26.367 
 
160.853 
±21.529 
 
169.111 
±28.188 
 
196.697 
±26.367 
Birth weight: 
p=0.489 
Diet: 
p=0.707 
Interaction: 
p=0.493 
 
Insulin  
(Ln) 
 
 
5.768 
(5.181-6.356) 
 
 
6.822 
(6.234-7.4) 
 
6.023 
(5.435-6.61) 
 
6.512 
(5.9-7.16) 
Birth weight: 
p=0.925 
Diet: 
p=0.015 
Interaction: 
p=0.34 
 
Ghrelin 
pg/ml 
 
644.582 
±105.106 
 
605.403 
±95.072 
 
535.566 
±119.179 
 
1052.39 
±141.014 
1 vs.2=0.784 
3vs.4=0.009 
1vs.3=0.498 
2vs.4=0.014 
 
Leptin 
pg/ml 
 
918.382 
±314.492 
 
2047.126 
±261.673 
 
1776.291 
±333.569 
 
2464.528 
±356.601 
Birth weight: 
p=0.05 
Diet: 
p=0.007 
Interaction: 
p=0.494 
 
Resistin 
pg/ml 
 
10081.595 
±1130.645 
 
9307.544 
±991.642 
 
 
 
9702.868 
±1264.1 
 
11718.658 
±1264.1 
Birth weight: 
p=0.39 
Diet: 
p=0.598 
Interaction: 
p=0.24 
 
Il-6 
pg/ml 
 
45.761 
±10.979 
 
101.397 
±29.96 
 
No detected 
 
21.498 
±12.988 
1 vs.2=0.05 
2vs.4=0.024 
 
MCP-1 
pg/ml 
 
110.906 
±22.847 
 
 
114.85 
±19.484 
 
64.803 
±26.381 
 
59.652 
±28.899 
Birth weight: 
p=0.05 
Diet: 
p=0.981 
Interaction: 
p=0.855 
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4.6.3 Glucose tolerance in Male mice 
Intraperitoneal glucose tolerance test (IPGTT) assessment in males showed 
significant differences in the fasting state, before the administration of the 
bolus of glucose in the peritoneum. Mice fed a HF diet had a higher basal 
glucose level than mice fed a NF diet (LBWm-HF vs. LBWm-NF p=0.027; 
HBWm-HF vs. HBWm-NF p=0.027; figure 4.6.3.1a). Furthermore, LBWm-
NF had a higher glucose than HBWm-NF (p=0.049; figure 4.6.3.1a). A 
marginal difference was seen between mice fed a HF diet (p=0.094; figure 
4.6.3.1a). However, there were not significant differences between groups at 
15, 30, 60 or 120 minutes after the glucose administration. This may suggest 
that mice fed a HF diet and LBWm-NF had an impaired fasting glucose 
compared to their counterparts.  
 
Further evaluation of the area under the curve (AUC) revealed a significant 
main effect of both birth weight and diet on the level of the glucose 
throughout the test duration, which was 120 minutes (birth weight: 
F(1,28)=4.333 p=0.047; diet: F(1,28)=4.63 p=0.04; figure 4.6.3.1b). There 
was not a significant interaction between factors (F(1,28)=0.144 p=0.707; 
figure 4.6.5b). Overall, LBWm mice had a higher AUC than HBWm mice, but 
similarly, mice fed a HF diet had a significantly higher AUC than mice fed a 
NF diet. These effects were independent one of each other. These may 
suggest that LBWm mice and mice fed a HF diet have an impaired glucose 
metabolism at 15 weeks old.  
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Figure 4.6.3.1 Glucose tolerance results in male and female offspring at 15 weeks 
old. Intraperitoneal glucose tolerance test (IPGTT) after administration of a glucose 
bolus a) and area under the curve (AUC) analysis of the IPGTT b). +: significant 
difference between LBWm-HF vs. LBWm-NF, and HBWm-HF vs. HBWm-NF in a) 
and main effect of diet in b). ^: significant difference between LBWm-NF vs. 
HBWm-NF. Significant main effect of birth weight represented with different letters 
in b). “: significant difference between LBWf-HF vs. HBWf-HF; !: significant 
difference between LBWf-HF vs. LBWf-NF; ^: significant difference between LBWf-
NF vs. HBWf-NF c). Kruskal Wallis analysis was performed in a) and c) and 2x2 
ANOVA analysis in c) and d). *p≤0.05. **p≤0.001. 
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4.6.4 Glucose tolerance in Female mice 
Contrary to the results obtained in males, female mice were not significantly 
different at the basal time (0 minutes). However, 15 minutes after the glucose 
administration, there was a significant difference between mice fed a HF, 
with LBWf-HF having the highest glucose at this time point compared to their 
counterparts (p=0.027; figure 4.6.4.1a). LBWf-HF had the highest level of 
glucose 30 minutes and 60 minutes after glucose injection. At 30 minutes, 
LBWf-HF had a significantly higher glucose level compared to HBWf-HF 
(p=0.007; figure 4.6.4.1a) and compared to LBWf-NF mice (p=0.029; figure 
4.6.4.1a). After 60 minutes of starting the test, significant differences were 
maintained between the groups mentioned before (LBWf-HF vs. HBWf-HF 
p=0.021; LBWf-HF vs. LBWf-NF p=0.029), and also, there was a significant 
difference between mice fed a NF diet, with HBWf-NF having the highest 
glucose level (p=0.024; figure 4.6.4.1a).  
 
Assessment of the area under the curve (AUC) revealed a significant 
interaction between both birth weight and diet (F(1,27)=8.945 p=0.006; figure 
4.6.4.1b). Therefore, a simple main effect was performed. LBWf-HF had a 
higher AUC compared to HBWf-HF (p=0.003) and compared to LBWf-NF 
mice (p=0.01). There were not significant differences between mice fed a NF 
diet (p=0.263) or between HBWf mice (p=0.186).  
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Figure 4.6.4.1 Glucose tolerance results in female and male offspring at 15 weeks 
old. Intraperitoneal glucose tolerance test (IPGTT) performed at 15, 30, 60 and 120 
minutes after administration of a glucose bolus a) and c) and area under the curve 
(AUC) analysis of the IPGTT b) and d). “: significant difference between LBWf-HF 
vs. HBWf-HF; !: significant difference between LBWf-HF vs. LBWf-NF; ^: 
significant difference between LBWf-NF vs. HBWf-NF . +: significant difference 
between LBWm-HF vs. LBWm-NF, and HBWm-HF vs. HBWm-NF in c) and main 
effect of diet in d). ^: significant difference between LBWm-NF vs. HBWm-NF. 
Significant main effect of birth weight represented with different letters in b). 
Statistical analysis was performed using a Kruskal Wallis analysis a) and c) or 2x2 
ANOVA b) and d). *p≤0.05, **p≤0.01. 
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4.7 The Effects of Birth Weight and on Organ Mass in Young 
Mice (From Week 3 Until Week 15) 
 
Offspring was dissected at the end of the study (15 weeks old) as described 
previously in methods 2.1.4. Organ mass and proportional organ weights to 
current body weight were recorded and analysed. A one-way ANOVA 
analysis was used to assess differences between groups.  
 
4.7.1  Organ mass in Males  
4.7.1.1 Brain mass in Males 
Brain mass in grams was significantly different between LBWm mice, with a 
higher mass in LBWm-HF mice  (p=0.023; figure 4.7.1.1.1a and table 
4.7.1.1.1). However, after normalising to current body weight (%), the relative 
mass of brain was not significantly different between LBWm mice any longer 
(p=0.516; figure 4.7.1.1.1b and table 4.7.1.1.1). Furthermore, differences 
between HBWm mice appeared significant, being higher in HBWm-NF mice 
(p=0.004; figure 4.7.1.1.1b and table 4.7.1.1.1) and marginally significant 
between mice fed a HF diet, with a higher mass in LBWm-HF mice 
(p=0.065; figure 4.7.1.1.1b and table 4.7.1.1.1). Comparable differences 
were maintained between mice fed a NF diet (p=0.567; figure 4.7.1.1.1b and 
table 4.7.1.1.1). 
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Figure 4.7.1.1.1 Brain mass in male and female offspring at 15 weeks old. Brain 
mass in grams a) and c) and normalised to current body weight expressed as 
percentage (relative brain mass  %) b) and d). Figures on the top correspond to 
males and figures below to females. Statistical analysis was performed using a one-
way ANOVA followed by a protected Fisher’s least significant difference (LSD) post 
hoc analysis.  Data presented as mean± SEM. LBWm-NF n=10; LBWm-HF n=14; 
HBWm-NF n=11, HBWm-HF n=14; LBWf-NF n=11; LBWf-HF n=14; HBWf-NF 
n=8, HBWf-HF n=8. N/S= no significant; *p≤0.05; **p≤0.01. 
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Table 4.7.1.1.1 Brain mass of male offspring at 15 weeks old. Brain (g)= brain mass 
in grams and Brain (%)= normalised brain mass to current body weight expressed 
as percentage. Statistical analysis was performed using a one-way ANOVA 
followed by a protected Fisher’s least significant difference (LSD) post hoc analysis.  
Data presented as mean± SEM.  
 
4.7.1.2 Brown adipose tissue mass (BAT) in Males  
Brown adipose tissue (BAT) in grams was significantly different between 
HBWm mice with a higher mass in HBWm-HF mice (p<0.001) but not 
between LBWm mice (p=0.691; figure 4.7.1.2.1a and table 4.7.1.2.1). A 
marginal difference was found between mice fed a NF diet, with higher mass 
in LBWm-NF mice (p=0.056; figure 4.7.1.2.1a and table 4.7.1.2.1) and not 
significant difference between mice fed a HF diet (p=0.201; figure 4.7.1.2.1a 
and table 4.7.1.2.1). Upon normalising BAT mass to body weight and 
expressed as percentage, the significant difference between HBWm mice 
was maintained (p=0.003; figure 4.7.1.2.1b and table 4.7.1.2.1) and the 
marginal difference between mice fed a NF diet became significant (p=0.013; 
Organ 
mass 
LBWm-NF1 LBWm-HF2 HBWm-NF3 HBWm-HF4 P value 
Brain 
(g) 
0.322 
±0.004 
0.34 
±0.006 
0.331 
±0.007 
0.342 
±0.002 
1 vs.2=0.023 
3vs.4=0.111 
1vs.3=0.319 
2vs.4=0.745 
Brain 
(%) 
1.15 
±0.014 
 
1.13 
±0.021 
1.169 
±0.027 
1.077 
±0.018 
1 vs.2=0.516 
3vs.4=0.004 
1vs.3=0.567 
2vs.4=0.065 
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figure 4.7.1.2.1b and table 4.7.1.2.1). The comparable differences found in 
absolute values were maintained after normalisation (LBWm-NF vs. LBWm-
HF p=0.669; LBWm-HF vs. HBWm-HF p=0.382; figure 4.7.1.2.1b and table 
4.7.1.2.1). 
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Figure 4.7.1.2.1 Brown adipose tissue (BAT) mass of male and female offspring at 
15 weeks old. BAT mass in grams a) and c) and normalised to current body weight 
expressed as percentage (relative BAT mass  %) b) and d). Figures on the top 
correspond to males and figures below to females. Statistical analysis was 
performed using a one-way ANOVA followed by a protected Fisher’s least 
significant difference (LSD) post hoc analysis.  Data presented as mean± SEM. 
LBWm-NF n=13; LBWm-HF n=14; HBWm-NF n=11, HBWm-HF n=15; LBWf-NF 
n=11; LBWf-HF n=14; HBWf-NF n=8, HBWf-HF n=8. N/S= no significant; *p≤0.05; 
**p≤0.01; ***p≤0.001. 
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Table 4.7.1.2.1 Brown adipose tissue (BAT) mass of male offspring at 15 weeks old. 
BAT (g)= brown adipose tissue mass in grams and BAT (%)= normalised brown 
adipose tissue mass to current body weight expressed as percentage. Statistical 
analysis was performed using a one-way ANOVA followed by a protected Fisher’s 
least significant difference (LSD) post hoc analysis.  Data presented as mean± 
SEM.  
 
4.7.1.3 Liver mass in Males  
Liver mass as absolute value (grams) was significantly different between 
mice fed a HF diet, being lower in LBWm-HF (p=0.022; figure 4.7.1.3.1a and 
table 4.7.1.3.1). Not differences were seen between the rest of the groups. 
However, after normalisation, differences between LBWm mice became 
significant, with LBWm-HF mice having a lower mass compared to LBWm-
NF (p=0.011; figure 4.7.1.3.1a and table 4.7.1.3.1), and the significant 
difference between mice fed HF diet was maintained (p=0.005; figure 
4.7.1.3.1a and table 4.7.1.3.1).  
Organ  
mass 
LBWm-NF1 LBWm-HF2 HBWm-NF3 HBWm-HF4 P value 
 
BAT 
 (g) 
 
0.189 
± 0.137 
 
0.198 
±0.016 
 
0.149 
±0.015 
 
0.222 
±0.01 
1 vs.2=0.691 
3vs.4<0.001 
1vs.3=0.056 
2vs.4=0.201 
 
BAT  
(%) 
 
0.677 
±0.045 
 
 
 
0.651 
±0.049 
 
0.514 
±0.043 
 
0.702 
±0.296 
1 vs.2=0.669 
3vs.4=0.003 
1vs.3=0.013 
2vs.4=0.382 
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Figure 4.7.1.3.1 Liver mass of male and female offspring at 15 weeks old. Liver 
mass in grams a) and c) and normalised to current body weight expressed as 
percentage (relative liver mass  %) b) and d). Figures on the top correspond to 
males and figures below to females. Statistical analysis was performed using a one-
way ANOVA followed by a protected Fisher’s least significant difference (LSD) post 
hoc analysis.  Data presented as mean± SEM. LBWm-NF n=11; LBWm-HF n=12; 
HBWm-NF n=11, HBWm-HF n=15; LBWf-NF n=12; LBWf-HF n=14; HBWf-NF 
n=8, HBWf-HF n=8. N/S= no significant; *p≤0.05; **p≤0.01. 
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Table 4.7.1.3.1 Liver mass of male offspring at 15 weeks old. Liver (g)= liver mass 
in grams and liver (%)= normalised liver mass to current body weight expressed as 
percentage. Statistical analysis was performed using a one-way ANOVA followed 
by a protected Fisher’s least significant difference (LSD) post hoc analysis.  Data 
presented as mean± SEM.  
 
4.7.1.4 Pancreas, spleen and heart masses in Males  
Assessment of pancreas, spleen and heart did not show any significant 
difference between groups in either absolute (grams) or relative (%) values 
(pancreas: figure 4.7.1.4.1 and table 4.7.1.4.1; spleen: figure 4.7.1.4.2 and 
table 4.7.1.4.1; heart 4.7.1.4.3 and table 4.7.1.4.1). 
 
 
 
Organ 
mass 
LBWm-NF1 LBWm-HF2 HBWm-NF3 HBWm-HF4 P value 
Liver 
 (g) 
1.296 
±0.023 
 
1.264 
±0.052 
 
1.327 
±0.059 
1.465 
±0.024 
1 vs.2=0.942 
3vs.4=0.232 
1vs.3=0.959 
2vs.4=0.022 
Liver 
 (%) 
4.613 
±0.074 
4.189 
±0.147 
4.715 
±0.135 
4.534 
±0.061 
1 vs.2=0.011 
3vs.4=0.598 
1vs.3=0.546 
2vs.4=0.005 
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Figure 4.7.1.4.1 Pancreas mass of male and female offspring at 15 weeks old. 
Pancreas mass in grams a) and c) and normalised to current body weight 
expressed as percentage (relative pancreas mass%) b) and d). Figures on the top 
correspond to males and figures below to females. Statistical analysis was 
performed using a one-way ANOVA followed by a protected Fisher’s least 
significant difference (LSD) post hoc analysis.  Data presented as mean± SEM. 
LBWm-NF n=13; LBWm-HF n=14; HBWm-NF n=11, HBWm-HF n=15; LBWf-NF 
n=12; LBWf-HF n=14; HBWf-NF n=8, HBWf-HF n=8. N/S= no significant; *p≤0.05; 
***p≤0.001. 
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Figure 4.7.1.4.2 Spleen mass of male and female offspring at 15 weeks old. Spleen 
mass in grams a) and c) and normalised to current body weight expressed as 
percentage (relative spleen mass%) b) and d). Figures on the top correspond to 
males and figures below to females. Statistical analysis was performed using a one-
way ANOVA followed by a protected Fisher’s least significant difference (LSD) post 
hoc analysis.  Data presented as mean± SEM. LBWm-NF n=13; LBWm-HF n=13; 
HBWm-NF n=11, HBWm-HF n=15; LBWf-NF n=10; LBWf-HF n=14; HBWf-NF 
n=8, HBWf-HF n=7. N/S= no significant; *p≤0.05; **p≤0.01. 
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Figure 4.7.1.4.3 Heart mass of male and female offspring at 15 weeks old. Heart 
mass in grams a) and c) and normalised to current body weight expressed as 
percentage (relative heart mass%) b) and d). Figures on the top correspond to 
males and figures below to females. Statistical analysis was performed using a one-
way ANOVA followed by a protected Fisher’s least significant difference (LSD) post 
hoc analysis. Data presented as mean± SEM. LBWm-NF n=12; LBWm-HF n=13; 
HBWm-NF n=11, HBWm-HF n=14; LBWf-NF n=10; LBWf-HF n=14; HBWf-NF 
n=7, HBWf-HF n=8. N/S= no significant; **p≤0.01. 
 
 
 
 
 
 
	   306	  
 
Table 4.7.1.4.1 Pancreas, spleen and heart masses of male offspring at 15 weeks 
old. Pancreas, spleen and heart (g)= respective masses in grams and pancreas, 
spleen and heart (%)= normalised masses to current body weight expressed as 
percentage. Statistical analysis was performed using a one-way ANOVA followed 
by a protected Fisher’s least significant difference (LSD) post hoc analysis.  Data 
presented as mean± SEM.  
 
 
 
 
Organ 
mass 
LBWm-NF1 LBWm-HF2 HBWm-NF3 HBWm-HF4 P value 
Pancreas 
(g) 
0.197 
±0.012 
 
0.225 
±0.012 
0.204 
±0.013 
0.221 
±0.007 
1 vs.2=0.275 
3vs.4=0.676 
1vs.3=0.975 
2vs.4=0.996 
 
Pancreas 
(%) 
0.705 
±0.041 
0.745 
±0.038 
0.711 
±0.037 
0.702 
±0.023 
1 vs.2=0.847 
3vs.4=0.998 
1vs.3=0.999 
2vs.4=0.799 
 
Spleen  
(g) 
0.079 
±0.003 
 
0.089 
±0.004 
0.084 
±0.004 
0.091 
±0.004 
1 vs.2=0.201 
3vs.4=0.551 
1vs.3=0.799 
2vs.4=0.991 
 
Spleen  
(%) 
0.282 
±0.013 
 
0.299 
±0.014 
0.296 
±0.015 
0.289 
±0.101 
1 vs.2=0.807 
3vs.4=0.982 
1vs.3=0.894 
2vs.4=0.946 
 
Heart  
(g) 
0.148 
±0.004 
0.155 
±0.005 
0.152 
±0.005 
0.161 
±0.006 
1 vs.2=0.736 
3vs.4=0.584 
1vs.3=0.955 
2vs.4=0.811 
 
Heart  
(%) 
0.529 
±0.013 
0.517 
±0.016 
0.535 
±0.019 
0.509 
±0.159 
1 vs.2=0.947 
3vs.4=0.674 
1vs.3=0.996 
2vs.4=0.984 
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4.7.1.5 Kidneys mass in Males  
Kidneys mass in grams was significantly higher in LBWm-HF compared to 
LBWm-NF (p=0.015; figure 4.7.1.5.1a and table 4.7.1.5.1) but not between 
HBWm mice (p=0.628; figure 4.7.1.5.1a and table 4.7.1.5.1). Furthermore, 
there was a significant difference between mice fed a NF diet with a higher 
mass in HBWm-NF mice han LBWm-NF mice (p=0.033; figure 4.7.1.5.1a 
and table 4.7.1.5.1) but it was comparable between mice fed a HF diet 
(p=0.919; figure 4.7.1.5.1a and table 4.7.1.5.1). After normalisation, relative 
kidneys mass was not longer significant, but it was marginal, between 
LBWm mice (p=0.062; figure 4.7.1.5.1b and table 4.7.1.5.1). The difference 
between mice fed a NF diet was maintained (HBWm-NF vs. LBWm-NF mice 
(p=0.015; figure 4.7.1.5.1b and table 4.7.1.5.1) as well as comparable 
differences between HBWm mice (p=0.181) and mice fed a HF diet 
(p=0.506; figure 4.7.1.5.1b and table 4.7.1.5.1). 
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Figure 4.7.1.5.1 Kidneys mass of male and female offspring at 15 weeks old. 
Kidneys mass in grams a) and c) and normalised to current body weight expressed 
as percentage (relative brain mass%) b) and d). Figures on the top correspond to 
males and figures below to females. Statistical analysis was performed using a one-
way ANOVA followed by a protected Fisher’s least significant difference (LSD) post 
hoc analysis.  Data presented as mean± SEM. LBWm-NF n=13; LBWm-HF n=12; 
HBWm-NF n=10, HBWm-HF n=15; LBWf-NF n=10; LBWf-HF n=14; HBWf-NF 
n=8, HBWf-HF n=8. N/S= no significant; *p≤0.05; **p≤0.01. 
	  	  	  	  	  	  
 
Organ 
mass 
LBWm-NF1 LBWm-HF2 HBWm-NF3 HBWm-HF4 P value 
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Table 4.7.1.5.1 Kidneys mass of male offspring at 15 weeks old. Kidneys (g)= 
kidneys mass in grams and kidneys (%)= normalised kidneys mass to current body 
weight expressed as percentage. Statistical analysis was performed using a one-
way ANOVA followed by a protected Fisher’s least significant difference (LSD) post 
hoc analysis.  Data presented as mean± SEM.  
	  
4.7.1.6 Skeletal muscle mass in Males  
Assessment of skeletal muscle mass (from right hind leg) in grams showed a 
significant difference between mice fed a HF diet, with a lower muscle mass 
in LBWm-HF than HBWm-HF mice (p<0.001; figure 4.7.1.6.1a and table 
4.7.1.6.1). There was also a significant difference between HBWm mice with 
a higher muscle mass in HBWm-HF than HBWm-NF mice (p=0.003; figure 
4.7.1.6.1a and table 4.7.1.6.1). However after normalisation, the significant 
difference between mice fed a HF diet was maintained (p=0.004; figure 
4.7.1.6.1a and table 4.7.1.6.1), but not the significant difference between 
HBWm mice (p=0.141; figure 4.7.1.6.1a and table 4.7.1.6.1), although the 
pattern was similar.  
 
Kidneys 
(g) 
0.289 
±0.005 
 
0.331 
±0.011 
0.324 
±0.009 
0.341 
±0.009 
1 vs.2=0.015 
3vs.4=0.628 
1vs.3=0.033 
2vs.4=0.919 
Kidneys 
(%) 
1.035 
±0.014 
 
1.101 
±0.031 
1.126 
±0.018 
1.079 
±0.026 
1 vs.2=0.062 
3vs.4=0.181 
1vs.3=0.015 
2vs.4=0.506 
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Figure 4.7.1.6.1 Skeletal muscle mass of male and female offspring at 15 weeks 
old. Muscle mass in grams a) and c) and normalised to current body weight 
expressed as percentage (relative brain mass%) b) and d). Figures on the top 
correspond to males and figures below to females. Statistical analysis was 
performed using a one-way ANOVA followed by a protected Fisher’s least 
significant difference (LSD) post hoc analysis.  Data presented as mean± SEM. 
LBWm-NF n=12; LBWm-HF n=14; HBWm-NF n=11, HBWm-HF n=14; LBWf-NF 
n=11; LBWf-HF n=14; HBWf-NF n=8, HBWf-HF n=8. N/S= no significant; *p≤0.05; 
**p≤0.01***p≤0.001. 
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Table 4.7.1.6.1 Skeletal muscle mass of male offspring at 15 weeks old. Muscle 
(g)= muscle mass in grams and muscle (%)= normalised muscle mass to current 
body weight expressed as percentage. Statistical analysis was performed using a 
one-way ANOVA followed by a protected Fisher’s least significant difference (LSD) 
post hoc analysis.  Data presented as mean± SEM.  
 
4.7.2 Organ mass in Females  
4.7.2.1 Brain mass in Females 
Brain mass as grams in females showed a significant difference between 
LBWf mice with a higher weight in LBWf-HF mice than LBWf-NF (p=0.05; 
figure 4.7.2.1.1a and table 4.7.2.1.1), but the difference between HBWf mice 
did not reach significance (p=0.576; figure 4.7.2.1.1a and table 4.7.2.1.1). 
Furthermore, LBWf-NF had a lower brain mass compared to HBWf-NF mice 
(p=0.009; figure 4.7.2.1.1a and table 4.7.2.1.1). Comparable masses were 
found between females fed a HF diet (p=0.663; figure 4.7.2.1.1a and table 
4.7.2.1.1). Similar brain masses were seen in their respective male groups, 
except from HBWm-NF mice, which had 0.015 ±0.006g less than its 
respective female group.  
 
Organ 
mass 
LBWm-NF1 LBWm-HF2 HBWm-NF3 HBWm-
HF4 
P value 
Muscle (g) 0.428 
±0.016 
 
0.419 
±0.025 
0.44 
±0.026 
0.55 
±0.026 
1vs.2=0.809 
3vs.4=0.003 
1vs.3=0.734 
2vs.4<0.001 
Muscle (%) 1.523 
±0.051 
 
1.398 
±0.089 
1.556 
±0.102 
1.734 
±0.079 
1vs.2=0.289 
3vs.4=0.141 
1vs.3=0.787 
2vs.4=0.004 
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Upon normalising brain mass to body weight and expressed as percentage, 
differences between LBWf mice and between females fed a NF diet were not 
maintained (p=0.144; p=0.589 respectively; figure 4.7.2.1.1b and table 
4.7.2.1.1). This suggested that the brain mass was proportional to their body 
weights. However, the difference between HBWf mice appeared significant, 
with a lower mass in HBWf-HF mice (p=0.004; figure 4.7.2.1.1b and table 
4.7.2.1.1), as well as the difference between females fed a HF diet with again 
a lower mass in HBWf-HF mice (p=0.012; figure 4.7.2.1.1b and table 
4.7.2.1.1). Similar pattern was found in males, but relative brain masses 
tended to be higher in males than their respective female groups (figure 
4.7.1.1.1 and table 4.7.1.1.1). 
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Figure 4.7.2.1.1 Brain mass of female and male offspring at 15 weeks old. Brain 
mass in grams a) and c) and normalised to current body weight expressed as 
percentage (relative brain mass %) b) and d). Figures on the top correspond to 
females and figures below to males. Statistical analysis was performed using a one-
way ANOVA followed by a protected Fisher’s least significant difference (LSD) post 
hoc analysis.  Data presented as mean± SEM. LBWf-NF n=11; LBWf-HF n=14; 
HBWf-NF n=8, HBWf-HF n=8. LBWm-NF n=10; LBWm-HF n=14; HBWm-NF 
n=11, HBWm-HF n=14. N/S= no significant; *p≤0.05; **p≤0.01. 
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Table 4.7.2.1.1 Brain mass of female offspring at 15 weeks old. Brain (g)= brain 
mass in grams and Brain (%)= normalised brain mass to current body weight 
expressed as percentage. Statistical analysis was performed using a one-way 
ANOVA followed by a protected Fisher’s least significant difference (LSD) post hoc 
analysis.  Data presented as mean± SEM.  
 
4.7.2.2 Brown adipose tissue (BAT) mass in Females 
Brown adipose tissue analysis showed differences between LBWf mice 
(p=0.013; figure 4.7.2.2.1a and table 4.7.2.2.1) and females fed a HF diet 
(p=0.017; figure 4.7.2.2.1a and table 4.7.2.2.1), with LBWf-HF mice having a 
lower BAT mass in both cases.  After normalisation to body weight, the 
significant difference between LBWf mice was maintained (p<0.001; figure 
4.7.2.2.1b and table 4.7.2.2.1), which was not significant between respective 
male groups (figure 4.7.1.2.1 and table 4.7.1.2.1). However, the significance 
was not maintained between mice fed a HF diet, which it was in males (figure 
4.7.1.2.1 and table 4.7.1.2.1). Moreover, difference between females fed a 
NF diet became significant with LBWf-NF mice having the highest mass 
(p=0.038; figure 4.7.2.2.1b and table 4.7.2.2.1), but it was not in the 
respective male groups (figure 4.7.1.2.1 and table 4.7.1.2.1). 
Organ 
mass 
LBWf-NF1 LBWf-HF2 HBWf-NF3 HBWf-HF4 P value 
Brain (g) 0.326 
±0.004 
0.339 
±0.005 
0.346 
±0.006 
0.342 
±0.003 
1 vs.2=0.05 
3vs.4=0.576 
1vs.3=0.009 
2vs.4=0.663 
Brain (%) 1.652 
±0.033 
 
1.571 
±0.045 
1.618 
±0.05 
1.412 
±0.029 
1vs.2=0.144 
3vs.4=0.004 
1vs.3=0.589 
2vs.4=0.012 
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Figure 4.7.2.2.1 Brown adipose tissue (BAT) mass of female and male offspring at 
15 weeks old. BAT mass in grams a) and c) and normalised to current body weight 
expressed as percentage (relative BAT mass  %) b) and d). Figures on the top 
correspond to females and figures below to males. Statistical analysis was 
performed using a one-way ANOVA followed by a protected Fisher’s least 
significant difference (LSD) post hoc analysis.  Data presented as mean± SEM. 
LBWf-NF n=11; LBWf-HF n=14; HBWf-NF n=8, HBWf-HF n=8; LBWm-NF n=13; 
LBWm-HF n=14; HBWm-NF n=11, HBWm-HF n=15. N/S= no significant; *p≤0.05, 
**p≤0.01, ***p≤0.001. 
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Table 4.7.2.2.1 Brown adipose tissue (BAT) mass of female offspring at 15 weeks 
old. BAT (g)= brown adipose tissue mass in grams and BAT (%)= normalised brown 
adipose tissue mass to current body weight expressed as percentage. Statistical 
analysis was performed using a one-way ANOVA followed by a protected Fisher’s 
least significant difference (LSD) post hoc analysis.  Data presented as mean± 
SEM.  
 
4.7.2.3 Liver mass in Females 
Absolute liver mass (g) was significantly different between LBWf mice, with 
LBWf-HF mice having a higher liver mass than LBWf-NF mice (p=0.01; 
figure 4.7.2.3.1a and table 4.7.2.3.1). Significance was also found between 
mice fed a NF diet with a higher liver mass in HBWf-NF mice than LBWf-NF 
mice (p=0.023; figure 4.7.2.3.1a and table 4.7.2.3.1) and between females 
fed a HF diet, with LBWf-HF mice having a lower liver mass than their 
counterpart (p=0.047; figure 4.7.2.3.1a and table 4.7.2.3.1). There was a 
marginal significant difference between HBWf mice (p=0.077; figure 
4.7.2.3.1a and table 4.7.2.3.1). However, after normalisation, differences 
were comparable between groups  (figure 4.7.2.3.1b and table 4.7.2.3.1). 
The trends seen in males were different, as LBWm-HF had the lowest 
Organ mass LBWf-NF1 LBWf-HF2 HBWf-NF3 HBWmfHF4 P value 
 
BAT (g) 
 
0.102 
± 0.005 
 
0.083 
±0.004 
 
0.092 
±0.009 
 
0.1029 
±0.004 
1 vs.2=0.013 
3vs.4=0.255 
1vs.3=0.275 
2vs.4=0.017 
 
BAT (%) 
 
0.519 
±0.03 
 
 
 
0.380 
±0.02 
 
0.431 
±0.043 
 
0.424 
±0.015 
1 vs.2<0.001 
3vs.4=0.872 
1vs.3=0.038 
2vs.4=0.261 
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relative mass compared to the other groups and the differences were 
significant between groups (figure 4.7.1.3.1 and table 4.7.1.3.1). 
 
 
Figure 4.7.2.3.1 Liver mass of female and male offspring at 15 weeks old. Liver 
mass in grams a) and c) and normalised to current body weight expressed as 
percentage (relative  liver mass %) b) and d). Figures on the top correspond to 
females and figures below to males. Statistical analysis was performed using a one-
way ANOVA followed by a protected Fisher’s least significant difference (LSD) post 
hoc analysis.  Data presented as mean± SEM. LBWf-NF n=12; LBWf-HF n=14; 
HBWf-NF n=8, HBWf-HF n=8; LBWm-NF n=11; LBWm-HF n=12; HBWm-NF 
n=11, HBWm-HF n=15. N/S= no significant; *p≤0.05, **p≤0.01. 
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Table 4.7.2.3.1 Liver mass of female offspring at 15 weeks old. Liver (g)= liver mass 
in grams and liver (%)= normalised liver mass to current body weight expressed as 
percentage. Statistical analysis was performed using a one-way ANOVA followed 
by a protected Fisher’s least significant difference (LSD) post hoc analysis.  Data 
presented as mean± SEM.  
 
4.7.2.4 Pancreas, spleen and heart masses in Females 
Contrary to the comparable differences between males (figure 4.7.1.4.1 and 
table 4.7.1.4.1), pancreas (g) was significantly higher in HBWf-HF mice than 
HBWf-NF mice (p=0.026; figure 4.7.2.4.1a and table 4.7.2.4.1) and it was 
also higher when compared to LBWf-HF mice (p=0.001; figure 4.7.2.4.1a 
and table 4.7.2.4.1). Comparable masses were found between LBWf mice 
(p=0.29; figure 4.7.2.4.1a and table 4.7.2.4.1) and females fed a NF diet 
(p=0.915; figure 4.7.2.4.1a and table 4.7.2.4.1). After normalising to body 
weight, the difference between HBWf mice disappeared (p=0.329; figure 
4.7.2.4.1b and table 4.7.2.4.1) but the significant difference between females 
fed a HF diet was maintained (p=0.029; figure 4.7.2.4.1b and table 4.7.2.4.1) 
as well as the comparable masses between those fed a NF diet (p=0.312; 
figure 4.7.2.4.1b and table 4.7.2.4.1). However, differences between LBWf 
Organ mass LBWf-NF1 LBWf-HF2 HBWf-NF3 HBWf-HF4 P value 
Liver (g) 0.907 
±0.046 
 
1.064 
±0.036 
 
1.065 
±0.036 
1.20 
±0.067 
1 vs.2=0.01 
3vs.4=0.077 
1vs.3=0.023 
2vs.4=0.047 
Liver (%) 4.597 
±0.205 
4.893 
±0.109 
4.957 
±0.131 
5.036 
±0.208 
1 vs.2=0.165 
3vs.4=0.768 
1vs.3=0.143 
2vs.4=0.553 
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mice were significant, with LBWf-HF mice having the lowest mass (p=0.02; 
figure 4.7.2.4.1b and table 4.7.2.4.1). 
 
 
Figure 4.7.2.4.1 Pancreas mass of female and male offspring at 15 weeks old. 
Pancreas mass in grams a) and c) and normalised to current body weight 
expressed as percentage (relative pancreas mass%) b) and d). Figures on the top 
correspond to females and figures below to males. Statistical analysis was 
performed using a one-way ANOVA followed by a protected Fisher’s least 
significant difference (LSD) post hoc analysis.  Data presented as mean± SEM. 
LBWf-NF n=12; LBWf-HF n=14; HBWf-NF n=8, HBWf-HF n=8; LBWm-NF n=13; 
LBWm-HF n=14; HBWm-NF n=11, HBWm-HF n=15. N/S= no significant; *p≤0.05, 
***p≤0.001. 
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Table 4.7.2.4.1 Pancreas mass of female offspring at 15 weeks old. Pancreas (g)= 
pancreas mass in grams and pancreas (%)= normalised pancreas mass to current 
body weight expressed as percentage. Statistical analysis was performed using a 
one-way ANOVA followed by a protected Fisher’s least significant difference (LSD) 
post hoc analysis.  Data presented as mean± SEM.  
 
 
Contrary to the similar differences seen between male groups (figure 
4.7.1.4.2 and table 4.7.1.4.2), assessment of spleen mass in grams showed 
that mice fed a HF diet had a heavier spleen than their counterparts (LBWf-
HF vs. LBWf-NF p=0.009; HBWf-HF vs. HBWf-NF p= 0.02; figure 4.7.2.4.2a 
and table 4.7.2.4.2). However after normalisation to body weight, there were 
not significant differences between groups but the pattern was maintained 
(figure 4.7.2.4.2b and table 4.7.2.4.2). 
 
 
 
Organ mass LBWf-NF1 LBWf-HF2 HBWf-NF3 HBWf-HF4 P value 
Pancreas (g) 0.161 
±0.009 
 
0.146 
±0.011 
0.159 
±0.0103 
0.198 
±0.011 
1 vs.2=0.29 
3vs.4=0.026 
1vs.3=0.915 
2vs.4=0.001 
 
Pancreas (%) 0.818 
±0.049 
0.667 
±0.041 
0.746 
±0.054 
0.821 
±0.047 
1 vs.2=0.02 
3vs.4=0.329 
1vs.3=0.312 
2vs.4=0.029 
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Figure 4.7.2.4.2 Spleen mass of female and male offspring at 15 weeks old. Spleen 
mass in grams a) and c) and normalised to current body weight expressed as 
percentage (relative spleen mass%) b) and d). Figures on the top correspond to 
females and figures below to males. Statistical analysis was performed using a one-
way ANOVA followed by a protected Fisher’s least significant difference (LSD) post 
hoc analysis.  Data presented as mean± SEM. LBWf-NF n=10; LBWf-HF n=14; 
HBWf-NF n=8, HBWf-HF n=7; LBWm-NF n=13; LBWm-HF n=13; HBWm-NF 
n=11, HBWm-HF n=15. N/S= no significant; *p≤0.05, **p≤0.01. 
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Table 4.7.2.4.2 Spleen mass of female offspring at 15 weeks old. Spleen (g)= 
pancreas mass in grams and spleen (%)= normalised spleen mass to current body 
weight expressed as percentage. Statistical analysis was performed using a one-
way ANOVA followed by a protected Fisher’s least significant difference (LSD) post 
hoc analysis.  Data presented as mean± SEM.  
 
 
Heart mass (g) was similar between groups as it was in male groups (figure 
4.7.2.4.3a and table 4.7.2.4.3). However, relative values (%) between LBWf 
mice were significantly different, with a higher mass in LBWm-NF mice 
compared to LBWf-HF mice (p=0.012; figure 4.7.2.4.3b and table 4.7.2.4.3), 
but there were similar between males. Comparable differences were 
maintained between others female groups.  
 
 
 
 
 
 
 
Organ mass LBWf-NF1 LBWf-HF2 HBWf-NF3 HBWf-HF4 P value 
Spleen (g) 0.068 
±0.005 
 
0.083 
±0.003 
0.077 
±0.004 
0.093 
±0.004 
1 vs.2=0.009 
3vs.4=0.02 
1vs.3=0.174 
2vs.4=0.10 
 
Spleen (%) 0.344 
±0.024 
 
0.382 
±0.014 
0.357 
±0.017 
0.384 
±0.021 
1 vs.2=0.125 
3vs.4=0.382 
1vs.3=0.634 
2vs.4=0.939 
 
	   323	  
 
 
Figure 4.7.2.4.3 Heart mass of female and male offspring at 15 weeks old. Heart 
mass in grams a) and c) and normalised to current body weight expressed as 
percentage (relative heart mass%) b) and d). Figures on the top correspond to 
females and figures below to males. Statistical analysis was performed using a one-
way ANOVA followed by a protected Fisher’s least significant difference (LSD) post 
hoc analysis. Data presented as mean± SEM. LBWf-NF n=10; LBWf-HF n=14; 
HBWf-NF n=7, HBWf-HF n=8; LBWm-NF n=12; LBWm-HF n=13; HBWm-NF 
n=11, HBWm-HF n=14. N/S= no significant; **p≤0.01. 
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Table 4.7.2.4.3 Heart mass of female offspring at 15 weeks old. Heart (g)= heart 
mass in grams and heart (%)= normalised heart mass to current body weight 
expressed as percentage. Statistical analysis was performed using a one-way 
ANOVA followed by a protected Fisher’s least significant difference (LSD) post hoc 
analysis.  Data presented as mean± SEM.  
	  
4.7.2.5 Kidneys mass in Females 
Absolute value of kidneys mass (g) was significantly higher in mice fed a HF 
diet compared to their counterparts (LBWf-HF vs. LBWf-NF p=0.031; HBWf-
HF vs. HBWf-NF p= 0.014; figure 4.7.2.5.1a and table 4.7.2.5.1). Also, 
HBWf-NF mice had a higher kidneys mass compared to LBWf-NF mice 
(p=0.05; figure 4.7.2.5.1a and table 4.7.2.5.1) as well as HBWf-HF vs. 
LBWf-HF p=0.005; figure 4.7.2.5.1a and table 4.7.2.5.1). However, relative 
values (%) were similar between groups (figure 4.7.2.5.1b and table 
4.7.2.5.1). Although a significant difference between females fed a NF diet 
was not evident, it was between their respective male groups (figure 
4.7.1.5.1 and table 4.7.1.5.1). 
 
 
Organ mass LBWf-NF1 LBWf-HF2 HBWf-NF3 HBWf-HF4 P value 
Heart (g) 0.119 
±0.006 
 
0.115 
±0.003 
0.126 
±0.004 
0.128 
±0.006 
1 vs.2=0.863 
3vs.4=0.993 
1vs.3=0.825 
2vs.4=0.185 
 
Heart (%) 0.613 
±0.035 
 
0.529 
±0.014 
0.587 
±0.023 
0.539 
±0.023 
1 vs.2=0.012 
3vs.4=0.219 
1vs.3=0.503 
2vs.4=0.767 
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Figure 4.7.2.5.1 Kidneys mass of female and male offspring at 15 weeks old. 
Kidneys mass in grams a) and c) and normalised to current body weight expressed 
as percentage (relative brain mass%) b) and d). Figures on the top correspond to 
females and figures below to males. Statistical analysis was performed using a one-
way ANOVA followed by a protected Fisher’s least significant difference (LSD) post 
hoc analysis. Data presented as mean± SEM. LBWf-NF n=10; LBWf-HF n=14; 
HBWf-NF n=8, HBWf-HF n=8; LBWm-NF n=13; LBWm-HF n=12; HBWm-NF 
n=10; HBWm-HF n=15. N/S= no significant; *p≤0.05, **p≤0.01. 
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Table 4.7.2.5.1 Kidneys mass of female offspring at 15 weeks old. Kidneys (g)= 
kidneys mass in grams and kidneys (%)= normalised kidneys mass to current body 
weight expressed as percentage. Statistical analysis was performed using a one-
way ANOVA followed by a protected Fisher’s least significant difference (LSD) post 
hoc analysis.  Data presented as mean± SEM.  
 
4.7.2.6 Skeletal muscle mass in Females 
Skeletal muscle assessment showed a different pattern between females 
and males. LBWf-HF mice had a higher muscle mass in grams compared to 
LBWf-NF mice (p=0.017; figure 4.7.2.6.1a and table 4.7.2.6.1), which was 
the contrary in males (figure 4.7.2.6.1 and table 4.7.2.6.1). The difference 
between HBWf mice did not reach significance (p=0.49; figure 4.7.2.6.1a 
and table 4.7.2.6.1), which it did between males (figure 4.7.1.6.1 and table 
4.7.1.6.1). Comparable differences between females fed a NF diet (p=0.127; 
figure 4.7.2.6.1a and table 4.7.2.6.1) and females fed a HF diet were found 
(p=0.147; figure 4.7.2.6.1a and table 4.7.2.6.1).  
 
 
 
Organ mass LBWf-NF1 LBWf-HF2 HBWf-NF3 HBWf-HF4 P value 
Kidneys (g) 0.217 
±0.007 
 
0.237 
±0.003 
0.238 
±0.004 
0.265 
±0.009 
1 vs.2=0.031 
3vs.4=0.014 
1vs.3=0.05 
2vs.4=0.005 
 
Kidneys (%) 1.095 
±0.028 
 
1.093 
±0.018 
1.108 
±0.018 
1.119 
±0.039 
1 vs.2=0.94 
3vs.4=0.781 
1vs.3=0.746 
2vs.4=0.466 
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After normalisation, relative muscle mass was marginally significant between 
LBWf mice, maintaining the same pattern as in mass in absolute values (g) 
(p=0.092; figure 4.7.2.6.1b and table 4.7.2.6.1) as well as between HBWf 
mice (p=0.067; figure 4.7.2.6.1b and table 4.7.2.6.1). However, differences 
between females fed a HF diet became significantly different, with a higher 
relative mass in LBWf-HF mice, (p=0.006; figure 4.7.2.6.1b and table 
4.7.2.6.1), what was opposite in males (figure 4.7.1.6.1 and table 4.7.1.6.1). 
Comparable difference was maintained between females fed a NF diet 
(p=0.492; figure 4.7.2.6.1b and table 4.7.2.6.1).  
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Figure 4.7.2.6.1 Skeletal muscle mass of female and male offspring at 15 weeks 
old. Muscle mass in grams a) and c) and normalised to current body weight 
expressed as percentage (relative brain mass%) b) and d). Figures on the top 
correspond to females and figures below to males. Statistical analysis was 
performed using a one-way ANOVA followed by a protected Fisher’s least 
significant difference (LSD) post hoc analysis.  Data presented as mean± SEM. 
LBWf-NF n=11; LBWf-HF n=14; HBWf-NF n=8, HBWf-HF n=8; LBWm-NF n=12; 
LBWm-HF n=14; HBWm-NF n=11; HBWm-HF n=14. N/S= no significant; *p≤0.05, 
**p≤0.01, ***p≤0.001. 
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Table 4.7.2.6.1 Muscle mass of female offspring at 15 weeks old. Muscle (g)= 
muscle mass in grams and muscle (%)= normalised muscle mass to current body 
weight expressed as percentage. Statistical analysis was performed using a one-
way ANOVA followed by a protected Fisher’s least significant difference (LSD) post 
hoc analysis.  Data presented as mean± SEM.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Organ mass LBWf-NF1 LBWf-HF2 HBWf-NF3 HBWf-HF4 P value 
Muscle (g) 0.317 
±0.022 
 
0.389 
±0.021 
0.366 
±0.026 
0.342 
±0.019 
1 vs.2=0.017 
3vs.4=0.49 
1vs.3=0.127 
2vs.4=0.147 
 
Muscle (%) 1.602 
±0.099 
 
1.834 
±0.111 
1.704 
±0.114 
1.407 
±0.067 
1 vs.2=0.092 
3vs.4=0.067 
1vs.3=0.492 
2vs.4=0.006 
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4.8 The Effects of Birth Weight and Diet on White Adipose 
Tissue Mass in Young Mice (From Week 3 Until Week 15) 
 
White adipose tissue was (WAT) was extracted and subdivided into 
subcutaneous (SAT) and internal adipose tissue (IAT). IAT was further 
subdivided into gonadal, retroperitoneal and mesenteric fat depots for 
regional analysis. Data was analysed based on absolute values (grams) and 
relative values (expressed as percentage of current body weight). A 2x2 
factorial ANOVA was performed to assess the effects of both birth weight 
and diet on white adipose tissue mass.  
 
4.8.1 White adipose tissue mass in Males 
Significant interactions were found between both birth weight and diet in all 
the independent white fat depots as well as in total white adipose tissue and 
internal adipose tissue expressed in grams (figure 4.8.1.1 and tables 4.8.1.1 
and 4.8.1.2). 
 
Total white adipose tissue in grams (Total WAT), subcutaneous (SAT), 
mesenteric adipose tissue and internal adipose tissue (IAT), were marginally 
significant between mice fed a NF diet, with LBWm-NF mice having higher 
masses compared to HBWm-NF mice (total WAT: p=0.057; SAT: p=0.063; 
mesenteric: p=0.07; IAT: p=0.056; figure 4.8.1.1 and tables 4.8.1.1 and 
4.8.1.2). However, retroperitoneal fat was significantly different between mice 
groups (p=0.042; figure 4.8.1.1 and tables 4.8.1.1 and 4.8.1.2).  
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However, an opposite pattern was seen in mice fed a HF diet, with HBWm-
HF mice having significant higher masses than LBWm-HF mice, except from 
gonadal and mesenteric fat, which were comparable between groups 
(gonadal: p=0.191; mesenteric; p=0.106; figure 4.8.1.1 and tables 4.8.1.1 
and 4.8.1.2).   
 
Furthermore, HBWm-HF mice had higher total WAT, SAT, IAT, and 
independent regional internal depots (gonadal, retroperitoneal and 
mesenteric adipose tissues) compared to HBWm-NF mice (figure 4.8.1.1 
and tables 4.8.1.1 and 4.8.1.2).  Significant differences between LBWm mice 
were also found, except from retroperitoneal and mesenteric fat, which were 
comparable between groups (retroperitoneal: p=0.747; mesenteric: p=0.346; 
figure 4.8.1.1 and tables 4.8.1.1 and 4.8.1.2). 
 
Significant interactions and therefore differences were maintained after 
normalising white fat masses to current body weight (%), except from Total 
WAT and IAT between LBWm mice, which became nearly significant (total 
WAT: p=0.067; IAT: p=0.057; figure 4.8.1.2 and table 4.8.1.1; figure 4.8.1.2 
and table 4.8.1.2), as well as IAT differences between HBWm-HF and 
LBWm-HF mice (p=0.096; figure 4.8.1.2 and table 4.8.1.2) maintaining all a 
similar trend as in absolute values. Comparable differences between groups 
were also maintained (figure 4.8.1.2 and tables 4.8.1.1 and 4.8.1.2). The 
marginal difference obtained in grams for mesenteric fat was significant in 
relative values (%) between mice fed a NF diet (p=0.02; figure 4.8.1.2 and 
table 4.8.1.2). 
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Figure 4.8.1.1 White adipose tissue mass in grams from male and female mice at 
week 15. Total WAT= total white adipose tissue, SAT=subcutaneous adipose 
tissue, IAT= internal adipose tissue as the sum of gonadal, retroperitoneal and 
mesenteric fat depots. Statistical analysis was performed using a 2x2 factorial 
ANOVA test..Data presented as mean± SEM. Dotted line in a)= for significant 
differences between mice fed a NF diet and mice fed a HF diet having the same 
birth weight. Continuous line in a)= for significant differences between LBWm mice 
and HBWm mice having the same diet. LBWm-NF n=11; LBWm-HF n=14; HBWm-
NF n=10, HBWm-HF n=15. Significant main effect of diet in b) + : *p≤0.05,** p≤0.01, 
***p≤0.001. Main effect of birth weight represented with different letters in b). LBWf-
NF n=12; LBWf-HF n=13; HBWf-NF n=7, HBWf-HF n=8. 
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Figure 4.8.1.2 White adipose tissue mass in percentage (%) from male and female 
mice at week 15. Total WAT= total white adipose tissue, SAT=subcutaneous 
adipose tissue, IAT= internal adipose tissue as the sum of gonadal, retroperitoneal 
and mesenteric fat depots. Statistical analysis was performed using a 2x2 factorial 
ANOVA test. Data presented as mean± SEM. Dotted line in a)= for significant 
differences between mice fed a NF diet and mice fed a HF diet having the same 
birth weight. Continuous line in a)= for significant differences between LBWm mice 
and HBWm mice having the same diet.  LBWm-NF n=11; LBWm-HF n=14; 
HBWm-NF n=10, HBWm-HF n=15. Significant main effect of diet in b) +: *p≤0.05, 
**p≤0.01, ***p≤0.001. Main effect of birth weight represented with different letters in 
b). LBWf-NF n=12; LBWf-HF n=13; HBWf-NF n=7, HBWf-HF n=8. 
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Table 4.8.1.1 Total white adipose tissue and subcutaneous adipose tissue from 
males at 15 weeks old. Total WAT (g)= total white adipose tissue; Total WAT (%)= 
total white adipose tissue as percentage of body weight. SAT (g)= subcutaneous 
adipose tissue in grams; SAT (%)= subcutaneous adipose tissue as percentage of 
body weight.  Statistical analysis was performed using a 2x2 factorial ANOVA test 
followed by simple main effects analysis, as interactions were significant. Data 
presented as mean± SEM.  
 
 
 
 LBWm-NF1 LBWm-HF2 HBWm-NF3 HBWm-HF4 P value 
 
Total WAT 
(g) 
 
2.779 
±0.205 
 
3.453 
±0.18 
 
2.064 
±0.205 
 
4.056 
±0.168 
1 vs.2=0.018 
3vs.4<0.001 
1vs.3=0.018 
2vs.4=0.018 
 
Interaction: F(1,44)=12.014 p=0.001 
 
Total WAT 
(%) 
 
9.859 
±0.599 
 
11.351 
±0.525 
 
7.302 
±0.599 
 
12.796 
±0.489 
1 vs.2=0.067 
3vs.4<0.001 
1vs.3=0.004 
2vs.4=0.05 
 
Interaction: F(1,44)=12.977 p=0.001 
 
SAT 
(g) 
 
1.274 
±0.105 
 
1.638 
±0.092 
 
0.918 
±0.105 
 
1.954 
±0.086 
1 vs.2=0.013 
3vs.4<0.001 
1vs.3=0.021 
2vs.4=0.016 
 
Interaction: F(1,44)=11.848 p=0.001 
 
SAT 
(%) 
 
4.521 
±0.321 
 
5.406 
±0.281 
 
3.254 
±0.321 
 
6.169 
±0.262 
1 vs.2=0.044 
3vs.4<0.001 
1vs.3=0.008 
2vs.4=0.05 
 
Interaction: F(1,44)=11.664 p=0.001 
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Table 4.8.1.2 Internal adipose tissue from males at 15 weeks old. Gonadal, 
retroperitoneal and mesenteric adipose tissues in grams (g)= and as percentages of 
body weight (%). IAT= internal adipose tissue as the sum of the aforementioned 
white adipose tissues in grams (g) and as percentage of body weight (%). Statistical 
analysis was performed using a 2x2 factorial ANOVA test followed by simple main 
effects analysis, as interactions were significant. Data presented as mean± SEM.  
 
 LBWm-NF1 LBWm-HF2 HBWm-NF3 HBWm-HF4 P value 
 
Gonadal 
(g) 
 
0.878 
±0.058 
 
1.192 
±0.056 
 
0.704 
±0.061 
 
1.291 
±0.05 
1 vs.2<0.001 
3vs.4<0.001 
1vs.3=0.046 
2vs.4=0.191 
Interaction: F(1,44)=5.838 p=0.02 
 
Gonadal 
(%) 
 
3.135 
±0.161 
 
3.928 
±0.154 
 
2.494 
±0.169 
 
4.079 
±0.138 
1 vs.2=0.001 
3vs.4<0.001 
1vs.3=0.009 
2vs.4=0.471 
Interaction: F(1,44)=6.43 p=0.015 
 
Retrop. 
(g) 
 
0.278 
±0.021 
 
0.302 
±0.021 
 
0.208 
±0.024 
 
0.414 
±0.019 
1 vs.2=0.437 
3vs.4<0.001 
1vs.3=0.034 
2vs.4<0.001 
Interaction: F(1,44)=17.845 p<0.001 
 
Retrop. 
(%) 
 
0.993 
±0.066 
 
1.009 
±0.059 
 
0.736 
±0.072 
 
1.302 
±0.059 
1 vs.2=0.86 
3vs.4<0.001 
1vs.3=0.012 
2vs.4=0.002 
Interaction: F(1,44)=17.311 p<0.001 
 
Mesent. 
(g) 
 
0.306 
±0.026 
 
0.354 
±0.025 
 
0.233 
±0.028 
 
0.397 
±0.023 
1 vs.2=0.188 
3vs.4<0.001 
1vs.3=0.062 
2vs.4=0.208 
Interaction: F(1,44)=5.196 p=0.027 
 
Mesent. 
(%) 
 
1.092 
±0.074 
 
1.164 
±0.071 
 
0.818 
±0.081 
 
1.246 
±0.066 
1 vs.2=0.486 
3vs.4<0.001 
1vs.3=0.016 
2vs.4=0.403 
Interaction: F(1,44)=5.891 p=0.019 
 
IAT 
(g) 
 
1.451 
±0.107 
 
1.815 
±0.099 
 
1.146 
±0.112 
 
2.102 
±0.092 
1 vs.2=0.016 
3vs.4<0.001 
1vs.3=0.056 
2vs.4=0.039 
Interaction: F(1,44)=8.301 p=0.006 
 
IAT 
(%) 
 
5.18 
±0.302 
 
 
5.982 
±0.278 
 
4.048 
±0.316 
 
6.627 
±0.258 
1 vs.2=0.057 
3vs.4<0.001 
1vs.3=0.013 
2vs.4=0.096 
Interaction: F(1,44)=9.416 p=0.004 
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Assessment of the internal to subcutaneous adipose tissue ratio showed an 
interaction between both birth weight and diet. Unexpectedly HBWm-NF had 
a higher ratio than HBWm-HF (p≤0.001; figure 4.8.1.3 and table 4.8.1.3), 
whilst differences between others groups did not reach significance. It was 
noticed that also in LBWm mice there was a similar trend as seen in the 
HBWm mice.  
 
 
Figure 4.8.1.3 Internal to subcutaneous adipose tissue ratio in male and female 
offspring at 15 weeks old. Statistical analysis was performed using a 2x2 factorial 
ANOVA test. Data presented as mean± SEM. LBWm-NF n=11; LBWm-HF n=14; 
HBWm-NF n=10, HBWm-HF n=15; LBWf-NF n=12; LBWf-HF n=13; HBWf-NF 
n=7, HBWf-HF n=8. ***p≤0.001. 
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Table 4.8.1.3 Internal to subcutaneous adipose tissue ratio of male offspring at 15 
weeks old. Statistical analysis was performed using a 2x2 factorial ANOVA test 
followed by simple main effects analysis, as interaction was significant. Data 
presented as mean± SEM. 
 
 
4.8.2 White adipose tissue mass in Females 
Contrary to males, there was a significant effect of both birth weight and diet 
on total WAT (g), SAT (g), retroperitoneal (g), mesenteric (g), gonadal fat (g), 
and IAT (g), and the interaction was not significant between variables, which 
suggested that both variables might affect adipose tissue mass 
independently one of each other. All the depots mentioned before were 
significantly higher in females fed a HF diet compared to female mice fed a 
NF diet, and at the same time, in those females with a high birth weight 
(HBWf) compared to females with a low birth weight (LBWf) (figure 4.8.2.1 
and tables 4.8.2.1 and 4.8.2.2).  
 
After normalisation to current body weight (relative body weight as 
percentage), significant differences were maintained when assessing 
SAT(%) (figure 4.8.2.2 and table 4.8.2.1), gonadal (%) and IAT (%) ( figure 
4.8.2.2 and table 4.8.2.2). However, main effect of birth weight was 
marginally significant after assessing total WAT (%) (p=0.086; figure 4.8.2.2 
 LBWm-NF1 LBWm-HF2 HBWm-NF3 HBWm-HF4 P value 
 
IAT:SAT 
 
 
1.21 
±0.037 
 
1.147 
±0.034 
 
1.315 
±0.04 
 
1.081 
±0.031 
1 vs.2=0.21 
3vs.4<0.001 
1vs.3=0.063 
2vs.4=0.158 
Interaction: F(1,44)=5.691 p=0.021 
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and tables 4.8.2.1) and retroperitoneal fat (%) (p=0.067; figure 4.8.2.2 and 
table 4.8.2.2). It was not significant for mesenteric (%) (p=0.152; figure 
4.8.2.2 and table 4.8.2.2). Moreover, the diet effect was maintained in these 
depots (total WAT(%): p<0.001; retroperitoneal (%): p=0.004; mesenteric 
(%): p<0.001; figure 4.8.2.2 and tables 4.8.2.1 and table 4.8.2.2). 
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Figure 4.8.2.1 White adipose tissue mass in grams from female and male mice at 
week 15. Total WAT= total white adipose tissue, SAT=subcutaneous adipose 
tissue, IAT= internal adipose tissue as the sum of gonadal, retroperitoneal and 
mesenteric fat depots. Statistical analysis was performed using a 2x2 factorial 
ANOVA test. Data presented as mean± SEM. Significant main effect of diet in a) +: 
*p≤0.05,** p≤0.01, ***p≤0.001. Main effect of birth weight represented with different 
letters in a). LBWf-NF n=12; LBWf-HF n=13; HBWf-NF n=7, HBWf-HF n=8. Dotted 
line in b)= for significant differences between mice fed a NF diet and mice fed a HF 
diet having the same birth weight. Continuous line in b)= for significant differences 
between LBWm mice and HBWm mice having the same diet. LBWm-NF n=11; 
LBWm-HF n=14; HBWm-NF n=10, HBWm-HF n=15. 
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Figure 4.8.2.2 White adipose tissue mass as percentage (%) from female and male 
mice at week 15. Statistical analysis was performed using a 2x2 factorial ANOVA 
test. Data presented as mean± SEM. Significant main effect of diet in a) +: 
*p≤0.05,** p≤0.01, ***p≤0.001. Main effect of birth weight represented with different 
letters in a). LBWf-NF n=12; LBWf-HF n=13; HBWf-NF n=7, HBWf-HF n=8. Dotted 
line in b)= for significant differences between mice fed a NF diet and mice fed a HF 
diet having the same birth weight. Continuous line in b)= for significant differences 
between LBWm mice and HBWm mice having the same diet. LBWm-NF n=11; 
LBWm-HF n=14; HBWm-NF n=10, HBWm-HF n=15. 
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Table 4.8.2.1 Total white adipose tissue and subcutaneous adipose tissue from 
females at 15 weeks old. Total WAT (g)= total white adipose tissue; Total WAT 
(%)= total white adipose tissue as percentage of body weight. SAT (g)= 
subcutaneous adipose tissue in grams; SAT (%)= subcutaneous adipose tissue as 
percentage of body weight.  Statistical analysis was performed using a 2x2 factorial 
ANOVA test followed by simple main effects analysis, as interactions were 
significant. Data presented as mean± SEM. 
 
 LBWf-NF1 LBWf-HF2 HBWf-NF3 HBWf-HF4 
 
Total WAT 
(g) 
 
1.465 
±0.163 
 
2.372 
±0.156 
 
1.851 
±0.213 
 
2.801 
±0.199 
 
Birth weight: F(1,36)=4.865 p=0.034; diet: F(1,36)=25.138 p<0.001;  
interaction: F(1,36)=0.014 p=0.907 
 
Total WAT 
(%) 
 
7.427 
±0.608 
 
10.646 
±0.584 
 
8.795 
±0.796 
 
11.708 
±0.744 
 
Birth weight: F(1,36)=3.115 p=0.086; diet: F(1,36)=19.821 p<0.001; 
interaction: F(1,36)=0.049 p=0.825 
 
SAT 
(g) 
 
0.813 
±0.104 
 
1.217 
±0.1 
 
1.046 
±0.136 
 
1.567 
±0.127 
Birth weight:  F(1,36)=6.153 p=0.018; diet: F(1,36)=15.475 p<0.001;  
interaction: F(1,36)=0.246 p=0.623 
 
SAT 
(%) 
 
4.124 
±0.415 
 
5.457 
±0.399 
 
4.918 
±0.543 
 
6.556 
±0.508 
 
Birth weight:  F(1,36)=4.053 p=0.05; diet: F(1,36)=9.98 p=0.003;  
interaction: F(1,36)=0.105 p=0.748 
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Table 4.8.2.2 Internal adipose tissue from females at 15 weeks old. Gonadal, 
retroperitoneal and mesenteric adipose tissues in grams (g)= and as percentages of 
body weight (%). IAT= internal adipose tissue as the sum of the aforementioned 
white adipose tissues in grams (g) and as percentage of body weight (%). Analysis 
was performed using a 2x2 factorial ANOVA. Data presented as mean± SEM.  
 LBWf-NF1 LBWf-HF2 HBWf-NF3 HBWf-HF4 
 
Gonadal 
(g) 
 
0.328 
±0.043 
 
0.477 
±0.041 
 
0.438 
±0.056 
 
0.609 
±0.052 
 
Birth weight: F(1,36)=6.2 p=0.018; diet: F(1,36)=10.857 p=0.002;  
interaction: F(1,36)=0.051 p=0.822 
 
Gonadal 
(%) 
 
1.665 
±0.171 
 
2.134 
±0.165 
 
2.047 
±0.224 
 
2.545 
±0.21 
 
Birth weight:  F(1,36)=4.167 p=0.049; diet: F(1,36)=6.201 p=0.018; 
interaction: F(1,36)=0.006 p=0.94 
 
Retrop. 
(g) 
 
0.181 
±0.026 
 
0.266 
±0.025 
 
0.228 
±0.034 
 
0.352 
±0.032 
Birth weight: F(1,36)=5.14 p=0.029; diet: F(1,36)=12.647 p=0.001;  
interaction: F(1,36)=0.436 p=0.513 
 
Retrop. 
(%) 
 
0.913 
±0.098 
 
1.187 
±0.094 
 
1.06 
±0.128 
 
1.46 
±0.12 
 
Birth weight:  F(1,36)=3.572 p=0.067; diet: F(1,36)=9.222 p=0.004;  
interaction: F(1,36)=0.323 p=0.573 
 
Mesent. 
(g) 
 
0.143 
±0.018 
 
0.242 
±0.017 
 
0.192 
±0.023 
 
0.274 
±0.022 
 
Birth weight: F(1,36)=4.174 p=0.048; diet: F(1,36)=20.715 p<0.001;  
interaction: F(1,36)=0.17 p=0.682 
 
Mesent. 
(%) 
 
0.725 
±0.069 
 
1.09 
±0.066 
 
0.896 
±0.09 
 
1.147 
±0.084 
Birth weight: F(1,36)=2.14 p=0.152; diet: F(1,36)=15.515 p<0.001;  
interaction: F(1,36)=0.535 p=0.469 
 
IAT 
(g) 
 
0.652 
±0.077 
 
0.985 
±0.074 
 
0.858 
±0.101 
 
1.235 
±0.095 
 
Birth weight: F(1,36)=6.765 p=0.013; diet: F(1,36)=16.397 p<0.001; 
interaction: F(1,36)=0.064 p=0.802 
 
IAT 
(%) 
 
5.18 
±0.302 
 
 
5.982 
±0.278 
 
4.048 
±0.316 
 
6.627 
±0.258 
Birth weight:  F(1,36)=4.925 p=0.033; diet: F(1,36)=12.077 p=0.001; 
interaction: F(1,36)=0.004 p=0.949 
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Internal to subcutaneous adipose tissue ratio was not significantly affected 
by birth weight or diet, and there was not interaction between both. Contrary 
to males, the differences tended to be higher in males fed a HF diet and in 
LBWf mice (figures 4.8.1.3 and 4.8.2.3 and tables 4.8.1.3 and table 4.8.2.3). 
 
 
 
Figure 4.8.2.3 Internal to subcutaneous adipose tissue ratio of female and male 
offspring at 15 weeks old. Statistical analysis was performed using a 2x2 factorial 
ANOVA test. Figure a) corresponds to males and figure b) to females. Data 
presented as mean± SEM. LBWf-NF n=12; LBWf-HF n=13; HBWf-NF n=7, HBWf-
HF n=8; LBWm-NF n=11; LBWm-HF n=14; HBWm-NF n=10, HBWm-HF n=15. 
***p≤0.001. 
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Table 4.8.2.3 Internal to subcutaneous adipose tissue ratio of female offspring at 15 
weeks old. Statistical analysis was performed using a 2x2 factorial ANOVA test 
followed by simple main effects analysis, as interaction was significant. Data 
presented as mean± SEM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 LBWf-NF1 LBWf-HF2 HBWf-NF3 HBWf-HF4 
 
IAT:SAT 
 
 
0.775 
±0.033 
 
0.817 
±0.03 
 
0.757 
±0.045 
 
0.793 
±0.039 
 
Birth weight:  F(1,36)=0.324 p=0.573; diet: F(1,36)=1.1 p=0.302; 
Interaction: F(1,36)=0.006 p=0.941 
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4.9 Adipocyte Size Distribution in White Adipose Tissue 	  
Subcutaneous and gonadal adipose tissue from male mice (only) were 
collected and processed as described in section 2.4.6. Total adipocyte 
number was analysed as per gram of tissue extracted and per total fat depot.  
 
Assessment of adipocyte number per gram of tissue showed comparable 
levels between groups (figure 4.9.1a). However, a significant interaction 
between both birth weight and diet was found when evaluating adipocyte 
number per fat depots (F(1,39)=4.921 p=0.032; figure 4.9.1b). HBWm-HF 
had a higher number of adipocytes when compared to HBWm-NF mice 
(p=0.008). Although LBWm-NF had a higher number of adipocytes than 
HBWm-NF, the difference did not reach statistical significance (p=0.144). An 
opposite trend was found between mice fed a HF diet, with LBWm-HF 
having a lower cell number than HBWm-HF but again, the difference was not 
significant (p=0.102).  
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Figure 4.9.1 Adipocyte number in gonadal adipose tissue from male mice at week 
15. Cell number expressed as per gram of tissue extracted (adipocyte number/gram 
tissue) a), and multiply by the amount of total gonadal tissue per mouse per group 
b). Statistical analysis was performed using a 2x2 factorial ANOVA test followed by 
a simple main effect analysis, as the interaction was significant between variables. 
Data presented as mean± SEM. LBWm-NF n=10; LBWm-HF n=12; HBWm-NF 
n=8, HBWm-HF n=13. * p≤0.05, ** p≤0.01.  
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Evaluation of subcutaneous adipose tissue per gram showed no differences 
between groups (figure 4.9.2a); but as in gonadal fat tissue, the total number 
of adipocytes per total fat depots were affected by birth weight and diet 
(F(1,42)=5.481 p=0.024; figure 4.9.2b). Differences between HBWm mice 
were significantly different, as in gonadal, with a higher adipocyte number in 
HBWm-HF mice compared to HBWm-NF mice (p<0.001). Furthermore, 
HBWm-HF mice had a significantly higher cell number than LBWm-HF mice 
(p=0.036). Comparable differences were found between mice fed a NF diet 
(p=0.231) or between LBWm mice (p=0.252).  
 
 
Figure 4.9.2 Adipocyte number in subcutaneous adipose tissue from male mice. 
Adipocyte number expressed as per gram of tissue extracted (cell number/gram 
tissue) a), and multiply by the amount of total gonadal tissue per mouse per group 
b). Statistical analysis was performed using a 2x2 factorial ANOVA test followed by 
a simple main effect analysis, as the interaction was significant between variables. 
Data presented as mean± SEM. LBWm-NF n=11; LBWm-HF n=13; HBWm-NF 
n=9, HBWm-HF n=13. * p≤0.05, ** p≤0.01.  
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After assessing adipocyte number in both gonadal and subcutaneous 
adipose tissue, an analysis of the relative frequency of adipocyte size 
distribution (%) was performed in order to see whether there was any 
difference in size between groups.  
 
There was a general bimodal distribution (two separated populations) of 
adipocytes in all groups when assessing both adipose tissues (figure 
4.7.1.1.3). The nadir, which is the lowest point in frequency, (i.e. where the 
curve between two populations was flat, the midpoint was designated the 
nadir) was used as the cut point between two cell populations, small and 
large adipocytes. The percentages of adipocytes below the nadir were 
designated as “small adipocytes” and above the nadir as the “large 
adipocytes”.  
 
There was a significant main effect of birth weight on the amount of small 
adipocytes in gonadal fat, with LBWm mice having a higher number of small 
adipocytes compared to HBWm mice (F(1,39)=7.312 p=0.01; figure 4.9.3 
and table 4.9.1). The main effect of birth weight in large adipocytes was 
HBWm mice having larger adipocytes than LBWm mice (F(1,40)=6.074 
p=0.018; figure 4.9.3 and table 4.9.1).  
 
The small to large adipocytes ratio confirmed the results above, as it was 
significantly affected by birth weight, with the LBWm mice having a higher 
ratio compared to HBWm mice (F(1,39)=11.48 p=0.002; table 4.9.1).  
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The peak diameter of large adipocytes, defined as the mean diameter at 
which frequency of the large adipocytes reached a maximum, was shifted to 
the right in HBWm-HF mice compared to HBWm-NF mice (p=0.001; figure 
4.9.3b and table 4.9.1). However, a comparable difference was seen 
between LBWm mice (p=0.479; figure 4.9.3a and table 4.9.1). There were 
not significant differences between mice fed a NF diet (p=0.078) or mice fed 
a HF diet (p=0.169; figure 4.9.3c-d and table 4.9.1). 
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Figure 4.9.3 Frequency distribution (%) of adipocytes extracted from gonadal 
adipose tissue from male mice at 15 weeks. Arrowheads indicate the nadir of each 
group, which corresponds to the lowest point between two populations of 
adipocytes (small-large adipocytes). Headless arrows indicate the peak diameter of 
large cells in each group. Statistical analysis was performed using a Kruskal-Wallis 
test followed by a Mann-Whitney test for range analysis. Data presented as median 
with interquartile range (25%-75%). LBWm-NF n=9-11; LBWm-HF n=13-14; 
HBWm-NF n=8-9, HBWm-HF n=13-14.  * p≤0.05,**p≤0.01. 
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Table 4.9.1 Frequency distribution (%) of adipocytes extracted from gonadal 
adipose tissue from male mice at 15 weeks. Nadir was the lowest point (cut off 
point) that separated two cell populations (small and large adipocytes).  Statistical 
analysis was performed using a 2x2 factorial ANOVA. Interaction was significant for 
the analysis of large peak (F(1,42)=5.208 p=0.02), and therefore a simple main 
effect analysis was performed. Data presented as mean±SEM. LBWm-NF n=9-11; 
LBWm-HF n=13-14; HBWm-NF n=8-9, HBWm-HF n=13-14.  * p≤0.05,**p≤0.01. 
 
 
 
 
 LBWm-NF1 LBWm-HF2 HBWm-NF3 HBWm-HF4 P value 
 
Nadir (um) 
 
56.818 
±2.482 
 
 
54.231 
±2.283 
 
 
50 
±2.911 
 
 
59.615 
±2.283 
 
 
 
Below nadir 
(small 
adipocytes) 
% 
 
52.728 
±5.329 
 
46.318 
±4.674 
 
38.176 
±5.618 
 
31.23 
±5.329 
Birth weight 
effect: 
p=0.01 
Diet effect: 
p=0.167 
Interaction: 
p=0.936 
Above nadir 
(large 
adipocytes) 
% 
46.955 
±5.187 
 
50.69 
±4.598 
57.75 
±5.735 
65.807 
±5.441 
Birth weight  
effect: 
p=0.018 
Diet effect: 
p=0.269 
Interaction: 
p=0.683 
Large peak 
(um) 
85 
±2.246 
 
87.143 
±1.991 
 
78.75 
±2.634 
 
91.154 
±2.066 
 
1 vs.2=0.479 
3vs.4=0.001 
1vs.3=0.078 
2vs.4=0.169 
Small:large 
adipocytes 
ratio 
1.632 
±0.252 
 
1.105 
±0.202 
 
0.603 
0.267 
0.502 
±0.239 
 
Birth weight  
effect: 
p=0.002 
Diet effect: 
p=0.201 
Interaction: 
p=0.381 
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There was a general bimodal distribution on subcutaneous adipose cells as 
in gonadal adipose cells (figure 4.9.4). There was not a significant difference 
in small or large adipocytes percentages, or in their ratio (table 4.9.2). 
However, when assessing the distribution of cells by range, there was a 
significant shift towards the right in the HBWm-HF group in respect to 
HBWm-NF group, with a higher frequency of adipocytes between 80-120µm 
(figure 4.9.4b). The difference between mice fed a HF diet was significant 
between 90-110 µm with a higher frequency of adipocytes in the HBWm-HF 
group in respect to LBWm-HF group (figure 4.9.4d). There was a significant 
higher percentage of adipocytes between 90-100µm in LBWm-NF mice 
compared to HBWm-NF mice (figure 4.9.4a); but a comparable difference 
between LBWm mice was seen (4.9.4c).  
 
Differences in the peak diameter of large adipocytes showed the same right 
shift of the HBWm-HF group when compared to HBWm-NF (p<0.001; figure 
4.9.4b and table 4.9.2) and to LBWm- HF groups (p<0.001; figure 4.9.4d ant 
table 4.9.2). However, the peak diameter of large adipocytes was not 
significantly different between mice fed a NF diet (p=0.155; figure 4.9.4c and 
table 4.9.2) or between LBWm mice (p=0.787; figure 4.9.4 and table 4.9.2).  
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Figure 4.9.4 Frequency distribution (%) of adipocytes extracted from subcutaneous 
adipose tissue from male mice at 15 weeks. Arrowheads indicate the nadir of each 
group, which corresponds to the lowest point between two populations of cells 
(small-large adipocytes). Headless arrows indicate the peak diameter of large 
adipocytes in each group. Statistical analysis was performed using a Kruskal-Wallis 
test followed by a Mann-Whitney test for range analysis. Data presented as median 
with interquartile range (25%-75%). LBWm-NF n=9-11; LBWm-HF n=13-14; 
HBWm-NF n=8-9, HBWm-HF n=13-14.  * p≤0.05,**p≤0.01. 
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Table 4.9.2 Frequency distribution (%) of adipocytes extracted from subcutaneous 
adipose tissue from male mice at 15 weeks. Nadir was the lowest point (cut off 
point) that separated two adipocyte populations (small and large adipocytes).  
Statistical analysis was performed using a 2x2 factorial ANOVA. Interaction was 
significant for the analysis of large peak (F(1,44)=57.1 p=0.011), and therefore a 
simple main effect analysis was performed. Data presented as mean± SEM. 
LBWm-NF n=9-11; LBWm-HF n=13-14; HBWm-NF n=8-9, HBWm-HF n=13-14. 
* p≤0.05,**p≤0.01. 
 
 
 LBWm-NF1 LBWm-HF2 HBWm-NF3 HBWm-HF4 P value 
 
Nadir (um) 
 
45 
±1.85 
 
 
48.571 
±1.483 
 
 
44.091 
±1.673 
 
 
50.714 
±1.483 
 
 
 
Below nadir 
(small 
adipocytes) 
% 
 
41.873 
±4.821 
 
44.498 
±4.273 
 
41.497 
±5.33 
 
44.156 
±4.273 
Birth weight 
effect: 
p=0.939 
Diet effect: 
p=0.576 
Interaction: 
p=0.997 
Above nadir 
(large 
adipocytes) 
% 
51.08 
±4.945 
 
51.75 
±4.195 
45.698 
±4.56 
49.054 
±4.042 
Birth weight 
effect: 
p=0.618 
Diet effect: 
p=0.945 
Interaction: 
p=0.519 
Large peak 
(um) 
68 
±2.412 
 
67.143 
±2.038 
 
63.182 
±2.299 
 
80.833 
±2.202 
 
1 vs.2=0.787 
3vs.4<0.001 
1vs.3=0.155 
2vs.4<0.001 
Small:large 
adipocytes 
ratio 
0.771 
±0.953 
 
0.985 
±0.18 
 
0.837 
±0.216 
 
1.058 
±0.18 
 
Birth weight 
effect: 
p=0.722 
Diet effect: 
p=0.273 
Interaction: 
p=0.986 
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Comparison of gonadal and subcutaneous adipocytes distribution within 
groups showed that LBWm mice gonadal adipocytes had a shift to the right 
(larger adipocytes) in respect to subcutaneous adipocytes with a significance 
difference between peaks of the large adipocytes (LBWm-NF: p=0.001; 
LBWm-HF: p<0.001; figure 4.9.5a-b and tables 4.9.1 and 4.9.2). Although 
the shift was less evident in HBWm mice (as seen in the figure below), it was 
however significantly different with a higher peak of large adipocytes in 
gonadal adipocytes than subcutaneous adipose cells (HBWm-NF: p<0.001; 
HBWm-HF: p=0.002; figure 4.9.5c-d and tables 4.9.1 and 4.9.2). 
 
Small adipocytes were significantly higher in subcutaneous adipose tissue 
compared to gonadal fat of HBWm-HF mice (p=0.037; figure 4.9.5d and 
tables 4.9.1 and 4.9.2). However, comparable differences were seen within 
others groups. Furthermore, the large adipocytes were significantly higher in 
gonadal than subcutaneous tissue of HBWm-HF mice (p=0.018; figure 
4.9.5d and tables 4.9.1 and 4.9.2). 
 
The small to large adipocytes ratio was significantly higher from gonadal 
tissue of LBWm-NF mice (p=0.031; figure 4.9.5a and tables 4.9.1 and 4.9.2). 
Significant difference was also seen in the ratio of HBWm-HF mice, but with 
an opposite trend: the highest ratio was seen in subcutaneous adipose 
tissue rather than gonadal. There were not significant differences within 
others groups.  
 
 
	   356	  
 
 
Figure 4.9.5 Frequency distribution (%) of adipocytes extracted from gonadal and 
subcutaneous adipose tissue from male mice at 15 weeks. Arrowheads indicate the 
nadir of each group, which corresponds to the lowest point between two populations 
of adipocytes (small-large adipocytes). Headless arrows indicate the peak diameter 
of large adipcoytes in each group. g= gonadal fat tissue, sub=subcutaneous 
adipose tissue. Statistical analysis was performed using a Kruskal-Wallis test 
followed by a Mann-Whitney test for range analysis. Data presented as median with 
interquartile range (25%-75%). LBWm-NF n=9-11; LBWm-HF n=13-14; HBWm-NF 
n=8-9, HBWm-HF n=13-14.  * p≤0.05,**p≤0.01. 
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4.10 The Effects of Birth Weight and Diet on Hypothalamic 
Activation in Young Mice at Week 15 
 
Neural activity in specific hypothalamic appetite centres was measured by 
using Manganese Enhancement (MEMRI), as described in section 2.4.2. 
Neural activity was analysed by measuring changes in Signal Intensities (SI), 
which were normalised and presented as normalised percentage 
enhancement (NPE). NPE were analysed in four hypothalamic centres: 
arcuate nucleus (ARC), paraventricular nucleus (PVN), ventromedial 
hypothalamus (VMH) and periventricular nucleus (Pe).  
 
4.10.1 Hypothalamic activity in Males 
Figures 4.10.1 and 4.10.2 showed the neural activity (NPE) within the ARC 
nucleus. Activity did not show a similar pattern between mice within the same 
birth weight category or fed the same diet. This suggested a possible 
dependency of activity on both factors. LBWm-HF had a significantly lower 
activity than LBWm-NF (p=0.002; figures 4.10.1.1 and 4.10.1.2a). However, 
the pattern was different between HBWm mice, with a higher neural activity 
in HBWm-HF mice compared to HBWm-NF mice, but the difference was not 
significantly different (p=0.11; figures 4.10.1.1 and 4.10.1.2b). Furthermore, 
there was a significant difference between mice fed a HF diet, with a higher 
activity in HBWm-HF mice compared to LBWm-HF mice (p<0.001; figures 
4.10.1.1 and 4.10.1.2d). Comparable difference was seen between mice fed 
a NF diet (p=0.44; figures 4.10.1.1 and 4.10.1.2c).	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Figure 4.10.1.1 Neural activity measured within the hypothalamic ARC nucleus in 
male and female offspring at 15 weeks. Neural activity was analysed by measuring 
time course changes in SIs and presented as normalised percentage enhancement 
(NPE %) from the ARC nucleus within the hypothalamus. The arrow indicates the 
start of intravenous (i.v.) MnCl2 infusion and the hatched bars indicate the duration 
of the i.v. infusion. Figure a) corresponds to males and figure b) to females. 
Statistical analysis was performed using a general estimated equation (GEE) test. 
Data presented as mean±SEM. LBWm-NF n=5; LBWm-HF n=5; HBWm-NF n=5, 
HBWm-HF n=5; LBWf-NF n=4; LBWf-HF n=3; HBWf-NF n=4, HBWf-HF n=3.   
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Figure 4.10.1.2 Neural activity measured within the hypothalamic ARC nucleus in 
male offspring at 15 weeks. Neural activity was analysed by measuring time course 
changes in SIs and presented as normalised percentage enhancement (NPE %) 
from the ARC nucleus within the hypothalamus. Figures a) and b) show the time 
course activity by diets (NF-HF respectively) in mice within the same birth weight 
category. Figure c) and d) show the time course activity by birth weight (LBWm-
HBWm respectively) in mice within the same diet category. The arrow indicates the 
start of intravenous (i.v.) MnCl2 infusion and the hatched bars indicate the duration 
of the i.v. infusion. Statistical analysis was performed using a general estimated 
equation (GEE) test. Data presented as mean± SEM. LBWm-NF n=5; LBWm-HF 
n=5; HBWm-NF n=5, HBWm-HF n=5.   
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Neural activity within the PVN, VMH and Pe nuclei showed, as in the ARC 
nucleus, a possible dependency of activity on the different levels of each 
factor.  
 
In the PVN nucleus, LBWm-NF has a significantly higher activity than both, 
LBWm-HF mice (p<0.001; figures 4.10.1.3 and 4.10.1.4a) and HBWm-NF 
mice; figures 4.10.1.3 and 4.10.1.4c). Similarly, HBWm-HF had a higher 
activity than HBWm-NF mice (p=0.03; figures 4.10.1.3 and 4.10.1.4b), and 
LBWm-HF mice (p<0.001; figures 4.10.1.3 and 4.10.1.4d). 
 
 
 
 
 
 
 
 
 
 
	   361	  
 
Figure 4.10.1.3 Neural activity measured within the hypothalamic PVN nucleus in 
male and female offspring at 15 weeks. Neural activity was analysed by measuring 
time course changes in SIs and presented as normalised percentage enhancement 
(NPE %) from the PVN nucleus within the hypothalamus. The arrow indicates the 
start of intravenous (i.v.) MnCl2 infusion and the hatched bars indicate the duration 
of the i.v. infusion. Figure a) corresponds to males and figure b) to females. 
Statistical analysis was performed using a general estimated equation (GEE) test. 
Data presented as mean± SEM. LBWm-NF n=5; LBWm-HF n=5; HBWm-NF n=5, 
HBWm-HF n=5; LBWf-NF n=4; LBWf-HF n=3; HBWf-NF n=4, HBWf-HF n=3.   
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Figure 4.10.1.4 Neural activity measured within the hypothalamic PVN nucleus in 
male offspring at 15 weeks. Neural activity was analysed by measuring time course 
changes in SIs and presented as normalised percentage enhancement (NPE %) 
from the PVN nucleus within the hypothalamus. Figures a) and b) show the time 
course activity by diets (NF-HF respectively) in mice within the same birth weight 
category. Figure c) and d) show the time course activity by birth weight (LBWm-
HBWm respectively) in mice within the same diet category.  The arrow indicates the 
start of intravenous (i.v.) MnCl2 infusion and the hatched bars indicate the duration 
of the i.v. infusion. Statistical analysis was performed using a general estimated 
equation (GEE) test. Data presented as mean± SEM. LBWm-NF n=5; LBWm-HF 
n=5; HBWm-NF n=5, HBWm-HF n=5.   
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In the VMH nucleus, LBWm-NF and HBWm-HF maintained a significantly 
higher activity and pattern compared to their counterparts as in the PVN 
(figures 4.10.1.5 and 4.10.1.6). LBWm-NF and HBWm-HF mice had a 
significantly higher NPE than LBWm-HF mice.  
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Figure 4.10.1.5 Neural activity measured within the hypothalamic VMH nucleus in 
male and female offspring at 15 weeks. Neural activity was analysed by measuring 
time course changes in SIs and presented as normalised percentage enhancement 
(NPE %) from the VMH nucleus within the hypothalamus. The arrow indicates the 
start of intravenous (i.v.) MnCl2 infusion and the hatched bars indicate the duration 
of the i.v. infusion. Figure a) corresponds to males and figure b) to females. 
Statistical analysis was performed using a general estimated equation (GEE) test. 
Data presented as mean± SEM. LBWm-NF n=5; LBWm-HF n=5; HBWm-NF n=5, 
HBWm-HF n=5; LBWf-NF n=4; LBWf-HF n=3; HBWf-NF n=4, HBWf-HF n=3.   
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Figure 4.10.1.6 Neural activity measured within the hypothalamic VMH nucleus in 
male offspring at 15 weeks. Neural activity was analysed by measuring time course 
changes in SIs and presented as normalised percentage enhancement (NPE %) 
from the VMH nucleus within the hypothalamus. Figures a) and b) show the time 
course activity by diets (NF-HF respectively) in mice within the same birth weight 
category. Figure c) and d) show the time course activity by birth weight (LBWm-
HBWm respectively) in mice within the same diet category. The arrow indicates the 
start of intravenous (i.v.) MnCl2 infusion and the hatched bars indicate the duration 
of the i.v. infusion. Statistical analysis was performed using a general estimated 
equation (GEE) test. Data presented as mean± SEM. LBWm-NF n=5; LBWm-HF 
n=5; HBWm-NF n=5, HBWm-HF n=5.   
 
	   366	  
In the Pe nucleus, male groups showed significant differences between 
LBWm mice with the highest activity in LBWm-NF mice  (p<0.001; figures 
4.10.1.7 and 4.10.1.8a) and mice fed a HF with HBWm-HF having a higher 
NPE than LBWm-HF mice (p<0.001; figure 4.10.1.7 and 4.10.1.8b), but no 
between mice fed a NF diet (p=0.14; figures 4.10.1.7 and 4.10.1.8c).  The 
difference between HBWm mice was marginally significant (p=0.08; figures 
4.10.1.7 and 4.10.1.8b).   
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Figure 4.10.1.7 Neural activity measured within the hypothalamic Pe nucleus in 
male and female offspring at 15 weeks. Neural activity was analysed by measuring 
time course changes in SIs and presented as normalised percentage enhancement 
(NPE %) from the Pe nucleus within the hypothalamus. The arrow indicates the 
start of intravenous (i.v.) MnCl2 infusion and the hatched bars indicate the duration 
of the i.v. infusion. Figure a) corresponds to males and figure b) to females. 
Statistical analysis was performed using a general estimated equation (GEE) test. 
Data presented as mean± SEM. LBWm-NF n=5; LBWm-HF n=5; HBWm-NF n=5, 
HBWm-HF n=5; LBWf-NF n=4; LBWf-HF n=3; HBWf-NF n=4, HBWf-HF n=3.   
	   368	  
	  	  	  
 
Figure 4.10.1.8 Neural activity measured within the hypothalamic Pe nucleus in 
male offspring at 15 weeks. Neural activity was analysed by measuring time course 
changes in SIs and presented as normalised percentage enhancement (NPE %) 
from the Pe nucleus within the hypothalamus. Figures a) and b) show the time 
course activity by diets (NF-HF respectively) in mice within the same birth weight 
category. Figure c) and d) show the time course activity by birth weight (LBWm-
HBWm respectively) in mice within the same diet category. The arrow indicates the 
start of intravenous (i.v.) MnCl2 infusion and the hatched bars indicate the duration 
of the i.v. infusion. Statistical analysis was performed using a general estimated 
equation (GEE) test. Data presented as mean± SEM. LBWm-NF n=5; LBWm-HF 
n=5; HBWm-NF n=5, HBWm-HF n=5.   
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4.10.2 Hypothalamic activity in Females 
 As in males, regional hypothalamic activation was different between 
depending on both birth weight and diet, but it did not seem to have 
independent factor effects. However, the patterns seen in female groups in 
all nuclei were contrary to the ones seen in their male counterparts.  
 
In the ARC nucleus, there was a significant difference between LBWf mice, 
with LBWf-HF having a higher NPE (activity) than LBWf-NF mice (p<0.001; 
figures 4.10.2.1 and 4.10.2.2a), whilst the opposite was observed between 
their male counterparts (figures 4.10.1.1 and 4.10.1.2a). HBWf-HF mice had 
a lower activity than HBWm-NF mice but the difference did not reach 
significance (p=0.69; figures 4.10.2.1 and 4.10.2.2b). Furthermore, LBWf-NF 
mice had a significantly lower activity when compared to HBWf-NF mice 
(p=0.03; figures 410.2.1 and 4.10.2.2c), which was also contrary to the 
pattern seen in their male counterparts  (figures 4.10.1.1 and 4.10.1.2c). 
LBWf-HF had a higher activity than HBWf-HF mice but the difference was 
not significant (p=0.19; figures 4.10.2.1 and 4.10.2.2d), whilst the pattern in 
males was opposite and significant (figures 4.10.1.1 and 4.10.1.2d).  
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Figure 4.10.2.1 Neural activity measured within the hypothalamic ARC nucleus in 
female and male offspring at 15 weeks. Neural activity was analysed by measuring 
time course changes in SIs and presented as normalised percentage enhancement 
(NPE %) from the ARC nucleus within the hypothalamus. The arrow indicates the 
start of intravenous (i.v.) MnCl2 infusion and the hatched bars indicate the duration 
of the i.v. infusion. Figure a) corresponds to females and figure b) to males. 
Statistical analysis was performed using a general estimated equation (GEE) test. 
Data presented as mean± SEM. LBWf-NF n=4; LBWf-HF n=3; HBWf-NF n=4, 
HBWf-HF n=3; LBWm-NF n=5; LBWm-HF n=5; HBWm-NF n=5, HBWm-HF n=5.  
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Figure 4.10.2.2 Neural activity measured within the hypothalamic ARC nucleus in 
female offspring at 15 weeks. Neural activity was analysed by measuring time 
course changes in SIs and presented as normalised percentage enhancement 
(NPE %) from the ARC nucleus within the hypothalamus. Figures a) and b) show 
the time course activity by diets (NF-HF respectively) in mice within the same birth 
weight category. Figure c) and d) show the time course activity by birth weight 
(LBWm-HBWm respectively) in mice within the same diet category. The arrow 
indicates the start of intravenous (i.v.) MnCl2 infusion and the hatched bars indicate 
the duration of the i.v. infusion. Statistical analysis was performed using a general 
estimated equation (GEE) test. Data presented as mean± SEM. LBWf-NF n=4; 
LBWf-HF n=3; HBWf-NF n=4, HBWf-HF n=3.   
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Similarly, the activity in the PVN was significantly higher in LBWf-HF mice 
compared to LBWf-NF (p=0.02; figures 4.10.2.3 and 4.10.2.4a), and in 
HBWf-NF mice in respect to LBWf-NF mice. However, the difference was 
not significantly different between HBWf mice as in the ARC nucleus 
(p=0.69; figures 4.10.2.3 and 4.10.2.4b). Male mice had again an opposite 
activity in respect to female groups (figures 4.10.1.3 and 4.10.1.4).  
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Figure 4.10.2.3 Neural activity measured within the hypothalamic PVN nucleus in 
female and male offspring at 15 weeks. Neural activity was analysed by measuring 
time course changes in SIs and presented as normalised percentage enhancement 
(NPE %) from the PVN nucleus within the hypothalamus. The arrow indicates the 
start of intravenous (i.v.) MnCl2 infusion and the hatched bars indicate the duration 
of the i.v. infusion. Figure a) corresponds to females and figure b) to males. 
Statistical analysis was performed using a general estimated equation (GEE) test. 
Data presented as mean± SEM. LBWf-NF n=4; LBWf-HF n=3; HBWf-NF n=4, 
HBWf-HF n=3; LBWm-NF n=5; LBWm-HF n=5; HBWm-NF n=5, HBWm-HF n=5.   
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Figure 4.10.2.4 Neural activity measured within the hypothalamic PVN nucleus in 
female offspring at 15 weeks. Neural activity was analysed by measuring time 
course changes in SIs and presented as normalised percentage enhancement 
(NPE %) from the PVN nucleus within the hypothalamus. Figures a) and b) show 
the time course activity by diets (NF-HF respectively) in mice within the same birth 
weight category. Figure c) and d) show the time course activity by birth weight 
(LBWm-HBWm respectively) in mice within the same diet category.  The arrow 
indicates the start of intravenous (i.v.) MnCl2 infusion and the hatched bars indicate 
the duration of the i.v. infusion. Statistical analysis was performed using a general 
estimated equation (GEE) test. Data presented as mean± SEM. LBWf-NF n=4; 
LBWf-HF n=3; HBWf-NF n=4, HBWf-HF n=3.   
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In the VMH and Pe nuclei, the only significant difference seen was 
between LBWf mice, with the highest activity in LBWf-HF mice (p=0.009 
and p=0.03 respectively; figures 4.10.2.5, 4.10.2.6a, 4.10.2.7 and 
4.10.2.8a). However, HBWf-NF mice activity tended to be higher than in 
both HBWf-HF and LBWf-NF mice (VMH: p=0.77 and p=0.47 
respectively; Pe: p=0.91 and 0.26 respectively; figures 4.10.2.5, 
4.10.2.6b-c, 4.10.2.7 and 4.10.2.8b-c). Similarly, LBWf-HF tended to be 
higher than HBWf-HF mice (p=0.36; figures 4.10.2.5, 4.10.2.6d, 4.10.2.7 
and 4.10.2.8d). Again, the patterns seen in male mice were different 
compared to their female counterparts (figures 4.10.1.5  and   
4.10.1.6). 
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Figure 4.10.2.5 Neural activity measured within the hypothalamic VMH nucleus in 
female and male offspring at 15 weeks. Neural activity was analysed by measuring 
time course changes in SIs and presented as normalised percentage enhancement 
(NPE %) from the VMH nucleus within the hypothalamus. The arrow indicates the 
start of intravenous (i.v.) MnCl2 infusion and the hatched bars indicate the duration 
of the i.v. infusion. Figure a) corresponds to females and figure b) to males. 
Statistical analysis was performed using a general estimated equation (GEE) test. 
Data presented as mean± SEM. LBWf-NF n=4; LBWf-HF n=3; HBWf-NF n=4, 
HBWf-HF n=3; LBWm-NF n=5; LBWm-HF n=5; HBWm-NF n=5, HBWm-HF n=5. 
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Figure 4.10.2.6 Neural activity measured within the hypothalamic VMH nucleus in 
female offspring at 15 weeks. Neural activity was analysed by measuring time 
course changes in SIs and presented as normalised percentage enhancement 
(NPE %) from the VMH nucleus within the hypothalamus. Figures a) and b) show 
the time course activity by diets (NF-HF respectively) in mice within the same birth 
weight category. Figure c) and d) show the time course activity by birth weight 
(LBWm-HBWm respectively) in mice within the same diet category.  The arrow 
indicates the start of intravenous (i.v.) MnCl2 infusion and the hatched bars indicate 
the duration of the i.v. infusion. Statistical analysis was performed using a general 
estimated equation (GEE) test. Data presented as mean± SEM. LBWf-NF n=4; 
LBWf-HF n=3; HBWf-NF n=4, HBWf-HF n=3.   
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Figure 4.10.2.7 Neural activity measured within the hypothalamic Pe nucleus in 
female and male offspring at 15 weeks. Neural activity was analysed by measuring 
time course changes in SIs and presented as normalised percentage enhancement 
(NPE %) from the Pe nucleus within the hypothalamus. The arrow indicates the 
start of intravenous (i.v.) MnCl2 infusion and the hatched bars indicate the duration 
of the i.v. infusion. Figure a) corresponds to females and figure b) to males. 
Statistical analysis was performed using a general estimated equation (GEE) test. 
Data presented as mean± SEM. LBWf-NF n=4; LBWf-HF n=3; HBWf-NF n=4, 
HBWf-HF n=3; LBWm-NF n=5; LBWm-HF n=5; HBWm-NF n=5, HBWm-HF n=5.   
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Figure 4.10.2.8 Neural activity measured within the hypothalamic Pe nucleus in 
female offspring at 15 weeks. Neural activity was analysed by measuring time 
course changes in SIs and presented as normalised percentage enhancement 
(NPE %) from the Pe nucleus within the hypothalamus. Figures a) and b) show the 
time course activity by diets (NF-HF respectively) in mice within the same birth 
weight category. Figure c) and d) show the time course activity by birth weight 
(LBWm-HBWm respectively) in mice within the same diet category. The arrow 
indicates the start of intravenous (i.v.) MnCl2 infusion and the hatched bars indicate 
the duration of the i.v. infusion. Statistical analysis was performed using a general 
estimated equation (GEE) test. Data presented as mean± SEM. LBWf-NF n=4; 
LBWf-HF n=3; HBWf-NF n=4, HBWf-HF n=3.   
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4.11 Summary 
 
LBWm mice had an increased accelerated growth and caught up in weight 
with HBWm mice at the age 9 weeks when fed a NF diet and at 11 weeks 
when fed a HF diet. However, LBWf mice remained smaller than HBWf mice 
throughout the study, despite the fact that they had a higher accelerated 
growth rate. 
 
There was a significant effect of birth weight and diet (interaction) on the total 
kilocaloric intake in males. HBWm-HF mice had a higher intake than LBWm-
HF and HBWm-NF mice. No significant differences were found between 
mice fed a NF diet (LBWm-NF vs. HBWm-NF) or between LBW mice 
(LBWm-NF vs. HBWm-HF). In female mice, diet exerted total kilocaric intake 
independently of birth weight, with a higher intake in females fed a HF diet 
than females fed a NF diet. LBWm mice were more efficient in gaining 
weight (FE) than HBWm mice irrespectively of the diet ingested. However, 
an interaction on factors (birth weight and diet) was evident in the female 
groups. LBWf mice had the highest FE when compared to their respective 
counterparts (LBWf-NF and HBWf-HF). 
 
Total body adiposity was affected by the interaction between birth weight and 
diet. LBWm-NF had a higher percentage of total adiposity compared to 
HBWm-NF mice, but similar percentage to LBWm-HF mice. HBWm-HF diet 
had a higher percentage of total adiposity than HBWm-NF mice, but similar 
percentage to LBWm-HF mice. However, birth weight and diet per se 
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influenced adiposity in female mice. HBWf mice had a higher adiposity than 
LBWf mice and at the same time, HF fed females had a higher adiposity 
than females fed a NF diet.  
 
IHCL in males was affected by birth weight only. LBWm mice had a higher 
IHCL content than HBWm mice, irrespectively of the diet consumed. 
Similarly, LBWf mice had a higher IHCL content than HBWf mice. Moreover, 
female mice were also affected by the diet per se. Female mice fed a HF diet 
had a significantly higher IHCL content than NF fed females.  
 
Adipose tissue distribution varied according to the interaction between diet 
and birth weigh in males. LBWm mice had a signficanlty higher SAT and IAT 
tissue content than HBWm-NF mice but similar relative levels to LBWm-HF 
mice. Female mice were affected only by diet. LBWf and HBWf that were 
fed a HF diet ahd the highest SAT and IATcontent.   
 
Glucose levels in a fed state were significantly higher in mice with a low birth 
weight (LBW) irrespectively of the diet ingested throughout the study. LBWf 
mice had the highest level of glucose when compared to both LBWf-NF and 
HBWf-HF mice. Similar levels of glucose were seen between HBWf mice. 
Insulin was increased in male mice fed a HF diet with a concomitant increase 
in glucagon levels in plasma. Females fed a HF diet had increased levels of 
insulin as males, but there was not a change in glucagon levels.  
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LBWm mice had an impaired fasting glucose as well as glucose intolerance 
compared to HBWm mice. Moreover, male mice fed a HF diet were glucose 
intolerant independently of the birth weight of mice. Conversely, female mice 
did not have significant differences in fasting glucose. However, LBWf-HF 
had higher levels of glucose during IPGTT test than both LBWf-NF and 
HBWf-HF mice.  
 
The number of adipocytes was significantly higher in HBWm-HF mice in 
subcutaneous adipose tissue only when compared to LBWm-HF mice. 
Larger adipocytes were found in the gonadal and subcutaneous adipose 
tissue of HBWm-HF mice compared to LBWm-HF mice. LBWm mice had a 
higher small to large adipocyte ratio than HBWm irrespectively of the diet 
consumed only in the gonadal adipose tissue.  
 
Neural acitivity in the hypothalamus was modulated by birth weight and diet 
and by gender. Overall, LBWm-HF mice presented the lowest activity in the 
centres of interest compared to LBWm-NF and HBWm-HF mice. 
Furthermore, LBWm-NF had a higher neural activity than HBWm-NF mice 
as well as HBWm-HF mice compared to this latter group.  
 
Conversely, LBWf-NF mice had a lower activity than LBWf-HF mice and 
HBWf-NF mice. No differences were detected between females fed a HF 
diet or between HBWf mice.  
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5. Study 3. Effects of Birth Weight and Diet on Body 
Composition in Matured Mice (from 16 weeks to 51 
weeks old) 
 
 
5.1 The Effects of Birth Weight and Diet on Body Weight in 
Matured Mice  (from 16 weeks to 51 weeks old) 
 
Body weights of offspring were monitored weekly for a period of 36 weeks, 
from early adulthood (week 16) until middle age (51 weeks). LBWm/f and 
HBWm/f were maintained on the same dietary regime as in study 2 (section 
2.2.3). The protocol of this preliminary study is described in section 2.3.  
 
5.1.1 Body weight in Male mice 
Figures 5.1.1.1 and 5.1.1.2 show the growth pattern of the 4 male groups 
following maintenance on both normal fat control diet (9% kcal fat intake) and 
purified moderated high fat diet (27% kcal fat intake).  
 
As expected, male mice fed a HF diet had a higher weight than those fed a 
NF diet in both, LBWm-HF (LBWm-HF vs. LBWm-NF p= 0.002, figures 
5.1.1.1 and 5.1.1.2a) mice and HBWm-HF mice (HBWm-HF vs. HBWm-NF 
p<0.001; figures 5.1.1.1 and 5.1.1.2b). This result suggests that birth weight 
did not affected body weight per se but the effect of diet was strong enough 
to modulate the body weight of male mice.  
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LBWm-NF and HBWm-NF were not significantly different at any time point 
as seen in figures 5.1.1.1 and 5.1.1.2c (LBWm-NF vs. HBWm-NF p=0.803).  
 
Differences between LBWm-HF and HBWm-HF were not significantly 
different throughout the 36 weeks period (LBWm-HF vs. HBWm-HF p= 
0.181; figures 5.1.1.1 and 5.1.1.2d). Although between groups difference 
was not significantly different, significant time point differences were seen 
during the first 9 weeks. After week 24, differences were not longer 
significant. This explains why the between groups analysis did not reach 
significance.  
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Figure 5.1.1.1 Body weight of male and female mice from early adulthood (week 16) 
until middle age week (week 51). LBWm/f and HBWm/f were subdivided into 4 
further groups according to the diet given from weaning until week 51, either a 
normal fat diet =NF or moderated high fat diet =HF. The groups were: Low birth 
weight males/females fed a normal fat diet =LBWm/f-NF; Low birth weight 
males/females fed a high fat diet= LBWm/f-HF; High birth weight males/females fed 
a normal fat diet =HBWm/f-NF; High birth weight males/females fed a high fat diet= 
HBWm/f-HF. Figure a) corresponds to males and b) to females. Statistical analysis 
was performed using a mixed general linear model (GLM) followed by a protected 
Fisher’s least significant difference (LSD) post hoc analysis.  Data presented as 
mean± SEM. LBWm-NF n=4; LBWm-HF n=10; HBWm-NF n=5, HBWm-HF n=5; 
LBWf-NF n=4; LBWf-HF n=4; HBWf-NF n=4, HBWf-HF n=5.  
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Figure 5.1.1.2 Body weight of male mice from early adulthood (week 16) until 
middle age week (week 51). a) LBWm-NF vs. LBWm-HF; b) HBWm-NF vs. 
HBWm-HF; c) LBWm-NF vs. HBWm-NF; d) LBWm-HF vs. HBWm-HF. Statistical 
analysis was performed using a mixed general linear model (GLM) followed by a 
protected Fisher’s least significant difference (LSD) post hoc analysis.  Data 
presented as mean± SEM. LBWm-NF n=4; LBWm-HF n=10; HBWm-NF n=5, 
HBWm-HF n=5. N/S= no significant differences, *p≤0.05; ** p≤0.01, ***p≤0.001. 
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5.1.2 Body weight in Female mice 
Figures 5.1.2.1 and 5.1.2.2 show the body weights of female offspring from 
week 16 until week 51. HF diet had a similar effect on female mice as in 
male offspring, with females fed a HF having a higher body weight than 
those females fed a NF diet (LBWf-HF vs. LBWf-NF p=0.019, figures 5.2.1 
and 5.2.2a; HBWf-HF vs. HBWf-NF p=0.002; figures 5.1.2.1 and 5.1.2.2b).  
 
Differences between LBWf-NF and HBWf-NF were not significant as seen in 
male mice (LBWf-NF vs. HBWf-NF p=0.433; figures 5.1.2.1 and 5.1.2.2c). 
However, there was a significant difference between mice fed a HF diet with 
LBWf-HF having a lower weight than HBWf-HF. Despite the fact that 
between groups difference was significant, LBWf-HF caught up in weight 
with HBWf-HF at week 43 (LBWf-HF vs. HBWf-HF p=0.035; figure 5.1.2.1 
and 5.1.2.2d). This catch up in weight was reached in part due to a decline in 
body weight of the HBWf-HF mice from week 42. Thus, the difference 
between groups was significant because of the body weight differences 
during week 16 until week 43. Contrary to males, LBWf-HF mice caught up 
in weight 9 weeks before the end of the study, whilst LBWm-HF mice caught 
up in weight 10 weeks after beginning the study. 
 
 
 
 
 
	   388	  
 
Figure 5.1.2.1 Body weight of female and male mice from early adulthood (week 16) 
until middle age week (week 51). LBWf/m and HBWf/m were subdivided into 4 
further groups according to the diet given from weaning until week 51 (normal fat 
diet =NF  or moderated high fat diet =HF. The groups were: Low birth weight 
females/males fed a normal fat diet =LBWf/m-NF; Low birth weight females/males 
fed a high fat diet= LBWf/m-HF; High birth weight females/males fed a normal fat 
diet =HBWf/m-NF; High birth weight females/males fed a high fat diet= HBWf/m-
HF. Statistical analysis was performed using a mixed general linear model (GLM) 
followed by a protected Fisher’s least significant difference (LSD) post hoc analysis.  
Data presented as mean± SEM. LBWf-NF n=4; LBWf-HF n=4; HBWf-NF n=4, 
HBWf-HF n=5. LBWm-NF n=4; LBWm-HF n=10; HBWm-NF n=5, HBWm-HF n=5. 
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Figure 5.1.2.2 Body weight of female mice from early adulthood (week 16) until 
middle age week (week 51). a) LBWf-NF vs. LBWf-HF; b) HBWf-NF vs. HBWf-HF; 
c) LBWf-NF vs. HBWf-NF; d) LBWf-HF vs. HBWf-HF. Statistical analysis was 
performed using a Mixed general linear model (GLM) followed by a protected 
Fisher’s least significant difference (LSD) post hoc analysis.  Data presented as 
mean± SEM. LBWF-NF n=4; LBWf-HF n=4; HBWf-NF n=4, HBWf-HF n=5. N/S= 
no significant differences, *p≤0.05; ** p≤0.01, ***p≤0.001. 
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5.1.3 Body weight gain in Male mice 
Assessment of body weight gain from week 19 to week 51 showed an 
enhanced total body weight gain in male mice fed a HF compared to mice 
fed a NF diet (LBWm-HF=12.952±1.107g, LBWm-NF= 4.615 ±0.436g, 
p<0.001; figure 5.1.3.1; HBWm-HF= 12.42±1.815g vs. HBWm-NF= 
4.84±1.1973g, p=0.001; figure 5.1.3.1). Difference between mice fed a NF 
was not significantly different (LBWm-NF vs. HBW-NF p=0.918; figure 
5.1.3.1). Similar body weight gain was seen between LBWm-HF and HBWm-
HF (p=0.767; figure 5.1.3.1).  
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Figure 5.1.3.1 Total body weight gain of male and female offspring from week 16 to 
week 51. Absolute values are given in grams. Figure a) corresponds to males and 
figure b) to females. Statistical analysis was performed using a one-way anova test 
followed by a protected Fisher’s least significant difference (LSD) a) or Tukey high 
significant difference (HSD) b) post hoc analysis.  Data presented as mean± SEM. 
LBWm-NF n=4; LBWm-HF n=10; HBWm-NF n=5, HBWm-HF n=5; LBWf-NF n=4; 
LBWf-HF n=4; HBWf-NF n=4, HBWf-HF n=5. N/S or figures without 
symbols/letters= no significant, **p≤0.01,***p≤0.001. 
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Similar pattern was seen when evaluating body weight gain normalised to 
initial body weight expressed as percentage (growth or relative body weight 
gain%). HF fed mice had a significantly higher relative body weight 
compared to mice fed a NF (LBWm-HF=45.722±3.896%, LBWm-NF= 
17.882 ±1.612%, p<0.001; figure 5.1.3.2; HBWm-HF= 36.691±4.491%, 
HBWm-NF= 17.764±4.251%, p=0.009; figure 5.1.3.2). Differences between 
mice fed a NF were not significantly different (LBWm-NF vs. HBW-NF 
p=0.987; figure 5.1.3.2). Although LBWm-HF had a higher relative body 
weight gain than HBWm-HF, it was not enough to reach statistical 
significance. (p=0.128; figure 5.1.3.2).  
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Figure 5.1.3.2 Relative body weight gain of male and female offspring from week 16 
to week 51. Relative values or growth change given as a percentage of the initial 
body weight: 100*(body weight 51 week- body weight 16 week)/ body weight 16 
week. Figure a) corresponds to males and figure b) to females. Statistical analysis 
was performed using a one-way ANOVA test followed by a protected Fisher’s least 
significant difference (LSD) a) or Tukey high significant difference (HSD) post hoc 
analysis b) post hoc analysis.  Data presented as mean± SEM. LBWm-NF n=4; 
LBWm-HF n=10; HBWm-NF n=5, HBWm-HF n=5; LBWf-NF n=4; LBWf-HF n=4; 
HBWf-NF n=4, HBWf-HF n=5. N/S or figure without symbols/letters= no significant, 
**p≤0.01, ***p≤0.001.  
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5.1.4 Body weight gain n Female mice 
HF feeding in female mice did not have the same significant impact as seen 
in males. LBWf-HF gained more weight than LBWf-NF but the difference did 
not reach statistical significance (LBWf-HF= 13.075±2.692g, LBWf-NF = 
5.8± 2.358g, p=0.244; figure 5.1.4.1). A narrower difference was seen 
between HBWF-HF and HBWf-NF (HBWf-HF= 10.575±2.7g, HBWf-NF= 
8.667± 1.551g, p=0.95; figure 5.1.4.1).  As in males, no differences were 
seen between female mice fed a NF diet (p=0.877; figure 5.1.4.1) or between 
female mice fed a HF (p=0.875; figure 5.1.4.1). 
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Figure 5.1.4.1 Total body weight gain of female and male offspring from week 16 to 
week 51. Absolute values are given in grams. Figure a) corresponds to females and 
figure b) to males. Statistical analysis was performed using a one-way ANOVA test 
followed by a Tukey high significant difference (HSD) a) or protected Fisher’s least 
significant difference (LSD) b) post hoc analysis.  Data presented as mean± SEM. 
LBWf-NF n=4; LBWf-HF n=4; HBWf-NF n=4, HBWf-HF n=5; LBWm-NF n=4; 
LBWm-HF n=10; HBWm-NF n=5, HBWm-HF n=5. N/S or figure without 
symbols/letters= no significant, **p≤0.01, ***p≤0.001. 
 
 
 
Similar pattern was seen when normalising body weight gain to initial body 
weight (growth or relative body weight gain%). LBWf-HF had the highest 
growth percentage but it was not significantly different from LBWf-NF or 
HBWf-HF (LBWf-HF= 60.088±12.0783%, LBWf-NF = 29.914± 11.234%, 
p=0.302; HBWf-HF =43.515±11.861% p=0.695; figure 5.1.4.2). There was 
not difference between female mice fed a NF diet (LBWf-NF= 29.914± 
11.234%, HBWf-NF = 42.674±7.122, p=0.88; figure 5.1.4.2). HBWf had a 
similar growth irrespective of the diet (p=0.999; figure 5.1.4.2). 
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Figure 5.1.4.2 Relative body weight gain of female and male offspring from week 16 
to week 51. Relative values or growth change given as a percentage of the initial 
body weight: 100*(body weight 51 week body weight 16 week)/ body weight 16 
week. Statistical analysis was performed using a one-way ANOVA test followed by 
a Tukey high significant difference (HSD) or protected Fisher’s least significant 
difference (LSD) b) post hoc analysis. Data presented as mean± SEM. LBWf-NF 
n=4; LBWf-HF n=4; HBWf-NF n=4, HBWf-HF n=5; LBWm-NF n=4; LBWm-HF 
n=10; HBWm-NF n=5, HBWm-HF n=5. N/S or figure without symbols/letters= no 
significant, **p≤0.01, ***p≤0.001 
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5.2 The Effects of Birth Weight and Diet on Caloric Intake in 
Matured Mice  (from 16 weeks to 51 weeks old) 
 
Total kilocalorie intake was calculated using weekly food intake 
measurements and the values of the caloric content of the diets mentioned in 
section 2.2, table 2.2.1, and section 2.3. 
 
5.2.1 Total kilocalorie intake in Male mice 
Figure 5.2.1.1 shows the total kilocalorie intake of LBWm and HBWm mice 
fed both a control fat diet (9% kcal fat intake) and a purified moderated high 
fat diet (27% kcal fat intake). 
 
Both groups fed a HF diet had a higher kilocalorie intake than those mice fed 
a NF. However, only HBWm-HF mice had a significantly higher intake than 
HBWm-NF mice (HBWm-HF=3440.687±136.566 kcalories, HBWm-
NF=2996.093±94.317 kcalories, p=0.016; LBWm-HF=3129.783±94.129 
kcalories, LBWm-NF=2849.415±47.526 kcalories, p=0.102; figure 5.2.1.1). 
Interestingly, there was a significant difference between mice fed a HF diet 
with LBWm-HF having a lower intake than HBWm-HF (p=0.04; figure 
5.2.1.1).  There was not a statistical significance between mice fed a NF diet 
(p=0.445; figure 5.2.1.1).  
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Figure 5.2.1.1 Male and female kilocalorie consumption from week 16 until week 51 
(36 weeks). Total kilocalories were obtained from calculated weekly-recorded food 
intake and the kilocalorie content per gram of each diet (NF= 3.6 kcal/g and HF=4.1 
kcal/g). Figure a) corresponds to males and figure b) to females. Statistical analysis 
was performed using a one-way ANOVA test followed by a protected Fisher’s least 
significant difference (LSD) post hoc analysis. Data presented as mean± SEM. 
LBWm-NF n=4; LBWm-HF n=11; HBWm-NF n=5, HBWm-HF n=6; LBWf-NF n=4; 
LBWf-HF n=4; HBWf-NF n=4, HBWf-HF n=5. *p≤0.05, ** p≤0.01, N/S= no 
significant difference.  
 
 
However, when normalising kilocalorie intake to body weight0.75(g), 
significant differences were not longer present (HBWm-HF= 219.196±6.653 
kcalories/bodyweight0.75, HBWm-NF= 225.092 ±6.794 kcalories/body 
weight0.75, p=0.896; HBWm-HF vs. LBWm-HF p=0.995; figure 5.2.1.2). 
LBWm-HF vs. LBWm-NF was not significantly different as seen in the 
absolute kilocalorie intake as well as mice fed a NF (LBWm-
	   399	  
HF=217.441±4.099 kcalories/body weight0.75, LBWm-NF=221.332 ±4.999 
kcalories/body weight0.75, p=0.964; LBWm-NF vs. HBWm-NF p=0.977).  
 
 
Figure 5.2.1.2 Male and female kilocalorie consumption from week 16 until week 51 
normalised to body weight0.75 (36 weeks). Total kilocalories were obtained from 
calculated weekly-recorded food intake and the kilocalorie content per gram of each 
diet (NF= 3.6 kcal/g and HF=4.1 kcal/g) and subsequent normalisation to body 
weight0.75. Figure a) corresponds to males and figure b) to females. Statistical 
analysis was performed using a one-way ANOVA test followed by a Tukey high 
significant difference (HSD) post hoc analysis.  Data presented as mean± SEM. 
LBWm-NF n=4; LBWm-HF n=11; HBWm-NF n=5, HBWm-HF n=6. ; LBWf-NF 
n=4; LBWf-HF n=4; HBWf-NF n=4, HBWf-HF n=5; LBWm-NF n=4; LBWm-HF 
n=11; HBWm-NF n=5, HBWm-HF n=6. 
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5.2.2 Total caloric intake in Female mice 
As in males, female mice fed a HF diet had a higher kilocalorie intake 
compared to those females fed a NF diet. However, only LBWf-HF had a 
significantly higher intake than LBWf-NF (LBWf-HF=2962.356±84.08 
kcalories, LBWf-NF=2568.192±176.764 kcalories, p=0.019; HBWf-
HF=2889.949±43.561kcalories, HBWf-NF=2674.112±89.932 kcalories, 
p=0.134; figure 5.2.2.1). No differences were seen between female groups 
fed a NF (LBWf-NF vs. HBWf-NF p=0.477; figure 5.2.2.1) or between 
females fed a HF diet (LBWf-HF vs. HBWf-HF p=0.598; figure 5.2.2.1).  
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Figure 5.2.2.1 Female and male kilocalorie consumption from week 16 until week 
51 (36 weeks). Total kilocalories were obtained from calculated weekly-recorded 
food intake and the kilocalorie content per gram of each diet (NF= 3.6 kcal/g and 
HF=4.1 kcal/g). Figure a) corresponds to females and figure b) to males. Statistical 
analysis was performed using a one-way ANOVA test followed by a protected 
Fisher’s least significant difference (LSD) post hoc analysis.  Data presented as 
mean± SEM. LBWf-NF n=4; LBWf-HF n=4; HBWf-NF n=4, HBWf-HF n=5. LBWm-
NF n=4; LBWm-HF n=11; HBWm-NF n=5, HBWm-HF n=6. * p≤0.05, ** p≤0.01, 
N/S= no significant difference.  
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However, when normalising kilocalorie intake to body weight0.75(g), 
significant differences were not longer present (LBWf-HF= 246.352±4.346 
kcalories/bodyweight0.75,LBWf-NF=262.534±13.915kcalories/bodyweight0.75 
p=0.185; figure 5.2.2.2). LBWf-NF vs. HBWf-NF was not significantly 
different as seen in the absolute kilocaloric intake (LBWf-
NF=262.534±13.915 kcalories/body weight0.75, HBWf-NF=243.053±5.437; 
p=0.117; figure 5.2.2.2). LBWf-HF had a higher kilocalorie intake than 
HBWf-HF but the difference did not reach statistical significance (LBWf-
HF=246.352±4.346 kcalories/bodyweight0.75, HBWf-HF= 225.969±7.02 
kcalories/bodyweight0.75; p=0.067; figure 5.2.2.2). There was not a significant 
difference between HBWf mice (HBWf-NF vs. HBWf-HF p=0.117; figure 
5.2.2.2). 
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Figure 5.2.2.2 Female and male kilocalorie consumption from week 16 until week 
51 normalised to body weight0.75 (36 weeks). Total kilocalories were obtained from 
calculated weekly-recorded food intake and the kilocalorie content per gram of each 
diet (NF= 3.6 kcal/g and HF=4.1 kcal/g) and subsequent normalisation to body 
weight0.75. Figure a) corresponds to females and figure b) to males. Statistical 
analysis was performed using a one-way ANOVA test followed by a Tukey’s high 
significant difference (HSD) post hoc analysis.  Data presented as mean± SEM. 
LBWf-NF n=4; LBWf-HF n=4; HBWf-NF n=4, HBWf-HF n=5; LBWm-NF n=4; 
LBWm-HF n=11; HBWm-NF n=5, HBWm-HF n=6.  
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5.3 The Effects of Birth Weight and Diet on Feed Efficiency in 
Matured Mice  (from 16 weeks to 51 weeks old) 
 
Feed efficiency was calculated as the body weight gain divided by total 
kilocalories consumed. Total caloric intake was calculated using weekly food 
intake measurements and the values of the caloric content of the diets 
mentioned in section 2.2, table 2.2.1, and section 2.3.  
 
5.3.1 Feed efficiency in Male mice 
Figure 5.3.1.1 show the feed efficiency of male groups.  Male mice fed a HF 
diet gained more weight per kilocalories consumed than mice fed a NF diet 
(LBWm-HF= 3.749±0.347 mg/kcalorie, LBWm-NF=1.341±0.23 mg/kcalorie 
p=0.001; HBWm-HF= 3.416±0.499 mg/kcalorie, HBWm-NF=1.759±0.319 
mg/kcalorie p=0.014; figure 5.3.1.1). No differences were seen between 
mice fed both NF and HF (LBWm-NF vs. HBWm-NF p=0.552; LBWm-HF 
vs. HBWm-HF p=0.531; figure 5.3.1.1).  
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Figure 5.3.1.1 Feed efficiency of male and female mice from week 16 until week 51 
(36 weeks). Total kilocalories were obtained from weekly-recorded food intake and 
the calculated kilocaloric content per gram of each diet (NF= 3.6 kcal/g and HF=4.1 
kcal/g). Figure a) corresponds to males and figure b) to females. Statistical analysis 
was performed using a one-way ANOVA test followed by a protected Fisher’s least 
significant difference (LSD) post hoc analysis. Data presented as mean± SEM. 
LBWm-NF n=4; LBWm-HF n=11; HBWm-NF n=5, HBWm-HF n=6; LBWf-NF n=4; 
LBWf-HF n=4; HBWf-NF n=4, HBWf-HF n=5. * p≤0.05, *** p≤0.001,N/S= no 
significant difference.  
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5.3.2 Feed efficiency in Female mice 
Contrary to males, female mice fed a HF diverged in their feed efficiency. 
Whilst LBWf-HF had a higher feed efficiency than LBWf-NF (LBWf-HF= 
4.554±0.756 mg/kcalorie, LBWf-NF=2.356±0.665 mg/kcalorie; p=0.05; figure 
5.3.2.1), HBWf-HF had a very similar feed efficiency compared to HBWf-NF 
(HBWf-HF=3.502±0.8 mg/kcalorie, HBWf-NF=3.458±0.444 mg/kcalorie; 
p=0.964; figure 5.3.2.1). No differences were seen between mice fed NF or 
mice fed a HF (LBWf-NF vs. HBWf-NF p=0.302; LBWf-HF vs. HBWf-HF 
p=0.288; figure 5.3.2.1). 
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Figure 5.3.2.1 Feed efficiency of female and male mice from week 16 until week 51 
(36 weeks). Total kilocalories were obtained from weekly-recorded food intake and 
the calculated kilocaloric content per gram of each diet (NF= 3.6 kcal/g and HF=4.1 
kcal/g). Figure a) corresponds to females and figure b) to males. Statistical analysis 
was performed using a one-way ANOVA test followed by a protected Fisher’s least 
significant difference (LSD) post hoc analysis.  Data presented as mean± SEM. 
LBWf-NF n=4; LBWf-HF n=4; HBWf-NF n=4, HBWf-HF n=5; LBWm-NF n=4; 
LBWm-HF n=11; HBWm-NF n=5, HBWm-HF n=6; *p≤0.05, *** p≤0.001, N/S= no 
significant difference.  
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5.4 The Effects of Birth Weight and Diet on White Adipose 
Tissue Mass in Matured Mice  (51 weeks old) 
 
White adipose tissue was (WAT) was extracted and subdivided into 
subcutaneous (SAT) and internal adipose tissue (IAT). IAT was further 
subdivided into gonadal, retroperitoneal and mesenteric fat depots. Male and 
female analysis is presented separately. 
 
5.4.1 White Adipose Tissue Mass  
5.4.1.1 White adipose tissue mass in Male mice 
At the time of the collection of tissues (week 51), body weights of mice fed a 
HF diet were heavier than mice fed a NF (LBWm-HF= 41.33±1.888g vs. 
LBWm-NF= 30.667±1.576g, p=0.009; HBWm-HF= 44.3±2.826g vs. HBWm-
NF= 32.02±0.1.533g, p=0.002; figure 5.4.1.1.1). No differences were seen 
between males fed a NF diet (LBWm-NF vs. HBWm-NF p=0.743; figure 
5.4.1.1.1) and between males fed a HF diet (LBWm-HF vs. HBWm-HF 
p=0.315; figure 5.4.1.1.1).  
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Figure 5.4.1.1.1 Body weight of male and female mice fed a NF and HF diet at week 
51 of age. Figure a) corresponds to males and figure b) to females. Statistical 
analysis was performed using a one-way ANOVA test followed by a protected 
Fisher’s least significant difference (LSD) post hoc analysis.  Data presented as 
mean± SEM. LBWm-NF n=4; LBWm-HF n=11; HBWm-NF n=5, HBWm-HF n=6; 
LBWf-NF n=4; LBWf-HF n=4; HBWf-NF n=4, HBWf-HF n=5. * p≤0.05, ** p≤0.01, 
N/S= no significant difference.  
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Total white adipose tissue was significantly higher in mice fed a HF than 
mice fed a NF (LBWm-HF vs. LBWm-NF p=0.004; HBWm-HF vs. HBWm-
NF p=0.006; figure 5.4.1.1.2). No differences were seen in mice fed a NF 
(LBWm-NF vs. HBWm-NF p=0.946; figure 5.4.1.1.2 and table 5.4.1.1.1) or 
between mice fed a HF (LBWm-HF vs. HBWm-HF p=0.663; figure 5.4.1.1.2 
and table 5.4.1.1.1).  
 
After normalisation of total white adipose tissue to current body weight (as 
percentage), differences between groups were maintained as seen in total 
white adipose tissue mass in grams (LBWm-HF vs. LBWm-NF p=0.002; 
HBWm-HF vs. HBWm-NF p=0.011; table 5.4.1.1.1 and figure 5.4.1.1.3). No 
differences were seen between males fed a NF diet (LBWm-NF vs. HBWm-
NF p=0.856; table 5.4.1.1.1 and figure 5.4.1.1.3) or between males fed a HF 
diet (LBWm-HF vs. HBWm-HF p=0.219; table 5.4.1.1.1 and figure 
5.4.1.1.3).  This suggests that at this time point of study, the dietary 
intervention had a major impact in total white adipose tissue independently of 
birth weight. 
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Table 5.4.1.1.1 Total white adipose tissue mass from male mice fed a NF and a HF 
diet. Total WAT (g)= total white adipose tissue in grams, total WAT= total white 
adipose tissue mass normalised to current body weight and presented as 
percentage. Statistical analysis was performed using a one-way ANOVA test 
followed by a protected Fisher’s least significant difference (LSD) post hoc analysis.  
Data presented as mean± SEM. LBWm-NF n=4; LBWm-HF n=10; HBWm-NF n=5, 
HBWm-HF n=6. 
 
 
Subcutaneous adipose tissue (SAT) had the same pattern as the total white 
adipose tissue with mice fed a HF having a higher SAT content than their 
counterparts (LBWm-HF vs. LBWm-NF p=0.001; HBWm-HF vs. HBWm-NF 
p=0.004; figure 5.4.1.1.2 and table 5.4.1.1.2). No differences were seen in 
mice fed a NF (LBWm-NF vs. HBWm-NF p=0.909; table 5.4.1.1.2 and figure 
5.4.1.1.2) and between mice fed a HF (LBWm-HF vs. HBWm-HF p=0.206; 
table 5.4.1.1.2 and figure 5.4.1.1.2).  
 
 LBWm-NF1 LBWm-HF2 HBWm-NF3 HBWm-HF4 P value 
 
 
 
Total 
WAT 
(g) 
 
 
 
3.269±0.81 
 
 
 
7.869±0.671 
 
 
 
3.161±0.725 
 
 
 
7.383±1.089 
1 vs.2=0.004 
 
3vs.4=0.006 
 
1vs.3=0.946 
 
2vs.4=0.663 
 
 
 
 
Total 
WAT 
% 
 
 
 
10.452±2.043 
 
 
 
18.491±0.981 
 
 
 
9.975±1.76 
 
 
 
16.204±1.601 
1 vs.2=0.002 
 
3vs.4=0.011 
 
1vs.3=0.856 
 
2vs.4=0.219 
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Assessment of normalised SAT showed a similar trend as seen in absolute 
values (in grams) with a higher SAT depot in mice fed a HF (LBWm-HF vs. 
LBWm-NF p<0.001; HBWm-HF vs. HBWm-NF p=0.01;	   table 5.4.1.1.2 and 
figure 5.4.1.1.3). However, contrary to the SAT in grams, there was a 
significantly higher amount of SAT (%) in LBWm-HF compared to HBWm-
HF (LBWm-HF vs. HBWm-HF p=0.03; table 5.4.1.1.2 and figure 5.4.1.1.3). 
 
 
Table 5.4.1.1.2 Subcutaneous white adipose tissue (SAT) mass from male mice fed 
a NF and a HF diet. SAT (g)= subcutaneous adipose tissue in grams, SAT (%)= 
subcutaneous adipose tissue mass normalised to current body weight and 
presented as percentage. Statistical analysis was performed using a one-way 
ANOVA test followed by a protected Fisher’s least significant difference (LSD) post 
hoc analysis.  Data presented as mean± SEM. LBWm-NF n=4; LBWm-HF n=10; 
HBWm-NF n=5, HBWm-HF n=6. 
 
 
 
 LBWm-NF1 LBWm-HF2 HBWm-NF3 HBWm-HF4 P value 
 
 
SAT 
(g) 
 
 
1.6±0.407 
 
 
3.992±0.251 
 
 
1.524±0.355 
 
 
3.385±0.461 
 
1 vs.2<0.001 
3vs.4=0.004 
1vs.3=0.909 
2vs.4=0.206 
 
 
SAT
% 
 
 
5.115±1.028 
 
 
9.297±0.2061 
 
 
4.811±0.867 
 
 
7.478±0.709 
 
1 vs.2=0.003 
3vs.4=0.01 
1vs.3=0.783 
2vs.4=0.03 
 
	   413	  
Gonadal, retroperitoneal and mesenteric fat depots were also significantly 
higher in mice fed a HF compared to those mice fed a NF (Gonadal: LBWm-
HF vs. LBWm-NF p=0.002; HBWm-HF vs. HBWm-NF p=0.006; 
retroperitoneal: LBWm-HF vs. LBWm-NF p=0.047; HBWm-HF vs. HBWm-
NF p=0.021; mesenteric: LBWm-HF vs. LBWm-NF p=0.01; HBWm-HF vs. 
HBWm-NF p=0.003; table 5.4.1.1.3 and figure 5.4.1.1.2).   
 
Differences between NF fed mice were not significantly different (Gonadal: 
LBWm-NF vs. HBWm-NF p=0.937; retroperitoneal: LBWm-NF vs. HBWm-
NF p=0.986; mesenteric: LBWm-NF vs. HBWm-NF p=0.947; figure 5.4.1.1.2 
and table 5.4.1.1.3) as in between HF fed mice (Gonadal: LBWm-HF vs. 
HBWm-HF p=0.403; retroperitoneal: LBWm-HF vs. HBWm-HF p=0.715; 
mesenteric: LBWm-HF vs. HBWm-HF p=0.487; table 5.4.1.1.3 and figure 
5.4.1.1.2). 
 
After normalisation of these regional fat compartments, significant 
differences were maintained (table 5.4.1.1.3 and figure 5.4.1.1.3).  
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Table 5.4.1.1.3 Regional internal fat depots mass from male mice fed a NF and a 
HF diet. Gonadal, retroperitoneal and mesenteric fat depots mass in grams (g), and 
normalised to current body weight and presented as percentage (%). IAT= internal 
adipose tissue mass as the sum of gonadal, retroperitoneal and mesenteric fat 
depots. Statistical analysis was performed using a one-way ANOVA test followed by 
a protected Fisher’s least significant difference (LSD) post hoc analysis.  Data 
presented as mean± SEM. LBWm-NF n=4; LBWm-HF n=10; HBWm-NF n=5, 
HBWm-HF n=6. 
 LBWm-NF1 LBWm-HF2 HBWm-NF3 HBWm-HF4 P value 
 
Gonadal 
(g) 
 
1.029±0.248 
 
2.452±0.203 
 
0.992±0.198 
 
2.182±0.296 
1 vs.2=0.002 
3vs.4=0.006 
1vs.3=0.937 
2vs.4=0.403 
 
 
Gonadal
% 
 
3.291±0.627 
 
5.632±0.316 
 
3.141±0.463 
 
4.981±0.469 
1 vs.2=0.001 
3vs.4=0.012 
1vs.3=0.844 
2vs.4=0.162 
 
 
Retrop. 
(g) 
 
0.327±0.097 
 
0.916±0.119 
 
0.321±0.085 
 
1.042±0.273 
1 vs.2=0.047 
3vs.4=0.021 
1vs.3=0.986 
2vs.4=0.715 
 
 
Retrop. 
% 
 
1.041±0.257 
 
2.204±0.228 
 
1.009±0.219 
 
2.212±0.464 
1 vs.2=0.04 
3vs.4=0.03 
1vs.3=0.959 
2vs.4=0.985 
 
 
Mesent. 
(g) 
 
0.313±0.063 
 
0.698±0.056 
 
0.323±0.09 
 
0.774±0.113 
1 vs.2=0.01 
3vs.4=0.003 
1vs.3=0.947 
2vs.4=0.487 
 
 
Mesent. 
(%) 
 
1.005±0.151 
 
1.646±0.076 
 
1.012±0.232 
 
1.703±0.167 
1 vs.2=0.011 
3vs.4=0.005 
1vs.3=0.978 
2vs.4=0.752 
 
 
IAT (g) 
 
1.669±0.408 
 
4.107±0.377 
 
1.637±0.371 
 
3.998±0.659 
1 vs.2=0.007 
3vs.4=0.007 
1vs.3=0.972 
2vs.4=0.865 
 
 
IAT% 
 
5.337±1.034 
 
9.63±0.578 
 
5.163±0.903 
 
8.726±0.985 
1 vs.2=0.004 
3vs.4=0.012 
1vs.3=0.909 
2vs.4=0.394 
 
	   415	  
Evaluation of the total internal adipose tissue as the sum of the gonadal, 
retroperitoneal and mesenteric fat depots, showed a similar pattern as the 
total adipose tissue and regional fat depots. HF mice had the highest IAT 
(LBWm-HF vs. LBWm-NF p=0.007; HBWm-HF vs. HBWm-NF p=0.007) 
with no significant differences between both groups fed either a HF diet or a 
NF diet (LBWm-NF vs. HBWm-NF p=0.972; LBWm-HF vs. HBWm-HF 
p=0.865; table 5.4.1.1.3 and figure 5.4.1.1.2). Differences were maintained 
after normalisation to current body weight as percentage (table 5.4.1.1.3 and 
figure 5.4.1.1.3).  
 
A comparison of the ratio of IAT to SAT tissue mass, showed not significant 
difference between groups (table 5.4.1.1.4).  
 
Table 5.4.1.1.4 Ratio of internal adipose tissue and subcutaneous adipose tissue 
from male mice fed a NF and a HF diet. IAT= Internal adipose tissue (as the sum of 
gonadal, retroperitoneal and mesenteric fat depots mass). Statistical analysis was 
performed using a one-way ANOVA test followed by a Tukey High significance 
difference (HSD) post hoc analysis.  Data presented as mean± SEM. LBWm-NF 
n=4; LBWm-HF n=10; HBWm-NF n=5, HBWm-HF n=6. 
 
 
 LBWm-NF1 LBWm-HF2 HBWm-NF3 HBWm-HF4 P value 
 
 
IAT:SAT 
 
 
1.047±0.666 
 
 
1.094±0.049 
 
 
1.078±0.048 
 
 
1.165±0.078 
 
1 vs.2=0.649 
3vs.4=0.385 
1vs.3=0.794 
2vs.4=0.385 
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Figure 5.4.1.1.2 White adipose tissue mass from male and female mice fed a NF 
and a HF diet at week 51. Total WAT= total white adipose tissue, 
SAT=subcutaneous adipose tissue, IAT= internal adipose tissue as the sum of 
gonadal, retroperitoneal and mesenteric fat depots. Significant differences in the 
figure correspond to mice fed a HF diet against mice fed a NF diet (LBWm/f-HF vs. 
LBWm/f-NF and HBWm/f-HF vs. HBWm/f-NF). Differences between male mice fed 
a NF as between mice fed a HF diet were not significantly different a). In the female 
group, there was a significant difference in the retroperitoneal fat depots, which 
were significantly different between mice fed a HF diet (LBWf-HF vs. HBWf-HF 
p=0.02) b). Statistical analysis was performed using a one-way ANOVA test 
followed by a protected Fisher’s least significant difference (LSD) post hoc analysis.  
Data presented as mean± SEM. LBWm-NF n=4; LBWm-HF n=10; HBWm-NF n=5, 
HBWm-HF n=6. * p≤0.05, ** p≤0.01; LBWf-NF n=4; LBWf-HF n=4; HBWf-NF n=4, 
HBWf-HF n=5. 
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Figure 5.4.1.1.3 White adipose tissue mass normalised to current body weight (%) 
from male mice fed a NF and a HF diet at week 51. Total WAT= total white adipose 
tissue, SAT=subcutaneous adipose tissue, IAT= internal adipose tissue as the sum 
of gonadal, retroperitoneal and mesenteric fat depots. Significant differences in the 
figure correspond to mice fed a HF diet against mice fed a NF diet (LBWm/f-HF vs. 
LBWm/f-NF and HBWm/f-HF vs. HBWm/f-NF), except from gonadal fat between 
HBWf-HF vs. HBWf-NF b). Differences between male mice fed a NF as between 
mice fed a HF diet were not significantly different, except from SAT between 
LBWm-HF vs. HBWm-HF p=0.035 a), as well as retroperitoneal fat depots in the 
female group b) which were significantly different between females fed a HF diet 
(p=0.004). Statistical analysis was performed using a one-way ANOVA test followed 
by a protected Fisher’s least significant difference (LSD) post hoc analysis.  Data 
presented as mean± SEM. LBWm-NF n=4; LBWm-HF n=11; HBWm-NF n=5, 
HBWm-HF n=6. * p≤0.05, ** p≤0.01, *** p≤0.001; LBWf-NF n=4; LBWf-HF n=4; 
HBWf-NF n=4, HBWf-HF n=5. 
 
	   418	  
5.4.1.2 White adipose tissue mass in Female mice 
Female mice assessment showed some differences in respect to male mice 
in body weights as well as for some of the fat depot masses at 51 weeks old. 
As in males, females fed a HF diet had a higher body weight but differences 
were only significant between LBWf mice (LBWf-HF=34.775±2.814g vs. 
LBWf-NF= 24.667±3.135g, p=0.023; HBWf-HF=35.475±2.322g vs. HBWf-
NF=28.867±1.988g, p=0.109; figure 5.4.1.2.1). It was noticed that HBWf-HF 
started losing weight from week 42 in comparison to the other groups as 
mentioned in section 5.1 (figures 5.1.2.1 and 5.1.2.2). This weight loss 
seemed to reduce the significant difference between HBWf. 
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Figure 5.4.1.2.1 Body weight of female and male mice fed a NF and HF diet at week 
51 of age. Statistical analysis was performed using a one-way ANOVA test followed 
by a protected Fisher’s least significant difference (LSD) post hoc analysis.  Data 
presented as mean± SEM. LBWf-NF n=4; LBWf-HF n=4; HBWf-NF n=4, HBWf-HF 
n=5; LBWm-NF n=4; LBWm-HF n=11; HBWm-NF n=5, HBWm-HF n=6. *p≤0.05, 
** p≤0.01, N/S= no significant difference.  
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Total white adipose tissue mass in grams was significantly higher in LBWf- 
HF compared to LBWf-NF (p=0.013; table 5.4.1.2.1 an figure 5.4.1.2.2) and 
HBWf-HF compared to LBWf-NF (p=0.05; table 5.4.1.2.1 an figure 
5.4.1.2.2). Differences between mice fed both NF and HF diets were not 
significantly different (LBWf-NF vs. HBWf-NF p=0.835; LBWf- HF vs. HBWf-
HF p=0.319; table 5.4.1.2.1 and figure 5.4.1.2.2).  
 
After normalisation to current body weight, total WAT remained significantly 
higher in LBWf-HF compared to LBWf-NF (p=0.005; table 5.4.1.2.1 and 
figure 5.4.1.2.3) and HBWf-HF vs. HBWf-NF (p=0.014; table 5.4.1.2.1 and 
figure 5.4.1.2.3). Mice fed a NF and HF did remain not significantly different 
(p=0.602 and 0.29 respectively). 
 
 
 
 
 
 
	   421	  
 
Table 5.4.1.2.1 Total white adipose tissue mass from female mice fed a NF and a 
HF diet. Total WAT (g)= total white adipose tissue in grams, total WAT= total white 
adipose tissue mass normalised to current body weight and presented as 
percentage. Statistical analysis was performed using a one-way ANOVA test 
followed by a protected Fisher’s least significant difference (LSD) post hoc analysis.  
Data presented as mean± SEM. LBWf-NF n=4; LBWf-HF n=4; HBWf-NF n=4, 
HBWf-HF n=5. 
 
 
 
 
 
 
 
 
 
 
 
 LBWf-NF1 LBWf-HF2 HBWf-NF3 HBWf-HF4 P value 
 
 
 
Total 
WAT 
(g) 
 
 
 
2.823±0.755 
 
 
 
6.964±1.709 
 
 
 
2.498±0.052 
 
 
 
5.565±0.687 
1 vs.2=0.013 
 
3vs.4=0.05 
 
1vs.3=0.835 
 
2vs.4=0.319 
 
 
 
 
Total 
WAT 
% 
 
 
 
10.252±2.092 
 
 
 
19.311±3 
 
 
 
8.723±0.528 
 
 
 
16.537±0.527 
1 vs.2=0.005 
 
3vs.4=0.014 
 
1vs.3=0.602 
 
2vs.4=0.29 
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Subcutaneous adipose tissue in grams was, as in males, higher in mice fed a 
HF compared to mice fed a NF diet (LBWf-HF vs. LBWf-NF p=0.021; 
HBWf-HF vs. HBWf-NF p=0.041; table 5.4.1.2.2 and figure 5.4.1.2.2). NF 
fed female mice did not differed significantly (LBWf-NF vs. HBWf-NF 
p=0.744; table 5.4.1.2.2 and figure 5.4.1.2.2) as well as HF fed mice (LBWf-
HF vs. HBWf-HF p=0.587; table 5.4.1.2.2 and figure 5.4.1.2.2).  
 
After normalisation to current body weight, SAT % was again significantly 
different in mice fed a HF (LBWf-HF vs. LBWf-NF p=0.039; HBWf-HF vs. 
HBWf-NF p=0.022; table 5.4.1.2.2 and figure 5.4.1.2.3). NF fed female mice 
did not differed significantly (LBWf-NF vs. HBWf-NF p=0.529; table 5.4.1.2.2 
and figure 5.4.1.2.3) as well as HF fed female mice (LBWf-HF vs. HBWf-HF 
p=0.868; table 5.4.1.2.2 and figure 5.4.1.2.3).  
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Table 5.4.1.2.2 Subcutaneous white adipose tissue (SAT) mass from female mice 
fed a NF and a HF diet. SAT (g)= subcutaneous adipose tissue in grams, SAT (%)= 
subcutaneous adipose tissue mass normalised to current body weight and 
presented as percentage. Statistical analysis was performed using a one-way 
ANOVA test followed by a protected Fisher’s least significant difference (LSD) post 
hoc analysis.  Data presented as mean± SEM. LBWf-NF n=4; LBWf-HF n=4; 
HBWf-NF n=4, HBWf-HF n=5. 
 
 
 
Gonadal adipose tissue mass in female mice was lower compared to male 
mice in all the groups (tables 5.4.1.1.3 and 5.4.1.2.3 and figures 5.4.1.1.2 
and 5.4.1.2.2). This fat depot mass was only significantly different between 
LBWf-HF vs. LBWf-NF (p=0.046). Moreover, the significance was 
maintained when normalising to current body weight (gonadal %; p=0.045). 
Although the difference between female mice fed was marginally significant, 
LBWf-HF had a two fold increase compared to HBWf-HF (p=0.076; table 
5.4.1.2.3 and figure 5.4.1.2.3). 
 LBWf-NF1 LBWf-HF2 HBWf-NF3 HBWf-HF4 P value 
 
 
SAT 
(g) 
 
 
1.6±0.474 
 
 
3.597±0.475 
 
 
1.338±0.024 
 
 
3.183±0.288 
 
1 vs.2=0.021 
3vs.4=0.041 
1vs.3=0.744 
2vs.4=0.587 
 
 
SAT
% 
 
 
5.802±1.354 
 
 
9.542±1.551 
 
 
4.683±0.348 
 
 
9.269±0.601 
 
1 vs.2=0.039 
3vs.4=0.022 
1vs.3=0.529 
2vs.4=0.868 
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Retroperitoneal fat (g) was significantly higher in females fed a HF (LBWf-HF 
vs. LBWf-NF p=0.009; HBWf-HF vs. HBWf-NF p<0.001; table 5.4.1.2.3 and 
figure 5.4.1.2.2).	   Furthermore, there was a significant difference between 
those mice fed a HF diet with LBWf-HF having a lower fat depot compared 
to HBWf-HF (p=0.02; table 5.4.1.2.3 and figure 5.4.1.2.2). Mice fed a NF 
were not significantly different (LBWf-NF vs. HBWf-NF p=0.938). Similar 
differences were maintained after normalisation to current body weight (table 
5.4.1.2.3 and figure 5.4.1.2.3). 
 
Mesenteric adipose tissue was significantly different between diets in both 
grams and relative values (%), with a higher mass in those females fed a HF 
diet (in grams: LBWf-HF vs. LBWf-NF p=0.017; HBWf-HF vs. HBWf-NF 
p=0.011; table 5.4.1.2.3 and figure 5.4.1.2.2; as percentage: (LBWf-HF vs. 
LBWf-NF p=0.032; HBWf-HF vs. HBWf-NF p=0.004; table 5.4.1.2.3 and 
figure 5.4.1.2.3). 
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Table 5.4.1.2.3 Regional internal fat depots mass from female mice fed a NF and a 
HF diet. Gonadal, retroperitoneal and mesenteric fat depots mass in grams (g), and 
normalised to current body weight and presented as percentage (%). IAT= internal 
adipose tissue mass as the sum of gonadal, retroperitoneal and mesenteric fat 
depots. Statistical analysis was performed using a one-way ANOVA test followed by 
a protected Fisher’s least significant difference (LSD) post hoc analysis.  Data 
presented as mean± SEM. LBWf-NF n=4; LBWf-HF n=4; HBWf-NF n=4, HBWf-HF 
n=5. 
 LBWf-NF1 LBWf-HF2 HBWf-NF3 HBWf-HF4 P value 
 
Gonadal 
(g) 
 
0.473±0.134 
 
1.92±0.663 
 
0.516±0.028 
 
0.876±0.296 
1 vs.2=0.046 
3vs.4=0.584 
1vs.3=0.951 
2vs.4=0.107 
 
 
Gonadal
% 
 
1.841±0.332 
 
4.92±1.351 
 
1.791±0.026 
 
2.45±0.551 
1 vs.2=0.045 
3vs.4=0.635 
1vs.3=0.973 
2vs.4=0.076 
 
 
Retrop. 
(g) 
 
0.335±0.089 
 
0.765±0.135 
 
0.323±0.005 
 
1.137±0.091 
1 vs.2=0.009 
3vs.4<0.001 
1vs.3=0.938 
2vs.4=0.02 
 
 
Retrop. 
% 
 
1.228±0.275 
 
2.029±0.19 
 
1.129±0.071 
 
3.119±0.237 
1 vs.2=0.031 
3vs.4<0.001 
1vs.3=0.786 
2vs.4=0.004 
 
 
Mesent. 
(g) 
 
0.341±0.096 
 
0.681±0.099 
 
0.32±0.017 
 
0.697±0.08 
1 vs.2=0.017 
3vs.4=0.011 
1vs.3=0.879 
2vs.4=0.89 
 
 
Mesent. 
(%) 
 
1.225±0.272 
 
1.852±0.207 
 
1.119±0.097 
 
2.061±0.132 
1 vs.2=0.032 
3vs.4=0.004 
1vs.3=0.715 
2vs.4=0.413 
 
 
IAT (g) 
 
1.218±0.291 
 
3.367±0.885 
 
1.159±0.036 
 
3.022±0.443 
1 vs.2=0.017 
3vs.4=0.045 
1vs.3=0.944 
2vs.4=0.659 
 
 
IAT% 
 
4.45±0.783 
 
8.8±1.656 
 
4.039±0.18 
 
8.245±1.077 
1 vs.2=0.02 
3vs.4=0.028 
1vs.3=0.82 
2vs.4=0.724 
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Evaluation of the total internal adipose tissue as the sum of the gonadal, 
retroperitoneal and mesenteric fat depots showed the diet had a major 
impact in the distribution of internal adipose. Female mice had the highest 
amount of IAT in both grams and as percentage of the current body weight  
(in grams: LBWf-HF vs. LBWf-NF p=0.017; HBWf-HF vs. HBWf-NF 
p=0.045; table 5.4.1.2.3 and figure 5.4.1.2.2; as percentage: (LBWf-HF vs. 
LBWf-NF p=0.02; HBWf-HF vs. HBWf-NF p=0.028; table 5.4.1.2.3 and 
figure 5.4.1.2.3). 
 
A comparison of the ratio of IAT to SAT tissue mass between the female 
groups showed not significant difference (table 5.4.1.2.4).  
 
Table 5.4.1.2.4 Ratio of internal adipose tissue and subcutaneous adipose tissue 
from female mice fed a NF and a HF diet. IAT= Internal adipose tissue (as the sum 
of gonadal, retroperitoneal and mesenteric fat depots mass). Statistical analysis 
was performed using a one-way ANOVA test followed by a Tukey High significance 
difference (HSD) post hoc analysis.  Data presented as mean± SEM. LBWf-NF 
n=4; LBWf-HF n=4; HBWf-NF n=4, HBWf-HF n=5. 
 
 
 LBWf-NF1 LBWf-HF2 HBWf-NF3 HBWf-HF4 P value 
 
 
IAT:SAT 
 
 
0.802±0.062 
 
 
0.918±0.055 
 
 
0.866±0.024 
 
 
0.84±0.177 
 
1 vs.2=0.853 
3vs.4=0.998 
1vs.3=0.975 
2vs.4=0.949 
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Figure 5.4.1.2.2 White adipose tissue mass from female and male mice fed a NF 
and a HF diet at week 51. Total WAT= total white adipose tissue, 
SAT=subcutaneous adipose tissue, IAT= internal adipose tissue as the sum of 
gonadal, retroperitoneal and mesenteric fat depots. Significant differences in the 
figure correspond to mice fed a HF diet against mice fed a NF diet (LBWf/m-HF vs. 
LBWf/m-NF and HBWf/m-HF vs. HBWf/m-NF), except from gonadal fat between 
HBWf-HF vs. HBWf-NF a). The differences between mice fed a NF as between 
mice fed a HF diet were not significantly different in female and male mice, except 
from retroperitoneal fat depots in the female group, which were significantly different 
between mice fed a HF diet (p=0.02). Statistical analysis was performed using a 
one-way ANOVA test followed by a protected Fisher’s least significant difference 
(LSD) post hoc analysis.  Data presented as mean± SEM. LBWf-NF n=4; LBWf-HF 
n=4; HBWf-NF n=4, HBWf-HF n=5; LBWm-NF n=4; LBWm-HF n=10; HBWm-NF 
n=5, HBWm-HF n=6. * p≤0.05, ** p≤0.01, *** p≤0.001. 
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Figure 5.4.1.2.3 White adipose tissue mass normalised to current body weight (%) 
from female and male mice fed a NF and a HF diet at week 51. Total WAT= total 
white adipose tissue, SAT=subcutaneous adipose tissue, IAT= internal adipose 
tissue as the sum of gonadal, retroperitoneal and mesenteric fat depots. Significant 
differences in the figure correspond to mice fed a HF diet against mice fed a NF diet 
(LBWf/m-HF vs. LBWf/m-NF and HBWf/m-HF vs. HBWf/m-NF), except from 
gonadal fat between HBWf-HF vs. HBWf-NF a). The differences between mice fed 
a NF as between mice fed a HF diet were not significantly different, except from 
retroperitoneal fat depots, which were significantly different between female mice 
fed a HF diet (p=0.004) a) as well as SAT between LBWm-HF vs. HBWm-HF 
p=0.035 b). Statistical analysis was performed using a one-way ANOVA test 
followed by a protected Fisher’s least significant difference (LSD) post hoc analysis. 
Data presented as mean± SEM. LBWf-NF n=4; LBWf-HF n=4; HBWf-NF n=4, 
HBWf-HF n=5; LBWm-NF n=4; LBWm-HF n=11; HBWm-NF n=5, HBWm-HF n=6. 
* p≤0.05, ** p≤0.01, *** p≤0.001. 
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5.5 The Effects of Birth Weight and Diet on Adipocyte Size 
Distribution in Matured Mice  (51 weeks old) 
 
Subcutaneous and gonadal adipose tissues from male mice were subdivided 
at the time of collection: approximately 50-60mg of tissue were used for 
adipocyte extraction and the remained tissue was stored at -80°C for further 
analysis. Detailed information of the protocol can be found in section 2.4.6. 
Adipocyte distribution assessment was performed in males only. 
 
Assessment of adipocyte number per gram of gonadal adipose tissue 
showed that mice fed a HF diet had a lower number of adipocytes per gram 
of tissue and no differences were seen between mice fed a NF diet (LBWm-
NF vs. LBWm-HF p=0.016; HBWm-NF vs. HBWm-HF p= 0.007; LBWm-NF 
vs. HBWm-NF p=0.35; figure 5.5.1.1a). No differences were found between 
mice fed a HF diet (LBWm-HF vs. HBWm-HF p=0.384; figure 5.5.1a). This 
result may suggest that HF fed mice had bigger adipocytes per gram of 
tissue compared to the mice fed a NF diet and therefore, appears as having 
a lower number of cells per gram. However, when analysing cell number per 
fat depot, the significant difference disappeared as well as the pattern. Mice 
fed a HF diet had a higher adipocytes number compared to NF fed mice but 
there was not a statistical significance between groups (LBWm-HF vs. 
LBWm-NF p=0.265; HBWm-HF vs. HBWm-NF p=0.619; figure 5.5.1b).  
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Figure 5.5.1 Adipocyte number in gonadal adipose tissue from male mice. 
Adipocyte number expressed as per gram of tissue extracted (adipocyte 
number/gram tissue) a), and multiply by the amount of total gonadal tissue per 
mouse per group b). Statistical analysis was performed using a one-way ANOVA 
test followed by a protected Fisher’s least significant difference (LSD) post hoc 
analysis. Data presented as mean± SEM. LBWm-NF n=3; LBWm-HF n=6; HBWm-
NF n=5, HBWm-HF n=6. * p≤0.05, ** p≤0.01. 
 
 
Assessment of subcutaneous adipose tissue showed a different pattern. 
There was a significant difference between HBWm mice with HBWm-NF 
having a higher number of adipocytes than HBWm-HF (HBWm-NF vs. 
HBWm-HF p=0.006; figure 5.5.2a). No difference was seen between LBWm 
mice (LBWm-NF vs. LBWm-HF p=0.679; figure 5.5.2a) or between mice fed 
a HF diet (LBWm-HF vs. HBWm-HF p=0.143; figure 5.5.2a). LBWm mice 
had a higher number of adipocytes compared to HBWm-NF but the 
difference was marginally significant (LBWm-NF vs. HBWm-NF p=0.07; 
figure 5.5.2a).  
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Evaluation of subcutaneous adipose tissue per total amount of fat depot 
showed a similar pattern as seen in gonadal adipose tissue. Mice fed a HF 
diet had a higher adipocytes number compared to NF fed mice and the 
difference between LBWm mice was significant, whilst the difference 
between HBWm mice was marginally significant (LBWm-HF vs. LBWm-NF 
p<0.001; HBWm-HF vs. HBWm-NF p=0.061; figure 5.5.2b). 
 
 
Figure 5.5.2 Adipocyte number in subcutaneous adipose tissue from male mice. 
Adipocyte number expressed as per gram of tissue extracted (adipocyte 
number/gram tissue) a), and multiply by the amount of total gonadal tissue per 
mouse per group b). Statistical analysis was performed using a one-way ANOVA 
test followed by a protected Fisher’s least significant difference (LSD) post hoc 
analysis. Data presented as mean± SEM. LBWm-NF n=3; LBWm-HF n=6; HBWm-
NF n=5, HBWm-HF n=6.  ** p≤0.01,*** p≤0.001. 
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After assessing adipocyte number in both gonadal and subcutaneous 
adipose tissue, an analysis of the relative frequency of cell size distribution 
(%) was performed in order to see whether there was any difference in size 
between groups in both adipose tissues.  
 
There was a general bimodal distribution (two separated populations) of cells 
in all groups when assessing gonadal adipose tissue. Assessment of the 
nadir showed that the nadir of LBWm-NF group was 48.667± 3.167µm whilst 
the nadir of LBWm-HF group was 71±2.449µm (p=0.001; figure 5.5.3a). 
HBWm-NF mice had a significantly lower nadir than HBWm-HF (HBWm-NF 
=46.25±3.146µm vs. HBWm-HF= 60±5µm, p=0.018; figure 5.5.3b) but it was 
similar nadir as LBWm-NF mice (p=0.662; figure 5.5.3c). HBWm-HF nadir 
was significantly lower than LBWm-HF mice (p=0.039; figure 5.5.3d).  
 
The percentages of cells below the nadir were designated as small 
adipocytes and above the nadir as the large adipocytes. LBWm-HF mice 
had the highest percentage of adipocytes below the nadir (44.718±3.801%) 
and it was significantly different when compared to LBWm-NF 
(14.172±2.831%; p<0.001; figure 5.5.3a) and against HBWm-HF mice 
(24.713±3.225%, p<0.001; figure 5.5.3d). Moreover, HBWm-HF had a 
higher percentage of adipocytes below the nadir than HBWm-NF 
(9.999±0.484%; p=0.008; figure 5.5.3b). No differences were found between 
mice fed a NF diet (p=0.45; figure 5.5.3c).  
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The small to large adipocytes ratio was higher in mice fed a HF diet than 
mice fed a NF diet (LBWm-HF=0.965±0.161 vs. LBWm-NF=0.16±0.029, 
p=0.014; HBWm-HF= 0.256±0.077 vs. HBWm-NF=0.115±0.005, p=0.046). 
At the same time, LBWm-HF had a significantly higher ratio than HBWm-HF 
(p=0.023).  
 
It was noticed that the peak diameter of large adipocytes in mice fed a HF 
diet was shifted to the right when compared to the mice fed a NF diet 
(LBWm-HF=105µm vs. LBWm-NF=88.333±3.333µm, p<0.001; figure 
5.5.3a; HBWm-HF= 105µm vs. HBWm-NF=87.5±2.5µm, p<0.001; figure 
5.5.3b). This means that a HF diet increased the diameter of adipocytes in 
mice at the same time that had a higher number of small adipocytes. No 
differences were seen between mice fed a NF diet or a HF (LBWm-NF vs. 
HBWm-NF p=0.746; figure 5.5.3c; LBWm-HF vs. HBWm-HF p=1.0; figure 
5.5.3d). 
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Figure 5.5.3 Frequency distribution (%) of adipocytes extracted from gonadal 
adipose tissue from male mice fed both a NF and HF diet. Arrowheads indicate the 
nadir of each group, which corresponds to the lowest point between two populations 
of adipocytes (small-large adipocytes). Headless arrows indicate the peak diameter 
of large adipcoytes in each group. Statistical analysis was performed using a 
Kruskal-Wallis test followed by a Mann-Whitney test for range analysis. Data 
presented as median with interquartile range (25%-75%). LBWm-NF n=3; LBWm-
HF n=6; HBWm-NF n=5, HBWm-HF n=6.  * p≤0.05,**p≤0.01. 
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Analysis of the relative frequency of cell size distribution (%) of 
subcutaneous adipose showed a general bimodal distribution (two separated 
populations) of adipocytes in all groups as it was seen in gonadal adipose 
tissue. Assessment of the nadir showed no differences between different 
diets (LBWm-NF=38.333± 3.333µm vs. LBWm-HF= 45±3.087µm (p=0.412; 
figure 5.5.4a; HBWm-NF=43±2µm vs. HBWm-HF=43.333±1.666µm, 
p=0.999; figure 5.5.4b) or between different birth weights (LBWm-NF vs. 
HBWm-NF p=0.723; figure 5.5.4c; LBWm-HF vs. HBWm-HF p=0.96; figure 
5.5.4d). 
  
The percentages of cells below the nadir (small adipocytes) was no different 
between diets (LBWm-NF=18.044± 3.39% vs. LBWm-HF= 21.676±3.15% 
(p=0.872; figure 5.5.4a; HBWm-NF=12.747±1.339% vs. HBWm-
HF=16.122±1.605%, p=0.874; figure 5.5.1.4b) or between different birth 
weights (LBWm-NF vs. HBWm-NF p=0.753; figure 5.5.4c; LBWm-HF vs. 
HBWm-HF p=0.496; figure 5.5.4d).  
 
The small to large adipocytes ratio was no different between groups (LBWm-
NF=0.228± 0.051 vs. LBWm-HF= 0.309±0.593, p=0.789; HBWm-
NF=0.202±0.052 vs. HBWm-HF=0.2104±0.109, p=0.999; LBWm-NF vs. 
HBWm-NF p=0.993; LBWm-HF vs. HBWm-HF p=0.517).  
 
Assessment of the peak diameter of large adipocytes showed a similar 
pattern as seen in the gonadal fat. The peak diameter of large adipocytes in 
mice fed a HF diet was shifted to the right when compared to the mice fed a 
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NF diet (LBWm-HF=87.857±5.654µm vs. LBWm-NF=58.333±4.409µm, 
p<0.001; figure 5.5.4a; HBWm-HF= 90±2.236µm vs. HBWm-NF=65µm, 
p=0.001; figure 5.5.4b). This means that a HF diet increased the diameter of 
adipocytes in mice but contrary to gonadal adipose tissue, it was not 
accompanied by a higher number of small adipocytes. No differences were 
seen between mice fed a NF diet or a HF (LBWm-NF vs. HBWm-NF 
p=0.361; figure 5.5.4c; LBWm-HF vs. HBWm-HF p=0.697; figure 5.5.4d).  
 
A further investigation on the differences between subcutaneous and 
gonadal fat adipocytes distribution within the same groups showed that 
subcutaneous adipose tissue nadir was higher in most of the groups in 
respect to gonadal adipose tissue (figures 5.5.5). Only HBWm-NF had a 
similar nadir in both fat depots (figures 5.5.5c).  
 
Comparisons of percentages between gonadal and subcutaneous fat 
showed a significantly lower percentage of small cells in the subcutaneous 
fat of LBWm-HF mice compared to gonadal fat (21.676±3.15% vs. 
44.718±3.801% p=0.001; figure 5.5.5b). The difference between HBWm-HF 
subcutaneous and gonadal fat depots was marginally significant 
(16.122±1.605% vs. 24.713±3.225% respectively, p=0.082; figure 5.5.5d). 
No differences were found between LBWm-NF subcutaneous and gonadal 
fat depots (18.044± 3.39% vs. 14.172±2.831% respectively, p=0.43; figure 
5.5.5a) or between HBWm-NF fat depots (12.747±1.339% vs. 
9.999±0.484%, p=0.15; figure 5.5.5c). 
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LBWm-HF subcutaneous adipocytes ratio (small to large adipocytes ratio) 
was significantly lower compared to the gonadal ratio (0.309±0.059 vs. 
0.965±0.161 respectively). This means that there were a higher number of 
small adipocytes in the gonadal fat of this group compared to their 
subcutaneous fat. No differences were seen between both fat depots within 
the others groups (LBWm-NF subcutaneous cell ratio: 0.228±0.051 vs. 
gonadal cell ratio: 0.16±0.029, p=0.311; HBWm-NF subcutaneous 
adipocytes ratio: 0.202 ±0.052 vs. gonadal cell ratio: 0.115±0.005, p=0.186; 
HBWm-HF subcutaneous adipocytes ratio: 0.2104±0.045 vs. gonadal 
adipocytes ratio: 0.256±0.077, p=0.451). 
 
 
Interestingly, the peak diameter of large adipocytes in subcutaneous adipose 
tissue was significantly lower compared to the peak of large adipocytes in 
gonadal adipose tissue within the groups (LBWm-NF subcutaneous large 
adipocytes peak: 58.333±4.409µm vs. gonadal large adipocytes peak: 
88.333±3.333µm, p=0.006; figure 5.5.1.5a; HBWm-NF subcutaneous large 
adipocytes peak: 65µm vs. gonadal large adipocytes peak: 87.5±2.5µm, 
p=0.003; figure 5.5.5c; LBWm-HF subcutaneous large adipocytes peak: 
93.333±1.666µm vs. gonadal large adipocytes peak: 105µm, p=0.001; figure 
5.5.5b; HBWm-HF subcutaneous large adipocytes peak: 90±2.236µm vs. 
gonadal large adipocytes peak: 105µm, p=0.001; figure 5.5.5d). 
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Figure 5.5.4 Frequency distribution (%) of adipocytes extracted from subcutaneous 
adipose tissue from male mice fed both a NF and HF diet. Arrowheads indicate the 
nadir of each group, which corresponds to the lowest point between two populations 
of cells (small-large adipocytes). Headless arrows indicate the peak diameter of 
large adipocytes in each group. Statistical analysis was performed using a Kruskal-
Wallis test followed by a Mann-Whitney test for range analysis. Data presented as 
median with interquartiles range (25%-75%). LBWm-NF n=3; LBWm-HF n=6; 
HBWm-NF n=5, HBWm-HF n=6.  * p≤0.05,**p≤0.01. 
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Figure 5.5.5 Frequency distribution (%) of adipocytes extracted from gonadal and 
subcutaneous adipose tissue of male mice fed both a NF and HF diet. Arrowheads 
indicate the nadir of each group, which corresponds to the lowest point between two 
populations of cells (small-large adipocytes). Headless arrows indicate the peak 
diameter of large adipcytes in each group. g= gonadal fat tissue, sub=subcutaneous 
adipose tissue. Statistical analysis was performed using a Kruskal-Wallis test 
followed by a Mann-Whitney test for range analysis. Data presented as median with 
interquartiles range (25%-75%). LBWm-NF n=3; LBWm-HF n=6; HBWm-NF n=5, 
HBWm-HF n=6.  * p≤0.05, **p≤0.01. 
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5.6 The Effects of Birth Weight and Diet on Metabolic Markers 
in Matured Mice  (51 weeks old) 
 
Plasma samples were used to assess metabolic markers in both male and 
female mice at week 51 after 36 weeks of dietary intervention. Samples were 
collected in a postprandial state.  
 
5.6.1 Metabolic markers in Male mice 
Whole blood glucose levels were similar between all the groups, although a 
marginal difference was seen between HBWm mice: HBWm-HF= 11.42 
±0.591mmol/L, HBWm-NF=9.933 ±0.569mmol/L p=0.067; LBWm-
HF=11.237 ±0.244mmol/L vs. LBWm-NF=10.167 ±0.775mmol/L p=0.586; 
LBWm-NF vs. HBWm-NF p=0.785; LBWm-HF vs. HBWm-HF p=0.76. 
 
Markers related to insulin secretion and insulin stimulation/regulation such as 
C-peptide, GIP and glucagon were not significantly different between groups 
(figure 5.6.1.1 and table 5.6.1.1). However, natural log values of insulin 
concentration in plasma were significantly different between HBWm mice 
only:  HBWm-NF vs. HBWm-HF p=0.035 (figure 5.6.1.1 and table 5.6.1.1). 
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Figure 5.6.1.1 Metabolic markers in plasma from male mice fed both a NF and HF 
diet. This figure shows some metabolic markers related to insulin secretion and 
stimulation/regulation such as c-peptide a), GIP b) and glucagon c), as well as 
levels of insulin in plasma. Insulin values were positively skewed for some of the 
groups and therefore, the data was natural log transformed before the analysis. 
Results for Ln (natural log) insulin are presented as mean with 95% confidence 
interval (CI). Statistical analysis was performed using a one-way ANOVA test 
followed by a protected Fisher’s least significant difference (LSD) post hoc analysis 
for c-peptide, GIP and glucagon. Data presented as mean± SEM. LBWm-NF n=4; 
LBWm-HF n=9; HBWm-NF n=4, HBWm-HF n=6. *p≤0.05. 
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The gut peptide ghrelin was affected by the different diet given to the mice; 
male mice fed NF had a higher ghrelin concentration in plasma compared to 
the male mice fed a HF diet. LBWm-NF vs. LBWm-HF p=0.016; HBWm-NF 
vs. HBWm-HF p=0.013. Differences were similar between groups of different 
that were fed the same diet LBWm-NF vs. HBWm-NF p=0.491; LBWm-HF 
vs. HBWm-HF p=0.286 (figure 5.6.1.2 and table 5.6.1.1).  
 
 
Figure 5.6.1.2 Ghrelin levels in plasma from male mice fed both a NF and HF diet. 
Statistical analysis was performed using a one-way ANOVA test followed by a 
protected Fisher’s least significant difference (LSD) post hoc analysis. Data 
presented as mean± SEM. LBWm-NF n=4; LBWm-HF n=9; HBWm-NF n=4, 
HBWm-HF n=6.  *p≤0.05. 
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Adipokines such as leptin and resistin were generally higher in mice fed HF 
but only reached significance between LBWm mice: (leptin: LBWm-HF vs. 
LBWm-NF p=0.022; HBWm-HF vs. HBWm-NF p=0.072; resistin: LBWm-HF 
vs. LBWm-NF p=0.033; HBWm-HF vs. HBWm-NF p=0.837; figure 5.6.1.3 
and table 5.6.1.1). Resistin was marginally significant between mice fed a HF 
diet, with LBWm-HF having a higher level compared to HBWm-HF (p=0.064 
figure 5.6.1.3 and table 5.6.1.1). 
 
 
Figure 5.6.1.3 Leptin and resistin levels in plasma from male mice fed both a NF 
and HF diet. Statistical analysis was performed using a one-way ANOVA test 
followed by a protected Fisher’s least significant difference (LSD) post hoc analysis. 
Data presented as mean± SEM. LBWm-NF n=4; LBWm-HF n=9; HBWm-NF n=4, 
HBWm-HF n=6.  *p≤0.05. 
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Proinflammatory cytokines markers such as IL-6 and MCP-1 were also 
assessed. IL-6 was higher in mice fed a HF but the differences only reached 
significance between HBWm mice. Moreover, HBWm-HF mice had a higher 
level of IL-6 compared to LBWm-HF mice (HBWm-HF vs. HBWm-NF 
p<0.001; LBWm-HF vs. LBWm-NF p=0.445; HBWm-HF vs. LBWm-HF 
p=0.017 figure 5.6.1.4 and table 5.6.1.1). MCP-1 did not differed significantly 
between groups (figure 5.6.1.4 and table 5.6.1.1). 
 
 
Figure 5.6.1.4 Proinflammatory markers in plasma from male mice fed both a NF 
and HF diet. Statistical analysis was performed using a one-way ANOVA test 
followed by a protected Fisher’s least significant difference (LSD) post hoc analysis. 
Data presented as mean± SEM. LBWm-NF n=4; LBWm-HF n=9; HBWm-NF n=4, 
HBWm-HF n=6.  *p≤0.05,***p≤0.001. 
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Table 5.6.1.1 Metabolic markers measured in plasma from male mice fed both a NF 
and a HF diet at week 51 of age. GIP= glucose dependant- insulinotropic peptide, 
IL6= interleukine 6, MCP-1= monocyte chemotactic peptide 1. Insulin values were 
positively skewed for some of the groups and therefore, the data was natural log 
transformed before the analysis. Results for Ln (natural log) insulin are presented 
as mean with 95% confidence interval (CI). Statistical analysis was performed using 
a one-way ANOVA test followed by a protected Fisher’s least significant difference 
(LSD) post hoc analysis. Data presented as mean± SEM. LBWm-NF n=4; LBWm-
HF n=9; HBWm-NF n=4, HBWm-HF n=6.  
 LBWm-NF1 LBWm-HF2 HBWm-NF3 HBWm-
HF4 
P value 
 
C-peptide 
pg/ml 
 
1303.034 
±131.658 
 
1696.258 
±164.892 
 
1260.298 
±110.689 
 
1368.484 
±173.369 
1 vs.2=0.504 
3vs.4=0.977 
1vs.3=0.331 
2vs.4=0.46 
 
GIP 
pg/ml 
 
97.46 
±21.852 
 
83.784 
±17.606 
 
61.433 
±16.247 
 
49.065 
±7.034 
1 vs.2=0.959 
3vs.4=0.97 
1vs.3=0.673 
2vs.4=0.46 
 
Glucagon 
pg/ml 
 
77.456 
±21.81 
 
104.905 
±24.273 
 
55.439 
±9.258 
 
69.947 
±18.817 
1 vs.2=0.882 
3vs.4=0.984 
1vs.3=0.955 
2vs.4=0.665 
 
Insulin 
(Ln) 
 
 
5.863 
(5.042-6.685) 
 
6.528 
(6.22-6.84) 
 
5.257 
(3.108-7.406) 
 
6.367 
(5.817-
6.448) 
1 vs.2=0.098 
3vs.4=0.035 
1vs.3=0.466 
2vs.4=0.605 
 
Ghrelin 
pg/ml 
 
693.819 
±85.577 
 
406.148 
±49.611 
 
607.407 
±129.488 
 
307.234 
±29.452 
1 vs.2=0.016 
3vs.4=0.013 
1vs.3=0.491 
2vs.4=0.286 
 
Leptin 
pg/ml 
 
2284.774 
±873 
 
6271.472 
±794.119 
 
2935.85 
±777.344 
 
5840.955 
±851.068 
1 vs.2=0.022 
3vs.4=0.072 
1vs.3=0.721 
2vs.4=0.738 
 
Resistin 
pg/ml 
 
8092.363 
±862.868 
 
13831.979 
±1545.701 
 
 
 
9432.845 
±703.675 
 
9924.049 
±1657.524 
1 vs.2=0.033 
3vs.4=0.837 
1vs.3=0.637 
2vs.4=0.064 
Il-6 
pg/ml 
 
15.266 
±6.285 
 
21.773 
±4.209 
 
7.702 
±3.059 
 
38.149 
±4.865 
1 vs.2=0.445 
3vs.4<0.001 
1vs.3=0.393 
2vs.4=0.017 
MCP-1 
pg/ml 
 
41.948 
±13.658 
 
 
49.997 
±9.339 
 
47.696 
±18.757 
 
47.26 
±9.089 
1 vs.2=0.971 
3vs.4=0.999 
1vs.3=0.992 
2vs.4=0.998 
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5.6.2 Metabolic markers in Female mice 
Female mice had significant differences between groups. LBWf mice had 
significantly higher levels of glucose than HBWf mice fed a NF diet (LBWf-
NF= 9.65±0.328mmol/L vs. HBWf-NF= 6.767±1.197mmol/L p=0.04) but 
differences did not reach significance between females fed a HF diet (LBWf-
HF=10.733±0.338mmol/L    vs.     HBWf-HF=9.35±0.3778mmol/L, p=0.203). 
Also, although diet affected HBWf mice (HBWf-HF vs. HBWf-NF, p=0.028), 
it did not affect LBWf mice (LBWf-HF=10.733±0.338mmol/L vs. LBWf-
NF=9.65±0.328mmol/L p=0.11). 
 
C-peptide levels and GIP were not significantly different between groups 
(figure 5.6.2.1a-b and table 5.6.2.1). However, the plasmatic levels of 
glucagon were significantly higher in LBWf-NF mice compared to HBWf-NF 
mice (p=0.009; figure 5.6.2.1c and table 5.6.2.1) and in the HBWf-HF mice 
compared to HBWf-NF mice (p=0.012; figure 5.6.2.1c and table 5.6.2.1). 
These significances were not seen between male groups (figure 5.6.1.1 and 
table 5.6.1.1).  Insulin was not significantly different between groups (figure 
5.6.2.1d and table 5.6.2.1). In the male group there was a significant 
difference between HBWm mice (figure 5.6.1.1d and table 5.6.1.1), whilst 
HBWf mice tended to have a very similar level of insulin.  
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Figure 5.6.2.1 Metabolic markers in plasma from female mice fed both a NF and HF 
diet. This figure shows some metabolic markers related to insulin secretion and 
stimulation/regulation such as c-peptide a), GIP b) and glucagon c), as well as 
levels of insulin in plasma. Statistical analysis was performed using a one-way 
ANOVA test followed by a protected Fisher’s least significant difference (LSD) post 
hoc analysis. Data presented as mean± SEM. LBWf-NF n=4; LBWf-HF n=3; HBWf-
NF n=4, HBWf-HF n=5. **p≤0.01. 
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The gut peptide ghrelin was not significantly different between groups. 
However, levels between HBWf-NF vs. HBWf-HF were marginally significant 
(p=0.068; figure 5.6.2.2 and table 5.6.2.1). The pattern seen between the 
female groups was similar to that seen between the male groups, but 
differences were more marked between males (figure 5.6.1.2 and table 
5.6.1.1). 
 
 
Figure 5.6.2.2 Ghrelin levels in plasma from female mice fed both a NF and HF diet. 
Statistical analysis was performed using a one-way ANOVA test followed by a 
protected Fisher’s least significant difference (LSD) post hoc analysis. Data 
presented as mean± SEM. LBWf-NF n=4; LBWf-HF n=3; HBWf-NF n=4, HBWf-HF 
n=5.   
 
 
 
Leptin was significantly different between female mice fed a NF diet with a 
higher level in LBWf-NF mice compared to HBWf-NF mice (p=0.044; figure 
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5.6.2.3a and table 5.6.2.1). Differences were also significantly different 
between HBWf mice (HBWf-NF vs. HBWf-HF p=0.013 figure 5.6.2.3a and 
table 5.6.2.1). Resistin was not statistically significant between groups (figure 
5.6.2.3b and table 5.6.2.1). 
 
 
Figure 5.6.2.3 Leptin and resistin levels in plasma from female mice fed both a NF 
and HF diet. Statistical analysis was performed using a one-way ANOVA test 
followed by a protected Fisher’s least significant difference (LSD) post hoc analysis. 
Data presented as mean± SEM. LBWf-NF n=4; LBWf-HF n=3; HBWf-NF n=4, 
HBWf-HF n=5.  *p≤0.05, ** p≤0.01. 
 
 
 
 
 
Proniflammatory cytokine IL-6 was higher in HBWf-HF compared to HBWf-
NF (p=0.019 figure 5.6.2.4a and table 5.6.2.1) as when compared to LBWf-
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HF  (p=0.048 figure 5.6.2.4a and table 5.6.2.1). MCP-1 was not different 
between groups (figure 5.6.2.4b and table 5.6.2.1) Although HBWf-HF had a 
higher level of MCP-1 in respect to the others groups, differences were not 
significantly different (figure 5.6.2.4b and table 5.6.2.1). 
 
 
Figure 5.6.2.4 Proinflammatory markers in plasma from female mice fed both a NF 
and HF diet. Statistical analysis was performed using a one-way ANOVA test 
followed by a protected Fisher’s least significant difference (LSD) post hoc analysis. 
Data presented as mean± SEM. LBWf-NF n=4; LBWf-HF n=3; HBWf-NF n=4, 
HBWf-HF n=5.  *p≤0.05. 
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Table 5.6.2.1 Metabolic markers measured in plasma from female mice fed both a 
NF and a HF diets at week 51 of age. GIP= glucose dependant- insulinotropic 
peptide, IL6= interleukine 6, MCP-1= monocyte chemotactic peptide 1. Statistical 
analysis was performed using a one-way ANOVA test followed by a protected 
Fisher’s least significant difference (LSD) post hoc analysis. Data presented as 
mean± SEM. LBWf-NF n=4; LBWf-HF n=3; HBWf-NF n=4, HBWf-HF n=5.  
	  	  	  
5.7 Summary 
 
 LBWf-NF1 LBWf-HF2 HBWf-NF3 HBWf-HF4 P value 
 
C-peptide 
pg/ml 
 
784.769 
±128.722 
 
803.279 
±228.928 
 
1061.313 
±156.047 
 
939.224 
±127.168 
1 vs.2=0.936 
3vs.4=0.596 
1vs.3=0.244 
2vs.4=0.556 
 
GIP 
pg/ml 
 
110.906 
±30.262 
 
88.345 
±27.319 
 
113.359 
±30.824 
 
101.178 
±26.963 
1 vs.2=0.953 
3vs.4=0.991 
1vs.3=0.999 
2vs.4=0.989 
 
Glucagon 
pg/ml 
 
175.292 
±16.1 
 
139.537 
±26.31 
 
78.668 
±5.619 
 
169.457 
±25.276 
1 vs.2=0.256 
3vs.4=0.012 
1vs.3=0.009 
2vs.4=0.337 
 
Insulin  
pg/ml 
 
211.531 
±51.818 
 
498.542 
±208.695 
 
401.296 
±152.919 
 
391.105 
±117.986 
1 vs.2=0.541 
3vs.4=0.999 
1vs.3=0.799 
2vs.4=0.944 
 
Ghrelin 
pg/ml 
 
671.743 
±23.332 
 
647.17 
±126.585 
 
714.567 
±128.934 
 
447.495 
±87.049 
1 vs.2=0.855 
3vs.4=0.068 
1vs.3=0.75 
2vs.4=0.158 
 
Leptin 
pg/ml 
 
3.677.637 
±459.097 
 
5170.113 
±1448.257 
 
1114.674 
±260.278 
 
5146.828 
±608.8 
1 vs.2=0.773 
3vs.4=0.013 
1vs.3=0.044 
2vs.4=0.999 
 
Resistin 
pg/ml 
 
11875.329 
±1771.242 
 
13645.245 
±3652.078 
 
 
 
9191.403 
±1379.455 
 
15064.9926 
±3521.526 
1 vs.2=0.978 
3vs.4=0.539 
1vs.3=0.93 
2vs.4=0.539 
 
Il-6 
pg/ml 
 
7.28 
±2.475 
 
20.333 
±8.161 
 
8.518 
±3.713 
 
48.706 
±12.948 
1 vs.2=0.306 
3vs.4=0.019 
1vs.3=0.928 
2vs.4=0.019 
 
MCP-1 
pg/ml 
 
75.24 
±32.814 
 
 
32.567 
±4.929 
 
46.439 
±18.802 
 
125.089 
±33.467 
1 vs.2=0.67 
3vs.4=0.242 
1vs.3=0.888 
2vs.4=0.107 
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Mice fed a HF diet were heavier than mice fed a NF diet throughout the 
study. LBWm mice had similar body weights to HBWm mice. Similarly, 
females fed a HF diet were the heaviest and LBWf-NF mice weight was 
similar to HBWf-NF mice throughout the study. However, LBWf-HF mice did 
not catch up in weight until week 43 of age.  
 
Body weight gains and percentage of growth in male mice was mainly 
modulated by the diet, with HF fed mice gaining more weight and faster. 
Conversely, differences between female groups were not statistically 
significant.  
 
Total kilocaloric intake was not significantly different between male mice as 
well as between female mice. FE was influenced by the diet. Male mice fed a 
HF diet were more efficient in gaining weight than males fed a NF diet. This 
pattern was seen also in LBWf-HF but not for HBWf-HF mice when 
compared to their respective counterparts. 
 
Adipsoe tissue distribution was modulated by the diet only irrespective of 
birth weights. Total WAT, SAT and IAT were higher in male amd female mice 
fed a HF diet than mice fed a NF diet. Moreover, LBWm-HF mice had a 
higher level of SAT than HBWm-HF mice and LBWf-HF mice had a lower 
retroperitoneal content than HBWf-HF mice. 
 
Adipocytes number per fat depot was not different in the gonadal fat of male 
mice but in the subcutaneous adipose tissue was significantly higher in mice 
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fed a HF diet. This group of mice had larger adipocytes than NF fed mice in 
both fat depots (gonadal and subcutaneous).  LBWf-HF mice tended to have 
more small adipocytes than HBWm-HF mice. 
 
Glucose levels in a fed state were not statistically significant between male 
groups. However, LBWf-NF had higher glucose levels than HBWf-NF mice 
as well as HBWf-HF mice compared to HBWm-NF mice. Insulin was higher 
in HBWm-HF diet compared to HBWm-NF mice and no differences were 
found between other groups. In females, insulin levels were similar between 
groups. HBWm/f fed a HF diet had the highest level of IL-6 in plasma. MCP-
1 levels in plasma were not diferent between groups in both genders. 
However, it tended to be higher in HBWf-HF mice than HBWf-NF and LBWf-
HF mice.  
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   454	  
6. Discussions and Conclusion 
Epidemiological, clinical and experimental data have shown that low birth 
weight, as an indicator of prenatal development conditions, may influence 
the risk of developing health complications later in life, such as insulin 
resistance, overweight/obesity, and further metabolic syndrome and non-
insulin dependent diabetes (type 2 diabetes) (Hales, Barker et al. 1991, 
Ozanne and Hales 2002, Poore and Fowden 2004, Poore and Fowden 2004, 
Gluckman, Hanson et al. 2008).  Moreover, some studies argue that the 
influence of birth weight on the onset of the aforementioned health risks 
seemed to be conditioned to a postnatal nutritional mismatch (Gluckman and 
Hanson 2004, Gluckman and Hanson 2004).  
 
Different studies have indicated that a positive deviation from the normal 
growth trajectory for specific species is more relevant than birth weight per 
se or that the additive effect of both factors is more deleterious in later life 
(Baird J et al, 2005; Isgainitis E, Jimenez-Chillaron, 2009; Ibanez L, et al, 
2006).  
 
In the current study, a murine model based on extremes (low and high) birth 
weights combined with a postnatal diet intervention, was used in order to 
identify the changes in different phenotypes and hypothalamic neural activity 
that can be connected to possible physiological alterations. To be able to 
determine whether the changes were linked to different life stages (in 
chronological age), the study was subdivided in 3 different studies that 
covered: lactation-prepubertal period (study1), puberty-early adulthood 
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(study2) and middle age (study3).  
6.1 Body Weight, Weight Gain, Feed Efficiency and 
Kilocaloric Intake  
Body weights were lower in LBWm/f mice compared to HBWm/f mice during 
lactation and at the time of weaning (study 1) and a similar trend was seen 
after the introduction of either a NF or a HF diet from week 3 until week 15 of 
age (study 2). However, differences between males were reduced between 
weeks 9 (LBWm-NF) to 11 of age (LBWm-HF). In study 3 (from week 16 to 
week 51 of age), LBWm/f-NF mice had similar body weight to HBWm/f-NF 
mice. However, LBWm-HF mice remained smaller until week 23 than 
HBWm-HF mice and LBWf-HF mice until week 42. Similar body weight 
differences have been seen in both genders in pigs at 3 months of age 
(Poore and Fowden 2004), as well as in children and young adults (Binkin, 
Yip et al. 1988, Matthes, Lewis et al. 1996, Hediger, Overpeck et al. 1998, 
Bouhours-Nouet, Dufresne et al. 2008); although these studies did not use 
nutritional interventions as here. Additionally, studies in monozygotic twins 
have reported that twins with that were heavier at birth were also taller and 
heavier as adults (Loos, Beunen et al. 2002). As expected, HF diet increased 
the body weight in mice irrespective of birth weight.  
 
Body weight gain, measured as weight gain in grams or as acceleration in 
growth, have been indicated as a common subsequent consequence of 
growth restriction in utero, reflected in low weight at birth (Bhargava, 
Sachdev et al. 2004, Isganaitis, Jimenez-Chillaron et al. 2009). In this study, 
this observation was corroborated in LBWm mice, which had a higher weight 
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gain (accelerated growth%) than HBWm mice during lactation (study 1) and 
(as grams and accelerated growth%) at young age (study2). In study 2, the 
increment in weight gain could be partially due to the higher feed efficiency 
(FE) seen in these mice in respect to HBWm mice. Furthermore, there was 
an independent main effect of diet, with a higher weight gain in males fed a 
HF diet. This enhanced weight gain could also be attributed to a higher FE in 
these mice.  
 
Other studies, have demonstrated a higher increase in FE after introducing a 
HF diet to mice (Corbett, Stern et al. 1986, Barbosa-da-Silva, Fraulob-Aquino 
et al. 2012); although a decrease FE has also been described in a short term 
overfeeding model (Rothwell and Stock 1979, Young, Saville et al. 1982). 
Moreover, HBWm-HF mice had a higher total kilocaloric intake than HBWm-
NF mice before and after nomalisation, which indicated that hyperphagia and 
FE were, at least in part, responsible for the higher weight gain of these 
mice. However, when HBWm-HF mice were compared to LBWm-HF mice, 
the latter had a lower feed intake, indicating that LBWm-HF mice gained 
weight by having a higher FE in the presence of hypophagia.  
 
In contrast, LBWm-HF mice compared to LBWm-NF mice had a higher 
intake before normalisation but tending to have a lower feed intake after 
normalisation to metabolic body mas (bw0.75) (Tschop, Speakman et al. 
2012). Dulloo’s studies and others have shown that acceleration in growth 
after early growth restriction or during weight recovery in adults could occur 
by different control systems such as overcompensatory hyperphagia, shift in 
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fuel partitioning or increased efficiency of the metabolic machinery 
(Crescenzo, Samec et al. 2003, Dulloo 2006, Dulloo, Jacquet et al. 2006), 
and that the response could be amplified when introducing a HF diet. 
According to this, it could be suggested that LBWm-NF mice accelerated 
their growth due in part to a higher feed efficiency (FE) in the absence of 
hyperphagia, and when fed a HF diet, it was due to a higher FE in the 
presence of hypophagia, perhaps as a compensatory effect to reduce further 
weight gain.  
 
Although LBWf mice were smaller than HBWf mice, absolute weight gain (in 
grams) was similar between them; however, females fed a HF diet had a 
higher weight gain irrespectively of birth weight, as seen in males. This is in 
accordance with the kilocaloric intake, where females fed a HF diet had the 
highest intake. Accelerated growth (%) was confirmed in LBWf mice, which 
had the highest percentage of growth, but there was not a significant effect of 
diet, contrary to males. Again, the high feed efficiency seen in LBWf-HF 
mice may contribute to an enhanced weight gain in respect to LBWf-NF and 
HBWf-HF.  
 
In study 3 (from week 16 to week 51 of age), body weight gain was 
modulated mainly by the diet, being enhanced in male mice fed a HF diet. 
Although energy intake was higher in males fed a HF diet before 
normalisation, there was not a significant difference between groups after 
normalisation to metabolic body mass, indicating that the intake was 
proportional to their metabolic needs. However, FE was higher in these mice 
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and also tended to be higher in LBWm-HF in respect to HBWm-HF mice, 
which could also be related to a pattern of higher weight gain in this group. 
These results suggested that HF diet did not further amplify ingestion of food 
but affected the efficiency of gaining weight per kilocalorie consumed (FE).  
 
In the female groups, there was not a significant difference in weight gain 
between groups, although LBWf-HF mice tended to have the highest weight 
gain. The higher weight gain presented in LBWf-HF mice could be mainly 
related to their higher FE as no changes in energy intake were seen (as in 
males). 
 
FE involves many complex processes and therefore, a gross change in FE 
does not assume net changes in all the processes. Energy intake, 
digestibility of nutrients, metabolism (anabolism and catabolism), body 
composition and energy expenditure (physical activity, basal metabolic rate 
and thermoregulation as production of heat), are some of the mechanisms 
associated with FE (Herd and Arthur 2009, Harris, Patience et al. 2012). To 
be able to understand what exactly caused an increase in FE, it would be 
necessary to assess each of these mechanisms. In the present study, it was 
not possible to evaluate each of these components. However, it has been 
suggested in other studies that accelerated growth after early growth arrest 
is a phenomenon that can occur in the absence of hyperphagia and 
therefore arises the possibility that sustained reduction in energy expenditure 
per se (decrease of thermogenesis in certain organs/tissues) as a 
compensatory metabolic process for the purpose of sparing energy for catch 
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up in growth (Cettour-Rose, Samec et al. 2005). Furthermore, it has been 
argued that because the rate of carbohydrate and protein oxidation is 
determined by intake of these nutrients, whereas the rate of fat oxidation is 
determined mainly by the gap between total energy expenditure and energy 
intake, excessive weight gain (mainly fat accretion) is the natural result of a 
diet rich in fat (Flatt 1987, Barbosa-da-Silva, Fraulob-Aquino et al. 2012).  
 
Another potential mechanism suggested to be involved in gaining weight is a 
decreased physical activity (Marques, Motta et al. 2010, Barbosa-da-Silva, 
Fraulob-Aquino et al. 2012). 
 
6.2 Body Composition by MRS and MRI 
Total body adiposity measured by MRS showed that at weaning (study 1), 
LBWm/f mice had a lower adiposity than HBWm/f mice. Murine studies with 
nutritional interventions during perinatal life have demonstrated that low birth 
weight mice under caloric restriction or low protein diets during gestation and 
lactation tended to have lower body weights and lower fat deposition than 
control mice (Shepherd, Crowther et al. 1997), corroborating the results in 
the present study. However, studies on low birth weigh infants showed that 
those born small for gestational age and that underwent increased weight 
gain, and caught up in weight with controls at the postnatal stage have 
higher fat deposition (Ounsted and Sleigh 1975, Ozanne and Hales 2004, 
Ozanne, Lewis et al. 2004, Desai, Gayle et al. 2005). In the present study, 
LBWm accelerated their growth but they did not catch up in weight, which 
could partially explain the low increment in fat deposition.  
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Total fat as measured by MRI, showed a different pattern in males and 
females. Whereas total fat, as measured by MRS, IAT, SAT and internal to 
subcutaneous ratio were lower on LBWm mice, they were higher in LBWf 
mice, especially total fat, IAT and internal to subcutaneous ratio. This 
suggested that female mice had a different fat patterning than males, and it 
seems to have a higher deposition of fat in adipose tissues than in other 
areas of the body. These differences in fat deposition exclude the hormonal 
changes related to puberty as the time of evaluation was before the onset of 
puberty. Previous reports have indicated that females haver higher body 
adiposity than males at birth, and tend to have higher skin fold thicknesses 
(Rodriguez, Samper et al. 2005). Both sexes also seemed to show relative 
decreases in body fat between 1 to 6 years; however, whereas girls then 
begin to increase in fatness again, increases in boys are mainly attributed to 
lean mass (Fomon, Haschke et al. 1982, Akinyinka, Sanni et al. 1999, Wells 
2000).  
 
There was also a lower IHCL content in both LBW males and females. This 
low level of hepatic content could also due to the fact that less fat is available 
to be stored or an alteration in the production long chain fatty acids 
(Goodridge, Klautky et al. 1996).  
 
 
In study 2 (from week 3 to week 15 of age), total body adiposity was 
affected by the interaction between birth weight and diet. The measurement 
of adiposity was performed at the end of the study, when mice were 15 
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weeks old. By this time, LBWm mice caught up in weight with their 
respective counterparts. There is evidence that mammalian catch up growth 
is characterised by a disproportionately higher rate of body fat than lean 
tissue gain (Graham, Cordano et al. 1969, Castilla-Serna, Perez-Ortiz et al. 
1996, Dulloo, Jacquet et al. 2002). This is partially in accordance with the 
present study. As mentioned before, there was an interaction between 
factors, which means that the effects of birth weight depended on the diets 
given to mice and vice versa. Although there was a higher adiposity level 
(MRS) and fat content (MRI) in LBWm-NF mice compared to HBWm-NF 
mice, it was not the case for LBWm-HF mice compared to HBWm-HF mice, 
which had similar fat content. Moreover, the levels of adiposity and total body 
fat in LBWm-HF mice compared to LBWm-NF mice were higher but the 
proportions to body weight (%) were comparable. This result can suggest 
that a HF diet did not further amplify the proportion of fat accretion in LBWm 
mice at this age, which could be in part due to the adaptive effect of a 
reduction of the kilocalorie intake of LBWm-HF mice to comparable levels of 
LBWm-NF mice as a compensatory response to a relatively higher feed 
efficiency, and therefore, maintained their proportional fat accretion.  
 
In this study, HF diet led to an increase accretion in both, subcutaneous and 
internal adipose tissue; however, after normalisation to body weight the 
proportion of these regional fat depots were significantly higher only in 
HBWm-HF compared to HBWm-NF mice. Birth weight led also to the 
progression of compartmental fat deposition, but only when fed a NF diet. 
However, when assessing the internal to subcutaneous ratio, diet and birth 
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weight effect were visible. This means that LBWm mice had a higher internal 
adipose tissue in respect to subcutaneous tissue when compared to HBWm 
mice. Despite the fact that LBWm-HF mice had comparable levels of total fat 
content to HBWm-HF mice, IAT and SAT were disproportionately distributed, 
having more IAT than SAT.  
 
Previous studies have evaluated the relationship between birth weight and 
body composition at different stages of life using surrogates of body 
composition such as waist to hip ratio (WHR), skinfold thickness and BMI (in 
kg/m2). Some of these studies indicated no association between birth weight 
and BMI (Rasmussen and Johansson 1998, Kahn, Narayan et al. 2000, 
Weyer, Pratley et al. 2000, Rogers and Group 2003, Singhal, Wells et al. 
2003, Te Velde, Twisk et al. 2003); others indicated a positive association 
between the two (Gale, Martyn et al. 2001, Oken and Gillman 2003, Sayer, 
Syddall et al. 2004) and others a negative or J-U shaped association 
(Valdez, Athens et al. 1994, Fall, Osmond et al. 1995, Curhan, Willett et al. 
1996, Yarbrough, Barrett-Connor et al. 1998, Parsons, Power et al. 2001).  
 
Overall, the evidence suggests that although birth weight may be related 
positively with BMI, it is not necessarily linked to increase adiposity, as BMI 
cannot differentiate between fat-free mass and adipose tissue. Therefore, 
misleading results can result from its interpretation. A high birth weight, 
although usually related to higher BMI later in life, has been also linked to 
less body fatness assessed by skinfold thickness and DXA (Okosun, Liao et 
al. 2000, Singhal, Wells et al. 2003), which suggested that the high BMI is 
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related to a higher lean mass rather than fat mass. However, no association 
between fat mass and birth weight (Singhal, Wells et al. 2003) or a higher 
risk of obesity with a higher birth weight has been reported (Yu, Han et al. 
2011, Schellong, Schulz et al. 2012).  
 
Overall, there is not a consistent finding in the literature about the effects of 
birth weight on adiposity and fat distribution, and this is in part due to the 
different indirect measures used as surrogates of fat content. In this study, 
more precise techniques were used for the measurement of fat content such 
as MRI and MRI. Here, I demonstrated that birth weight had an inverse effect 
on the IAT:SAT ratio, and this effect was independent of the diet given during 
the study. However, there was an independent effect of diet, with HF fed 
mice having a higher IAT:SAT ratio.  
 
This suggested that either a low birth weight or a high fat diet could 
independently be a risk of a disproportional fat accretion in young mice, and 
this could be partially related to higher energy intakes and/or higher feed 
efficiencies. Moreover, it was demonstrated that intrahepatocellular lipid 
content (IHCL) was modulated by birth weight and diet per se, with a higher 
hepatic content in LBWm mice as well as in HF fed males.  
 
Interestingly, in the female group there were independent effects of both birth 
weight and diet in the percentage of adiposity measured by MRS. HBWf 
mice had the highest adiposity when compared to LBWf mice. At the same 
time, HF fed females had the highest adiposity when compared to NF fed 
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females. This is in accordance with the higher energy intake observed in 
these mice, and the higher efficiency in LBWf-HF mice only. However, when 
looking at adipose tissue distribution, there was an effect of diet only, as it 
was in the percentage of fat measured by MRS. This result suggests that 
LBWf mice had similar total fat and adipose tissue distribution as the HBWf 
mice, despite the fact of having a lower weight at 15 weeks of age, which 
could explain the lack of differences in energy intake and feed efficiency by 
birth weight. As MRS takes into account the whole body adiposity rather that 
total fat as the sum of IAT and SAT, the results suggested that HBWf mice 
might have higher lipid content in other areas (ectopic deposition), apart from 
these fat depots. However, the IHCL was higher in LBWf mice and females 
fed a HF diet. Therefore, the ectopic deposition should take place in other 
organs, but this assumption was unfortunately not assessed in this study. 
The IAT to SAT ratio was not different between groups, which indicated a 
comparable proportion of these compartmental adipose tissues between 
groups. As in males, there is much controversy as to the association 
between birth weight and fat deposition in females (Fall, Osmond et al. 1995, 
Martyn, Hales et al. 1998, Yarbrough, Barrett-Connor et al. 1998, Parsons, 
Power et al. 2001, Ros, Lichtenstein et al. 2001, Kuh, Bassey et al. 2002, 
Kuh, Hardy et al. 2002, Loos, Beunen et al. 2002). Studies in middle aged or 
elderly subjects have also demonstrated a contradictory role for birth weight 
on fat deposition. The majority of the studies have shown a negative 
relationship between birth weight and different surrogates of fat measured in 
both genders, others found no association (Martyn, Hales et al. 1998, 
Yarbrough, Barrett-Connor et al. 1998), a positive relationship (Vestbo, 
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Damsgaard et al. 1996), or a J-U association (Schellong, Schulz et al. 2012).  
 
In study 3, (from week 16 to week 51 of age), it was not possible to measure 
adiposity by MRS or MRI for technical reasons. However, an evaluation of an 
adipose tissue index was performed, using dissected fat depots. Matured 
mice (week 51 of age) were mainly affected by the diet rather than for 
differences, in birth weight in both male and females. As mentioned in 
section 6.2.1, male mice fed a HF diet gain more weight and this weight gain 
was mainly related to a higher FE rather than hyperphagia. It could be 
speculated that the body weight gained at this age was related to their higher 
fat deposition, which at the same time was associated with a higher 
efficiency of weight gain per kilocalorie consumed. Furthermore, these mice 
had a higher SAT and IAT (as the sum of retroperitoneal, mesenteric and 
gonadal fat tissue). Although mice fed a HF diet did not have significant 
differences in total fat, it was observed that LBWm-HF mice tended to have 
a higher total fat content. Furthermore, they had a significantly higher SAT 
than HBWm-HF mice and tended to have higher levels of gonadal fat. This 
indicated that fat distribution was differently modulated between mice fed a 
HF diet.  
 
In females, there was also a different pattern of distribution in the IAT tissue; 
there was no difference between HBWf mice in the gonadal fat pads, but 
there was in LBWf mice. Furthermore, LBWf-HF mice had a higher gonadal 
fat than HBWf-HF mice. However, the latter had a higher retroperitoneal fat 
than the former.  
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6.3 Glucose Tolerance and Metabolic Hormones 
Previous studies have shown that low birth weight animals that underwent 
undernutrition in the perinatal period, presented a higher glucose tolerance 
than those that catch up in weight with control animals or than control 
animals, and those that catch up after and appropriate postnatal nutrition had 
similar levels of glucose and insulin as control animals (Shepherd, Crowther 
et al. 1997, Chen, Martin-Gronert et al. 2009). Other studies conducted in 
infants have shown similar glucose levels between infants with a low birth 
weight and high birth weight but higher whole body, muscle and hepatic 
insulin sensitivities in the latter group (Bouhours-Nouet, Dufresne et al. 
2008).  
 
In this study, LBWm mice had a lower glucose than HBWm mice and higher 
in LBWf than their counterparts. The levels of insulin were slightly higher 
than HBWm mice but not significantly whereas in LBWf mice it was 
significantly higher. LBWm mice seemed to have higher levels of insulin for 
the amount of glucose in periphery, and this could be a sign of early 
hyperinsulinemia. LBWf mice had higher levels of insulin and higher levels of 
glucose than HBWf mice, which could be an indication of lack of insulin 
sensitivity.  As c-peptide levels were not different between males groups, it 
could be excluded the possibility of a higher secretion in small males. 
However, c-peptide was much higher in LBWf mice, indicating a 
hypersecretion of insulin in respect to HBWf mice. The presence of higher 
levels of insulin might be linked to other processes such as insulin resistance 
in certain organs and redistribution of glucose to others (Summermatter, 
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Marcelino et al. 2009). As previously demonstrated, liver growth was 
impaired in LBWm mice, and therefore this could be a sign of a lower insulin-
growth dependent signaling, and thus, be partially involved in the small 
increase of insulin in periphery. Moreover, muscle growth was also blunted. 
However, brain growth was spared, which indicated that the glucose might 
be redirected to this organ mainly. In the case of the LBWf mice, there was 
not an asymmetrical growth of organs relative to their weights, although they 
tended to have a spared brain growth. 
 
Evidence is available that suggests that the state of hyperinsulinemia or 
higher insulin to glucose ratio during catch up growth is an early event that 
has been attributed to a reduction in thermogenesis per se rather than 
hyperphagia, excess fat mass or elevated free fatty acids in circulation 
(Crescenzo, Samec et al. 2003). This is in accordance with the results of fat 
content from LBWm mice, which did not exceed that in HBWm mice. 
However in the females groups, LBWf did exceed the fat content of the 
HBWf mice. Other insulin related hormones were also investigated. While 
glucose is the most potent stimulus of insulin release, other factors stimulate 
insulin secretion, such as GIP and GLP-1 (Holst 1994, Drucker 2001). These 
hormones are released from the gut following a meal. In this study, GIP was 
measured and its levels were higher in LBWm/f mice than HBWm/f mice, 
which implies a higher stimulation of insulin release. Higher GIP levels then 
could indicate that beta cells had to be highly stimulated in order to secrete 
similar levels of insulin in the circulation in LBWm and higher levels in LBWf.  
In previous studies it has been shown that higher levels of insulin during 
	   468	  
catch up seems to reside in a beta cell hyperresponsiveness, and this has 
not been explained by intra cellular alterations in secretion per se nor in the 
exocytosis mechanisms (Casimir, de Andrade et al. 2011). Instead, this has 
been attributed to a contribution of neural hormonal effectors such as GLP-1 
and GIP (Casimir, de Andrade et al. 2011) as could be linked in the present 
study.  
 
Previous investigations have reported an increase in glucose intolerance with 
overweight/obesity, introduction of a HF diet (Winzell and Ahren 2004), and 
high internal or hepatic fat (Gabriely, Ma et al. 2002, Fabbrini, Magkos et al. 
2009). Different responses to a HF diet have been observed within same 
strains such as a lean but diabetic phenotype or normal/higher glucose 
sensitivity when combined with a low protein diet during lactation (Burcelin, 
Crivelli et al. 2002, Ozanne, Lewis et al. 2004).  
 
In study 2 (from week 3 until week 15 of age), as aforementioned, LBWm 
mice had a higher level of IAT:SAT ratio as well as IHCL content, 
independently of the diet. This seemed to be in accordance with the impaired 
glucose they manifested (in a fed state). Moreover, it was also observed that 
a HF feeding induced a higher IAT:SAT independently of birth weight, which 
might be associated with the fact that these mice presented an impaired 
fasting glucose. Interestingly, LBWm-NF mice had also impaired fasting 
glucose when compared to HBWm-NF mice but it was not the case between 
mice fed a HF diet. Additionally, the same groups that had impaired fasting 
glucose presented a higher total adiposity, SAT and IAT when compared to 
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their respective counterparts. The AUC added also evidence of a relationship 
between glucose tolerance and internal adiposity.  
 
However, as mice matured (study 3), levels of glucose seemed to stabilise 
decreased and were comparable between groups. It has been shown that 
glucose levels in non-obese C57BL/6 mice decreased between the 3-12 
months of age and then rises again after 24-month of age with an increase in 
islet size and pancreatic insulin content at the age of 21-24 months (Leiter, 
Premdas et al. 1988). However, in this study, levels of glucose were 
generally lower in all mice obese and non-obese. Despite this, HF fed mice 
did tend to have higher levels of glucose, with HBWm-HF having a marginal 
significance against HBWm-NF mice.  
 
Previous studies have indicated a higher susceptibility to develop impaired 
glucose metabolism and diabetes in mammals with a low birth weight that 
catch up growth (Hales, Barker et al. 1991, Hales and Barker 2001, Dulloo, 
Jacquet et al. 2006). Dulloo’s studies also showed that mice presenting 
weight recovery after weight loss or early growth restriction, showed 
hyperinsulinemia with skeletal muscle insulin resistance accompanied by 
adipose tissue insulin sensitivity. The biological significance of this thrifty 
metabolism seems to be an adaptive response in order to achieve both 
blood glucose homeostasis and replenishment of fat stores. A maladaptive 
response in the presence of an energy dense diet, will lead to a pronounced 
state of hyperinsulinemia, hyperglycemia and excess fat deposition (Dulloo 
and Girardier 1990, Dulloo 2006, Summermatter, Marcelino et al. 2009). 
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In young mice (study 2), mice fed a HF diet were hyperinsulinemic, 
deposited higher fat mass (grams) and tended to have higher levels of 
glucose (fed state) when compared to mice fed a NF diet. Higher levels of 
insulin were needed in HF fed mice in order to decrease glucose levels in 
circulation; however, the LBWm-HF mice seemed to have less sensitivity to 
the effect of insulin as the levels of glucose were higher than in HBWm-HF 
mice. There was no difference between plasma insulin concentrations in 
mice fed a NF diet, despite the fact that LBWm-NF mice had higher levels of 
glucose; this may indicate that the levels of insulin secreted were not enough 
to decrease glucose levels, which could be attributed to paracrine 
mechanisms such as glucagon secretion (Cryer 1981, Dinneen, Alzaid et al. 
1995). In fact in this study, the levels of glucagon were higher in this group 
than in other groups, and therefore impairment in the glucagon response 
might increase the levels of hepatic glucose production and subsequently 
help to increase the levels of glucose in periphery and decrease the levels of 
insulin (Cryer 1981, Baron, Schaeffer et al. 1987). 
 
However in older mice (study 3), levels of insulin were generally increased in 
HF fed mice but it was only significantly higher in HBWm-HF mice in respect 
to their respective counterparts. Moreover, it was noticed that despite the fact 
that mice fed a HF diet had similar levels of total fat, IAT and internal to 
subcutaneous ratio, the levels of SAT were reduced in HBWm-HF mice, 
which could caused the reduction of the effect of birth weight at this age. 
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As the difference in total fat, IAT and SAT between LBWm mice was more 
accentuated than in a young age, it would be expected to have an 
exacerbated impairment of insulin response in these mice. However, a 
similar response was seen as in young mice in glucose and insulin 
concentration. Also, it should not be excluded the possibility of a pronounced 
impairment of glucose tolerance or impaired fasting glucose in these mice, 
which could not be assessed in this study. It should be also notice that the 
sample size was smaller at this time and thus differences are more difficult to 
be identified. In general, these results suggest that glucose metabolism was 
not affected by fat mass. 
 
Young females (study 2) did have a different metabolic profile than males in 
general. Fasting glucose was not different between groups. However, LBWf-
HF mice had impaired glucose tolerance as demonstrated by the IPGTT and 
AUC, when compared to their counterparts. Moreover, as in males, fed HF 
females had higher levels of insulin than females fed a NF diet. IHCL levels 
seemed to be related to the glucose impairment seen in this group of mice.  
 
Matured females (study 3), as in males, did have lower levels of glucose and 
insulin than younger females. However, by this age, differences in glucose 
were evident. In general, LBWf-NF mice had higher levels of glucose than 
HBWf-NF mice and also in HBWf-HF mice when compared to those fed a 
NF diet. However, there were not differences in the levels of insulin, although 
tended to be lower in LBWf-NF mice than in other groups. As insulin levels 
failed to increase as a compensatory response to decrease the glucose 
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concentration in plasma, it raises the possibility of an altered response in the 
secretory/inhibitory mechanisms. Unexpectedly, glucagon levels were 
significantly higher in LBWf-NF mice when compared to HBWf-NF mice, 
which could explain the lower levels of insulin and the higher levels of 
glucose as the result of an impaired response of glucagon in this group 
(Cryer 1981, Baron, Schaeffer et al. 1987, Dinneen, Alzaid et al. 1995). 
Moreover, HBWf-HF also had a higher glucagon levels than HBWf-NF mice 
in the presence of higher glucose levels in the former group with no changes 
in insulin secretion (c-peptide) or insulin level.  
 
Overall, the results in young mice suggested that an increase in total 
adiposity, internal or IHCL might be linked with an altered glucose 
metabolism in a fed-fasting dependent manner, whilst the relationship 
between these factors and glucose metabolism are modulated by an 
interaction between diet, birth weight and other factors than by changes in fat 
mass per se.  
 
It is known that the central effects of leptin include reduction of food intake 
and body weight gain and increased energy expenditure (Seeley, van Dijk et 
al. 1996, Mistry, Swick et al. 1997); but also it has been described a trophic 
factor in early life (Bouret, Draper et al. 2004, Bouret and Simerly 2004). 
Leptin levels decrease upon negative balance in both humans and adult 
mice (Maffei, Halaas et al. 1995). Neonatal mice need to maximise food 
intake and maintain a high thermoregulatory response to optimise survival, 
and therefore levels of leptin are high in neonates. This suggests that leptin 
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may function differently in neonates and adults. Here, it was shown that the 
levels of leptin tended to be higher in LBWm mice but it was similar between 
females and did not correspond to the levels of fat deposition in these mice 
as shown in previous studies.  
 
Although the relationship between leptin and obesity is well established, 
controversy over the alterations in resistin concentration in response to 
obesity still exists; in humans for example, it has been associated to 
inflammation rather than obesity (Burcelin 2008, Gharibeh, Al Tawallbeh et 
al. 2010, Schwartz and Lazar 2011). In the present study, the levels of leptin 
were more robust and in accordance with previous studies. Leptin and 
resistin changed according to total fat in young males and leptin changed 
according to whole body adiposity in young females. In older male mice, 
levels of leptin changed in accordance to fat mass but resistin was not when 
comparing HBWm mice.  Leptin levels in matured females were related to fat 
mass when comparing mice fed a NF vs. HF diet; unexpectedly, leptin levels 
in LBWf-NF were higher despite having similar levels of fat mass with HBWf-
NF mice. This might indicate that higher levels are needed in order to 
maintained the body weight, lower feed efficiency and/or similar energy 
intake in the former group. 
 
Proinflammatory adipokines in circulation are usually connected to a low-
grade chronic inflammation when developing obesity and/or insulin 
resistance (Yu and Ginsberg 2005). According to this, at weaning (study 1) 
levels of the proinflammatory cytokines IL-6, MCP-1 and TNF-alpha seemed 
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to be linked to the insulin resistance state of LBWf mice. However, LBWm 
had only a higher MCP-1 levels, suggesting a different role of MCP-1. MCP-1 
plays vital roles in immune response, angiogenesis and pregnancy outcome. 
Increased MCP-1 concentration in intrauterine growth restricted neonates 
during postnatal life may be attributed to gradual initiation of angiogenesis 
supporting the initiation of accelerated growth (Briana, Boutsikou et al. 2007). 
 
IL-6 seems to correlate positively with fat mass and insulin resistance and 
increase adipocyte lipolysis (Yu and Ginsberg 2005). In young adults (study 
2) and older mice (study3), IL-6 and MCP-1 did not correlate with fat mass 
or insulin resistance in both males and females.  
 
Ghrelin, a peptide hormone is known to affect growth hormone secretion, 
appetite and energy balance. Its level in the circulation has been considered 
of prognostic value for catch up growth and it has been found to be elevated 
in growth restricted infants that accelerated their growth when compared to 
Appropriate for Gestational Age (AGA) and Large for Gestational Age (LGA) 
(Fidanci, Meral et al. 2010). Ghrelin concentration was not different between 
LBWm/f and HBWm/f mice at weaning (study 1), and therefore did not 
correlate with levels of adiposity at this early age as it has been observed in 
adults (Tschop, Weyer et al. 2001, Shiiya, Nakazato et al. 2002) or with 
differences in weight gain. Perhaps, similar levels were enough for LBWm/f 
to accelerate their growth without catching up in weight.  
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Consistently, fat masses were associated with a reduced concentration of 
ghrelin in plasma in male mice. The results in males in study 2 and study 3 
agreed with previous studies showing obesity reduces circulating ghrelin in 
periphery (Tschop, Weyer et al. 2001, Shiiya, Nakazato et al. 2002). 
Unexpectedly, ghrelin leves in matured LBWf-HF mice was similar to that of 
LBWf-NF despite the fact of having higher fat accumulation.  
 
6.4 Adipocyte Size Distribution in Subcutaneous Adipose 
Tissue  
Models of accelerated growth that mimic fat mass accretion, after weight loss 
or growth restriction, have shown that the compensatory enhanced capacity 
of glucose uptake in WAT is associated with adipose tissue hyperplasia and 
controlled hypertrophic growth, with a maintained small adipose size in 
respect to the control animals (Cettour-Rose, Samec et al. 2005, 
Summermatter, Marcelino et al. 2009). Others, have found an increased in 
adipose size without hyperplasia as early as 3 weeks of age in murine 
models of growth restriction followed by accelerated growth as well as in diet 
induced obesity in humans (Desai, Guang et al. 2008). 
 
 In young mice (study 2), subcutaneous and gonadal adipocyte number was 
not different between groups when compared per gram of fat mass; however, 
when comparing cell number per fat depot, significant differences appeared 
only between HBWm mice in both fat depots and between mice fed a HF 
diet in SAT.  As mice aged (study 3), differences in adipocyte number were 
seen. Mice that were fed a HF diet had a lower number of adipocytes per 
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gram of gonadal fat, but there were not differences when assessing cell 
number per fat depot, although there was a trend towards a high number in 
the same HF fed mice in gonadal tissue. In SAT a similar pattern was seen 
between LBWm mice in the adipocyte number per gram of tissue, but it was 
significantly higher in LBWm-HF mice when compared to LBWm-NF and 
HBWm-HF mice when assessing adipocytes per fat depot.  
 
Further assessment of adipocyte size distribution indicated that there were 
not significant differences between young LBWm mice in both fat depots, 
although mice fed a HF tended to have a higher number of small adipocytes 
in SAT but larger adipocytes in gonadal fat tissue. These results indicated 
that fat mass accretion in LBWm-HF mice had a similar adipocyte size 
distribution, as LBWm-NF and therefore it was not greatly affected by the 
introduction of a HF diet at this young age. It would be expected to have an 
amplified response in these early growth restricted mice after the introduction 
of an energy dense diet. It could be speculated that the time of exposure was 
not sufficiently long to show significant changes in adipocyte size distribution 
or that the concomitant hyperplasia and moderate hypertrophy channeled 
part of the lipid pool in newly formed adipocytes and matured adipocytes in a 
proportionate manner (Summermatter, Marcelino et al. 2009).  In contrast, 
HBWm-HF mice had a different adipocyte distribution than those fed a NF 
diet. The peak diameter of the large adipocytes in the former group was 
shifted to the right, which indicated that the mean diameter of large 
adipocytes was higher in this group compared to mice fed a NF diet, with no 
differences in small adipocytes. Matured mice fed a HF had a similar 
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response; in gonadal adipose tissue LBWm-HF and HBWm-HF had a higher 
ratio of small to large adipocytes compared to their counterparts, and also 
the peak diameter of large adipocytes was shifted to the right indicating there 
was a concomitant increase in both small and the mean size of large cells. 
However in SAT there was a shift to the right in the diameter of large 
adipocytes but it was not accompanied by an increase in small adipocytes.  
 
Despite the fact that young LBWm mice had similar adipocyte size 
distribution and similar adipocyte number in both SAT and gonadal fat tissue, 
LBWm-HF mice presented hyperinsulinemia, impaired fasting glucose and 
were glucose intolerant compared to LBWm-NF mice, as HBWm-HF 
compared to HBWm-NF mice. However, it was noticed that the levels of 
leptin and resistin were higher in HBWm-HF than HBWm-NF but it was 
similar between LBWm mice. This could indicate that the degree of leptin 
resistance is related to an increase in the peak diameter of large adipocytes 
independently of insulin resistance and glucose intolerance status. By week 
51 of age (study 3), levels of leptin were similarly higher in mice fed a HF 
diet in respect to their counterparts indicating that LBWm mice became 
leptin resistant at a much later stage than HBWm mice. 
 
Birth weight seemed to have an effect on SAT and gonadal adipocyte size 
distribution; young LBWm-NF mice had a slight deviation to the right in the 
SAT, which could be an indication of the initiation of lipid flow going towards 
mature adipocytes. Moreover, HBWm-HF mice were shifted to the right 
compared to LBWm-HF mice. By 51 weeks of age, there were not apparent 
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differences between mice fed a NF diet or HF fed mice. 
 
In gonadal fat tissue, young LBWm mice (study 2) had a higher number of 
small cells and this pattern was maintained in matured LBWm-HF mice only.  
At the same time, the peak diameter of the large adipocytes was shifted 
slightly to the right in young LBWm-NF, as in the SAT tissue but differences 
were not apparent at matured age. Young HBWm-HF mice were again 
shifted to the right instead of LBWm-HF mice. These results suggested than 
young LBWm-HF mice did not have hypertrophic adipocytes in either SAT or 
gonadal fat tissue in respect to young HBWm-HF mice, which could indicate 
that there was still an ongoing dynamic process of catch up fat involving a 
sustained hypersinsulinemia, increased lipogenesis, hyperplastic growth with 
delay hypertrophy (Summermatter, Marcelino et al. 2009). If a reduced 
increment of size with no changes in adipogenesis but maintained 
lipogenesis is present, this could indicate an inability to store excess energy 
by increasing the size of matured adipocytes and/or by increasing the 
production of fully differentiated and functionally capable adipocytes 
(McLaughlin, Sherman et al. 2007). In the case of an increase in storage 
demand, the inability of the fat depot to mature a new group of adipocytes 
due to an impaired differentiation, would lead to the storage of lipids in non-
adipose tissue (ectopic deposition) (Savage, Petersen et al. 2005). In this 
study it was shown that LBWm mice had a higher IAT:SAT ratio than HBWm 
mice independently of the diet given. This inability if accompanied with a 
possible reduction in the expression of genes related to adipogenesis could 
confirm that the excess of small cells is not due to proliferation but rather to 
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dysfunctional differentiated adipocytes (McLaughlin, Sherman et al. 2007).  
However, adipogenic gene expression could not be assessed in study 2 and 
study 3. By week 51 of age (study 3), mice fed a HF diet had similar mean 
size of large cells, but LBWm-HF mice had again a higher number of small 
cells in gonadal fat but not in SAT.  
 
6.5 Gene Expression in Subcutaneous Adipose Tissue 
Expression of genes involved in insulin signaling, adipogenesis, lipid 
metabolism (lipogenesis-lipolysis) and thermoregulation were increased in 
LBWm mice in respect to HBWm mice at weaning (study 1). However, there 
was a reduction in expression of genes involved in the same pathways in 
LBWf when compared to HBWf mice suggesting a gender dependent 
modulation of these mechanisms.  
 
Previous studies have shown that growth restricted offspring undergoing 
accelerated growth, exhibited an upregulation in the expression of 
adipogenic and lipogenic related genes (Summermatter, Marcelino et al. 
2009) with an apparent adipose cell hyperplasia without alteration in the IRS-
1/PIK3/Akt activation. However, Isganaitis’s studies (Isganaitis, Jimenez-
Chillaron et al. 2009) have shown that genes controlling the flux of glucose 
towards lipogenesis were upregulated (i.e., FAS, LPL, SREBP1c), whereas 
the expression of genes related to adipocyte differentiation /proliferation 
(PPARg2, CEBP1a) and thermogenesis were unaltered. Isganaitis results 
were consistent with the marked hypertrophy without hyperplasia seen at the 
end of catch up which is more likely to predispose to reduce insulin 
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sensitivity in adipose tissue (Dulloo 2009). These findings are in line with a 
thrifty hypertrophic catch up fat with impaired adipogenic response (Dulloo 
2009). The paradoxical results in these studies could be associated with 
different murine models used (rat-mice).  
 
The present study seems to be consistent with the onset of a hyperplastic 
catch up fat. Summermattter and colleagues measured insulin signaling 
activity but he did not assessed mRNA expression, and therefore it can not 
be excluded the possibility of an upregulation in the expression of these 
insulin related genes (Summermatter, Marcelino et al. 2009). The only gene 
expression he assessed was for the gene GLUT4 and this was upregulated 
as in the present study.  
 
Expression of genes related to thermogenesis and lipolysis (PGC1a, UCP1, 
HSL, beta 3 adrenergic receptor) were also upregulated in LBWm mice. This 
suggested that the lipid turnover (lipogenesis-lipolysis) on these mice was 
increased as well as energy dissipation in the form of heat contributing to the 
recycling of fatty acids into SAT and/or production of heat for 
thermoregulation and therefore reducing the accumulation of fatty acids in 
circulation and redirection to other tissues. These changes seemed to be 
independent of fat mass.  
 
The reduced SAT insulin signaling in LBWf mice might be a reflection of an 
early impairment of insulin action in adipose tissue increasing the risk of lipid 
storage in other fat depots as seen in study 1(section 3.6.2), and perhaps in 
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other organs not studied. Models of maternal low protein diet in murine 
models have associated low birth weigh in females with hyperinsulinemia, in 
the absence of glucose intolerance, and reduced expression of insulin 
signaling proteins at 21 months but not at early ages in epidydimal fat and 
muscle (Hales, Desai et al. 1996, Sugden and Holness 2002). It should be 
noted that the models in these studies differed from the present study; the 
maternal nutrition was not altered at any time point, and the differences in 
body weight at birth and early postnatal age were the result of a natural 
perinatal growth in an isogenic mice. In this study LBWf mice were 
hyperinsulemic and hyperglycemic suggesting a degree of insulin resistance 
at young age independently of fat mass as in males.  
 
As young LBWf mice (study 2) continued being smaller than HBWf mice but 
had similar levels of SAT, the results obtained at young age could indicate 
that there was a delay in catch-up fat at weaning, but it was not a permanent 
response. As thermogenesis and lipid turnover were also downregulated, it 
seemed that these mice have a reduced metabolism suggesting that energy 
demands at this age were higher than energy supply.  
 
6.6 Hypothalamic Activity in Young Mice (study 2) 
The hypothalamus is well recognised for its pivotal role in regulation of food 
intake and energy homeostasis (Remmers and Delemarre-van de Waal 
2011). Appetite regulation involves different signals coming from the 
periphery and from the central nervous system (Elmquist, Coppari et al. 
2005, Chaudhri, Field et al. 2008). Food intake and energy expenditure are 
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the components of energy balance and both of them are in perfect 
equilibrium in such a way that body weight is maintained within a specific set 
point (Sternson, Shepherd et al. 2005). The hypothalamus contains different 
nuclei that are interconnected among them and therefore they can act under 
the influence of some of them and/or by themselves, which makes more 
complex the relationship between hypothalamic activity and energy 
regulation.  
  
In the current study, functional MEMRI was used to assess neural activity in 
specific appetite related nuclei within the hypothalamus. Previous studies 
from our group have demonstrated the use of this technique in evaluating the 
hypothalamic response to fed/fasted states, as well as the effect of gut 
peptides injected peripherally on hypothalamic activity (Kuo, Herlihy et al. 
2005, Kuo, Herlihy et al. 2006, Parkinson, Chaudhri et al. 2009, Parkinson, 
Chaudhri et al. 2009).  
 
There was not a clear pattern of an effect of birth weight per se but it seemed 
that both diet and birth weight interacted in a way that different responses 
were seen in mice fed a HF and NF diet depending on the birth weight.  
 
There was an upregulation in HBWm mice fed a HF diet (HBWm-HF) when 
compared to HBWm fed a NF diet in the PVN and VMH nuclei but not in the 
ARC or Pe nuclei, although a similar trend was observed. Moreover, when 
the former group was compared to its counterpart that was fed the same diet 
(LBWm-HF), it exhibited a constant upregulation in all the nuclei.  
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In contrast, a different response to HF diet was seen in LBWm-HF when 
compared to LBWm-NF mice. There was a reduced activity in the former in 
all nuclei.  Furthermore, LBWm-NF mice had a higher activity than HBWm-
NF mice in the PVN and VMH nuclei.  
 
As aforementioned, previous studies have correlated a fasted state with an 
enhanced SI (activity) in the ARC, PVN and VMH nuclei (Kuo, Herlihy et al. 
2006). If fasting, in the context of a reduced satiation state, increases neural 
activity, then an increase in cumulative caloric intake could imply a similar 
pattern as a fasted state. In study 2, where neural activity was evaluated, 
HBWm-HF had a higher total kilocaloric intake than both HBWm-NF and 
LBWm-HF mice suggesting that these mice had a lower level of satiation. If 
the levels of satiation are reduced in this group of mice, the high activation in 
the hypothalamus could indicate an activation of orexigenic rather than 
anorexigenic neuropeptides (Lin and Huang 1999).  
 
LBWm-NF had a higher kilocaloric intake than both HBWm-NF and LBWm-
HF but differences did not reach significance. However, the pattern seemed 
to be partially in accordance with the neural activity within the hypothalamus. 
PVN and VMH were the only nuclei with a significant difference between the 
former group and HBWm-NF mice. However, the pattern of ARC and Pe 
activity was similar. As ARC nucleus has an incomplete blood brain barrier 
(BBB), it allows the entrance of signals from periphery (Peruzzo, Pastor et al. 
2000). Therefore, the lack of differences between groups could suggest that 
the changes seen in others nuclei are the result of a feedback between 
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signaling coming from brain stem, nuclei cross talk or central signaling and 
not from the ARC nucleus. It should not be excluded that different signals 
coming to the ARC with different effect could polarise the gross change in 
activity (Parkinson, Chaudhri et al. 2009). 
 
Ablation of the VMH has been linked to reduce sympathetic activity, which 
increases weight gain and fat accumulation in the absence of hyperphagia, 
and therefore increases the chances of developing obesity (Ruffin and 
Nicolaidis 1999). LBWm-HF tended to have a lower intake of energy than 
LBWm-NF but had an increase feed efficiency which means that they gained 
more weight per kilocalorie consumed with a proportional increase in total fat 
mass. Consequently, this group of mice had a lower activity in the VMH 
nucleus than LBWm-NF mice suggesting an association with a higher feed 
efficiency not only with this group but also against HBWm-HF mice. This 
increase in efficiency might be related to, at least in part, the vagus nerve 
and/or reduce activity of the sympathetic nervous system (Ruffin and 
Nicolaidis 1999).  
 
It should be noted that whilst MEMRI generates quantitative measure of a 
stimulus, it cannot discriminate between different neural populations within 
the same nuclei and therefore, alterations in SI indicate gross changes of 
stimulatory and inhibitory signals. To be able to distinguish the specific 
neuropeptides/receptors activated or inhibited, it would be necessary to use 
in vitro techniques such as co-labeling with c-fos. However, expression of c-
fos might be induced by diverse stimuli other than neural activation, such as 
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growth factors, neural differentiation and apoptosis. Also, as in MEMRI, the 
absence of c-fos activity does not imply the absence of changes in activation, 
which makes more complex the interpretation (Yamamori 1991, Yu, Chen et 
al. 1994, Roca, Shin et al. 2004, Parkinson, Chaudhri et al. 2009). 
 
Neural activity in females was more complex and different to males. Overall 
LBWf-HF mice had a higher neural activity in all the nuclei when compared 
to LBWf-NF mice. However differences between females fed a HF diet were 
not apparent (LBWf-HF and HBWf-HF) as between HBWf mice (HBWf-
NF/HF). However, HBWf-NF had a higher activity in the ARC and PVN 
nuclei than LBWf-NF mice only. In this case, there were not differences in 
kilocaloric intake. Therefore, different activation could indicate other changes 
rather than appetite regulation per se and further investigation should be 
carry out in order to clarify what other regulatory responses could be 
associated with the activity seen in both females and males.  
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6.7 Conclusion  	  
In this study, I investigated the impact of birth weight and nutritional 
challenge on different phenotypic traits as well as hypothalamic neural 
activity in a murine model at different ages.  
 
The results suggest that extreme birth weights within a normal range in an 
isogenic mouse model, as well as postnatal nutrition, influenced growth, 
glucose and lipid metabolism, body fat patterning and appetite regulation in 
an age-gender dependent manner.  
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6.8 Limitations of the Study  
The present study has several limitations. The study only included extreme 
birth weights, low and high birth weights, from a normal birth weight range 
excluding mice with an intermediate birth weight. It is assumed that 
intermediate values would be expected for all the measurements but this fact 
is only speculative and it should be carried out across all birth weights 
categories in further studies.  
 
Segmentation analysis following MRI was performed for the quantification of 
adipose tissue mass but lean mass was not measured; therefore, this only 
gives partial information of the body composition. However, images were 
stored and this quantification could be carried out in the future from the same 
images. Furthermore, although lean and fat mass can be quantified with MRI 
techniques, bone mineral density cannot be. Therefore, it would still give 
limited information of the body composition in vivo.  
 
Separate groups of animals were used for MEMRI, biochemical analysis and 
IPGTT, in order to reduce the levels of stress. It is possible that neural 
changes observed in some animals may not be always reflected in the 
biochemical phenotypes or with glucose tolerance directly. However, it can 
be expected that there exist similarities within the groups at least in part, 
similarities within the groups as an inbred strain was used throughout this 
study. Thus, the reduced genetic variation might help to overcome potential 
individual variations to a certain extent.  
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As MEMRI is a functional technique that gives an overall picture of the 
possible alterations in hypothalamic neural activation, it does not give 
information of the particular subset of neural populations activated. Thus, 
other techniques with better spatial/temporal resolution may be needed to 
identify the underlying cellular components responsible for the in vivo MEMRI 
images. However, the temporal effects seen with MEMRI cannot be 
duplicated by in vitro techniques, which in turn could complicate the 
interpretation of the results.   
 
Gene expression in SAT was carried out to evaluate transcriptional changes. 
However, the changes seen at this level do not imply changes at the 
posttranscriptional level or in activity. Therefore, protein expression in 
conjunction with activity assessment should be evaluated in further studies.  
 
In study 3, the number of animals per group was low and therefore, the lack 
of changes can be related to the sample size introducing false negatives in 
the interpretation. Furthermore for technical reasons adipose tissue 
distribution could not be assessed using MRI and could not be associated 
with changes at younger age. However, fat pad mass collected at the end of 
the study can give an adipose index relatively similar to that using MRI, 
although differences can be present as not all the regions quantified by MRI 
were taken into account in the calculation of adipose index. Changes in 
hepatic lipid at matured age could not be assessed for the same technical 
reason and thus, could not be correlated with other changes at this age and 
earlier stages.   
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6.9 Future Work 
Having observed changes in fat mass and hepatic lipid content at early ages, 
the next step would be to investigate what molecular changes took place. 
However, similar changes between groups do not necessary imply the 
absence of changes at the molecular level and therefore would be interesting 
to assess if there were underlying changes at the molecular levels even in 
the absence of phenotypic changes.  
 
I would also like to investigate gene and protein expression as well as activity 
of certain enzymes in different tissues such as SAT, IAT, and liver. I 
evaluated gene expression in SAT at weaning, but I would like to extent the 
assessment to gonadal and retroperitoneal fat and not only for gene 
expression but to the aforementioned investigation. I would like to carry on 
evaluating adipogenesis, lipid metabolism and thermoregulation 
mechanisms. 
 
IPGTT was carried out at 15 weeks of age, but unfortunately changes in 
insulin levels during the IPGTT could not be measured. It would be 
interesting to see whether changes insulin could occur as an effect of birth 
weight and diet at this same age as well as at weaning and 51 weeks of age. 
It would also bring more information about the state of insulin sensitivity 
between the groups in the absence or presence of hyperglycemia.  
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As mentioned previously, changes in neuropeptides and receptors involved 
in appetite regulation and energy balance should be carried out to identify 
the possible pathway that was implicated in the changes of neural activity 
within the hypothalamic nuclei. For example, co-labelling of neuropeptides 
such as NPY/AgRP and POMC/CART and receptors such as MC3R/MC4R 
with c-fos could help to discriminate whether an orexigenic or anorexigenic 
response (respectively) is associated with changes in neural activity (c-fos).  
 
Recent studies have shown that epigenetic modifications might have an 
important role in altering gene expression. Changes in methylation and 
histone modification in response to early life programming and HF feeding 
have been identified (Park, Stoffers et al. 2008, Sandovici, Smith et al. 2011, 
Sandovici, Hammerle et al. 2013). It would be interesting to evaluate the role 
of epigenetics in the early programming of glucose/lipid metabolism and fat 
patterning and to what extent the effect persists after introducing energy 
dense diet postnatally. 
 
As energy balance is due to an equilibrium between energy intake and 
energy expenditure, it would be important to assess production of heat, 
locomotor activity, and resting metabolic rate (energy expenditure) at 15 
weeks and 51 weeks of age. I would not expect to evaluate this in mice at 21 
days as it would involved too much stress for the young pups.  
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